<SEC-DOCUMENT>0001628280-23-013357.txt : 20230427
<SEC-HEADER>0001628280-23-013357.hdr.sgml : 20230427
<ACCEPTANCE-DATETIME>20230427072041
ACCESSION NUMBER:		0001628280-23-013357
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		89
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		23851863

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bax-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252,d:a96c30333efb48e3af554b764666aed6--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20230331" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bax-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N18yLTEtMS0xLTE0MjYyNA_009b9f5a-ac36-4d10-9fc6-de70f609ba50">false</ix:nonNumeric><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N18zLTEtMS0xLTE0MjYyNA_c0d4a575-3148-4421-823c-4d807580da54">2023</ix:nonNumeric><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N180LTEtMS0xLTE0MjYyNA_6f43ed4a-9293-43cb-850f-a2bd91c3ff00">Q1</ix:nonNumeric><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N181LTEtMS0xLTE0MjYyNA_92c3dd4b-0638-4f7e-8837-c2784f175d23">0000010456</ix:nonNumeric><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N182LTEtMS0xLTE0MjYyNA_d55f7047-d836-4772-84a2-480a3313b45f">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i5b4886e6fb2e496c92895c5e21b2ca46_D20230101-20230331" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5Nw_058c585b-8103-4c06-82dd-1458b96650eb">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i94cea0cc9a13461d932c6e9ca4283393_D20230101-20230331" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA4NQ_0ec20cf7-5fe4-4e5f-af12-88aff4a5d833">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i5610c9c40f1541588c111ed258e20b5b_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfNC0xLTEtMS0xNDI2MjQ_d6d893fc-8438-4923-a849-d968822074f7">3</ix:nonNumeric><ix:nonNumeric contextRef="ifb101e2dce6d4a8da899e7f908565f3f_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfOC0xLTEtMS0xNDI2MjQ_be44d27a-b5dc-44a9-a881-152d9306c990">1</ix:nonNumeric><ix:nonNumeric contextRef="i91e5bce880e748fa8fd4e3630bd445ad_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMTItMS0xLTEtMTQyNjI0_54ac5a69-e474-4299-8398-6e75810761e9">1</ix:nonNumeric><ix:nonNumeric contextRef="i61cf97becb9c4e1a9b859df1e52905f9_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMTYtMS0xLTEtMTQyNjI0_5caf3791-870c-486c-a5b1-c3adba882b54">1</ix:nonNumeric><ix:nonNumeric contextRef="ib69465f840b74ac28588c55cf8bf2541_I20230331" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMjAtMS0xLTEtMTQyNjI0_0da06f34-6c7f-47e2-988d-ed38182147ae"></ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bax-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1722827f9deb4a7c96da1d99bfa95a6a_I20230420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0940ea73b3b94072b07c67b32d418ff6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01ba7452daab4c4b92575193d9e5f92b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c666c1fd3384543a02c18e41beb10c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia504d0c0578e43abb57742fcbac04df9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fbb9d28165848e7b735c76a24f97442_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i569f70b56e6e4546a2b0440c1c1b4dd6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a604e834034d2e80798d244359c92e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086a01f241704bcaba8f2f58797f4896_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903a903783024d0c822c638260089e91_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c67e5be4a9c454b9d1c77df627b3423_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4edd866db741baa51307eb018f3d9f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68252ad5814845d2b86cdb16badea3ea_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe84036cbe4d4876bfc384531e6ff350_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd566d2dac84388a0dc10cf986cbde7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefe188762f1241fa87f6153d43d125bf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40418177dcd1484c97237105cd4eacb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594c4d36a82e4345a1148e4403700728_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adea57705bd4eb780aaa0eaaec735f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f43fae8a584013afd3637231c43053_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie465403042354662a73d63fe8476ff82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7990853ab5584403a5cbfd42f7d394b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff3416cbddea4d21a603a12d26373af8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63fca21e0f0c47a6803f298e2ba68799_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfa36d74d3d45f69917cc8c0e03163d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549981689c2d46afb3aab51cfc3c1fa2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c1210990e74a9b95fe24b71553ad83_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d202d13044e48c6b29936c91e8c157b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ecdb3fe5d0e4b8e827b13f44d1963b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4799c9ebd14c07b2231243699099b4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745ad501a79c44d6aec90e097e8047c9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0e5d98eeff04b8996adc2d0bb0ff481_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8aefd6cba0d4106847bb6b58cb837e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ac1583fbba246859aa51f7df3cee508_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74b8716ad88248e28c4c5356153e3a7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d5af7f312e4865be66979f792580ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b93924f957421ba38aa7f8e31ae06b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f07e528dbe484f982e220a41fa1577_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4cf6a305b9149389378aa6125813d6e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fa64dff379543ff9a0e870c10d36e3b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdd748bfd4df44c5b9b7a1d75b53c8cd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9122ce6ade864b9f939af3570b2a12d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ba1d1d1ab4a4b58bbc7c4edd43217e8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5b28bd50b747f58909a56b3ce1d3cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1ede9bd1eb4a41881ac35ef3560275_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9f83b89e384e909e618e9f0fc79b8c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18c60cecc4dd4674a79048e6dec4f65c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8750ae5d3034349b54eb62120194f7c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ea658ef4e8a4402a8e9549a454537cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9691d0cc94e2490085471645d739eab9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92dec25d7c34b37b1430e2c4a7835d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib369cfb36a82482b8db8a6063f7d16d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ebf6db10af94658bfb39f075c42d0ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie473cdb19c1847169b73a323e42bd39a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i8a56dbdd4ff14331a905150029de9251_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e14096fdd04423a5333d25f12d89a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2809f872c14e8ebe75278e58f5b315_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i5251aea994574c9583ba547d9a6bac1f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie998dbec09874c54aeb8ff608dc85931_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a129980c2e0429f900251c40212bfea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>bax:site</xbrli:measure></xbrli:unit><xbrli:context id="i83ac75103174457caa01d60ace762a52_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f5b61f71de4b578b8f219e50d9e242_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18ed76e0fa040a8aac24e70b8c0d1b2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bax:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="icb1e1e86edba409592faffa2c09656e7_I20120731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54acfe1b3c9e4d72a0d864d5c38acb28_I20161130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dcdbf9afbfe48f697caa407b52ea2a9_I20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b54d14b4714bb8909d97f501750950_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cda740eb170402f8aecbd918a7cb4dc_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a3e16bcba5455287abc55ac7a72c7b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f4bdbd9802f43e4b40fdb623ef4c6b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a1fa71e8d34f8f8b550e41ec2f74b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34a05a406da4126b9897e999764cf3b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddc00ddfcf9a4d538640cf78c5d1745c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614575b7558142db88b525cd20152c5e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1731323823d48a9ad85ad284c1026de_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e585fdb356847ee95bef768d6c8f6fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabbe53c3b4844245a71aa4170a3d6951_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe94c791c144fb3901d9ccada083e46_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i891fc74d6b294098b52b2dbacb9d8244_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4974271eca4848daac4ef6f3c0268466_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ba818d615df44fa9ab8dc663c356b0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc59f5aaa04945a290aa672855b1c1ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i573b5203abe64eee9fc6bd8d764b6765_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154a7b3c49ee48b38613d9dec8d98845_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc57a64dfa914805848eec366284d706_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b3a5ddf7f0b4ea8ad0c518d49a70509_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86fbdd6384f94375a9f88c4a431213fb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b60f9d6630f49ffa53859e738234d11_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibab71210a8c94981891c3847d80b517f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5d70874f80c482cb0e5b8513c4530c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2eb0cff5ab142898e3663ceebe5e867_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic023f2fc593e4fd29470ad3b703a07c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16554c4f2d744cd9a29f4b0265752f73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91aae7c820be40a39dc2a16e37f937df_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide752f889a824123acdfc488ef4c92da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c4b44d7aaf45f6a6e5c398103bc5cb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b2d8e97e8244178d692d6892f4a85a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5610c9c40f1541588c111ed258e20b5b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb101e2dce6d4a8da899e7f908565f3f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e5bce880e748fa8fd4e3630bd445ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61cf97becb9c4e1a9b859df1e52905f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib69465f840b74ac28588c55cf8bf2541_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if002ac6e967144bd96115173fc7cf29a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4886e6fb2e496c92895c5e21b2ca46_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95b5cb2f8e647f6a99def589a703561_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cea0cc9a13461d932c6e9ca4283393_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i934c0cc8c80045549e4782969e1e7b84_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6b196d8914241ada05ff36938bc292e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e73cac1b5c4796a4109810e816823d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabeea204152c4e01befa7939da13274f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieab095ac3325476aa40d27526c3ce9d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc44eeeb3fe4cf8a2fa2850b25dbd4f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830f0bf194924d0e87c143bb795d1c61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ec046897a2946cd93ab85a15ee56c94_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bd13a49b7d429e82c8bdf69b96e60b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30142c94438942e98469e05b1af863d8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3508ca5e5c14a48b24d540f5319e20b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51119038860e46bab77a4b1e87a97094_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23951dd4106e4790ac61468e0c4ec8df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341560a16fc74ca08d74ea499cbe59d7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib97450461ad646f683e7377c9387239a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieed79c5aca8f438cb35994e6accb8277_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32733260a4bf466da30a8f6e7a69dc20_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9352b2578b4ff8af90d6737f465636_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7dff2da3bb745e083dfc8efbc4a6a2d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ffe0a066678436faeb952bbc5692853_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50262bb8dfd6483883e178e4d08c0ce7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12de3de1a9974944bc8378eba2c65c03_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79bf91abd1634761a2195c7f9d8d118a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7a0d7a1030b4a098fc24e15ad2a801d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820a760c47924ab98c99c4b2a9096d78_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc6075f06dbd490298097b3ed5cd4821_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf1bbc48b59745a293d43e19e9033459_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac2f4acb21d4eda95086e8322451c06_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id093cc65fe2e41f685c58769f4731abe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1f8777b66c4f1abea702af4a4f50d8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ae97fbb983b4c339641d89166090167_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d21ce85e8b546008235897f9720292f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a674bd62d60412dae3e15bda3d6fd5d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18171446335341e6972e6ad0f0855341_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7450c4c4ea47f395399141fae391aa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32eccbe2241e419fbbbba27ba8251c58_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f4f3a644eb645e3b6ffb4f9285599fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326ca958c6174cbd9f53bd4911788519_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ffdd9abc5b147d1b6b3131424e764b8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48702d534ce34e3d895104c00a42f7b9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f8be4d668c436690b8ef4eaa3b1289_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37ecf3e2ffa240ab97ef06571c436317_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae75aad13a8b4f4a9d28f6c2a411306e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36331106af6b44069480b11afb1c4eb7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id70635d3e9e24de284e21b0565f0a12c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a994bb1351d426e972cb4ab45bf9e31_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if15645b93aa34aadb9ab25d167667aa4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e5c3586df22467d826986ca298658b2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifddaa3fea1ec401fb23364d3c78814ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a9ffd20fe44b3494b57e15f7d91ccb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a56542c97d47a0b0f0459e24442e08_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4237b6bc47b47e3be8d39761a9c6aa6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2481cb453dff4f67b82d44e30bd6d0fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cff1006b2cd4700a226e1343371d967_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f9f21fee0414681bd88793126bd2d5d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0865a1d47314456a3bf5d603919e3aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65045dd2524b4052a661a980309aee0e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a6dd9348044feb8a8e67e815565350_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58acde9af12d40e88ea03e411ef7469a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8bcd8e837bc4dc08f1912d660ad261c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2ec3cee867481bae76001f58c40302_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8332d3c37964860a2fa8f6c0f6e8183_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b5d26e5e396479bb46016c7624c2225_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c506923a318493ea4d9c20cbab2421a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f1768ac76934e2091b109112b486b74_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0ac9d56de7f4427a9059c8e448f30f0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54c320fa8384fc9acd727cd9b93cb52_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88faf063570c4244819342e4932cf151_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic892496e521b4b4180628d9710fcfde4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639893b243a5412089b13acbee4be7d8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5f7268c6da45c28b4cc8a8092641d4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3ca618644448a69e18c4788006dcfb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4c6783bfa6492680542b292f98ef46_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7bcb4770d143ccb5cf3653c8dbd7ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04066796b2e844dd9677b2763ae8e6ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie43580480246408d913ffd6f7571c3c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i700fd4a0950a4c45b9412d578fea8869_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i406d564a78fd4100975bf9f358114ad6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed76db4cef84a44b19a64f1d1833488_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50189ca1ce5346128884acb2fd951604_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i556f482c728a4e6abc7fcb69f24c8e79_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e11ed2205046a495eb41670b8242bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5191430d4c4fa5b3ea2beb1699b836_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f02dbb147d48a7be36808b0e938d20_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42fee9757d10432cb8ae120e6b418ddd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5a84bea14647598fb6658816f37588_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5848326be84436ade2b47357ffcccf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38f1c5a1ba7442d1a6b301c41e26e0bd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e9e48c329d4d63aa8ed4f54c4d2d61_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d7f02b816254b8aa330323c3a69a6f8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50a9fd6731664971b019d860f06b8d7a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf58d18ba69645c388a1b80e92a29a6a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857194e9005945168ca557c8b9cd6cf6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080f246a03434c36b738f2ab73889cb7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i723a8f8cd90d40c5b923bb953965b6f0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45cdbf59bba942c799174d71fc78424f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7480c0baf3ef4031958b631683211304_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ace030c17a84199b8a58d5de02660b0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb0c4c8a0364ddab4ced3d467f03536_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9afb4c625184a3f99e2cb5a2e3d5eaf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8d9d2e13254a4a851b924c07c94850_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcdaac085a184fd991190127986b186a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd11f2b19d644626913c68555b6a3ed3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba969a96aa1a4d5c9b9694620c56457c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd088a28be84475899676efd77df7fb1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0844e0faf2924757a27a663c5f70585f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe3d35593ef467a942d74f57b0d973f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee715c6013774f86871bc93f1f3c5581_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ded499efde348f38db33fa32a02f9c7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf53b679288243c4b2c60ffa46acdbc7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ebac333e6b4b7e824140ded41ed412_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i360dc4f66e284c169a8571d8f06cfb23_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27eafd0032b54ff9b789fb388acb51f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i301ed7692b8f4861bf3943d034b41d27_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbd6d4f17c1483890abb77740b35017_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d39b8e7b0d742918fa14009236396be_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf871b9974004097959095e896164ea5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef6dc9c2a204c7eb7bd1ef80318af8e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:NewOperatingModelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd8645e550c4ed8952d05182e882159_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:IntegrationActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c12720ec2d4657b11334d2f5c03900_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab2e3d03af0e4a9d8b80b6d36fc10ad6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7cece8bf1314a0bb7e3af8e0b6c6632_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ff73073d6be424295feaeb2acc57d80_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47e22ae3131468e92ac7e7b3405265d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9538dd5f2a2244a9adcb80fb4dd92160_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f02046af9547bf90a5a5fecea5c89e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c66e4f9c56742b18ccfe453072a0567_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f7c52bc902e4958a1aa1af5261b13dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98bfbbe989f94db8a2f6860f5daea064_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd110d5b3b474fb9a4243053206a4b98_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc91ff6eb4746318f5c648bd8d956ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae9704eed9e408f85ac8af9ab07b959_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A130SeniorNotesDueMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747bc7554666414992b2b24bb2e4b2b9_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A04SeniorNotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cedfb9fb234c4fa8f05974b6a48de8_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A13SeniorNotesDueMay2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9faaf9a5d1d4dc39fc43d27a01f474a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be3a0f43b6f4f4697b04212b8b81e2d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i496040ce8ccb46e6bb87e3ad9f95ec52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc935ff843a4dc29ec8c895720e3066_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a795c4b1fb4e3084ef17809809118d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib752bbb3f58f4422b1f965bc7c89f074_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2285dfc1a7402a99c067a6e802ca97_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i189d98535fb942c99329457fb43522d1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c25693c2f1b4a5f9dfc483f5ca0a8b2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab0be122c59428e9024680a862f2c0d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaad8a6fd0bd4705ab16d4fb5b21406c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66a9ab3f00c6441596fadb7fc37919f1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8118589f429a4a0ca38950943ac2978a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91cf39a12b99429d8289596966b89fe2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ecdd9ca5f54679995d5d378c4d06ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46477fce4d7049aab502d6b4eb1ab53b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c1f79300409417e829d19d1e521ffde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i671ceedc0954414bbc1ef559a31dc3b0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8311fb17141a43e08936804f2663ce41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc0855e415a24ea2bbed65f9964a98ca_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6620927c944ffab75861c764f15bbf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9582e8bab32a4622a5341a018568c9a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56e1d124500c4886b5441bdd89954116_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d40aa82836d4e5d80dbeabff53e5546_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b248d3ee7c433a940949503db3e3fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d5a655bb88c41bfb5152c5fc3f19595_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i607c52fdcfa04c428b2116b4f6436aa0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifad00739353c4b57be82940bf374498e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf5014e9c356493ea281263e29225f8c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8107d66cdfef47cc96732db00726b56e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f96dbbad654789adba4c76777fb89d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a401be8e879440883b9309dd7cd46eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05af2841efd44956a910f7e3b2175557_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ecc9bb48ea468fbe53ecaa9574ab83_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff491835ffe4fdf8c4b26233dcb9a9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1672a644c104e0cba0f5a365004ec05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ead0a6833745b5a2c9a8c87f3eb359_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c61a0314afd43cd8e3a9aaaf26630eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icda293782fa046d38a077f41e8d52047_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f90874bfa6d48fba1bed7ac9573fcf6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f96fffbf70b48c3af05ddc881ed1a92_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5885ecc04c124fd88f7d20f0411c5299_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39589615eba84af88bd227d8332e4d0b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc8aeefbd654849815b65f8dedd082d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe45285509d54b74948837ef32da5fb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4465ac79533347819eb60404998c9a41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb955fb2b1749fa979c87c9f7a93003_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39e31f62b29442da1752786dc58134e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8411fdd837b543e6b9186cdf5182839f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bax:segment</xbrli:measure></xbrli:unit><xbrli:context id="i5bd21c5a704642b7add19a18376900db_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if10723145fec4c039ea5033c9599406a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2931aa2efeee464695085541f236afb5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353419505f7f47a39847c9b26776c895_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bd1d9d744b4e77b5508602e287cf98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96 id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ia96c30333efb48e3af554b764666aed6_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xNjY_7808a1fe-8345-42ea-b9a6-f563e763f6d3">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ODZhMmE3MGUyMjRhNDM3MGFlNWUzNjczMGMwMzNiMGYvdGFibGVyYW5nZTo4NmEyYTcwZTIyNGE0MzcwYWU1ZTM2NzMwYzAzM2IwZl8wLTAtMS0xLTE0MjYyNA_b51712fb-2a28-4323-87e2-a5c7169723c1">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yODM_ad699735-5677-492c-bafd-1dbf3457d480">March&#160;31, 2023</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6OTk2MjJkYjk1ZDE4NDk5MGIyYmQ0OWJiNzJkN2M4MzUvdGFibGVyYW5nZTo5OTYyMmRiOTVkMTg0OTkwYjJiZDQ5YmI3MmQ3YzgzNV8wLTAtMS0xLTE0MjYyNA_62c09e87-40d8-4830-9c1f-c2d55fa414c6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Commission file number  <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8zNzA_edba1689-9800-4068-8f12-47b953bdc6ad">1-4448</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:21.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF80NTU_20551448-9ce1-4f64-ab45-98e7df146924">BAXTER INTERNATIONAL INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8wLTAtMS0xLTE0MjYyNA_1935d321-0786-4c1c-b773-cec3b8f991ae">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8wLTQtMS0xLTE0MjYyNA_65b97f54-4241-446f-8165-dc34171c6d2d">36-0781620</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTAtMS0xLTE0MjYyNA_cf85c8bb-ef46-422d-aa81-14fe1feeda00">One Baxter Parkway,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTEtMS0xLTE0MjYyNA_b5d0033a-9ae4-41b7-8c0e-7008f1d6d735">Deerfield,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTItMS0xLTE0MjYyNA_c9dc8abb-ed46-48c3-a209-a47592d1c3ab">Illinois</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTQtMS0xLTE0MjYyNA_e8bf704f-8310-4bce-aa3c-aa6b81d6cff8">60015</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZWQyNDYzYTNiNmY2NGViZjhkMDg2MjYxNTYxNTBjODcvdGFibGVyYW5nZTplZDI0NjNhM2I2ZjY0ZWJmOGQwODYyNjE1NjE1MGM4N18wLTItMS0xLTE0MjYyNA_e5e2cced-e5df-4346-b45e-8b955410396d">224.</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZWQyNDYzYTNiNmY2NGViZjhkMDg2MjYxNTYxNTBjODcvdGFibGVyYW5nZTplZDI0NjNhM2I2ZjY0ZWJmOGQwODYyNjE1NjE1MGM4N18wLTMtMS0xLTE0MjYyNA_820d34b2-9fe3-4f3c-95b1-b65622dad758">948.2000</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTAtMS0xLTE0MjYyNA_a5a3130d-40e3-4483-ba54-8408e7d0a310"><ix:nonNumeric contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTAtMS0xLTE0MjYyNA_cc8436b6-67cf-453a-b979-d5c44fc79e5c">Common Stock, $1.00 par value</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTItMS0xLTE0MjYyNA_14e4ce3e-d3ac-4438-a25a-f372e25b3c5f"><ix:nonNumeric contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTItMS0xLTE0MjYyNA_8db624b9-0dab-44ff-9f8c-776da28a44b3">BAX (NYSE)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTQtMS0xLTE0MjYyNA_fb011bd4-9441-4960-a8e9-5e5ab528d7fb">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18yLTQtMS0xLTE0MjYyNA_8cbaeba3-df51-47bf-a875-2ef6f6fad407">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTAtMS0xLTE0MjYyNA_4b2d2968-a8c5-4926-a3ed-1ef98ea0caf4">0.4% Global Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTItMS0xLTE0MjYyNA_677b63e5-aae5-47d0-98a2-31ceb8068b04">BAX 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTQtMS0xLTE0MjYyNA_db8ab794-c72a-4b46-b8b5-81b3a26ac959">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTAtMS0xLTE0MjYyNA_3958224b-b3bc-4d5a-9cdb-be3192049b40">1.3% Global Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTItMS0xLTE0MjYyNA_54eac8cc-53b9-438a-b523-faf75faf4c53">BAX 25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTQtMS0xLTE0MjYyNA_bc859006-9531-48b6-b7e2-ed7ccc5038d1">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTAtMS0xLTE0MjYyNA_15f658a1-1b56-47fa-80ba-e7ba5ea8166f">1.3% Global Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTItMS0xLTE0MjYyNA_57b0375d-08be-4be7-99d9-8621bda8a16e">BAX 29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTQtMS0xLTE0MjYyNA_d806be2a-be3e-4c7c-b2dd-9a2fab316c02">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xMDg2_14ea5591-d84f-4d00-baad-250280aa4df0">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xMzc4_83b1737f-38e5-4f30-a7dc-62615917894b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8wLTAtMS0xLTE0MjYyNA_c990ef1e-c391-4ad9-8bd5-9aa5c1265c0f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8xLTQtMS0xLTE0MjYyNA_7cc18a2d-f549-4f19-bea1-3ea618f04dec">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8yLTEtMS0xLTE0MjYyNA_4e4cf0e8-63d9-4182-8025-c56d3b2f8a05">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yMjM3_ea8086ba-b5a1-42f6-b790-f96f95893bf3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock, par value $1.00 per share, outstanding as of April&#160;20, 2023 was <ix:nonFraction unitRef="shares" contextRef="i1722827f9deb4a7c96da1d99bfa95a6a_I20230420" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yMjI2_e8685d82-fea4-4524-a44a-91a8e1625b38">505,850,082</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">BAXTER INTERNATIONAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the quarterly period ended March&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_10">PART I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_19">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_22">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_25">Condensed Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_88">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_112">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_112">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_112">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_115">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_115">39</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_118">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_118">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_118">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_121">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_121">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_121">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_127">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_127">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_130">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_130">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia96c30333efb48e3af554b764666aed6_133">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#ia96c30333efb48e3af554b764666aed6_133">42</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="ia96c30333efb48e3af554b764666aed6_13"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="ia96c30333efb48e3af554b764666aed6_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except share information)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMi0xLTEtMS0xNDI2MjQ_c39df3ac-458d-4b97-8258-1afdc85cb014">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMi0yLTEtMS0xNDI2MjQ_99db5387-e9c9-4433-b894-583f83ce285b">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo0ZGUxOTFkNWY4OWM0NzMzOGNlNGQzYWM3NWM0NDUwMV80Ng_2bd9a226-d0d5-478e-82e2-e1b748b73497">122</ix:nonFraction> in 2023 and $<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo0ZGUxOTFkNWY4OWM0NzMzOGNlNGQzYWM3NWM0NDUwMV81OQ_3904a800-7354-4515-b852-d47b427ebb1c">114</ix:nonFraction> in 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0xLTEtMS0xNDI2MjQ_1fac8903-3f69-4888-8abe-b433ed21b823">2,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0yLTEtMS0xNDI2MjQ_61428fb0-6dbc-4a98-b03d-9b57697699b0">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNC0xLTEtMS0xNDI2MjQ_4eef2a5d-5aa3-4366-bbba-f9f0c687333c">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNC0yLTEtMS0xNDI2MjQ_ad06e582-d10d-43ec-82cc-fee64bd5a261">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNS0xLTEtMS0xNDI2MjQ_7a2df1bf-2ca7-4a3a-b5d9-87c69f55dc0c">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNS0yLTEtMS0xNDI2MjQ_e11b1d1d-7d71-4131-b82c-1eaf4dfa16ab">916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNi0xLTEtMS0xNDI2MjQ_781317f5-014d-4e45-a22b-41448c9ca022">8,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNi0yLTEtMS0xNDI2MjQ_6de68f34-588c-4cfb-8904-4e83fbf3950b">8,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNy0xLTEtMS0xNDI2MjQ_106edac5-9843-4d8e-bba5-396a1fdd3b8f">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNy0yLTEtMS0xNDI2MjQ_184c26d6-844e-415f-923e-5a044df40610">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOC0xLTEtMS0xNDI2MjQ_13da78e6-3d4b-46e3-ba9d-e7bfe98d6dc4">6,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOC0yLTEtMS0xNDI2MjQ_412786d4-6cad-4e77-b6aa-b543f3534270">6,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOS0xLTEtMS0xNDI2MjQ_f1d832f5-7c11-4d94-8e69-b74e2a861a15">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOS0yLTEtMS0xNDI2MjQ_a2f53b6d-4fa0-4ffe-93b1-adcf6cb96f87">6,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTAtMS0xLTEtMTQyNjI0_6400ef8f-f59f-4801-bcd9-be5c661f88a0">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTAtMi0xLTEtMTQyNjI0_a62478a3-4305-408a-8c14-7205238d3f8e">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTEtMS0xLTEtMTQyNjI0_d3bf10ed-652f-4fb3-b363-9ca25a9afd56">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTEtMi0xLTEtMTQyNjI0_7e8033bb-c823-4b13-bfc5-2b88e9c3b3db">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTItMS0xLTEtMTQyNjI0_c4d55631-1ddc-4a0a-a3e4-014c2b3f7450">28,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTItMi0xLTEtMTQyNjI0_8b5eade0-5189-448b-b7c8-c9f63241be2a">28,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTQtMS0xLTEtMTQyNjI0_a73b27bb-577f-48ab-99f6-664aa4be75a0">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTQtMi0xLTEtMTQyNjI0_6cb4ab8a-5f14-4f35-a5e3-62ad55371901">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTUtMS0xLTEtMTQyNjI0_a2d90a6e-7e2f-4719-a793-5b384b548b1b">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTUtMi0xLTEtMTQyNjI0_313284d0-00ae-4ba4-b13c-82c911b9528c">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTYtMS0xLTEtMTQyNjI0_63dbe87f-92af-4578-9255-d0fed2ad01f2">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTYtMi0xLTEtMTQyNjI0_736260fc-87df-4488-b5fc-9bfe07353c88">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTctMS0xLTEtMTQyNjI0_dfa93b6f-1fe1-440c-b895-221187e219e6">2,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTctMi0xLTEtMTQyNjI0_c91c33b5-dd7e-4c29-a352-4141e4ff9e84">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTgtMS0xLTEtMTQyNjI0_43d09323-b64f-43a2-9dd3-1a977a4be31f">4,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTgtMi0xLTEtMTQyNjI0_551a67b5-e089-43e8-aec7-01d0be9010b6">4,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTktMS0xLTEtMTQyNjI0_4a5f2742-303b-4d49-82c5-10e0c06a9874">15,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTktMi0xLTEtMTQyNjI0_cfa80c3e-f9a8-4181-9293-2213a1cc60f0">15,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjAtMS0xLTEtMTQyNjI0_b1fbe88f-05f3-4f9e-acb9-832902bbfe0b">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjAtMi0xLTEtMTQyNjI0_056b5697-98e3-4ec3-9637-8eaeaa3d35ba">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjEtMS0xLTEtMTQyNjI0_20a4af9b-b560-46f2-b659-f0b71dc13b64">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjEtMi0xLTEtMTQyNjI0_1b38d624-c74e-4f49-ac29-2f857d8c78d5">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjItMS0xLTEtMTQyNjI0_fa3e04e1-b450-4b66-97d3-d7047904d316">22,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjItMi0xLTEtMTQyNjI0_ed06ac6c-a8e0-4e3f-bfa1-42fbd4afbe52">22,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjMtMS0xLTEtMTQyNjI0_6f1e8413-c540-4583-a79d-f0c1180ac91d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjMtMi0xLTEtMTQyNjI0_391bba79-9d14-47b9-b4f8-131ec443e309"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfMTg_2ba36db3-93a2-4d8f-ba60-3114a5c5cdb1"><ix:nonFraction unitRef="usdPerShare" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfMTg_ce6ca01e-d692-46c5-99a3-44fef6fb5be0">1</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNDM_adf244bd-0b2d-46dc-a29e-10c5db8aaf05"><ix:nonFraction unitRef="shares" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNDM_dee51893-d735-44ff-8227-ab27df466f19">2,000,000,000</ix:nonFraction></ix:nonFraction> shares, issued <ix:nonFraction unitRef="shares" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNjE_07d3cea7-2886-4db9-ad81-9e140b775cc1"><ix:nonFraction unitRef="shares" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNjE_879f1668-65e5-4288-82a0-1fd92352bdbd">683,494,944</ix:nonFraction></ix:nonFraction> shares in 2023 and 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMS0xLTEtMTQyNjI0_3c97f181-62be-414b-bf37-fd2438f7a38a">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMi0xLTEtMTQyNjI0_67cf9ac5-465c-4747-9c3f-a063efde7681">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock in treasury, at cost,<ix:nonFraction unitRef="shares" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246OGRhZDU2ZTZmNjMxNDJjZTk1NzAwMzYxMDVhMDJlYWNfMzg_49bf6c43-c769-4bcb-9fdc-0146dcbd5de6">177,658,649</ix:nonFraction> shares in 2023 and <ix:nonFraction unitRef="shares" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246OGRhZDU2ZTZmNjMxNDJjZTk1NzAwMzYxMDVhMDJlYWNfNTg_e7eceab7-9130-4f13-8ea1-aa3922933885">179,062,594</ix:nonFraction> shares in 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMS0xLTEtMTQyNjI0_4a10bff6-dd2e-4019-ae29-62db308a2a33">11,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMi0xLTEtMTQyNjI0_ef83ea97-e877-476a-bdf8-8088666ec209">11,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjctMS0xLTEtMTQyNjI0_963f3772-d65b-4996-97f0-45be33e880c2">6,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjctMi0xLTEtMTQyNjI0_b7d18290-db5c-4686-ab41-6913c3c15e1f">6,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjgtMS0xLTEtMTQyNjI0_78d61afb-c733-48ae-ae1e-4a2e9733d731">13,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjgtMi0xLTEtMTQyNjI0_dc1a0763-ef7e-48e1-a201-85a92e03735a">14,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjktMS0xLTEtMTQyNjI0_8306bdec-57c6-4e37-8d87-dbdf932784cc">3,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjktMi0xLTEtMTQyNjI0_1cd863b6-6d80-4e57-be81-774ae83abbb4">3,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzAtMS0xLTEtMTQyNjI0_e18ea181-2805-4ac2-a5ea-5d58335d9580">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzAtMi0xLTEtMTQyNjI0_7a1c0b24-0caa-410f-81b4-2e0a887bfbc1">5,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzEtMS0xLTEtMTQyNjI0_9b3a4655-e8d4-48b1-88c0-314fb279160c">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzEtMi0xLTEtMTQyNjI0_ae074f9d-f742-4bea-b827-c5fe068e101e">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzItMS0xLTEtMTQyNjI0_6a6c14a5-9908-47c8-889c-b5bc8dbecf93">5,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzItMi0xLTEtMTQyNjI0_fec218f6-6af0-4132-a45f-2fb1793dcc89">5,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzMtMS0xLTEtMTQyNjI0_a218c0c9-51e1-4fd1-9f7d-d2961e2022bd">28,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzMtMi0xLTEtMTQyNjI0_afa9a29d-cd95-4738-8735-e0b09cf47616">28,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Income (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.695%"><tr><td style="width:1.0%"></td><td style="width:73.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.828%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMi0xLTEtMS0xNDI2MjQ_0e8704b8-b063-4aba-8248-8eca3bac3208">3,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMi0yLTEtMS0xNDI2MjQ_714d95c2-60f4-460d-aa6c-e1d6ec0de86e">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMy0xLTEtMS0xNDI2MjQ_735e4a92-9a5d-47cc-899f-fc1a7b93a7e5">2,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMy0yLTEtMS0xNDI2MjQ_d6b99cfb-abc4-4852-9bed-d1702fe298b0">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNC0xLTEtMS0xNDI2MjQ_e15d2b06-6053-4d6f-a5e3-f5925e70afec">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNC0yLTEtMS0xNDI2MjQ_63405dae-4e68-42b1-85dc-da352116c715">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNS0xLTEtMS0xNDI2MjQ_9856f3ad-e459-4000-967a-c0bc89a36808">1,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNS0yLTEtMS0xNDI2MjQ_4c173892-d7a4-4cf2-aca1-8af0d4841b72">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNi0xLTEtMS0xNDI2MjQ_83ce9e62-9f06-496f-834f-2a731cbaaa6a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNi0yLTEtMS0xNDI2MjQ_389b1ec9-ddc9-4ad9-b93f-919343ba861c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOC0xLTEtMS0xNDI2MjQ_0f977b6c-cd75-4362-bc3b-14425e7df1e9">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOC0yLTEtMS0xNDI2MjQ_aa7f10f7-ba5c-4f13-8050-d52c19dbc0bf">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOS0xLTEtMS0xNDI2MjQ_547bb0b2-2804-4a80-a043-122327b88482">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOS0yLTEtMS0xNDI2MjQ_aecba5e4-74cf-41bb-998d-b0d5f3559a1a">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTAtMS0xLTEtMTQyNjI0_d5363b04-38de-41b2-8192-f03d4e55a5e1">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTAtMi0xLTEtMTQyNjI0_630c48e0-03b8-4ede-93ab-15f2d7ac5be2">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTEtMS0xLTEtMTQyNjI0_0a204982-20cf-41ac-aa11-f2d0a60b8be0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTEtMi0xLTEtMTQyNjI0_4b77026d-522e-4f61-8294-c7098a097ea5">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTItMS0xLTEtMTQyNjI0_a2474c57-e400-430d-8200-8f19444db67d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTItMi0xLTEtMTQyNjI0_d5254488-0a6e-4754-83c4-f84bdd1f699d">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTMtMS0xLTEtMTQyNjI0_5bffe7e0-fccc-4edd-aa9a-e6bd5016d409">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTMtMi0xLTEtMTQyNjI0_2b1fe4d6-9a3c-440d-ab4e-2d7a1ef13013">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTQtMS0xLTEtMTQyNjI0_ea2aa02f-ef64-40b5-ad4d-90c985b6167d">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTQtMi0xLTEtMTQyNjI0_2dee814c-8aae-4569-9c6c-e7140330f2aa">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTUtMS0xLTEtMTQyNjI0_456e79e9-1a30-410d-9e20-f8ae68af2aa5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTUtMi0xLTEtMTQyNjI0_6f259a06-b485-4936-ba2a-879de294274e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Baxter stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTYtMS0xLTEtMTQyNjI0_f3d16d5a-5a41-4fbd-b2ae-8e55b41f598e">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTYtMi0xLTEtMTQyNjI0_aac5743f-2ae3-43f7-8452-cb977c3ac3a5">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTgtMS0xLTEtMTQyNjI0_4703179c-508d-48b8-891f-5b6aee846c80">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTgtMi0xLTEtMTQyNjI0_de9d9d2b-849b-4265-b155-66b83f750ed4">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTktMS0xLTEtMTQyNjI0_a789b6b2-745e-4817-a0d0-c7dc2b1c4279">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTktMi0xLTEtMTQyNjI0_b63cfcb4-e1dc-4d2f-b7d3-bb7d5d10e35f">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of shares outstanding</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjEtMS0xLTEtMTQyNjI0_0f0a8063-605c-4569-93ad-f890105cfc17">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjEtMi0xLTEtMTQyNjI0_994e0b0b-0c5b-4d1a-b084-5a44a3778470">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjItMS0xLTEtMTQyNjI0_e946a5d8-50ab-473e-a8b7-dbaf08fc751e">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjItMi0xLTEtMTQyNjI0_3d8791e6-df2e-4c07-ba2e-fa697366ffaa">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.959%"><tr><td style="width:1.0%"></td><td style="width:74.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.266%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMi0xLTEtMS0xNDI2MjQ_6b78bf4b-169b-48e7-bbd3-17a5c20d1d55">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMi0yLTEtMS0xNDI2MjQ_dfc7735e-dac5-4ebb-8a40-fd173d85a9d1">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjoxNjkxOTUzMGExN2M0MTM1YmM1MWFhY2M2N2U3ZjM1NV83MA_27c2ad07-b340-4bef-907c-afc9204d192c">13</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjoxNjkxOTUzMGExN2M0MTM1YmM1MWFhY2M2N2U3ZjM1NV83Nw_0017eaae-45ae-4dc0-986e-10bb88593952">11</ix:nonFraction>) for the three months ended March 31, 2023 and 2022, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0xLTEtMS0xNDI2MjQ_90c7ef21-8794-41a4-8fc1-8fa8281391a0">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0yLTEtMS0xNDI2MjQ_eb04c039-9013-4fd1-abc0-96554c0d35f0">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjpmZmFlMjM0MzZhMTY0ZWUwOGVhY2JmNzg5YzkzM2FhZV82OQ_c7a5a456-83b8-434d-ad78-8241e6da008a">1</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjpmZmFlMjM0MzZhMTY0ZWUwOGVhY2JmNzg5YzkzM2FhZV83Ng_039a760e-8e83-4a76-a55d-af9d1f85ca94">3</ix:nonFraction> for the three months ended March 31, 2023 and 2022, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0xLTEtMS0xNDI2MjQ_1859105d-f81c-4688-9b8c-377059ab7b74">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0yLTEtMS0xNDI2MjQ_79753db2-bc1a-4a6b-8775-398aa2c6f9ec">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging activities, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjozMDk3MGRlMWFmNjQ0ZjI5YTk3ZjQ3MGE0ZTdlZGE2MF80Ng_7703d46c-b3cd-488e-b9b8-63f3c7c01de8"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjozMDk3MGRlMWFmNjQ0ZjI5YTk3ZjQ3MGE0ZTdlZGE2MF80Ng_9cb369fd-acf7-4691-b548-c3851c3701f3">1</ix:nonFraction></ix:nonFraction>) for the three months ended March 31, 2023 and 2022.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0xLTEtMS0xNDI2MjQ_78c396bf-cc56-4ce1-a226-5689bb77711d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0yLTEtMS0xNDI2MjQ_27c3992d-b2ab-4531-af68-e06f07521c20">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities, net of tax expense of <ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo2OTRlMTY4NDFkZjg0ZjU4OTYwMWNlOWZiMTg5YTlhNF81NDk3NTU4MTQxODk_850c6c17-50b5-464c-af87-25b649522297">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo2OTRlMTY4NDFkZjg0ZjU4OTYwMWNlOWZiMTg5YTlhNF82Mg_6990331a-d733-4055-baa1-5a61ef35ce2d">1</ix:nonFraction> for the three months ended March 31, 2023 and 2022, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0xLTEtMS0xNDI2MjQ_ce8a0333-c901-4716-bc23-7bebdd02290e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0yLTEtMS0xNDI2MjQ_bcb187d7-9d9b-4533-aff7-e2349d4aa8ab">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOC0xLTEtMS0xNDI2MjQ_005ea97b-aafa-4eae-a859-3837f6e1dd82">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOC0yLTEtMS0xNDI2MjQ_11a6f7a3-d9a1-4598-9d48-ae0c448a0c49">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOS0xLTEtMS0xNDI2MjQ_8235cc66-ffea-4026-ba3c-c15fa26fc8bf">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOS0yLTEtMS0xNDI2MjQ_ebce60cd-86e4-4ef0-a141-b7bbc838131f">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTAtMS0xLTEtMTQyNjI0_f1dc0c48-bc43-465e-97db-385420b789d7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTAtMi0xLTEtMTQyNjI0_a988c929-fb6b-4ed2-9ba1-0c7d914fbf64">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Baxter stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTEtMS0xLTEtMTQyNjI0_a39d543d-4718-4152-9ff2-47bbb342ea19">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTEtMi0xLTEtMTQyNjI0_5b2ece8b-d949-43fa-8969-d05cc84505a9">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Changes in Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares<br/>in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in<br/>treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0xLTEtMS0xNDI2MjQ_f578c812-54c6-4a9d-b3f9-a60a6c15086a">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0yLTEtMS0xNDI2MjQ_329fff48-2da1-4cf0-8172-7fd690e3f199">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0940ea73b3b94072b07c67b32d418ff6_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0zLTEtMS0xNDI2MjQ_05b54c94-fafa-4aaf-b437-6895569910d4">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0940ea73b3b94072b07c67b32d418ff6_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy00LTEtMS0xNDI2MjQ_84f074c1-dcbb-483d-ab38-645b49feef9f">11,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ba7452daab4c4b92575193d9e5f92b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy01LTEtMS0xNDI2MjQ_48f31b44-fdd7-4b2c-a365-e878cf101fe5">6,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c666c1fd3384543a02c18e41beb10c8_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy02LTEtMS0xNDI2MjQ_4d02b34f-d5eb-4aef-9463-e37860fe6f6b">14,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia504d0c0578e43abb57742fcbac04df9_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy03LTEtMS0xNDI2MjQ_431fb5fd-4b47-4ff5-959f-7202714c8d35">3,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbb9d28165848e7b735c76a24f97442_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy04LTEtMS0xNDI2MjQ_2e9f865b-21e1-4210-b2d4-0cb017ec7584">5,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569f70b56e6e4546a2b0440c1c1b4dd6_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy05LTEtMS0xNDI2MjQ_45b9c526-0dbf-43cc-a1ef-5189c309f73c">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0xMC0xLTEtMTQyNjI0_e580f513-0905-4e3f-88b7-9de3bb9c76e1">5,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS02LTEtMS0xNDI2MjQ_ea3acd3f-7112-46ce-a61f-ec39b75687c6">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS04LTEtMS0xNDI2MjQ_ed1a9898-8ac0-4652-aa33-868c7a0c6870">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS05LTEtMS0xNDI2MjQ_dfb72f94-d0e0-47d9-812d-b3b88c362bef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS0xMC0xLTEtMTQyNjI0_0f8a1101-5edc-4ffe-89b1-7faa48042554">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a604e834034d2e80798d244359c92e_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi03LTEtMS0xNDI2MjQ_67fabb19-2e52-40b8-a0a1-ddc479e66952">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi04LTEtMS0xNDI2MjQ_d7da6f8f-bb4d-4fe1-a1c6-5bc5a9ca8010">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi0xMC0xLTEtMTQyNjI0_61b828fb-7125-4a4e-91e0-991be45616e4">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC0zLTEtMS0xNDI2MjQ_a1ecd3bf-530a-4cc5-8344-853d7bd37df6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC00LTEtMS0xNDI2MjQ_f1f30a03-8ac7-4497-baec-dafe6625d753">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i086a01f241704bcaba8f2f58797f4896_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC01LTEtMS0xNDI2MjQ_ec2f48ca-86da-4cd0-9fc2-c4237818520a">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC04LTEtMS0xNDI2MjQ_4fd8ed1b-4726-4bdd-8517-873f25d360f3">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC0xMC0xLTEtMTQyNjI0_90b4e02a-3719-42e3-a4c4-561cec75f137">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS02LTEtMS0xNDI2MjQ_a11be9b5-f5ba-4965-bbd8-0810bc91baf0">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS04LTEtMS0xNDI2MjQ_364375cc-3f2d-40a8-a511-5b53396310cc">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS0xMC0xLTEtMTQyNjI0_5d11673d-6dd5-42cc-874e-a5d930cf9034">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTAtOS0xLTEtMTQyNjI0_b34173eb-6fef-49e3-9c5c-eb16f86821d6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTAtMTAtMS0xLTE0MjYyNA_bc8059be-add9-4e92-8dd7-1016511f0470">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i903a903783024d0c822c638260089e91_I20230331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMS0xLTEtMTQyNjI0_6b079395-22c7-412c-92e6-b41699bdb4d5">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903a903783024d0c822c638260089e91_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMi0xLTEtMTQyNjI0_3a83dcbe-1b58-4d13-b9dd-08f9d6e774ef">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c67e5be4a9c454b9d1c77df627b3423_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMy0xLTEtMTQyNjI0_1fcaa6aa-2cc1-43d3-84c0-ae36afd55382">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c67e5be4a9c454b9d1c77df627b3423_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNC0xLTEtMTQyNjI0_083edb58-85a7-4dbc-ac29-fc6e46c5445c">11,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4edd866db741baa51307eb018f3d9f_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNS0xLTEtMTQyNjI0_bfdbbcf8-6d64-4d7c-91c1-cfe5ebf3fb66">6,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68252ad5814845d2b86cdb16badea3ea_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNi0xLTEtMTQyNjI0_e283abb1-b4e3-4f42-bc73-358a1434e900">13,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe84036cbe4d4876bfc384531e6ff350_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNy0xLTEtMTQyNjI0_90d5d201-161f-4a51-a888-94007a993cb0">3,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd566d2dac84388a0dc10cf986cbde7_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtOC0xLTEtMTQyNjI0_7aa91b5c-38a1-4afb-a8e5-3235a9314220">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe188762f1241fa87f6153d43d125bf_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtOS0xLTEtMTQyNjI0_ae465050-13bc-4c3e-b601-f20bc69ac45a">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMTAtMS0xLTE0MjYyNA_2a979ab0-d6d9-48ad-8dc9-de10977414d0">5,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0xLTEtMS0xNDI2MjQ_b8fba7ab-6f81-4363-9982-9cb390bd84fa">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0yLTEtMS0xNDI2MjQ_45744762-9c0e-4e86-a7c1-2de75c1175b3">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40418177dcd1484c97237105cd4eacb8_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0zLTEtMS0xNDI2MjQ_134812ac-36bf-4faa-9632-c24779455fc6">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40418177dcd1484c97237105cd4eacb8_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy00LTEtMS0xNDI2MjQ_33c68d7b-a5a0-4ecc-a52e-31a632015a43">11,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594c4d36a82e4345a1148e4403700728_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy01LTEtMS0xNDI2MjQ_3a9bcd4d-358e-4d0f-b238-4bc57ae12137">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adea57705bd4eb780aaa0eaaec735f2_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy02LTEtMS0xNDI2MjQ_c6579eb8-7eab-4066-bdcc-e32052aa5771">17,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f43fae8a584013afd3637231c43053_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy03LTEtMS0xNDI2MjQ_c41f4117-060b-4225-bd4b-22e61e0860b7">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie465403042354662a73d63fe8476ff82_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy04LTEtMS0xNDI2MjQ_ebe92896-16c0-4f10-8b5b-c8391e60a186">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7990853ab5584403a5cbfd42f7d394b7_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy05LTEtMS0xNDI2MjQ_6c9a93ca-4f00-40fa-909f-bfe47314dcfd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0xMC0xLTEtMTQyNjI0_732e31bf-b8a9-4496-be67-cd92594ebeaf">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS02LTEtMS0xNDI2MjQ_ba1089fb-7db5-484b-aae9-a0299a126566">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS04LTEtMS0xNDI2MjQ_b9e05ce7-2427-49cf-8fa3-c6d1134e36a4">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS05LTEtMS0xNDI2MjQ_6b445495-a885-4f19-a847-c07ced2e2ad3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS0xMC0xLTEtMTQyNjI0_6f3f5f2d-d1c5-41e1-aaac-10b10516a14e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63fca21e0f0c47a6803f298e2ba68799_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi03LTEtMS0xNDI2MjQ_fbb975e8-7a64-458a-b83f-788bbbc41455">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi04LTEtMS0xNDI2MjQ_db881846-cba8-43fe-a6b4-3140525b96c1">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi0xMC0xLTEtMTQyNjI0_cc28c4f4-194f-4e3e-ae50-bd4337ced6d5">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC0zLTEtMS0xNDI2MjQ_a9ff906d-4f25-4312-8c70-282f3b31d400">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC00LTEtMS0xNDI2MjQ_76510c42-3452-406c-b086-17bd090d7385">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cfa36d74d3d45f69917cc8c0e03163d_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC01LTEtMS0xNDI2MjQ_9246425a-9426-41e4-972e-20e960b78aaa">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC04LTEtMS0xNDI2MjQ_6f38faca-6f16-43f6-b5e8-01edc1f34f07">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC0xMC0xLTEtMTQyNjI0_61b63708-309c-470c-8f89-17dc44d39324">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS02LTEtMS0xNDI2MjQ_8364d7d0-5b85-4782-9bfe-6fd7c9a660ed">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS04LTEtMS0xNDI2MjQ_a3a570cb-b8ba-4f3d-9822-3aa58bfaee3c">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS0xMC0xLTEtMTQyNjI0_2f2311e3-6a5b-49de-9827-401ce21d2c39">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTAtOS0xLTEtMTQyNjI0_589a8864-3f6e-48c2-8565-1336305c0134">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTAtMTAtMS0xLTE0MjYyNA_2bbe5cb0-7db8-4d7d-9189-bb4bfe9f9e72">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i549981689c2d46afb3aab51cfc3c1fa2_I20220331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMS0xLTEtMTQyNjI0_5294cebc-2338-469a-8ea2-5aeda7c8cf22">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549981689c2d46afb3aab51cfc3c1fa2_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMi0xLTEtMTQyNjI0_1a83beef-9fe4-499b-acf2-67a672319b26">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c1210990e74a9b95fe24b71553ad83_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMy0xLTEtMTQyNjI0_b6b1b528-7f7e-44a3-9944-23dea487efc5">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c1210990e74a9b95fe24b71553ad83_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNC0xLTEtMTQyNjI0_5cc520d8-7949-4b3c-a935-d44d527ef79c">11,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d202d13044e48c6b29936c91e8c157b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNS0xLTEtMTQyNjI0_4051ce81-5507-4c23-b3c2-84e0b67b9c95">6,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecdb3fe5d0e4b8e827b13f44d1963b1_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNi0xLTEtMTQyNjI0_4d3df59f-6e0a-4725-b2bd-f7dfc62d34b3">16,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a4799c9ebd14c07b2231243699099b4_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNy0xLTEtMTQyNjI0_76f50f7d-8d9a-4a35-a5f9-96208bf4c8cc">3,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745ad501a79c44d6aec90e097e8047c9_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtOC0xLTEtMTQyNjI0_b03fd037-cf9f-4b0c-a7f8-44cdf21a1abb">9,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e5d98eeff04b8996adc2d0bb0ff481_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtOS0xLTEtMTQyNjI0_d17b098f-0113-4c51-a3fc-f28158ded4c5">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMTAtMS0xLTE0MjYyNA_67a4a374-0bed-482f-868d-ec1fc306c4c7">9,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMy0xLTEtMS0xNDI2MjQ_f946a4b9-e6bb-4d6d-aba4-a3ba92bb445e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMy0yLTEtMS0xNDI2MjQ_fd3f237d-6fa0-463d-915c-2af3673333c2">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to cash flows from operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNS0xLTEtMS0xNDI2MjQ_5c844527-89a2-42bc-bdec-46b5cb8ea171">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNS0yLTEtMS0xNDI2MjQ_456d82c5-0928-43b8-992f-fa1aa9369056">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNi0xLTEtMS0xNDI2MjQ_234658ac-f1c5-4cd7-9a88-663fcf826110">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNi0yLTEtMS0xNDI2MjQ_ede14fb2-fe6a-4d10-b1f1-58a2c9bc4579">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNy0xLTEtMS0xNDI2MjQ_5ea67b2b-912f-4020-9370-7cb200726b5a">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNy0yLTEtMS0xNDI2MjQ_b1a3caf6-3e79-4be8-ac06-aad7ea9cbc9d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension and other postretirement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfOC0xLTEtMS0xNDI2MjQ_92a81969-2abf-473f-a76b-8a8faf517567">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfOC0yLTEtMS0xNDI2MjQ_bdd6592d-dee0-4c6e-8599-6bed6f168aa9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTMtMS0xLTEtMTQyNjI0_eafb0c84-0e58-4cab-87dc-44da3e886417">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTMtMi0xLTEtMTQyNjI0_4e1ba81b-7856-4d38-b6b2-0973603199d7">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in balance sheet items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTUtMS0xLTEtMTQyNjI0_721c3001-505f-4abb-8b4c-6546cafd8b16">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTUtMi0xLTEtMTQyNjI0_01763aa2-c07c-4ac8-ba95-b6203f4e43f9">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTYtMS0xLTEtMTQyNjI0_cab7666f-9ce6-464d-a61c-2d8f618fdd0c">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTYtMi0xLTEtMTQyNjI0_0cf4efb7-0dde-4bac-97ee-9db95c0f4b13">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTctMS0xLTEtMTQyNjI0_ad6d8027-b7ca-48a1-a10d-8bcd2d9abb04">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTctMi0xLTEtMTQyNjI0_2c8d13be-06e0-4ce8-807e-1bcd8f436b84">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTgtMS0xLTEtMTQyNjI0_d8516559-358c-42ee-8ed8-231aeae9595c">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTgtMi0xLTEtMTQyNjI0_067a88bb-c8fc-47f8-9ea6-7fb61ac2c40b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTktMS0xLTEtMTQyNjI0_bbc1db13-2f33-4e63-a667-74b1095091c4">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTktMi0xLTEtMTQyNjI0_a34bf0a4-e642-4c66-8229-84ecccc50d70">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjAtMS0xLTEtMTQyNjI0_8226a77f-56b8-4c53-8187-7ed312583d1a">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjAtMi0xLTEtMTQyNjI0_6d4551cd-3933-402a-814e-c974b2c1c898">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjMtMS0xLTEtMTQyNjI0_a6ad418e-dd38-40b7-b844-6523584f860a">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjMtMi0xLTEtMTQyNjI0_cbe49a60-8d64-4588-ba31-10928410a6a8">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjUtMS0xLTEtMTQyNjI0_b715a77c-014c-4471-8c1e-59150e06ed5b">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjUtMi0xLTEtMTQyNjI0_2214ac3f-a589-42b2-bade-269b82210644">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired, and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjYtMS0xLTEtMTQyNjI0_0ef438c2-ea7b-4af4-abe3-04ee411b3075">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjYtMi0xLTEtMTQyNjI0_8885a5c9-788b-4770-85a1-75f9d09f5ef3">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjctMS0xLTEtMTQyNjI0_e6ae2ae2-06b8-471e-8b50-413eb8e78007">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjctMi0xLTEtMTQyNjI0_b4e29906-cc62-4580-b061-83a9a5c97cc3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjgtMS0xLTEtMTQyNjI0_559ef970-3b40-4b6f-8a00-8a80f3d202fc">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjgtMi0xLTEtMTQyNjI0_41bbdd64-f160-44f7-bd17-0f2c79f7d38d">304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzAtMS0xLTEtMTQyNjI0_62feb418-4ff6-4e80-b42f-d96bfaf69373">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzAtMi0xLTEtMTQyNjI0_cda3fdad-8472-481f-a62c-a392ea951275">404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decreases in debt with original maturities of three months or less</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzItMS0xLTEtMTQyNjI0_cdddacf8-f1d4-4acc-beb8-ead28413af7a">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzItMi0xLTEtMTQyNjI0_9b9fcfcd-4bd3-4af3-b30a-366af4603e96">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzMtMS0xLTEtMTQyNjI0_1efcc5be-d1c6-4540-815a-2c909f26e611">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzMtMi0xLTEtMTQyNjI0_c4919858-1f84-4f6a-b0db-29572433d773">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock issued under employee benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzQtMS0xLTEtMTQyNjI0_b35dfd56-efd7-4b10-a9ee-86d99c1644fc">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzQtMi0xLTEtMTQyNjI0_3516afb9-d64a-4c20-9aad-d49e6bf71523">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzctMS0xLTEtMTQyNjI0_d3424785-24d1-45a4-88c0-b6d9a12e483c">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzctMi0xLTEtMTQyNjI0_83f01273-ebe3-400f-bc2a-85ebaad400b5">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzgtMS0xLTEtMTQyNjI0_fa08b882-689c-432a-83b2-95eb19e47091">372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzgtMi0xLTEtMTQyNjI0_660c47d6-ad4b-4fa4-bbc8-81a9ffbc1732">548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzktMS0xLTEtMTQyNjI0_e0016120-7944-42dd-81f2-fd1ac67d698a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzktMi0xLTEtMTQyNjI0_c0c844cd-971b-4fe4-9f3b-9e187efa573e">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDAtMS0xLTEtMTQyNjI0_1bc4bc17-7e59-455a-b17d-1f588bab2372">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDAtMi0xLTEtMTQyNjI0_596342ea-f9e5-4fd1-8a4e-e5f76efb5c1e">657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934" continuedAt="i66bae27ee44645068b4e0639c027cf56" footnoteRole="http://www.xbrl.org/2003/role/footnote"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2023, December&#160;31, 2022, and March&#160;31, 2022 (in millions):</ix:footnote></span><ix:continuation id="i66bae27ee44645068b4e0639c027cf56"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0xLTEtMS0xNDI2MjQ_cd7eb4e8-fc6e-4023-bcd7-26087fc51c3a">1,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0yLTEtMS0xNDI2MjQ_84ecd203-2199-40f4-b1ff-0270bf59b81e">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0zLTEtMS0xNDI2MjQ_fe13988e-a277-41ac-9862-f7e1a9949a50">2,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0xLTEtMS0xNDI2MjQ_ea000005-c2db-45b4-af76-a6d89ea02ae9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0yLTEtMS0xNDI2MjQ_61fe613c-3bbf-4c2e-8ee6-3d4bec2df6b5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0zLTEtMS0xNDI2MjQ_fbdee8e7-f2b7-4fc0-8bdc-4e241997f555">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0xLTEtMS0xNDI2MjQ_9441da64-b35f-476c-939c-e84bdd504979">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0yLTEtMS0xNDI2MjQ_9d16268f-33d3-4821-bd5c-c87fded69269">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0zLTEtMS0xNDI2MjQ_a1f2201d-27b2-4394-80bf-b2abe633783a">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div id="ia96c30333efb48e3af554b764666aed6_34"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">1. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxMg_1069e69d-c537-4b83-8b55-c0a84fb4a280" continuedAt="i685571a21df44e9a8a1c8a893eca2481" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i685571a21df44e9a8a1c8a893eca2481"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxOQ_8e01b762-59f2-4d66-895b-e27cc06922b1" continuedAt="i2bbe2338be004864ae790fe34e620e22" escape="true">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we, our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 Annual Report).</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2bbe2338be004864ae790fe34e620e22">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</ix:continuation> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we announced our intention to separate our Renal Care and Acute Therapies product categories into a new, publicly traded company. While the completion of the proposed spinoff is subject to satisfaction of customary conditions, we are targeting completion of the planned separation by July 2024 or earlier. Additionally, we announced that we are pursuing strategic alternatives (including a potential sale) for our BioPharma Solutions product category. </span></div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="bax:RisksAndUncertaintiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxNQ_20cae7c1-a069-4c7c-b72f-3230402c9679" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supply Constraints and Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the challenges caused by global economic conditions, among other factors, may continue to have an adverse effect on our business.</span></div></ix:nonNumeric></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMw_73910736-84da-464b-b2f3-cddc40817d6a" continuedAt="i602f5e46199f479fa96d5717a7a79b40" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i602f5e46199f479fa96d5717a7a79b40" continuedAt="i523ce17fd2234f7f82ab6d69eae5b8dc"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNA_2e1081ce-b821-4e91-a25b-3440212c31ff" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfMi0xLTEtMS0xNDI2MjQ_ba07f21c-d8f6-4a75-a000-7102cbc53c62">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfMi0yLTEtMS0xNDI2MjQ_ff2f1118-4ec3-4b72-9e1a-f02a468193cd">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNC0xLTEtMS0xNDI2MjQ_a91d8e47-0115-4ec7-b349-22eb4d337a2b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNC0yLTEtMS0xNDI2MjQ_6d880137-caf4-4590-abb8-155137eadb08">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNS0xLTEtMS0xNDI2MjQ_551fc6e4-7ee6-4ed1-adc9-3c36d2d3932f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNS0yLTEtMS0xNDI2MjQ_3569ae46-0153-42b4-b9c6-1548beb70a65">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNi0xLTEtMS0xNDI2MjQ_9ac9ec1a-956b-4b27-8376-7a9f1ca598b5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNi0yLTEtMS0xNDI2MjQ_db4ef58b-0ed7-4aba-997c-1fa62ce854c3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNy0xLTEtMS0xNDI2MjQ_4479dec6-446f-41cf-a66d-e88625967812">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNy0yLTEtMS0xNDI2MjQ_eaa4a47f-ca62-4ddf-ae3c-456f082a1ea8">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i523ce17fd2234f7f82ab6d69eae5b8dc" continuedAt="i756b622123dc4b0883de72de4ab41515"><div style="margin-top:13pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNQ_c58a73e4-9afb-4e58-b3cb-f63b77b31a07" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMS0xLTEtMS0xNDI2MjQ_3b426d4f-39b1-451e-a913-54414b778807">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMS0yLTEtMS0xNDI2MjQ_17c859c2-87bc-41f7-8879-fc65dd807de1">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMi0xLTEtMS0xNDI2MjQ_13a20903-e368-4a7f-a8a8-d7158b9955e1">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMi0yLTEtMS0xNDI2MjQ_e5e7ece4-3d97-42be-8a5c-05ca79256e96">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMy0xLTEtMS0xNDI2MjQ_bdee2d68-c063-4840-8688-64c57fe2cd6c">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMy0yLTEtMS0xNDI2MjQ_2142e8a2-4b94-457d-a6bd-d7a85c6238bb">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfNC0xLTEtMS0xNDI2MjQ_29d22bdb-d448-4bfc-95f9-b3be1a9971f7">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfNC0yLTEtMS0xNDI2MjQ_2feb4f3f-329f-4af8-b24f-d13ffba5638f">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNg_b86105fa-e83e-4268-9ab0-c38a60d37729" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMS0xLTEtMS0xNDI2MjQ_d152904a-bef9-489e-a06d-44f6d5deedae">11,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMS0yLTEtMS0xNDI2MjQ_7b67a7fd-e99f-43d3-aed1-3cb5bf5ac581">11,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMi0xLTEtMS0xNDI2MjQ_c58cb848-d09e-4e0c-a676-b38fb0e5e67f">6,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMi0yLTEtMS0xNDI2MjQ_37da9933-c8de-43e7-8841-62877f5a36d3">6,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMy0xLTEtMS0xNDI2MjQ_9cf538ad-da88-4617-8189-43711beb1a6c">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMy0yLTEtMS0xNDI2MjQ_c6b7cd2c-0dde-4b94-a422-d463c00f0f33">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMA_ea47e932-c0f4-49cc-b6b6-5cec55312600" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMi0xLTEtMS0xNDI2MjQ_8a997748-0940-4fe2-9840-9e765db0c1db">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMi0yLTEtMS0xNDI2MjQ_b30a70a2-d651-4c3a-9246-c6f4ba71ce68">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMy0xLTEtMS0xNDI2MjQ_c35ac96d-1004-411e-9702-8a75353e13b2">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMy0yLTEtMS0xNDI2MjQ_32c01011-531d-4c8b-9ca5-0d91d6ec60de">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfNC0xLTEtMS0xNDI2MjQ_34fa9e44-19c6-4205-96c6-f3bca40da63d">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfNC0yLTEtMS0xNDI2MjQ_db651e63-b659-453c-bd44-1a3ee92b712d">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMQ_8ad090bf-daac-4e56-a543-d3010c3ccfca" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Income, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMi0xLTEtMS0xNDI2MjQ_9295f747-a622-458f-94cd-5f87110c3283">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMi0yLTEtMS0xNDI2MjQ_586c34c7-0c4b-4ec6-b728-ab54e0446ad5">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMy0xLTEtMS0xNDI2MjQ_88a7a15c-bb9c-45df-8dd3-cf6bb8d173b1">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMy0yLTEtMS0xNDI2MjQ_d88637c3-481f-4bbc-ad3b-c87241f4d0b1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNS0xLTEtMS0xNDI2MjQ_152e5f5d-85e9-4ce5-991b-02b2c544b3ca">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNS0yLTEtMS0xNDI2MjQ_5dbbb57d-aac8-4a75-aa77-b7ce59a384dd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNy0xLTEtMS0xNDI2MjQ_da64059c-d1f4-43c3-847d-7a15625b1583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNy0yLTEtMS0xNDI2MjQ_7c2f37b6-42f9-4ef7-b974-8c6445707c1f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfOC0xLTEtMS0xNDI2MjQ_e75e22b3-e1c9-4328-ba3a-37ad75eb7d6b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfOC0yLTEtMS0xNDI2MjQ_dd4aaf4a-9ab5-47b4-9863-8ac7c6f2667b">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTQ1Ng_71caf30f-599f-4de4-9c0c-3b2dacd14d1f">26</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTQ2Mw_2fb3d8de-c26a-40cc-bb6f-1b0a3bd1bab3">14</ix:nonFraction>&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i756b622123dc4b0883de72de4ab41515">Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="if8aefd6cba0d4106847bb6b58cb837e9_D20230101-20230331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTU3Ng_57e240ba-b37b-41e7-82d6-673d9a93a70e">70</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8ac1583fbba246859aa51f7df3cee508_D20220101-20220331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTU4Mw_7520c119-d13a-48b7-9f45-e31123e8fd62">53</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="ia96c30333efb48e3af554b764666aed6_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">3. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzcyOQ_53167a86-da2b-4685-b7f4-1849e917056b" continuedAt="ibc37fa7b7a7c4baf9a91e7fb859f6ff8" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ix:nonNumeric></span></div><ix:continuation id="ibc37fa7b7a7c4baf9a91e7fb859f6ff8" continuedAt="ib3de6b0ae4af4f5a90f966887d8e0ca4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzczMA_2a2707d7-3906-49c5-bcb7-8e18f8502f54" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b8716ad88248e28c4c5356153e3a7f_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0xLTEtMS0xNDI2MjQ_6e7ca70d-e00d-4880-9b10-10b34499911d">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d5af7f312e4865be66979f792580ac_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0yLTEtMS0xNDI2MjQ_203d186c-9fa3-43c0-bed4-03a5672581ea">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b93924f957421ba38aa7f8e31ae06b_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0zLTEtMS0xNDI2MjQ_49945d1c-c89b-4bbc-9915-9eee8029674d">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f07e528dbe484f982e220a41fa1577_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS00LTEtMS0xNDI2MjQ_385b2e05-b0ae-4c97-95f4-48f66a591344">3,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS01LTEtMS0xNDI2MjQ_e373e7b2-1ed8-4d3f-86ae-5b7537222db6">6,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cf6a305b9149389378aa6125813d6e_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0xLTEtMS0xNDI2MjQ_9214e87d-2bf5-48a4-aa5e-e06b0b11bec7">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa64dff379543ff9a0e870c10d36e3b_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0yLTEtMS0xNDI2MjQ_7f9bb666-1007-4560-9009-3ca970894ad3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd748bfd4df44c5b9b7a1d75b53c8cd_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0zLTEtMS0xNDI2MjQ_1f6f17c1-1b18-47b5-9318-9c6ecb1a6c0c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9122ce6ade864b9f939af3570b2a12d5_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi00LTEtMS0xNDI2MjQ_af8e7006-6fa2-4124-b2eb-035e01e6f381">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi01LTEtMS0xNDI2MjQ_b79b3654-eba8-448b-a030-7916338334c2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba1d1d1ab4a4b58bbc7c4edd43217e8_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0xLTEtMS0xNDI2MjQ_72261a38-7d9b-48ce-ab78-fb7e7e6abf95">2,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5b28bd50b747f58909a56b3ce1d3cb_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0yLTEtMS0xNDI2MjQ_64c366ee-ef10-48a6-a37d-362ab2ad6228">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1ede9bd1eb4a41881ac35ef3560275_I20230331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0zLTEtMS0xNDI2MjQ_7cfe1c70-8095-4de9-9779-fc0a11b7f73e">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9f83b89e384e909e618e9f0fc79b8c_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy00LTEtMS0xNDI2MjQ_90c60c24-dd6b-44cd-b11d-01211ce1eb70">3,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy01LTEtMS0xNDI2MjQ_a54f6c31-e6ad-4fd4-9abb-be4b18682f54">6,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods ended March&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjE5OTAyMzI2OTE3OQ_2a4ed85a-f229-4440-870a-95c16f6a3512">no</ix:nonFraction> reductions in goodwill relating to impairment losses.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib3de6b0ae4af4f5a90f966887d8e0ca4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzczMg_ddae0a08-bc43-4253-9a7f-6f6b672b0fd5" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0xLTEtMS0xNDI2MjQ_26cb527b-364e-4a73-894b-480965a0618b">3,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0yLTEtMS0xNDI2MjQ_012561a7-a7ab-43a3-9f1b-26fc0960f9a8">3,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0zLTEtMS0xNDI2MjQ_fa6a58ea-92d6-449f-b5de-deb742ced415">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9691d0cc94e2490085471645d739eab9_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy00LTEtMS0xNDI2MjQ_03afba3e-28b1-48ce-a280-37d783b7e63e">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy01LTEtMS0xNDI2MjQ_2581a171-5acc-45f4-981a-2ddfa94d4716">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy02LTEtMS0xNDI2MjQ_ace2c503-70b6-4afe-ab07-b01bc78be290">9,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0xLTEtMS0xNDI2MjQ_4794258b-11a3-4bc1-aa85-904b3f435c7e">529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0yLTEtMS0xNDI2MjQ_16804a25-427c-4f4d-9aa0-a071d0eb043f">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0zLTEtMS0xNDI2MjQ_0e0e9a84-6108-4887-bb93-4baaf148cd3d">246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC02LTEtMS0xNDI2MjQ_2c9ff652-9b5c-4530-a63f-d4ada03464b1">2,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0xLTEtMS0xNDI2MjQ_e961e0fb-0607-4263-90d8-e1dce64bb2b1">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0yLTEtMS0xNDI2MjQ_448e02b9-81a8-4acd-acc7-86440e63ecb7">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0zLTEtMS0xNDI2MjQ_4f39bc7e-d838-4f04-a414-5c7fbafe6c99">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9691d0cc94e2490085471645d739eab9_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS00LTEtMS0xNDI2MjQ_4b4a43d0-1ae3-474e-a3fb-de09d816fdea">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS01LTEtMS0xNDI2MjQ_891540ef-3dcc-4d4b-9de5-601ef8245524">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS02LTEtMS0xNDI2MjQ_79b3a232-7e56-4810-938c-59efd77afd6f">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0xLTEtMS0xNDI2MjQ_60c5c62d-fb34-491a-bcb7-65cda2b76b77">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0yLTEtMS0xNDI2MjQ_7ac4ef52-b661-4f4f-8bf4-575f5d75e32a">3,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0zLTEtMS0xNDI2MjQ_f390a25e-2237-4ea5-a8ad-169c8f6fa0fb">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ebf6db10af94658bfb39f075c42d0ba_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy00LTEtMS0xNDI2MjQ_1b68fcea-7d44-4bb3-9752-521b1dc2d956">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie473cdb19c1847169b73a323e42bd39a_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy01LTEtMS0xNDI2MjQ_e9a676f2-f217-49d0-a14d-bc57a414443b">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy02LTEtMS0xNDI2MjQ_c6bac4af-00d0-4013-8438-9c89e38b59bd">9,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0xLTEtMS0xNDI2MjQ_281696a1-013c-47d1-8a1f-cf2239a2c711">470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0yLTEtMS0xNDI2MjQ_7ff0935f-dd71-499f-a9bc-43bdad1a0706">1,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0zLTEtMS0xNDI2MjQ_cc561f87-9a10-483d-b18a-5d0d3b43166b">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC02LTEtMS0xNDI2MjQ_8392fe94-53d8-4750-a258-4c687de148c8">2,593</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0xLTEtMS0xNDI2MjQ_b674efdb-be5c-43e7-a101-89f744abacf1">2,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0yLTEtMS0xNDI2MjQ_972b65de-676c-4635-80ee-fa3d3d424a74">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0zLTEtMS0xNDI2MjQ_9cb17c1b-c075-47e1-9d86-580d1525e426">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ebf6db10af94658bfb39f075c42d0ba_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS00LTEtMS0xNDI2MjQ_fe3721f5-c7d2-4fa7-ba15-a0501f372dd3">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie473cdb19c1847169b73a323e42bd39a_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS01LTEtMS0xNDI2MjQ_0194da32-b13a-4e2a-80f9-83a10b4192da">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS02LTEtMS0xNDI2MjQ_d3bd47ea-9489-4083-a653-6c5cf91ec0a3">6,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjY2Mw_e0d70aae-e4e5-4dcd-9f1c-c43453ff5612">162</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjY3MA_341d1969-d109-45f1-9a67-0ff5ab966dbd">217</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">4. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjY0Mw_667773b9-11bc-4f02-ae85-2644e326aa15" continuedAt="i2ee48a79b0ff4442853873a4dd242ac2" escape="true">FINANCING ARRANGEMENTS</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i2ee48a79b0ff4442853873a4dd242ac2" continuedAt="i9801206e0f534507a6034891e9fa069c"> </ix:continuation></span></div><ix:continuation id="i9801206e0f534507a6034891e9fa069c"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we amended the credit agreements governing our U.S. dollar-denominated term loan credit facility and revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to amend the net leverage ratio covenant to increase the maximum net leverage ratio for the four fiscal quarters ending March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMTk0Ng_fd5da7dc-41ea-4c39-b131-3a3a12d1bc1b">2.5</ix:nonFraction>&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;<ix:nonFraction unitRef="eur" contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjAxOA_7253dfe8-ed43-4448-804b-57058940060f">200</ix:nonFraction> million. Each of the facilities matures in 2026. There were <ix:nonFraction unitRef="usd" contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjA3Mw_10bbac71-1d13-452e-a55d-ae6450364d52"><ix:nonFraction unitRef="usd" contextRef="i8a56dbdd4ff14331a905150029de9251_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjA3Mw_40dd2197-9b2f-40ac-a60d-7ca607f7e1dc">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under these credit facilities as of March&#160;31, 2023 or December&#160;31, 2022.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. Based on our covenant calculations as of March&#160;31, 2023 we have capacity to draw approximately $<ix:nonFraction unitRef="usd" contextRef="i50e14096fdd04423a5333d25f12d89a7_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTczNw_91b2da56-bf08-46e6-b2ed-d1aafe461a87">2.2</ix:nonFraction>&#160;billion under our credit facilities, less commercial paper borrowings which were $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTg5Mw_d50891bb-fd70-4348-8fa3-c3eef23694f3">50</ix:nonFraction> million as of March&#160;31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTg4OQ_d50891bb-fd70-4348-8fa3-c3eef23694f3">50</ix:nonFraction> million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="idb2809f872c14e8ebe75278e58f5b315_I20230331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjQ1NQ_686e611e-cbe3-41f7-9496-b9f796798a15">5.42</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="i5251aea994574c9583ba547d9a6bac1f_D20230101-20230331" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjQ5OQ_266620c0-96cf-4013-a1db-85ee60090321">28</ix:nonNumeric> days. As of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjUyMA_4b3705bc-be8f-4c22-a6f9-f25292cef94a">299</ix:nonFraction> million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="ie998dbec09874c54aeb8ff608dc85931_I20221231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjU5Ng_a4ba97c8-0ef0-4349-84de-b5da24dc16d0">4.75</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjY0MA_7dd81c06-e6fe-4be0-a78d-51734db36955">32</ix:nonNumeric> days.</span></div></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">5. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfODczNA_13101419-6de3-4f51-97e9-487ebdaa7493" continuedAt="i6177455205ab402a979f4f4b10c99694" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i6177455205ab402a979f4f4b10c99694" continuedAt="i9686cf4de0724c52b2e74e6278b722d1"> </ix:continuation></span></div><ix:continuation id="i9686cf4de0724c52b2e74e6278b722d1" continuedAt="i39af93552b74413a8e4e43ed13834105"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2023 and December&#160;31, 2022, our total recorded reserves with respect to legal and environmental matters were $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjI3_130d4e77-8115-45ea-8c08-f749d5773120">29</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjM0_838a87a8-8ed6-41da-8f52-80f0be8ab993">28</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i39af93552b74413a8e4e43ed13834105" continuedAt="i9bf60fc81d9348b8bb58e4f2bcc5cc76"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at <ix:nonFraction unitRef="site" contextRef="i8a129980c2e0429f900251c40212bfea_D20230101-20230331" decimals="INF" name="bax:SiteContingencyNumberOfSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjI0NQ_110f29ff-1cd4-4258-9ead-0289f4277e25">six</ix:nonFraction> Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2023 and December&#160;31, 2022, our environmental reserves, which are measured on an undiscounted basis, were $<ix:nonFraction unitRef="usd" contextRef="i83ac75103174457caa01d60ace762a52_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjg3OA_6e311cbc-92d6-40d9-87c7-aeb7454c15d0">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia6f5b61f71de4b578b8f219e50d9e242_I20221231" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjg4NQ_1f6cc772-c01a-4c91-9d87-d531480673b7">19</ix:nonFraction> million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, <ix:nonFraction unitRef="lawsuit" contextRef="ia18ed76e0fa040a8aac24e70b8c0d1b2_I20200331" decimals="INF" name="bax:LossContingencyNumberOfLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjM5NQ_111af4e4-763f-43d8-8995-c2f9b5685bad">two</ix:nonFraction> lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. On December 16, 2022, we filed a motion to dismiss and for a more definite statement. In response, Plaintiffs filed a First Amended Complaint on January 6, 2023. We answered the First Amended Complaint on January 27, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We acquired Hill-Rom Holdings, Inc. (Hillrom) on December 13, 2021. In July 2021, Hill-Rom, Inc., a wholly-owned subsidiary of Hillrom, received a subpoena from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. In October 2022, the DOJ issued a separate Civil Investigative Demand (CID) addressed to Hillrom, requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Baxter is cooperating fully with the DOJ in responding to the CID. The DHHS and DOJ often issue these types of requests when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9bf60fc81d9348b8bb58e4f2bcc5cc76">answer to the complaint on January 28, 2022 and filed a motion challenging certain aspects of plaintiff's case on May 27, 2022.</ix:continuation></span></div><div id="ia96c30333efb48e3af554b764666aed6_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">6. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfODA0_cc031618-967a-4f90-9bf1-f4594954d1a6" continuedAt="ifc45031e0d004ed78aa78b82f932e450" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="ifc45031e0d004ed78aa78b82f932e450" continuedAt="i8fa39df0ccb8405c9b6611e7e5a89dfb"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three months ended March&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usdPerShare" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMTEw_c4ba8c49-c87b-4108-ad69-d87988037ecd">0.29</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMTg3_208d476b-84bc-4c67-b569-b805bc6f6baa">0.28</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8fa39df0ccb8405c9b6611e7e5a89dfb">In July 2012, our Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="icb1e1e86edba409592faffa2c09656e7_I20120731" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMjk3_eb39f26f-70ec-4dfc-8f74-60a163506608">2.0</ix:nonFraction> billion of our common stock. Our Board of Directors increased this authority by an additional $<ix:nonFraction unitRef="usd" contextRef="i54acfe1b3c9e4d72a0d864d5c38acb28_I20161130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMzg2_0b2f25d7-9343-4b8c-8d61-9fc8e6fe03c3"><ix:nonFraction unitRef="usd" contextRef="i4dcdbf9afbfe48f697caa407b52ea2a9_I20180228" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMzg2_e751553a-b3d7-414a-a433-97af0423402a">1.5</ix:nonFraction></ix:nonFraction> billion in each of November 2016 and February 2018, by an additional $<ix:nonFraction unitRef="usd" contextRef="i82b54d14b4714bb8909d97f501750950_I20181130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNDUw_b390ba77-baf6-4cc5-b4bf-90ff7a01a451">2.0</ix:nonFraction> billion in November 2018 and by an additional $<ix:nonFraction unitRef="usd" contextRef="i3cda740eb170402f8aecbd918a7cb4dc_I20201031" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNDkx_e5433c16-4ad4-4b1c-a971-6b98674b2393">1.5</ix:nonFraction>&#160;billion in October 2020. During the first quarter of 2023 and 2022, we did not repurchase any shares under this authority. We had $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNzQ2_c90861dd-d255-46f5-a3e3-0562f29da95d">1.3</ix:nonFraction> billion remaining available under the authorization as of March&#160;31, 2023.</ix:continuation>  </span></div><div id="ia96c30333efb48e3af554b764666aed6_58"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">7. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA2NQ_c3dfe419-0dd6-43eb-94c3-a9977ef10ade" continuedAt="i8dfae5bfea3c4f4d9eb5f0576a4dc5d8" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="i8dfae5bfea3c4f4d9eb5f0576a4dc5d8" continuedAt="i1f8535d92e82463eb7461a54646ba3ae"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income, cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans, gains and losses on cash flow hedges and unrealized gains and losses on available-for-sale debt securities.</span></div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA3Mg_10860920-e76d-4532-9d94-8e1d42571000" escape="true"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a3e16bcba5455287abc55ac7a72c7b_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0xLTEtMS0xNDI2MjQ_66fad8dd-508c-4bea-a590-a4fa02b2c903">3,386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f4bdbd9802f43e4b40fdb623ef4c6b4_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0yLTEtMS0xNDI2MjQ_fad1d63e-a225-40d2-817b-ff22e9d576dc">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38a1fa71e8d34f8f8b550e41ec2f74b8_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0zLTEtMS0xNDI2MjQ_987aa1a7-de54-436c-a70b-d60f6684f908">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34a05a406da4126b9897e999764cf3b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi00LTEtMS0xNDI2MjQ_1a343250-e44f-4c0c-847b-0290c52db34e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddc00ddfcf9a4d538640cf78c5d1745c_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi01LTEtMS0xNDI2MjQ_85c59601-6162-4d8d-9af6-c8a8e3395622">3,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0xLTEtMS0xNDI2MjQ_10d25f45-9d60-425a-a79d-b241dafa92c4">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0yLTEtMS0xNDI2MjQ_c238e319-85bb-4b9a-8389-2ee024b65874">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0zLTEtMS0xNDI2MjQ_2b8bc078-c433-41e6-b187-09f9c30235c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy00LTEtMS0xNDI2MjQ_1d746e33-8015-474f-93b6-ea250a71c58d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy01LTEtMS0xNDI2MjQ_e5429997-fe0f-4839-907f-9dce640a2d89">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0xLTEtMS0xNDI2MjQ_1989d402-1867-4f3d-9663-c984ec33e6c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0yLTEtMS0xNDI2MjQ_c1715829-c9e0-466e-9a4e-d37473ce60be">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0zLTEtMS0xNDI2MjQ_41028971-3c62-4239-b355-194724ebcb1e">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC00LTEtMS0xNDI2MjQ_7713d1d9-26fa-4a1a-aced-4e80019fcd5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC01LTEtMS0xNDI2MjQ_d92f0f9c-d786-4050-9ba9-d78941e6df87">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0xLTEtMS0xNDI2MjQ_6f227065-5e7c-48cf-85ff-7df4c9f5f09b">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0yLTEtMS0xNDI2MjQ_cb9cc040-0b4f-4dd2-84f3-f5b9929b011a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0zLTEtMS0xNDI2MjQ_b807fe53-7971-4cd7-a7ac-cf9af526e1c6">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS00LTEtMS0xNDI2MjQ_8070ed04-4d87-4059-a973-0bb57b27f208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS01LTEtMS0xNDI2MjQ_06645578-22e3-4de4-8e55-9653c6dd1635">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1731323823d48a9ad85ad284c1026de_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0xLTEtMS0xNDI2MjQ_97bc62e2-1e96-4943-9989-95ae96fbb389">3,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e585fdb356847ee95bef768d6c8f6fe_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0yLTEtMS0xNDI2MjQ_4159fbab-387a-4f2d-8427-fcdb72cfabd7">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabbe53c3b4844245a71aa4170a3d6951_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0zLTEtMS0xNDI2MjQ_f10d363c-69f0-42c2-a71f-1483e50868eb">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe94c791c144fb3901d9ccada083e46_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi00LTEtMS0xNDI2MjQ_abde78f1-b1f0-41e9-bb55-33cb1261ee20">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fc74d6b294098b52b2dbacb9d8244_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi01LTEtMS0xNDI2MjQ_4cd4f2b9-2d07-44da-abad-a0eddef3779a">3,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4974271eca4848daac4ef6f3c0268466_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0xLTEtMS0xNDI2MjQ_ee2cc97c-d083-4600-a3f9-29b1469e53c2">2,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ba818d615df44fa9ab8dc663c356b0e_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0yLTEtMS0xNDI2MjQ_382555b7-0525-417e-ba3b-a4d63f6d29d6">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc59f5aaa04945a290aa672855b1c1ab_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0zLTEtMS0xNDI2MjQ_c31a62ba-cdf9-466d-95a3-72be8feb04bb">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573b5203abe64eee9fc6bd8d764b6765_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi00LTEtMS0xNDUyNjM_df3ccbb6-4e16-4a32-a11e-21c818d35a83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i154a7b3c49ee48b38613d9dec8d98845_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi00LTEtMS0xNDI2MjQ_98166ecb-099c-4a06-ad71-9fc7630e237c">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0xLTEtMS0xNDI2MjQ_9c4404e8-53dc-4b84-8dcd-c2039cfba782">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0yLTEtMS0xNDI2MjQ_75903bd1-317a-4bb2-897a-ec1e05c25151">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0zLTEtMS0xNDI2MjQ_75947599-92a2-4e64-a2c5-3e8945f434f0">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC00LTEtMS0xNDUyNzE_85b74337-fa9a-415e-9b88-d1d0c1a40d74">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC00LTEtMS0xNDI2MjQ_f740fc81-c823-4bbc-adcd-eb8ac742fb5d">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0xLTEtMS0xNDI2MjQ_b5633ca7-0cec-448e-bddc-01a89b7bc5d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0yLTEtMS0xNDI2MjQ_d3632d10-a2af-4d45-8891-ee7e724a7f8b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0zLTEtMS0xNDI2MjQ_793d65a8-4526-40bf-8a12-80d3a00e0ef0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS00LTEtMS0xNDUyNzE_a58dacd0-2fd7-4a50-ad0c-8b7f02ee1566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS00LTEtMS0xNDI2MjQ_9469fc5d-0b71-45a6-92d1-2b8431a2ae0f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0xLTEtMS0xNDI2MjQ_3ca67994-667a-417c-a800-eaccca3ff3e9">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0yLTEtMS0xNDI2MjQ_54efedba-1ccd-459a-b803-a79b1a95df36">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0zLTEtMS0xNDI2MjQ_4f6461b0-6740-42a3-baf1-c932320c585f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi00LTEtMS0xNDUyNzk_f8b93dab-e8c8-470f-84f8-1f9968530c9d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi00LTEtMS0xNDI2MjQ_afb06115-7cab-46e3-9afa-5e7aed8c6835">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc57a64dfa914805848eec366284d706_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0xLTEtMS0xNDI2MjQ_4a470f0a-ec32-476a-aad9-55fbbcd1a76b">2,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3a5ddf7f0b4ea8ad0c518d49a70509_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0yLTEtMS0xNDI2MjQ_993aea4a-bcd8-4eaf-8ece-f192d5394f49">338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86fbdd6384f94375a9f88c4a431213fb_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0zLTEtMS0xNDI2MjQ_197a677a-9c4c-45d1-8bf6-073a94f9d665">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b60f9d6630f49ffa53859e738234d11_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy00LTEtMS0xNDUyNzk_04364994-6cd2-4a2a-bec1-667ea57c9a71">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibab71210a8c94981891c3847d80b517f_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy00LTEtMS0xNDI2MjQ_8c44fe82-74cd-4e61-a230-5a08805fe764">3,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1f8535d92e82463eb7461a54646ba3ae" continuedAt="i27ec869043bd461588620413855a8660"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA2OQ_b0f6af4a-8e35-444f-aabb-abf9b5508bb7" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfNy0xLTEtMS0xNDI2MjQ_0ed7b407-8377-474c-bfbb-18db657fa7a5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfNy0yLTEtMS0xNDI2MjQ_af5e399f-0d17-48b9-8a41-5858ac5a3536">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOC0xLTEtMS0xNDI2MjQ_b1760ef7-2616-47ec-ae9b-0689ada9566f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOC0yLTEtMS0xNDI2MjQ_3677b8af-1db4-4f22-b88f-7d997659a5d8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOS0xLTEtMS0xNDI2MjQ_4b625179-1410-41d1-a8a2-60bd7446a355">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOS0yLTEtMS0xNDI2MjQ_e91f085a-f922-4f5e-9707-7ef89ae6c616">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5d70874f80c482cb0e5b8513c4530c3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTEtMS0xLTEtMTQyNjI0_4107c653-15d7-471b-a0b4-b9626d625085">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2eb0cff5ab142898e3663ceebe5e867_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTEtMi0xLTEtMTQyNjI0_0b0a5380-56d6-466f-b7bb-c3000061bad6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic023f2fc593e4fd29470ad3b703a07c8_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTItMS0xLTEtMTQyNjI0_2c7fd57b-70e9-40e9-bd21-2bae9de57cb1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16554c4f2d744cd9a29f4b0265752f73_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTItMi0xLTEtMTQyNjI0_9a8da52f-9950-48fa-be46-7d3fd409ead2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTMtMS0xLTEtMTQyNjI0_3030af61-d2b8-4d40-a259-470fd026ecdd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTMtMi0xLTEtMTQyNjI0_c70e7ded-acf8-469d-b4f6-bb19d4621dc7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTQtMS0xLTEtMTQyNjI0_abd943e2-7a5f-4ef1-affe-a3f101a9dfdc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTQtMi0xLTEtMTQyNjI0_a887e39b-d83f-4a54-b9a7-89f254918209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTUtMS0xLTEtMTQyNjI0_b7afd0cc-bb20-416c-ace4-5829c96d88db">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTUtMi0xLTEtMTQyNjI0_abdcbd0f-232e-447b-8b1f-b89558d1fd27">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91aae7c820be40a39dc2a16e37f937df_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTYtMS0xLTEtMTQyNjI0_d4d77250-baeb-419b-8362-8505ae3d3fe1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide752f889a824123acdfc488ef4c92da_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTYtMi0xLTEtMTQyNjI0_cea0738d-5e63-49dd-9a18-47061cd57bdb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i27ec869043bd461588620413855a8660">Refer to Note 10 for additional information regarding the amortization of pension and OPEB items and Note 13 for additional information regarding hedging activity</ix:continuation>.</span></div><div id="ia96c30333efb48e3af554b764666aed6_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">8. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODU_037a2b05-2e6b-4f23-a9e6-48261446311f" continuedAt="ife6b6b5a187f4f11b8461a0aa41acc7e" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="ife6b6b5a187f4f11b8461a0aa41acc7e" continuedAt="i2969dd5465824939a97fe0753c78d2b9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between <ix:nonNumeric contextRef="i48c4b44d7aaf45f6a6e5c398103bc5cb_D20230101-20230331" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfODA1_728d154c-21a6-47bb-810f-1fb73b928d7f">30</ix:nonNumeric>-<ix:nonNumeric contextRef="i21b2d8e97e8244178d692d6892f4a85a_D20230101-20230331" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfODA4_c970e1fc-5249-461f-8ee8-f739987c8799">90</ix:nonNumeric> days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjU1NQ_9d071c45-4142-4b30-b074-04ed37f799a5">9.9</ix:nonFraction> billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately <ix:nonFraction unitRef="number" contextRef="i5610c9c40f1541588c111ed258e20b5b_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjkzMQ_88a3b367-31a8-4a77-b8ab-bf5b8137b18e">25</ix:nonFraction>% of this amount as revenue over the remainder of 2023, <ix:nonFraction unitRef="number" contextRef="ifb101e2dce6d4a8da899e7f908565f3f_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjk4Ng_c104493b-69e2-4431-bedb-615cd433b0d3">35</ix:nonFraction>% in 2024, <ix:nonFraction unitRef="number" contextRef="i91e5bce880e748fa8fd4e3630bd445ad_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5NzU1ODI1Njg0_6087e750-7a43-4c32-9171-4d256ee5b2aa">20</ix:nonFraction>% in 2025, <ix:nonFraction unitRef="number" contextRef="i61cf97becb9c4e1a9b859df1e52905f9_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMzAxMQ_1d55cf70-317f-4c1c-954e-f6ba335e7a73">10</ix:nonFraction>% in 2026 and <ix:nonFraction unitRef="number" contextRef="ib69465f840b74ac28588c55cf8bf2541_I20230331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMzAyNA_05313f55-cb81-44bb-b892-6b1cc5d59369">10</ix:nonFraction>% thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2969dd5465824939a97fe0753c78d2b9" continuedAt="i8b2afd80fabf48f282320fd44d75ca4a"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in  accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2023 and 2022 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTMyNQ_51ad5f88-cfd6-493c-85fd-43780d75837e">2.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNDkxNg_a7f1c4fe-e968-4d63-9a4a-87b93b86f9ce">2.4</ix:nonFraction> billion as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to <ix:nonNumeric contextRef="if002ac6e967144bd96115173fc7cf29a_D20230101-20230331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTA4NA_1b827771-1a3b-4ebe-a5e7-b8d2d424126b">90</ix:nonNumeric> days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5Nw_058c585b-8103-4c06-82dd-1458b96650eb">one</span> to <ix:nonNumeric contextRef="ib95b5cb2f8e647f6a99def589a703561_D20230101-20230331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTUwMw_3a3d9471-b053-4de0-b44f-4ce5f2c2923a">five years</ix:nonNumeric>. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA4NQ_0ec20cf7-5fe4-4e5f-af12-88aff4a5d833">one</span> to <ix:nonNumeric contextRef="i934c0cc8c80045549e4782969e1e7b84_D20230101-20230331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA5MQ_9aa3e80e-5e1f-4bca-8739-88ad79fcab40">seven years</ix:nonNumeric>. </span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODE_3a030a6e-9afe-4ca0-8a00-7a44b5dc8999" continuedAt="ic87cf4b6e5b14e54b3497030d0286613" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6b196d8914241ada05ff36938bc292e_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMS0xLTEtMS0xNDI2MjQ_d51f1303-3b51-497a-8bda-2d7e71bd995c">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e73cac1b5c4796a4109810e816823d_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMS0yLTEtMS0xNDI2MjQ_3aa7d5aa-7748-439d-9ece-d69793bff7fe">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabeea204152c4e01befa7939da13274f_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMi0xLTEtMS0xNDI2MjQ_a4be45a3-4623-4ea2-9abc-a6454b1d0b6e">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieab095ac3325476aa40d27526c3ce9d6_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMi0yLTEtMS0xNDI2MjQ_c67ea28f-c4fb-47b1-a082-96557bb56699">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc44eeeb3fe4cf8a2fa2850b25dbd4f_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMy0xLTEtMS0xNDI2MjQ_732bbfb2-a9da-4964-9cea-f354280c857d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830f0bf194924d0e87c143bb795d1c61_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMy0yLTEtMS0xNDI2MjQ_d6544e97-1774-48d7-a86b-c034bee65cd1">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfNC0xLTEtMS0xNDI2MjQ_a316ab17-46ce-4184-879f-6f783497002a">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfNC0yLTEtMS0xNDI2MjQ_23297c91-36db-4701-8461-3ef40a152af0">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8b2afd80fabf48f282320fd44d75ca4a" continuedAt="ic0933864b6f84a79976fb04c5f292fc1"><ix:continuation id="ic87cf4b6e5b14e54b3497030d0286613"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March&#160;31, 2023 and 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMS0xLTEtMS0xNDI2MjQ_c336d7f3-4a9e-4bcc-b3ed-d978dae806d9">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMS0yLTEtMS0xNTQyMDk_11a5e64d-b760-40a1-8b9e-f603b6aa70d0">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="bax:ContractWithCustomerLiabilityDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMi0xLTEtMS0xNDI2MjQ_96dad7cf-bed5-4478-9cd3-330432a0ac32">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:ContractWithCustomerLiabilityDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMi0yLTEtMS0xNTQyMDk_cf927d1a-59d0-43b6-80b9-71ca8139a131">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="bax:ContractWithCustomerLiabilityTotalRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMy0xLTEtMS0xNDI2MjQ_6a367565-46d0-4058-89d6-79f8b9d3eace">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:ContractWithCustomerLiabilityTotalRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMy0yLTEtMS0xNTQyMDk_3d1261bb-9707-424b-905c-9c096654c746">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="bax:ContractWithCustomerLiabilityCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNC0xLTEtMS0xNDI2MjQ_56151e49-99c3-4415-8130-340ca5ec2359">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:ContractWithCustomerLiabilityCurrencyTranslation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNC0yLTEtMS0xNTQyMjY_7a14ca8a-e464-45bc-b3f9-a764ffafc9eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNS0xLTEtMS0xNDI2MjQ_af2dfdcf-8de8-47a1-b63c-a764ffe41dc7">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNS0yLTEtMS0xNTQyMDk_ad5fa5d6-50ef-4d06-9a1e-c002373d7246">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTQ2Mg_9d020e76-d0b1-4047-b3e7-748c3c05a153">68</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTQ3Mw_e7a7feb2-f7b5-474e-8ffd-b38b280ecab3">50</ix:nonFraction> million of revenue was recognized that was included in contract liabilities as of December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec046897a2946cd93ab85a15ee56c94_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMS0xLTEtMS0xNTc0MzA_96128a54-494c-4dfd-aaad-be689aeff2d1">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bd13a49b7d429e82c8bdf69b96e60b_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMS0yLTEtMS0xNTc0Mzg_ca793c11-3ef6-4ef0-8c06-5d4fe5682cb4">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30142c94438942e98469e05b1af863d8_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMi0xLTEtMS0xNTc0MzA_27e0127e-3974-4650-b15e-db4b858d89d9">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3508ca5e5c14a48b24d540f5319e20b_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMi0yLTEtMS0xNTc0Mzg_a57c35f3-4a7a-4fb5-bd60-0bc3709c4c52">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMy0xLTEtMS0xNTc0MzA_a316ab17-46ce-4184-879f-6f783497002a">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMy0yLTEtMS0xNTc0Mzg_23297c91-36db-4701-8461-3ef40a152af0">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51119038860e46bab77a4b1e87a97094_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNS0xLTEtMS0xNTc0MzA_4b97ee00-2b0c-4dd8-afc2-76ddf86f2c64">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23951dd4106e4790ac61468e0c4ec8df_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNS0yLTEtMS0xNTc0Mzg_d460a5e1-fb87-43e4-b897-c9b750aa61b4">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341560a16fc74ca08d74ea499cbe59d7_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNi0xLTEtMS0xNTc0MzA_ff221c57-7146-4fa0-8176-c58a6c854ddb">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib97450461ad646f683e7377c9387239a_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNi0yLTEtMS0xNTc0Mzg_2e1cd325-9381-42be-8255-15d7ce913475">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNy0xLTEtMS0xNTc0MzA_1d197418-fd15-44c7-8b8b-34e90f26f0a0">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNy0yLTEtMS0xNTc0Mzg_7c2985af-a7d8-4671-87f1-c65cdb2fed92">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODI_c718e025-a5a6-4aa2-89af-4262a3f76257" continuedAt="i3d12080e8f844fa8a3379b9719568e91" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieed79c5aca8f438cb35994e6accb8277_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0xLTEtMS0xNDI2MjQ_71d29b0d-ddff-419f-9760-1518c11b72cd">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32733260a4bf466da30a8f6e7a69dc20_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0yLTEtMS0xNDI2MjQ_ff83c064-eac8-499e-9ca5-27a6c2f2f38e">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9352b2578b4ff8af90d6737f465636_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0zLTEtMS0xNDI2MjQ_4ec0b093-8ee7-4e36-b753-1ae94b3373e1">892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dff2da3bb745e083dfc8efbc4a6a2d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy00LTEtMS0xNDI2MjQ_ff925943-66bb-4478-a52d-9dbfde46051c">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffe0a066678436faeb952bbc5692853_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy01LTEtMS0xNDI2MjQ_621f4c29-797b-4e56-9f01-8b103a56711b">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50262bb8dfd6483883e178e4d08c0ce7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy02LTEtMS0xNDI2MjQ_b88d1a7c-74e4-4f72-9312-9b8e58fbac67">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12de3de1a9974944bc8378eba2c65c03_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0xLTEtMS0xNDI2MjQ_d8db6cce-71a6-40a0-95a0-7ed728a7fad0">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bf91abd1634761a2195c7f9d8d118a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0yLTEtMS0xNDI2MjQ_5f3e29ea-1523-45c3-80d4-f166ec7d01ab">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7a0d7a1030b4a098fc24e15ad2a801d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0zLTEtMS0xNDI2MjQ_27cb272d-ccc3-47e0-8042-7f931cba8063">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820a760c47924ab98c99c4b2a9096d78_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC00LTEtMS0xNDI2MjQ_42643656-90f2-41e7-96ac-4fbf0cd4f75a">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6075f06dbd490298097b3ed5cd4821_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC01LTEtMS0xNDI2MjQ_19eaa5c6-a51f-40b3-9e20-3329df860f00">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf1bbc48b59745a293d43e19e9033459_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC02LTEtMS0xNDI2MjQ_710c3012-2c41-4ec4-8617-4c43f33fbd32">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac2f4acb21d4eda95086e8322451c06_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0xLTEtMS0xNDI2MjQ_b28df9e8-d84c-4a62-9bb0-99cb7fc0e20e">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id093cc65fe2e41f685c58769f4731abe_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0yLTEtMS0xNDI2MjQ_f3634c54-edd7-4940-8ca9-ce000e32bd90">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1f8777b66c4f1abea702af4a4f50d8_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0zLTEtMS0xNDI2MjQ_662bec28-a463-4330-ab5e-12fa155a1cf2">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ae97fbb983b4c339641d89166090167_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS00LTEtMS0xNDI2MjQ_106fb3dc-0ac0-429b-9362-3919393de3c2">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d21ce85e8b546008235897f9720292f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS01LTEtMS0xNDI2MjQ_426cb6c8-5adc-444e-a95c-cfda1e6b5efa">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a674bd62d60412dae3e15bda3d6fd5d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS02LTEtMS0xNDI2MjQ_a9275716-b872-46c4-b02d-f1473622f40b">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18171446335341e6972e6ad0f0855341_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0xLTEtMS0xNDI2MjQ_5b28e2b7-3e61-4ab6-9e48-6ec5949faeaa">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7450c4c4ea47f395399141fae391aa_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0yLTEtMS0xNDI2MjQ_e67e8fc3-7944-49f8-9535-c0176db244ec">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32eccbe2241e419fbbbba27ba8251c58_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0zLTEtMS0xNDI2MjQ_23626325-15fd-4e65-af9b-7d0af7c586ba">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4f3a644eb645e3b6ffb4f9285599fe_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi00LTEtMS0xNDI2MjQ_95840d79-26b8-4455-8be0-8b5253b66497">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326ca958c6174cbd9f53bd4911788519_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi01LTEtMS0xNDI2MjQ_4bfe765c-0531-4c89-9ea8-1dbd0046375c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffdd9abc5b147d1b6b3131424e764b8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi02LTEtMS0xNDI2MjQ_f56bff3c-16bd-434c-a153-0e9febdb818c">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48702d534ce34e3d895104c00a42f7b9_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0xLTEtMS0xNDI2MjQ_09827a13-69c9-4306-86f5-f3d8e86614ea">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77f8be4d668c436690b8ef4eaa3b1289_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0yLTEtMS0xNDI2MjQ_228411b4-e8f2-48c7-83ed-e2511a965025">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ecf3e2ffa240ab97ef06571c436317_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0zLTEtMS0xNDI2MjQ_38df9252-6ca3-4fad-8689-8f4098a50106">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae75aad13a8b4f4a9d28f6c2a411306e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy00LTEtMS0xNDI2MjQ_5f8214d2-7b35-48af-be3a-4cb17fe49be5">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36331106af6b44069480b11afb1c4eb7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy01LTEtMS0xNDI2MjQ_0676f0fe-c7d8-4684-98f6-ba5b130d549f">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70635d3e9e24de284e21b0565f0a12c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy02LTEtMS0xNDI2MjQ_36c7bf42-1952-4869-8e85-526c4d3d33f9">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a994bb1351d426e972cb4ab45bf9e31_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0xLTEtMS0xNDI2MjQ_d962d383-2a1b-47b5-9fa8-53fa1b2e16e2">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15645b93aa34aadb9ab25d167667aa4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0yLTEtMS0xNDI2MjQ_f6a7e5bc-3436-4231-928d-392173f79c6c">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5c3586df22467d826986ca298658b2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0zLTEtMS0xNDI2MjQ_10b6f70e-c075-48e7-9ff4-6e6bb7fa09d3">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifddaa3fea1ec401fb23364d3c78814ad_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC00LTEtMS0xNDI2MjQ_b1e2774b-2e96-44e2-b9af-54f233edacb2">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a9ffd20fe44b3494b57e15f7d91ccb_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC01LTEtMS0xNDI2MjQ_1a720f8d-0efc-49e5-be3b-3057ede7118e">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a56542c97d47a0b0f0459e24442e08_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC02LTEtMS0xNDI2MjQ_205c5c38-4e90-47ee-87d6-ad8929bd853f">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4237b6bc47b47e3be8d39761a9c6aa6_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0xLTEtMS0xNDI2MjQ_410ee862-ddb4-4d90-ba45-31782eba9034">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2481cb453dff4f67b82d44e30bd6d0fb_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0yLTEtMS0xNDI2MjQ_497c5dfb-2645-4ea6-b511-a31a24a55138">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cff1006b2cd4700a226e1343371d967_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0zLTEtMS0xNDI2MjQ_dbd2223e-dab2-439d-9555-735931fa1a63">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f9f21fee0414681bd88793126bd2d5d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS00LTEtMS0xNDI2MjQ_2610b225-699f-4f4a-85d6-e68738df1dd8">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0865a1d47314456a3bf5d603919e3aa_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS01LTEtMS0xNDI2MjQ_2e59d67c-5c9c-4d42-b719-ea3ddd6cda1b">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65045dd2524b4052a661a980309aee0e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS02LTEtMS0xNDI2MjQ_e1238efd-16ff-42fb-ad44-8155407fb433">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a6dd9348044feb8a8e67e815565350_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMS0xLTEtMTQyNjI0_5c399045-8161-4286-88ff-c0f72676ae27">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58acde9af12d40e88ea03e411ef7469a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMi0xLTEtMTQyNjI0_fe74e2b1-6b48-4739-bd8f-9b61304377ea">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8bcd8e837bc4dc08f1912d660ad261c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMy0xLTEtMTQyNjI0_0943d2c7-5dce-417a-96fb-4940db542357">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae2ec3cee867481bae76001f58c40302_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNC0xLTEtMTQyNjI0_f3d3c9dd-28b5-4630-8ca6-5ac1555b5e27">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8332d3c37964860a2fa8f6c0f6e8183_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNS0xLTEtMTQyNjI0_0adcea80-cc16-4dab-9a71-095c1875d937">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5d26e5e396479bb46016c7624c2225_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNi0xLTEtMTQyNjI0_421b1e89-a9b3-48b6-84fc-dc9bcc4c4844">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c506923a318493ea4d9c20cbab2421a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMS0xLTEtMTQyNjI0_08ec6ce9-55fe-42be-afc5-8737e73dd71f">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1768ac76934e2091b109112b486b74_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMi0xLTEtMTQyNjI0_ef52bea4-5dd9-49df-8eb4-312db5f8e6ae">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ac9d56de7f4427a9059c8e448f30f0_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMy0xLTEtMTQyNjI0_0be8df65-5b76-4c8d-b6d5-f3f5e098e8f8">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54c320fa8384fc9acd727cd9b93cb52_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNC0xLTEtMTQyNjI0_5fce53ae-69dc-464b-8c2e-0963aa4f3607">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88faf063570c4244819342e4932cf151_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNS0xLTEtMTQyNjI0_e8d073d3-7500-43e0-8439-6c9fe71a634f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic892496e521b4b4180628d9710fcfde4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNi0xLTEtMTQyNjI0_e40e99a2-52e8-49dd-a5a0-4c8f0cf11d92">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639893b243a5412089b13acbee4be7d8_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMS0xLTEtMTQyNjI0_718aabdd-61fc-4f46-80b0-c1d6c4a2ba24">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5f7268c6da45c28b4cc8a8092641d4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMi0xLTEtMTQyNjI0_4c9a5d42-75cb-41eb-86f7-ef555a2160b9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c3ca618644448a69e18c4788006dcfb_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMy0xLTEtMTQyNjI0_c300de87-2493-4345-a01d-3db9ec0c74a4">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4c6783bfa6492680542b292f98ef46_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNC0xLTEtMTQyNjI0_29162997-fd9e-4324-99d0-f9aa47dd1796">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7bcb4770d143ccb5cf3653c8dbd7ea_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNS0xLTEtMTQyNjI0_0f4cbfb4-bf78-43cd-a831-163499fc3a57">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04066796b2e844dd9677b2763ae8e6ee_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNi0xLTEtMTQyNjI0_0be81440-fa03-4ad5-baea-59db45fa43c1">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43580480246408d913ffd6f7571c3c4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMS0xLTEtMTQyNjI0_23ad4dcb-a1ef-450b-9a59-71539e333bf7">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700fd4a0950a4c45b9412d578fea8869_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMi0xLTEtMTQyNjI0_63a279a9-fee7-445e-953e-11933a3960bd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406d564a78fd4100975bf9f358114ad6_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMy0xLTEtMTQyNjI0_f9d4c705-5c8b-440b-b775-f9f75d4d235f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed76db4cef84a44b19a64f1d1833488_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNC0xLTEtMTQyNjI0_1a475243-7366-495d-b92a-25bb1f89050b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50189ca1ce5346128884acb2fd951604_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNS0xLTEtMTQyNjI0_872516be-20f3-49b0-84ac-d26004705d74">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556f482c728a4e6abc7fcb69f24c8e79_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNi0xLTEtMTQyNjI0_4fc00098-75bd-49fe-96f5-3068df721bb1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e11ed2205046a495eb41670b8242bf_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMS0xLTEtMTQyNjI0_68998ddd-fcb4-49b2-9884-a1137e670191">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5191430d4c4fa5b3ea2beb1699b836_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMi0xLTEtMTQyNjI0_49bd6d51-0804-48d4-ba15-3149cd7591c9">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMy0xLTEtMTQyNjI0_3e67196d-a1e7-4b29-848b-5619879b358e">3,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f02dbb147d48a7be36808b0e938d20_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNC0xLTEtMTQyNjI0_0f7b75a0-99c1-42e9-915a-37110851db6a">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42fee9757d10432cb8ae120e6b418ddd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNS0xLTEtMTQyNjI0_c51b036f-6cd6-4137-a49d-43f671840dd7">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNi0xLTEtMTQyNjI0_f3fff65d-31a9-4801-ae4b-6652a0210916">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic0933864b6f84a79976fb04c5f292fc1"><ix:continuation id="i3d12080e8f844fa8a3379b9719568e91"><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Global Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease medical equipment, such as smart beds, renal dialysis equipment and infusion pumps, to customers, often in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODM_31727caf-ea1f-4675-83f9-01ba505a16f7" escape="true"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODM_f12aa58e-ddfe-4d46-914e-bd1a0ec526bc" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMS0xLTEtMS0xNDI2MjQ_11345ccb-6e43-4b39-afc8-eebe9216730b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMS0yLTEtMS0xNDI2MjQ_fd0ed408-b210-49fe-8914-aaa684d54ba1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMi0xLTEtMS0xNDI2MjQ_0ba13b7a-0e57-49c4-a7a8-ede0eb6bf5fc">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMi0yLTEtMS0xNDI2MjQ_d647f3b3-56cd-486f-b551-d5ec2887c2df">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMy0xLTEtMS0xNDI2MjQ_4658f10d-959b-4a66-b52a-b05fe584db46">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMy0yLTEtMS0xNDI2MjQ_f70ac036-36a3-48a8-bc1a-d8983d317f27">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfNC0xLTEtMS0xNDI2MjQ_27eba016-0281-4656-8947-dd7af6a3118d">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfNC0yLTEtMS0xNDI2MjQ_e242c991-caac-4dcd-8466-f783831cac3e">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.137%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAxNzE_5b6cbab5-4cf7-4c2e-a6a3-8b499f003b67">82</ix:nonFraction> million as of March&#160;31, 2023, of which $<ix:nonFraction unitRef="usd" contextRef="icd5a84bea14647598fb6658816f37588_I20191231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAxOTM_f3ff79b9-ed19-46f0-91af-cd63830b2b13">24</ix:nonFraction> million originated in 2019 and prior, $<ix:nonFraction unitRef="usd" contextRef="icd5848326be84436ade2b47357ffcccf_I20201231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyMjY_8473eecd-b0b8-4166-a32e-87ca28f036c3">21</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyMzg_fd7b3386-a2c6-4db9-abe2-5d5e0a5c3be8">20</ix:nonFraction>&#160;million in 2021, $<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyNTA_a044b86f-d877-41db-98e6-ffa8fdd4bd86">14</ix:nonFraction> million in 2022, and $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyNjY_f772ef6d-d9dd-4168-8678-8c283993ee54">3</ix:nonFraction>&#160;million in 2023.</span></div></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_67"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">9. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxNQ_e2f9eef7-2019-4cb4-ac74-ada7adaf840d" continuedAt="i793292071f3d4f1bbd5c3f5507dddb81" escape="true">BUSINESS OPTIMIZATION CHARGES</ix:nonNumeric></span></div><ix:continuation id="i793292071f3d4f1bbd5c3f5507dddb81" continuedAt="i24f80046e8d74d1fad68e1ea4d2061b2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2023, we have incurred cumulative pre-tax costs of $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfNjQ2_0096d07a-58c6-49db-bd5d-9e586d690d19">1.6</ix:nonFraction> billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfOTc3_f49ec4b7-ec10-4a07-85ba-7e6c48b4a1d5">24</ix:nonFraction> million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="bax:BusinessOptimizationChargeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxNg_d0d827c5-3d8b-4761-9078-75b2c4192fd1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMi0xLTEtMS0xNDI2MjQ_50234265-762c-4e11-bdc5-8ef4f364ee9d">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMi0yLTEtMS0xNDI2MjQ_01e165e3-c868-4548-8fb9-2b3102bd30a3">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMy0xLTEtMS0xNDI2MjQ_5b43a160-0dea-494c-8a9d-e195c5e298af">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMy0yLTEtMS0xNDI2MjQ_1301af76-9cce-47f4-8068-cd12c9b0dd25">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfNS0xLTEtMS0xNDI2MjQ_bb8a4014-f4de-4b37-baf7-cda8dc810e64">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfNS0yLTEtMS0xNDI2MjQ_7a6200ac-451d-4e44-ab56-dc845c64958b">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i24f80046e8d74d1fad68e1ea4d2061b2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three months ended March&#160;31, 2023 and 2022, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxMQ_f0e65d91-d402-4083-bf45-e3acd1f8b6a1" continuedAt="i03a9db246a2b4dd3b7ea0d1275836da1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f1c5a1ba7442d1a6b301c41e26e0bd_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0xLTEtMS0xNDI2MjQ_7335128f-d9b4-45ce-84e6-8431f1b77621">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e9e48c329d4d63aa8ed4f54c4d2d61_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0yLTEtMS0xNDI2MjQ_d1ced006-b709-4d76-80a3-4ff20d54c48a">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7f02b816254b8aa330323c3a69a6f8_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0zLTEtMS0xNDI2MjQ_0215cfcb-5b3a-4207-aa8e-55ee114b7861">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a9fd6731664971b019d860f06b8d7a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi00LTEtMS0xNDI2MjQ_786d05f5-1ab2-4450-9b4d-702e174a2b9e">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf58d18ba69645c388a1b80e92a29a6a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0xLTEtMS0xNDI2MjQ_b1dd6cbf-c63c-41b4-bfd8-51d548db1013">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857194e9005945168ca557c8b9cd6cf6_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0yLTEtMS0xNDI2MjQ_cdccb12d-4636-4d0e-a1c3-1cc54acc67a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080f246a03434c36b738f2ab73889cb7_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0zLTEtMS0xNDI2MjQ_3beb6343-9d34-44c3-920f-ea260980adc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723a8f8cd90d40c5b923bb953965b6f0_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy00LTEtMS0xNDI2MjQ_9aa828f6-f467-41fc-a2cb-10bcc4620c67">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cdbf59bba942c799174d71fc78424f_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0xLTEtMS0xNDI2MjQ_d82ac440-ec62-46dd-a9dc-664209f66e42">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7480c0baf3ef4031958b631683211304_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0yLTEtMS0xNDI2MjQ_9aad4d43-482d-479c-885f-89ce75e7ef17">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ace030c17a84199b8a58d5de02660b0_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0zLTEtMS0xNDI2MjQ_0777bff5-1f4a-4dfd-afbf-d27e294ba5f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcb0c4c8a0364ddab4ced3d467f03536_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC00LTEtMS0xNDI2MjQ_ae5e9a32-b4b7-49fe-b7f2-724851dd1046">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9afb4c625184a3f99e2cb5a2e3d5eaf_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0xLTEtMS0xNDI2MjQ_ac821844-ecbc-4c88-9e8a-db37b2d1f4bb">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9d2e13254a4a851b924c07c94850_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0yLTEtMS0xNDI2MjQ_75d2334a-8133-4618-adfa-23096a7cf2e1">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcdaac085a184fd991190127986b186a_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0zLTEtMS0xNDI2MjQ_08ae7ec6-88ca-4001-8715-99b74001c40b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS00LTEtMS0xNDI2MjQ_78ab5adf-1f76-4b10-9e19-16ed77efea9f">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><ix:continuation id="i03a9db246a2b4dd3b7ea0d1275836da1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd11f2b19d644626913c68555b6a3ed3_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0xLTEtMS0xNDI2MjQ_30669dcd-a082-4142-8d08-258644c1853f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba969a96aa1a4d5c9b9694620c56457c_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0yLTEtMS0xNDI2MjQ_f648483b-87ce-46aa-8a82-b15d72cbaa21">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd088a28be84475899676efd77df7fb1_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0zLTEtMS0xNDI2MjQ_286c060b-32fb-416c-aa75-22f501dd87e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0844e0faf2924757a27a663c5f70585f_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi00LTEtMS0xNDI2MjQ_36a515d1-64e0-47af-9062-da77705d0640">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe3d35593ef467a942d74f57b0d973f_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0xLTEtMS0xNDI2MjQ_ba6ddf02-35df-4247-98ad-34a9ae0963b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee715c6013774f86871bc93f1f3c5581_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0yLTEtMS0xNDI2MjQ_97fd5b57-7707-4bfe-a627-e765a07f617b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ded499efde348f38db33fa32a02f9c7_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0zLTEtMS0xNDI2MjQ_67fe7a95-6349-4e65-a2a7-cdb38f136319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf53b679288243c4b2c60ffa46acdbc7_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy00LTEtMS0xNDI2MjQ_4773fac9-5c46-46c5-977c-c150cf5a4c22">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ebac333e6b4b7e824140ded41ed412_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0xLTEtMS0xNDI2MjQ_1eef68a6-b1dd-4e3c-ab6d-428b7a011fc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i360dc4f66e284c169a8571d8f06cfb23_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0yLTEtMS0xNDI2MjQ_d2af98f4-0a6f-4d76-8dda-f3d6bf5b559d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eafd0032b54ff9b789fb388acb51f5_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0zLTEtMS0xNDI2MjQ_312814fa-29ce-470f-a886-e2b69ba76352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301ed7692b8f4861bf3943d034b41d27_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC00LTEtMS0xNDI2MjQ_bf35d19a-9c0a-4fad-95a7-2dca434a7c4b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbd6d4f17c1483890abb77740b35017_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0xLTEtMS0xNDI2MjQ_bbe28957-f072-46da-bcc3-fbd51b983969">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d39b8e7b0d742918fa14009236396be_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0yLTEtMS0xNDI2MjQ_18e60310-f428-4307-89d1-d56cdb9e70d5">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf871b9974004097959095e896164ea5_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0zLTEtMS0xNDI2MjQ_12521712-4b65-4441-9b8a-b095393ae09d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS00LTEtMS0xNDI2MjQ_e1f7abc8-b033-4d29-b0f1-f57872eb8ea1">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i8ef6dc9c2a204c7eb7bd1ef80318af8e_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MjUyOA_ece48a94-d355-4053-9216-4c9099cd7fd5">78</ix:nonFraction>&#160;million of the restructuring charges reflected in the table above, consisting of employee termination costs, were related to the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="icbd8645e550c4ed8952d05182e882159_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3Mjk3NQ_68cdb79b-bd3c-4856-bfb3-d5d766aca528">56</ix:nonFraction>&#160;million of the restructuring charges reflected in the table above were related to integration activities for the Hillrom acquisition, consisting of $<ix:nonFraction unitRef="usd" contextRef="ib5c12720ec2d4657b11334d2f5c03900_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MzA0NA_0cd055d8-4c6a-41f1-b565-446fb9f71758">38</ix:nonFraction>&#160;million of employee termination costs, $<ix:nonFraction unitRef="usd" contextRef="iab2e3d03af0e4a9d8b80b6d36fc10ad6_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MzA3Mg_e2c53649-7c25-4885-a6d8-6c2fec186e7f">12</ix:nonFraction>&#160;million of contract termination and other costs and $<ix:nonFraction unitRef="usd" contextRef="ie7cece8bf1314a0bb7e3af8e0b6c6632_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3Mjk4OQ_f4ab1700-e11d-41d6-954f-21ad77c69a10">6</ix:nonFraction>&#160;million of asset impairments.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxMw_bb4c4a72-e090-4124-8c31-90eefda8206b" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ff73073d6be424295feaeb2acc57d80_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMS0xLTEtMS0xNDI2MjQ_522bd641-fa46-4b94-9bc5-781b04ffe3ba">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMi0xLTEtMS0xNDI2MjQ_08e99033-3551-4391-a14f-fc584ceb02b1">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMy0xLTEtMS0xNDI2MjQ_54c85db3-0298-4892-b27c-38ce6d16d15c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNC0xLTEtMS0xNDI2MjQ_82dc64f7-9587-4e31-81c3-b4d39ea9fc16">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNS0xLTEtMS0xNDI2MjQ_94d953b9-4cc1-47d0-98d4-5986e1d35af0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47e22ae3131468e92ac7e7b3405265d_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNi0xLTEtMS0xNDI2MjQ_4cb6f839-d679-4eb5-9cb0-007ade21ce3f">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of March&#160;31, 2023 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2024.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">10. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RleHRyZWdpb246MWIyMGUyOGI1NjQ1NDY2OGFlNmY1MzhlMjVjNWY0NTBfODQ1_91e1430b-d825-41fd-9759-8cd1279531cc" continuedAt="ic6346cac1c4c4f3e8e36bdb6f4954188" escape="true">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ix:nonNumeric></span></div><div style="margin-top:10pt"><ix:continuation id="ic6346cac1c4c4f3e8e36bdb6f4954188"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RleHRyZWdpb246MWIyMGUyOGI1NjQ1NDY2OGFlNmY1MzhlMjVjNWY0NTBfODQx_cd3563ee-f34e-4834-a20d-2ec4d94a56fe" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMy0xLTEtMS0xNDI2MjQ_cd4b442f-36ea-448e-945a-c110e91fa06a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMy0yLTEtMS0xNDI2MjQ_0f4a121b-c0d6-4d64-9ef0-b2830511974d">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNC0xLTEtMS0xNDI2MjQ_fb3570bf-56dd-4394-b4c6-8acbe42c8057">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNC0yLTEtMS0xNDI2MjQ_cb216658-d422-4f50-99a0-c34b40535dad">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNS0xLTEtMS0xNDI2MjQ_76a9d14b-aa4e-4594-af85-789de52435ca">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNS0yLTEtMS0xNDI2MjQ_f6991e3e-e4c2-4eda-9840-e32ddfe8dbda">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNi0xLTEtMS0xNDI2MjQ_fa015aba-b7ab-487a-8901-9ad87b0c0447">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNi0yLTEtMS0xNDI2MjQ_3e528988-65d0-4371-b797-cf9bb132c266">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNy0xLTEtMS0xNDI2MjQ_059efc9c-f850-4fd2-8ea5-b4a2bff712f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNy0yLTEtMS0xNDI2MjQ_676fd516-cac4-4f1b-9190-d99725b6a23e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfOS0xLTEtMS0xNDI2MjQ_0db7b93a-9e6b-4190-ba7f-06b454fe122c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfOS0yLTEtMS0xNDI2MjQ_fcabe3f8-a45e-4b6d-b417-62f0c2fd495f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTAtMS0xLTEtMTQyNjI0_858ba820-254f-4fb5-be7c-ddbb73d8b302">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTAtMi0xLTEtMTQyNjI0_fa545479-16a1-4467-96e8-527b7d46b175">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTEtMS0xLTEtMTQyNjI0_ed930c95-d86f-4bde-a775-e59b69968c3f">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTEtMi0xLTEtMTQyNjI0_cc55cfde-9d3b-4200-b8fb-5b6240224e6f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="ia96c30333efb48e3af554b764666aed6_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> 11. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfMTU1Ng_29e2269e-b7c9-4fea-a38d-44763375311c" continuedAt="ifcfe74471a00476dab127fe9cf28f7df" escape="true">INCOME TAXES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ifcfe74471a00476dab127fe9cf28f7df" continuedAt="i4b6841653f5e4fe3aff2f183b11f0632"> </ix:continuation></span></div><ix:continuation id="i4b6841653f5e4fe3aff2f183b11f0632"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfNTg_c94ba282-2b2a-4364-95b1-9744e34986a5">35.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfNjU_79bf498a-6672-4832-b32f-a59e10a4dc85">22.3</ix:nonFraction>% for the three months ended March 31, 2023 and 2022, respectively. Our effective income tax rate can differ from the <ix:nonFraction unitRef="number" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfMjE0_2c9b2dd0-e98f-47e2-b0cc-b2c8af38cb7b">21</ix:nonFraction>% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances, increases or decreases in liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to tax shortfalls on stock compensation awards and an increase in our liabilities for uncertain tax positions, partially offset by a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none were individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_76"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">12. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMTE2Nw_60ab1a1b-67a4-43ba-a688-a5f8b0dafd78" continuedAt="i5920e9860a8c4a84b8adee877c3f1fb7" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i5920e9860a8c4a84b8adee877c3f1fb7" continuedAt="i362ac0171da04f0498e7e10c2f8b6d2e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMTE2OA_18956669-ebb7-465b-bcfb-3314f8ee2216" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMi0xLTEtMS0xNDI2MjQ_a527345d-70a1-482b-a2ad-22326c322cbd">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMi0yLTEtMS0xNDI2MjQ_dc09c924-adf3-4c13-b575-8256982da745">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMy0xLTEtMS0xNDI2MjQ_a7d01031-feba-4451-8bfd-be266ca5ae45">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMy0yLTEtMS0xNDI2MjQ_87eb2669-ff35-4fb8-90c2-39c62a8e05ae">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfNC0xLTEtMS0xNDI2MjQ_eab563e0-21c9-4ce6-8c51-3bcf61c44d08">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfNC0yLTEtMS0xNDI2MjQ_f9ac1761-34d4-460d-8fc3-30af9dedd3ad">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i362ac0171da04f0498e7e10c2f8b6d2e">The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes <ix:nonFraction unitRef="shares" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfODI4_c32701b5-d931-40b6-83de-702288ec4ef4">17</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMjc0ODc3OTA3MTQyMg_83814830-728c-4dab-af68-0d9238ad2ffe">4</ix:nonFraction> million shares issuable under equity awards for the three months ended March&#160;31, 2023 and 2022, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">13. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwNg_34e1c17a-1c2c-4d7b-8502-82c1bfadd435" continuedAt="i9f71194e921442a1aa0105c51b1981a0" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="i9f71194e921442a1aa0105c51b1981a0" continuedAt="iae02b5754aa342dcbfa44cd1640c1281"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $<ix:nonFraction unitRef="usd" contextRef="i9538dd5f2a2244a9adcb80fb4dd92160_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzU1NQ_628ac493-e033-410f-905b-55cb1b7db5ad">386</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id4f02046af9547bf90a5a5fecea5c89e_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzU2Mg_0b26b3c1-6b69-42eb-ae96-0d2e6466111d">398</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at March&#160;31, 2023 is <ix:nonNumeric contextRef="i4c66e4f9c56742b18ccfe453072a0567_D20230101-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzcxMQ_5ebd427e-2fd8-4c9e-9939-53ca0eb7d9a6">12</ix:nonNumeric> months for foreign exchange contracts. There were <ix:nonFraction unitRef="usd" contextRef="i8f7c52bc902e4958a1aa1af5261b13dd_I20221231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzc1Nw_38c00733-1b1d-4d35-966a-f3a885948bc7"><ix:nonFraction unitRef="usd" contextRef="i98bfbbe989f94db8a2f6860f5daea064_I20230331" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzc1Nw_52b3c302-c9ba-49b5-b638-119a7c6083aa">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iae02b5754aa342dcbfa44cd1640c1281" continuedAt="ia979b2d6cdb545f4a8c6b2ab3d38f9e5"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ibd110d5b3b474fb9a4243053206a4b98_I20221231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDY1MQ_2e8072a2-313b-4925-8693-b8d6fa57a5e7"><ix:nonFraction unitRef="usd" contextRef="i8bc91ff6eb4746318f5c648bd8d956ae_I20230331" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDY1MQ_f66fc176-977e-4d5b-ab96-09274a7e0afc">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i0ae9704eed9e408f85ac8af9ab07b959_I20170531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDc4NA_bc26615e-be05-479b-92c4-b1f9764e006f">600</ix:nonFraction> million of senior notes due May 2025. In May 2019, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i747bc7554666414992b2b24bb2e4b2b9_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDgzNA_084e8601-377d-451e-967e-0a9136884dce">750</ix:nonFraction> million of senior notes due May 2024 and &#8364;<ix:nonFraction unitRef="eur" contextRef="ic5cedfb9fb234c4fa8f05974b6a48de8_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDg2NA_7d5cf402-3285-4b38-a664-0a59510e6dee">750</ix:nonFraction> million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2023, we had an accumulated pre-tax unrealized translation gain in AOCI of $<ix:nonFraction unitRef="usd" contextRef="id9faaf9a5d1d4dc39fc43d27a01f474a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTE4OQ_cde6521b-0e69-4e75-bf20-55ecf9747a88">47</ix:nonFraction> million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTc5MQ_21268304-3fcf-431e-9c2a-c302a3eec7fa"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTc5MQ_f29dd2e5-7bf2-40e0-b460-85f84454630b">no</ix:nonFraction></ix:nonFraction> cash flow hedge dedesignations in the first three months of 2023 or 2022 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were <ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjE4MQ_2f62ae85-6e2c-49f1-bf8c-3b133b3e4b7c"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjE4MQ_cd7b96f0-1985-4567-9880-28b4e7eb5794">no</ix:nonFraction></ix:nonFraction> fair value hedges terminated during the first three months of 2023 or 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gain or loss recognized in AOCI is not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were <ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjQ3Nw_200c90e4-3469-440a-9468-786e87401637"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjQ3Nw_940ab267-4682-4792-8855-e1e266f737a8">no</ix:nonFraction></ix:nonFraction> net investment hedges terminated during the first three months of 2023 or 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $<ix:nonFraction unitRef="usd" contextRef="i8be3a0f43b6f4f4697b04212b8b81e2d_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzAwMg_a289ac71-5c4b-4be7-84a3-d51aab7c0199">632</ix:nonFraction>&#160;million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i496040ce8ccb46e6bb87e3ad9f95ec52_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzAxOA_df84385e-7585-43a1-8385-3d54b331b1ad">753</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwNw_e2a4d8ee-ac00-440b-ba18-1432fb709150" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc935ff843a4dc29ec8c895720e3066_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy0xLTEtMS0xNDI2MjQ_e2c08e7e-3d1d-4141-bef0-dc1cee86f8ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a795c4b1fb4e3084ef17809809118d_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy0zLTEtMS0xNDI2MjQ_43683746-90e9-4981-afa0-a27a2da8c259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib752bbb3f58f4422b1f965bc7c89f074_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy02LTEtMS0xNDI2MjQ_d627c403-d753-40ee-9374-69261dba3040">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea2285dfc1a7402a99c067a6e802ca97_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy04LTEtMS0xNDI2MjQ_cb1efaa2-ebef-4376-8361-6a103dcb9a95">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i189d98535fb942c99329457fb43522d1_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC0xLTEtMS0xNDI2MjQ_530d9c8a-9a29-4e87-8507-e60d24d5b58b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c25693c2f1b4a5f9dfc483f5ca0a8b2_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC0zLTEtMS0xNDI2MjQ_6b5630c3-f105-4cbd-9f6a-866d819cd95d">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab0be122c59428e9024680a862f2c0d_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC02LTEtMS0xNDI2MjQ_899aad96-513c-4beb-9b31-986d29e7d3a0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaad8a6fd0bd4705ab16d4fb5b21406c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC04LTEtMS0xNDI2MjQ_c882a4f6-e12b-4aa3-b02a-279803304e1d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66a9ab3f00c6441596fadb7fc37919f1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS0xLTEtMS0xNDI2MjQ_568e550c-b742-4527-ae17-c42217c8e9c1">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8118589f429a4a0ca38950943ac2978a_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS0zLTEtMS0xNDI2MjQ_95d0c49f-86ff-4a60-bb64-1e34b365cbff">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cf39a12b99429d8289596966b89fe2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS02LTEtMS0xNDI2MjQ_50e15ac3-b265-41e9-a682-1bf68cfc8cfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ecdd9ca5f54679995d5d378c4d06ee_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS04LTEtMS0xNDI2MjQ_df7a4204-cffb-41dc-85f4-c6a49cd230ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi0xLTEtMS0xNDI2MjQ_3aefc7c5-6718-458c-beaa-a0fb0e21d78c">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi0zLTEtMS0xNDI2MjQ_a784a51e-11f8-4fcd-acab-1dc7939f13cf">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi02LTEtMS0xNDI2MjQ_9ed538b5-d56a-4227-ad49-a8ac28b1d419">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi04LTEtMS0xNDI2MjQ_a180f834-bff7-446b-825b-4d10ca0094bb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46477fce4d7049aab502d6b4eb1ab53b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmE1NWNiOGJmNWNjYTQ4MjNiNTkzYTQzMjg4ZjA3YjE4L3RhYmxlcmFuZ2U6YTU1Y2I4YmY1Y2NhNDgyM2I1OTNhNDMyODhmMDdiMThfMy0yLTEtMS0xNDI2MjQ_9def2fbc-5073-4c75-b460-c3a36d3f91f7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1f79300409417e829d19d1e521ffde_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmE1NWNiOGJmNWNjYTQ4MjNiNTkzYTQzMjg4ZjA3YjE4L3RhYmxlcmFuZ2U6YTU1Y2I4YmY1Y2NhNDgyM2I1OTNhNDMyODhmMDdiMThfMy00LTEtMS0xNDI2MjQ_b739449a-6133-492f-8666-0f5dba81514f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><ix:continuation id="ia979b2d6cdb545f4a8c6b2ab3d38f9e5" continuedAt="i853f800986e7458b9dff9ec0324c192c"><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzU2Nw_ea5775b6-2f53-48e2-b5ed-bca1ab60eca5">3</ix:nonFraction> million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwOQ_d37a0814-8341-46ef-a9e5-fae3d389a07a" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2023.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671ceedc0954414bbc1ef559a31dc3b0_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNC0yLTEtMS0xNDI2MjQ_224aa358-ba1f-4030-82a5-aaa098a90eb8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8311fb17141a43e08936804f2663ce41_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNC01LTEtMS0xNDI2MjQ_790b7f47-0e5b-434a-bd21-86719c7e9b65">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0855e415a24ea2bbed65f9964a98ca_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNi0yLTEtMS0xNDI2MjQ_12d99a88-5d68-4778-9acb-4f4d26c63d6f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0855e415a24ea2bbed65f9964a98ca_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNi01LTEtMS0xNDI2MjQ_1732c6f3-4ff0-4887-bf89-55bf097ec11e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6620927c944ffab75861c764f15bbf_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOC0yLTEtMS0xNDI2MjQ_bbf981e2-79bb-4049-8a27-5cf995c9f171">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9582e8bab32a4622a5341a018568c9a6_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOC01LTEtMS0xNDI2MjQ_3cf76e16-1ac1-4e9c-960e-4fda01380dca">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOS0yLTEtMS0xNDI2MjQ_364a5a11-204d-4b1f-b1d5-2687c3417049">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOS01LTEtMS0xNDI2MjQ_cfdd1d38-d0fb-4f15-b9f0-1050d29a3186">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e1d124500c4886b5441bdd89954116_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNC0yLTEtMS0xNDI2MjQ_fe51bf43-75f7-415e-9767-d7009c2a3ee3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d40aa82836d4e5d80dbeabff53e5546_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNC01LTEtMS0xNDI2MjQ_2aba6554-7491-4558-a68a-c78d1b5cad25">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNi0yLTEtMS0xNDI2MjQ_91c63140-3450-4b89-b0aa-2f6bb757217d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNi01LTEtMS0xNDI2MjQ_9ba92cf3-61a3-4466-b9e1-033e70398989">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b248d3ee7c433a940949503db3e3fb_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOC0yLTEtMS0xNDI2MjQ_cd679f39-b2fc-4dbe-9890-7ea6a9818a51">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d5a655bb88c41bfb5152c5fc3f19595_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOC01LTEtMS0xNDI2MjQ_0b61018a-279e-40f1-8d06-c12efa4de670">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOS0yLTEtMS0xNDI2MjQ_890fcc6b-4193-46d6-8e3d-1cade7388896">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOS01LTEtMS0xNDI2MjQ_6e0ee229-884b-4651-92bf-73ac32cc4339">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODc5OQ_75b25814-d3af-4859-b80c-885cae94fc28" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi0xLTEtMS0xNDI2MjQ_b55d12cd-ee42-4a47-870f-d898bbc7d927">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi0yLTEtMS0xNDI2MjQ_0e0a3ceb-15e3-4bb0-b82b-ab9ae752b346">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi00LTEtMS0xNDI2MjQ_ef921e0a-01e7-48a6-9d50-44146b4e5c52">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi01LTEtMS0xNDI2MjQ_85e9bfca-9e78-42ea-88eb-055890f65331">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy0xLTEtMS0xNDI2MjQ_3ee128f1-0805-4d7e-8cff-77a244efb637">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy0yLTEtMS0xNDI2MjQ_d25fbce9-7461-4fbf-b89e-8139dba0e6c9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy00LTEtMS0xNDI2MjQ_e2856bfd-9db9-48b8-a96b-c9f5138b535d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy01LTEtMS0xNDI2MjQ_8c74e186-0e29-47ac-be13-dbafd783154e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC0xLTEtMS0xNDI2MjQ_59c080a5-3316-4ac8-8456-848a90002ac0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC0yLTEtMS0xNDI2MjQ_69c3210a-caec-49ae-817e-d35f0a9d9e91">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC00LTEtMS0xNDI2MjQ_459233a3-3d59-405c-92cd-e22cbdcf85b1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC01LTEtMS0xNDI2MjQ_a34645f6-ac33-4045-a42f-f2d8626bf021">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i853f800986e7458b9dff9ec0324c192c"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwMw_0a0157c1-1734-44a9-bd9e-60a22ece77b7" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607c52fdcfa04c428b2116b4f6436aa0_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi0xLTEtMS0xNDI2MjQ_0d943f79-4700-42bb-b81e-ddd091925835">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad00739353c4b57be82940bf374498e_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi0yLTEtMS0xNDI2MjQ_e4652ef3-f047-4668-af6a-edf11474846f">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607c52fdcfa04c428b2116b4f6436aa0_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi00LTEtMS0xNDI2MjQ_86b9e9d2-d34c-4efc-8ba6-b446e845e682">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad00739353c4b57be82940bf374498e_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi01LTEtMS0xNDI2MjQ_71f4b3ee-85a7-4e1d-a181-bda4b42cff1f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div></ix:nonNumeric></ix:continuation><div id="ia96c30333efb48e3af554b764666aed6_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">14. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxOQ_3e14fcb3-86a7-4b48-b50f-1100905ca70d" continuedAt="i8e9ca7a669c44831ba883e23a0665e98" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i8e9ca7a669c44831ba883e23a0665e98" continuedAt="ic42fa9673357472a905bb96d8d94a468"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNQ_6e69f5f6-44d5-46da-ac4f-dfc93bdaefa4" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0xLTEtMS0xNDI2MjQ_30f32742-d6d5-45ee-aec4-ec955de9a3c6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0yLTEtMS0xNDI2MjQ_70902633-3d2c-407a-a666-9e615d7b6f09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0zLTEtMS0xNDI2MjQ_221bc864-0ee3-4104-bd57-df9c08506114">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy00LTEtMS0xNDI2MjQ_7b0c0a2f-16c0-479b-b88c-da1df25ec83c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0xLTEtMS0xNDI2MjQ_becf91e3-85fb-4b00-9c8f-5970bb2b34a3">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0yLTEtMS0xNDI2MjQ_4dd4c31e-03b3-4300-b25a-0927997a9a73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0zLTEtMS0xNDI2MjQ_3514bba4-ecd6-432d-b26d-2e821824fb67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS00LTEtMS0xNDI2MjQ_9f1300f7-6597-42f4-bd65-edddb5297d34">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0xLTEtMS0xNDI2MjQ_2ccfc1c9-ee63-473c-8554-9aa712a2000c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0yLTEtMS0xNDI2MjQ_9d7bed27-b940-4aec-b246-3192e0c44b18">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0zLTEtMS0xNDI2MjQ_a14c90d4-d11d-44cf-9adb-5fd32de2a807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi00LTEtMS0xNDI2MjQ_3f4b77cc-6f6e-4cb2-9ca7-2d6fe5227409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0xLTEtMS0xNDI2MjQ_c7d4cd4c-d18a-49e2-a84c-4e3823beca98">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0yLTEtMS0xNDI2MjQ_be127a8e-50e9-4c73-8715-ccd3cb768e78">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0zLTEtMS0xNDI2MjQ_fa93d471-140e-4906-aab4-a66c076aa3f7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy00LTEtMS0xNDI2MjQ_0909d655-b03c-4281-9bc6-bf300e9c4cd8">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0xLTEtMS0xNDI2MjQ_44ef853d-f0a8-4c3d-8f1f-fcd2c7fdaf2d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0yLTEtMS0xNDI2MjQ_1dd8726f-da45-4d26-a43b-d135bbcf212b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0zLTEtMS0xNDI2MjQ_a6f1c3ec-d232-4175-a41c-7f5d180ad28c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS00LTEtMS0xNDI2MjQ_91e720d6-be30-4eac-b264-b95feba8d84a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMS0xLTEtMTQyNjI0_91946f3f-38d6-4259-9ba4-97fb33dba09d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMi0xLTEtMTQyNjI0_7cac0e40-5924-4607-8ee7-8e3d57d08015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMy0xLTEtMTQyNjI0_25f5a02d-0db1-4df3-b618-c6a7ebe1df9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtNC0xLTEtMTQyNjI0_3ea0469e-1ef1-4783-ab88-7c5c8ca111aa">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5014e9c356493ea281263e29225f8c_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMS0xLTEtMTQyNjI0_6754d150-8f75-46d0-8422-ac7324d60a7d">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMi0xLTEtMTQyNjI0_39fe5319-5201-4b45-8bfc-76d52ab5bf04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMy0xLTEtMTQyNjI0_126ef5f4-3f44-44aa-9fce-7a9607b908a2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItNC0xLTEtMTQyNjI0_5507d820-89aa-4fa8-b449-6823aa3ea364">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:49.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0xLTEtMS0xNDI2MjQ_d598c15d-ab1f-4b50-b4ba-099edb5e17b7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0yLTEtMS0xNDI2MjQ_dae98e2d-5ddf-403e-86f8-e22a7f297772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0zLTEtMS0xNDI2MjQ_eac12014-3f03-4a7d-9821-75217748d801">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy00LTEtMS0xNDI2MjQ_47b2e1d3-3cec-4f33-a100-1d036d724585">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0xLTEtMS0xNDI2MjQ_4a4795ae-5765-4bac-a7e4-2c61855eed4a">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0yLTEtMS0xNDI2MjQ_391916cb-e5d7-48f3-9518-c30dd70e283f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0zLTEtMS0xNDI2MjQ_612fba8d-e145-4b17-924d-c296ff840656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS00LTEtMS0xNDI2MjQ_5d39311d-8b84-47a8-9e4d-31f2234382ba">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0xLTEtMS0xNDI2MjQ_10ba0c47-2802-4fdc-b6c0-ea8231a5facb">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0yLTEtMS0xNDI2MjQ_9c6c3930-edb2-468b-b598-77401dc3d796">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0zLTEtMS0xNDI2MjQ_95632357-8c23-491e-9647-01a959531616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi00LTEtMS0xNDI2MjQ_8e47843f-a040-4de2-8cb4-baca9f56ee13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0xLTEtMS0xNDI2MjQ_1d54bddb-05a4-4fa4-a6e0-57d9ea41f911">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0yLTEtMS0xNDI2MjQ_834c8f21-fd72-4f18-8f45-ad7339f6fc0c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0zLTEtMS0xNDI2MjQ_e7aa544c-d032-48c3-ba62-3fa9e6cc0824">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy00LTEtMS0xNDI2MjQ_aa7766aa-e6c1-4a0b-b220-ab4a453ae811">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0xLTEtMS0xNDI2MjQ_654dcd76-9e25-4bde-8a64-48c6f06d5f28">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0yLTEtMS0xNDI2MjQ_9974e7da-163f-4906-91d4-2321c90590c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0zLTEtMS0xNDI2MjQ_1aae1501-b7b2-44da-92b8-11896ef57ebc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS00LTEtMS0xNDI2MjQ_29d91a13-cf8c-4e22-9702-03aeaee95e7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMS0xLTEtMTQyNjI0_60e94d2c-c57c-4605-9a29-5b6c8ebc4719">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMi0xLTEtMTQyNjI0_3683b56a-182a-4830-8eb0-442ae12b9a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMy0xLTEtMTQyNjI0_24c625d3-a8a1-4d79-8d6f-0f433ec55f9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtNC0xLTEtMTQyNjI0_bff6a6b8-c303-4bf9-8ecb-30a75362de48">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMS0xLTEtMTQyNjI0_4ffa16e4-57f4-4b83-bdf6-247415c414ca">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMi0xLTEtMTQyNjI0_eef01cef-5bd8-441b-be66-583f64b0a512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMy0xLTEtMTQyNjI0_7b243f56-70b5-4ff5-bae5-f3ab331bde5a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05af2841efd44956a910f7e3b2175557_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItNC0xLTEtMTQyNjI0_a09160b6-4911-4754-a111-dd0d37662431">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMTk0_70bb2803-ee00-4ab8-ac78-058f952c300f"><ix:nonFraction unitRef="usd" contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMTk0_7266a7d3-b8de-4e17-b972-9bb4f30e1aee">1.7</ix:nonFraction></ix:nonFraction> billion, respectively, included money market and other short-term funds of approximately $<ix:nonFraction unitRef="usd" contextRef="i37ecc9bb48ea468fbe53ecaa9574ab83_I20230331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMjg1_91c6757e-b9b4-4edd-9e94-afe61abdddcb">369</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8ff491835ffe4fdf8c4b26233dcb9a9d_I20221231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMjky_fadda5c1-9144-4099-a718-a2c7d5f31f5e">341</ix:nonFraction> million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic42fa9673357472a905bb96d8d94a468" continuedAt="ica52037f782b440d8bbe73d30874e27a"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNg_0df80f4c-cafe-4e91-a164-36aa0ad75d66" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1672a644c104e0cba0f5a365004ec05_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy0xLTEtMS0xNDI2MjQ_443b61de-1c5f-4dc6-bff8-d0e4c93a772e">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ead0a6833745b5a2c9a8c87f3eb359_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy0yLTEtMS0xNDI2MjQ_aaae5667-f28b-4c37-9044-63ceb4de6161">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c61a0314afd43cd8e3a9aaaf26630eb_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy00LTEtMS0xNDI2MjQ_6ba2fad4-628e-439a-94a8-2c0b2c0713ce">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda293782fa046d38a077f41e8d52047_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy01LTEtMS0xNDYxOTE_f8d43a9e-98b1-4fad-8882-106cd8f61b9d">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC0xLTEtMS0xNDI2MjQ_fd024d25-3440-4598-9333-b52fa27aa19f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC0yLTEtMS0xNDI2MjQ_58699a75-2fd0-4224-aa32-7574807e4e0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC00LTEtMS0xNDI2MjQ_c2a83629-4f92-4807-834a-461e211a1cc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC01LTEtMS0xNDYxOTE_8e278327-0750-4c22-9a12-fc582b44a8e6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS0xLTEtMS0xNDI2MjQ_e0b5d5fb-02d4-4024-92bb-d969ba0fdf64">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS0yLTEtMS0xNDI2MjQ_36696c1d-e0f3-43f3-888c-10b0d68cface">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS00LTEtMS0xNDI2MjQ_bb05c889-a6f0-46c8-aa82-29871c25ec4a">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS01LTEtMS0xNDYyMDM_bd9c451d-7d19-421c-82d4-25bed9c0e87c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi0xLTEtMS0xNDI2MjQ_268f5793-83cd-4950-8f03-56bb167894be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi0yLTEtMS0xNDI2MjQ_1bd1790e-901e-4d71-9fa1-1cb2b36d9dd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi00LTEtMS0xNDI2MjQ_26f87118-a71c-4271-9f0f-f7c87cd8609e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi01LTEtMS0xNDYyMDM_5dc7ec2b-9029-418d-8da3-72e6be605c9d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy0xLTEtMS0xNDI2MjQ_2fb5e67a-dbf3-4ee3-a916-69042eab37e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy0yLTEtMS0xNDI2MjQ_c6f852d3-82bd-44fd-8f55-d800d5ac5084">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy00LTEtMS0xNDI2MjQ_03d4d0d6-5dcf-4708-be92-a3835e823c6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy01LTEtMS0xNTgzODk_2602ef8b-8eac-4259-826c-b5b74067e9d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC0xLTEtMS0xNDI2MjQ_53f3fe87-b658-48fa-aee8-7fa200ccd1ef">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC0yLTEtMS0xNDI2MjQ_84f10db6-4052-4d57-8237-6ad49ca780be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC00LTEtMS0xNDI2MjQ_55bc038a-bbda-4792-a8f3-f854a1d8354a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC01LTEtMS0xNDYyMTE_60ef0b8d-13ed-4696-9c87-49de66072df6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f90874bfa6d48fba1bed7ac9573fcf6_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtMS0xLTEtMTQyNjI0_cdeec621-145c-45cd-9b6e-f476913298ed">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f96fffbf70b48c3af05ddc881ed1a92_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtMi0xLTEtMTQyNjI0_8bdbc3fa-802f-47fc-9f8d-1d24c45c3b61">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5885ecc04c124fd88f7d20f0411c5299_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtNC0xLTEtMTQyNjI0_574909c8-596e-483f-af06-fb8f9a2ecf2a">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39589615eba84af88bd227d8332e4d0b_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtNS0xLTEtMTQ2MjE5_f88fabc5-ad59-404f-8859-a33ebb008b4a">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNw_4fa3419e-de46-4fa7-a50c-250a37606e1e" continuedAt="id5041cd3c53c402ba7d7c673a788cdbe" escape="true">For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2023 and December&#160;31, 2022.</ix:nonNumeric></span></div><ix:continuation id="id5041cd3c53c402ba7d7c673a788cdbe"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy0xLTEtMS0xNDI2MjQ_3acd7795-68ab-4bea-b364-5758359cf56e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy0yLTEtMS0xNDI2MjQ_b23ea312-ce73-4fd1-ac77-a177414d437e">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4465ac79533347819eb60404998c9a41_I20230331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy00LTEtMS0xNDI2MjQ_9a41a281-edc5-47e4-92ea-a5b7f40101e5">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy01LTEtMS0xNDI2MjQ_f842c284-867c-4739-b30c-fe7e7b735bb8">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC0xLTEtMS0xNDI2MjQ_f46763ec-86e2-4899-8395-57f8d1fb38d0">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC0yLTEtMS0xNDI2MjQ_fd9669b8-8cf7-4aee-af34-e29c114e7b30">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4465ac79533347819eb60404998c9a41_I20230331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC00LTEtMS0xNDI2MjQ_9efea693-3323-479f-9d8e-7d91538a7685">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC01LTEtMS0xNDI2MjQ_23063f16-f78b-4c71-b62c-7576ed46bd3c">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS0xLTEtMS0xNDI2MjQ_49cba917-ccdf-4060-8202-82e23980a10e">15,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS0yLTEtMS0xNDI2MjQ_1c681887-91ba-4828-bf42-0a8c2d3d6f1e">15,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4465ac79533347819eb60404998c9a41_I20230331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS00LTEtMS0xNDI2MjQ_5b5a6378-273d-4738-a825-5749f1ca5feb">14,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS01LTEtMS0xNDI2MjQ_d72ab5e0-1ed3-403a-8824-47cd68785045">13,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of equity investments without readily determinable fair values that we measure at cost, less impairment were $<ix:nonFraction unitRef="usd" contextRef="id39e31f62b29442da1752786dc58134e_I20230331" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDE4Mw_cb166b83-abac-444c-a13a-7eb17e60e5a8">103</ix:nonFraction> million as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i8411fdd837b543e6b9186cdf5182839f_I20221231" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDE5OQ_13d5e59f-54fe-4e9f-b18c-9b16492f3c8f">104</ix:nonFraction> million as of December&#160;31, 2022. When applicable, we also adjust the measurement of such equity investments for observable prices in orderly transactions for an identical </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ica52037f782b440d8bbe73d30874e27a">or similar investment of the same issuer. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</ix:continuation></span></div><div id="ia96c30333efb48e3af554b764666aed6_85"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">15. <ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5Mg_34fd1c70-2927-466f-863c-342dd0d92b2a" continuedAt="ib59ed8c187dc4e39812149f8589346ea" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ib59ed8c187dc4e39812149f8589346ea" continuedAt="i0e4ba3473e834ceda36f0cdeeaa20d00"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on <ix:nonFraction unitRef="segment" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfNjE_8f65c018-18fe-47a9-a9ce-1de42c9be72f">four</ix:nonFraction> segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a global segment for our Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5Mw_91ac3f8d-ee32-44e2-9f42-51550bddd8ff" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd21c5a704642b7add19a18376900db_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMy0xLTEtMS0xNDI2MjQ_c337e523-c44d-43c6-9253-e32d633dae3f">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMy0yLTEtMS0xNDI2MjQ_c31f4e8b-5f15-4caa-a00e-7325a69dc247">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if10723145fec4c039ea5033c9599406a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNC0xLTEtMS0xNDI2MjQ_e1685c7f-55fe-40a0-b78b-51aded9b3041">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNC0yLTEtMS0xNDI2MjQ_b0202cec-e85a-4d56-b367-b69d6e56edb6">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNS0xLTEtMS0xNDI2MjQ_8d5d9da2-011f-4838-8b8a-2b5be450d035">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNS0yLTEtMS0xNDI2MjQ_c460dc97-e65f-413d-a129-fa2933816123">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNi0xLTEtMS0xNDI2MjQ_9bf5de6f-a7f5-412c-8202-5389456654ec">731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2931aa2efeee464695085541f236afb5_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNi0yLTEtMS0xNDI2MjQ_b3b4cfbe-9ce0-4134-b1e1-910e59e426bd">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNy0xLTEtMS0xNDI2MjQ_8de7030f-ca4c-49f2-a2d6-cf585a1b6f20">3,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNy0yLTEtMS0xNDI2MjQ_99838f20-d6e1-40d4-9509-24d3fb327872">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd21c5a704642b7add19a18376900db_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfOS0xLTEtMS0xNDI2MjQ_c54186cd-2616-4d52-af1d-05433fa88fee">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfOS0yLTEtMS0xNDI2MjQ_0c4d503d-7e1a-4d5f-8b9f-8913e9f51c0d">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if10723145fec4c039ea5033c9599406a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTAtMS0xLTEtMTQyNjI0_df01736c-5223-45ca-8c5b-8c766894e001">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTAtMi0xLTEtMTQyNjI0_12251f9f-2f96-4a59-a1de-741649176d94">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTEtMS0xLTEtMTQyNjI0_a829ab36-7e93-449e-8374-b6f558170519">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTEtMi0xLTEtMTQyNjI0_9762e310-84ee-49e8-95aa-0694d94062d6">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTItMS0xLTEtMTQyNjI0_77053b53-e59f-4292-8efc-dbec6d4d82c7">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2931aa2efeee464695085541f236afb5_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTItMi0xLTEtMTQyNjI0_eef78e2a-16f6-4031-b1fd-cd91f6adbb34">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTMtMS0xLTEtMTQyNjI0_16598020-038f-4d37-9c15-a8465a7390d4">852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTMtMi0xLTEtMTQyNjI0_19314413-cec8-41e2-821b-df4f6fefb140">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0e4ba3473e834ceda36f0cdeeaa20d00"><div style="margin-top:10pt"><ix:nonNumeric contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5NA_cd272968-86a6-40a9-83a3-f65c96a28390" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMi0xLTEtMS0xNDI2MjQ_83721879-d938-4965-a3fa-31cc596ac99e">852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMi0yLTEtMS0xNDI2MjQ_483224fd-b6a6-4faa-b953-a3860fb63340">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i353419505f7f47a39847c9b26776c895_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMy0xLTEtMS0xNDI2MjQ_0950475b-186f-43e1-8a37-782ad3510c1f">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22bd1d9d744b4e77b5508602e287cf98_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMy0yLTEtMS0xNDI2MjQ_9c8ddeb1-ff51-47f2-9785-c16468ea3c6d">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNC0xLTEtMS0xNDI2MjQ_946d1f73-c401-4fa9-9d04-de0de46b80e6">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNC0yLTEtMS0xNDI2MjQ_0a2ad29a-f466-4947-af05-0ed7e1ceef92">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNS0xLTEtMS0xNDI2MjQ_aee2eb94-f6a2-40b1-a856-e018aa0f74a0">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNS0yLTEtMS0xNDI2MjQ_df819cd0-f6f7-4909-8d0d-1a3960e9fc3f">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNi0xLTEtMS0xNDI2MjQ_b30ade73-4082-4b99-8076-c9c97c0f7c45">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNi0yLTEtMS0xNDI2MjQ_3d08711c-74cc-42a6-b14d-1f7a8bc6fba2">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNy0xLTEtMS0xNDI2MjQ_41817a2c-a8fb-467c-a7ba-3bef91ebdbcd">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNy0yLTEtMS0xNDI2MjQ_5271b875-c0ff-4d18-aa31-7bf532290afb">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are implementing a new operating model intended to simplify and streamline our operations and we expect that our reportable segments will be changed to align with that new operating model when it is fully implemented, which is currently expected in the second half of 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to our Annual Report on Form 10-K for the year ended December&#160;31, 2022 for management&#8217;s discussion and analysis of our financial condition and results of operations. The following is management&#8217;s discussion and analysis of our financial condition and results of operations for the three months ended March&#160;31, 2023 and 2022.</span></div><div id="ia96c30333efb48e3af554b764666aed6_91"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECENTLY ANNOUNCED STRATEGIC ACTIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we announced the following planned strategic actions that are intended to enhance our operational effectiveness, accelerate innovation and drive additional stockholder value: (a) a proposed spinoff of our Renal Care and Acute Therapies product categories into an independent publicly traded company focused on kidney care (the proposed spinoff), (b) our development of a new operating model to simplify our operations and (c) our pursuit of strategic alternatives (including a potential sale) for our BioPharma Solutions (BPS) product category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed spinoff is currently expected to be completed by July 2024 or earlier, subject to the satisfaction of customary conditions. In the first quarter of 2023 we generated $1.1 billion of net sales from our Renal Care and Acute Therapies product categories, representing approximately 29% of our consolidated net sales. Additionally, in the first quarter of 2023 we generated $139 million of net sales from our BPS product category, representing approximately 4% of our consolidated net sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023 we incurred significant separation and transaction-related costs related to the proposed spinoff and our pursuit of strategic alternatives (including a potential sale) for our BPS product category. For the remainder of 2023 and the first half of 2024 we expect to continue to incur such costs, which will adversely impact our earnings and operating cash flows. Additionally, if these proposed actions are consummated, we expect to incur some amount of dis-synergies following those transactions due to the reduced size of our company and, as a result, we will need to undertake actions to help ensure that our cost structure is appropriate to support our remaining businesses. There can be no guarantees that the proposed spinoff or the sale of, or other strategic transaction involving, our BPS product category will be completed in the manner or over the timeframes described above, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also starting to implement a new operating model intended to simplify and streamline our operations and better align our manufacturing footprint and supply chain to our commercial activities. The new operating model will have significant impacts on our systems and processes across our entire company and we expect to have those broader operational changes, including our updated management reporting framework for the new operating model, fully implemented during the second half of 2023. At that time, we expect that our reportable segments will be changed to align with the new operating model. However, there could be no guarantees that the implementation of our new operating model will be completed within that timeframe. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FACTORS AFFECTING OUR RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Constraints, Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, increased interest rates, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. Due to the nature of our products, which include dense consumable medical products such as IV fluids, and the geographic locations of our manufacturing facilities, which often require us to transport our products long distances, we are more susceptible to increases in freight costs and other supply chain challenges than certain of our industry peers. We expect to continue to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories (including those acquired in our December 2021 acquisition of Hill-Rom Holdings, Inc. (Hillrom)) due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations are also affected by macroeconomic conditions and levels of business confidence. The war in Ukraine and the sanctions and other measures being imposed in response to this conflict have increased the levels of economic and political uncertainty. In response, we continue to monitor the developing situation with respect to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ongoing business in Russia and are working on reducing our product offerings in Russia while remaining compliant with all applicable U.S. and European Union sanctions and regulations. While Russia and Ukraine do not constitute a material portion of our business, a significant escalation or expansion of economic disruption or the conflict&#8217;s current scope could have an adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as COVID-19. COVID-19 had, and COVID-19 or any other future public health crisis could in the future have, an adverse impact on, among other things, our expenses, operations, supply chains and distribution systems. Over the course of the COVID-19 pandemic, our business was impacted by shifting healthcare priorities and significant volatility in the demand for our products, and any resurgence of the pandemic or any new public health crisis could again impact healthcare priorities and cause volatility in the demand for our products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the existence of high inflation rates in the United States and in many of the countries where we conduct business has resulted in, and may continue to result in, higher interest rates, shipping costs, labor costs and other costs and expenses, as well as weakening exchange rates. We have experienced and may continue to experience inflationary increases in manufacturing costs and operating expenses as well as negative impacts from weakening exchange rates as a result of general macroeconomic factors, and may not be able to pass these cost increases on to our customers in a timely manner or at all, which could have a material adverse impact on our profitability and results of operations. Inflation and general macroeconomic factors have caused certain of our customers to reduce or delay orders for our products and services and could cause them to do so in the future, which could have a material adverse impact on our sales and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For further discussion, please refer to Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Baxter stockholders for the three months ended March&#160;31, 2023 totaled $44 million, or $0.09 per diluted share, compared to $71 million, or $0.14 per diluted share, for the three months ended March&#160;31, 2022. Net income for the three months ended March&#160;31, 2023 included special items which decreased net income by $253&#160;million, or $0.50 per diluted share, respectively, as further discussed below. Net income for the three months ended March&#160;31, 2022 included special items which decreased net income by $400&#160;million, or $0.79 per diluted share, as further discussed below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our special items and the related impact by line item on our results for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Margin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture-related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product-related items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Gross Margin Ratio</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3 pts)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6 pts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, General and Administrative (SG&amp;A) Expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture-related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on SG&amp;A Ratio</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 pts</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 pts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and Development (R&amp;D) Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on R&amp;D Ratio</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 pts</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Operating Expense (Income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Tax Expense</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effects of special items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Effective Tax Rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 pts</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 pts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense is identified as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and our Board of Directors assess performance. Additional special items are identified above because they are highly variable, difficult to predict and of a size that may substantially impact our reported results of operations for the period. Management believes that providing the separate impact of those items on our results in accordance with U.S. GAAP may provide a more complete understanding of our operations and can facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2023 and 2022 were impacted by costs associated with our execution of programs to optimize our organization and cost structure. These restructuring and other business optimization costs included actions related to our current implementation of a new operating model intended to simplify and streamline our operations, our integration of Hillrom, rationalization of certain manufacturing and distribution facilities and transformation of certain general and administrative functions. Our results in 2023 and 2022 included business optimization charges of $134 million and $81 million, respectively. Refer to Note 9 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding these charges and related liabilities. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2023 included $7 million of net benefits from acquisition and integration-related items. Acquisition and integration benefits reflected $13 million of net gains from changes in the estimated fair </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">values of contingent consideration liabilities, partially offset by $6 million of integration costs, which primarily included third party consulting costs related to our integration of Hillrom. Our results in 2022 included $171 million of acquisition and integration-related expenses. Those costs included $29 million of integration-related costs and $159 million of incremental cost of sales from the fair value step-ups on acquired Hillrom inventory that was sold in 2022. Other integration expenses in 2022 included third party consulting costs related to our integration and related cost savings activities. Those acquisition and integration-related expenses related to Hillrom were partially offset by $17 million of net gains from changes in the estimated fair values of contingent consideration liabilities assumed in the Hillrom acquisition. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2023 and 2022 included $12 million and $11 million, respectively, of incremental costs to comply with the European Union's medical device regulations for previously registered products, which primarily consist of contractor costs and other direct third-party costs. We consider the adoption of these regulations to be a significant one-time regulatory charge and believe that the costs of initial compliance for previously registered products over the implementation period are not indicative of our core operating results. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2023 included $16 million of divestiture-related costs, primarily reflecting costs of external advisors supporting our activities to prepare for the proposed spinoff of our Renal Care and Acute Therapies product categories and our pursuit of strategic alternatives (including a potential sale) for our BPS product category. Refer to "Recently Announced Strategic Actions" above for more information.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included charges of $23 million related to warranty and remediation activities arising from two field corrective actions on certain of our infusion pumps.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Reflected in this item is the income tax impact of the special items identified in this table. The tax effect of each special item is based on the jurisdiction in which the item was incurred and the tax laws in effect for each such jurisdiction.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET SALES</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual<br/>currency rates</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency unfavorably impacted net sales by 4 percentage points during the first quarter of 2023 compared to the prior-year period, principally due to the strengthening of the U.S. Dollar relative to the Euro, British Pound, Chinese Renminbi, Turkish Lira, Australian Dollar and Japanese Yen.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparisons presented at constant currency rates reflect local currency sales at the prior period&#8217;s foreign exchange rates. This measure provides information on the change in net sales assuming that foreign currency exchange rates had not changed between the prior and the current period. We believe that the non-GAAP measure of change in net sales at constant currency rates, when used in conjunction with the U.S. GAAP measure of change in net sales at actual currency rates, may provide a more complete understanding and facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Product Category Net Sales Reporting </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product categories include the following:</span></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our parenteral nutrition therapies and related products.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BioPharma Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patient Support Systems</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Front Line Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment. </span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Surgical Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of other miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.120%"><tr><td style="width:1.0%"></td><td style="width:43.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.868%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual currency rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.287%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care net sales were flat in the first quarter of 2023, as compared to the prior-year period. Sales performance for the period reflects a 4% negative impact from foreign exchange rates, as compared to the prior-year period, and lower sales in China primarily due to government-based procurement initiatives and the recent termination of a distribution agreement in the U.S., partially offset by patient growth in PD and recent government tender awards in EMEA.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery net sales decreased 3% in the first quarter of 2023, as compared to the prior-year period. The decrease was driven by lower sales of infusion pumps, primarily due to supply constraints, higher U.S. distributor chargebacks and customer rebates in the current year period and a 3% negative impact from foreign exchange rates, partially offset by increased international demand for our IV administration sets and solutions, reflecting a recovery in hospital admission rates and surgical procedures.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals net sales were flat in the first quarter of 2023, as compared to the prior-year period, reflecting increased demand for our international pharmacy compounding services and U.S. injectable products, partially offset by a 5% negative impact from foreign exchange rates, as compared to the prior-year period, and lower demand internationally for injectable products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition net sales decreased 1% in the first quarter of 2023, as compared to the prior-year period. The decrease was driven by a 4% negative impact from foreign exchange rate changes, as compared to the prior-year period, partially offset by increased demand for our nutrition compounding services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery net sales increased 8% in the first quarter of 2023, as compared to the prior-year period. The increase was driven by continued recovery in surgical procedures, partially offset by a 3% negative impact from foreign exchange rate changes, as compared to the prior-year period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies net sales decreased 4% in the first quarter of 2023, as compared to the prior-year period. The decrease was driven by a 3% negative impact from foreign exchange rate changes, as compared to the prior-year period, and lower COVID-related demand for our CRRT systems.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions net sales decreased 11% in the first quarter of 2023, as compared to the prior-year period. The decrease was primarily driven by lower sales of manufacturing services and supply packaging related to the production of COVID-19 vaccines on behalf of multiple pharmaceutical companies, reflecting a challenging comparison against a strong prior-year period. The decrease also includes a 2% negative impact from foreign exchange rates, as compared to the prior-year period. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems net sales decreased 9% in the first quarter of 2023, as compared to the prior-year period. The decrease reflects lower demand for hospital beds, which we believe was driven by current capital spending constraints at certain of our customers, lower rental revenues and a 1% negative impact from foreign exchange rates, as compared to the prior-year period, partially offset by increased sales in our connected care offerings.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care net sales increased 3% in the first quarter of 2023, as compared to the prior-year period. The increase was driven by increased demand for our physical assessment tools and cardiology products, partially offset by a 1% negative impact from foreign exchange rates, as compared to the prior-year period.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Surgical Solutions net sales increased 4% in the first quarter of 2023, as compared to the prior-year period. The increase was driven by strong international demand, partially offset by a 4% negative impact from foreign exchange rates, as compared to the prior-year period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin and Expense Ratios</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Margin</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross margin ratio was 36.9% and 36.4% in the first quarter of 2023 and 2022, respectively. The special items identified above had an unfavorable impact of approximately 4.3 and 8.6 percentage points on the gross margin ratio in the first quarter of 2023 and 2022, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the gross margin ratio decreased in the first quarter of 2023 compared to the prior-year period primarily due to the adverse cost impacts of raw materials inflation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SG&amp;A</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SG&amp;A expenses ratio was 27.7% and 28.4% in the first quarter of 2023 and 2022, respectively. The special items identified above had an unfavorable impact of approximately 4.5 and 5.3 percentage points on the SG&amp;A expenses ratio in the first quarter of 2023 and 2022, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the SG&amp;A expenses ratio was flat in the first quarter of 2023 compared to the prior-year period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The R&amp;D expenses ratio was 4.5% and 4.0% in the first quarter of 2023 and 2022, respectively. The special items identified above had an unfavorable impact of approximately 0.2 percentage points on the R&amp;D expenses ratio in the  first quarter of 2023 and no impact on the R&amp;D expenses ratio in the first quarter of 2022. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items the R&amp;D expenses ratio increased in the first quarter of 2023 compared to the prior-year period as a result of increased project-related expenditures, particularly related to our connected care portfolio.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Optimization Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts have included restructuring the organization, optimizing our manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. From the commencement of our business optimization actions in the second half of 2015 through March&#160;31, 2023, we have incurred cumulative pre-tax costs of $1.6 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments, and accelerated depreciation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect to incur additional pre-tax costs, primarily related to the implementation of business optimization programs, of approximately $24&#160;million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods. For example, we expect to incur additional restructuring charges during 2023 related to our implementation of a new operating model intended to simplify and streamline our operations (including our manufacturing footprint), as discussed above under "Recently Announced Strategic Actions." Refer to Note 9 in Item 1 of this Quarterly Report on Form 10-Q for additional information regarding our business optimization programs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Operating Income, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income, net was $13 million in the first quarter of 2023 and $17 million in the first quarter of 2022. In both periods these amounts were comprised of changes in the estimated fair value of contingent consideration liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $117 million in the first quarter of 2023 and $85 million in the first quarter of 2022. The increase in 2023 was driven by higher interest rates on our floating rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $1 million in the first quarter of 2023 and $16 million in the first quarter of 2022. In the first quarter of 2023, other income, net was primarily due to pension and other postretirement benefits and increases in the fair value of marketable equity securities partially offset by foreign exchange losses. In the first quarter of 2022, other income, net was due to foreign exchange gains and pension and other postretirement benefits.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was 35.7% and 22.3% in the first quarter of 2023 and 2022, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances, increases or decreases in liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to tax shortfalls on stock compensation awards and an increase in our liabilities for uncertain tax positions, partially offset by a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none were individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Segment Results</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our global operations based on four segments, consisting of the following geographic segments related to legacy Baxter business: Americas, EMEA and APAC, and a global segment for our Hillrom business. We use net </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales and operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our segments. The following is a summary of financial information for our reportable segments:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating income (loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $1.6 billion and $481 million, respectively, in the first quarter of 2023 and $1.6 billion and $610 million, respectively, in the first quarter of 2022. The decrease in operating income was due to raw materials inflation, higher supply chain costs and lower sales in our BioPharma Solutions and Acute Therapies product categories, partially offset by higher sales in our Pharmaceuticals, Advanced Surgery and Renal Care product categories. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EMEA</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $714 million and $106 million, respectively, in the first quarter of 2023 and $699 million and $119 million, respectively, in the first quarter of 2022. The decrease in operating income was primarily due to an unfavorable impact of foreign exchange rates on results, as compared to the prior-year period, an unfavorable product mix and higher supply chain and raw materials costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">APAC</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $602 million and $107 million, respectively, in the first quarter 2023 and $627 million and $151 million, respectively, in the first quarter of 2022. The decrease in operating income was driven by the unfavorable impact of foreign exchange rates on results, as compared to the prior-year period, and higher supply chain and raw materials costs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $731 million and $158 million, respectively, in the first quarter of 2023 and $755 million and $200 million, respectively, in the first quarter of 2022. The decrease in operating income was due to lower sales in our Patient Support Systems product category, an unfavorable product mix and higher supply chain costs, partially offset by higher sales in our Front Line Care and Global Surgical Solutions product categories.   </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate operating loss in the first quarter of 2023 was lower than the prior-year period primarily due to lower intangible asset amortization expense and acquisition and integration-related expenses, partially offset by higher business optimization charges and increased centrally managed manufacturing and supply chain costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the statement of cash flows for the three-month periods ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Operations </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023, cash provided by operating activities was $479 million, as compared to cash provided by operating activities of $208 million in the first three months of 2022, an increase of $271 million. Cash flows from operations in the current year period was favorably impacted, as compared to the prior year period, by lower annual payouts under our employee incentive compensation plans, which were determined based on our 2022 performance, and by the timing of accounts payable payments. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Investing Activities </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023, cash used for investing activities included payments for acquisitions and investments of $3 million and capital expenditures of $172 million. In the first three months of 2022, cash used for investing activities included payments for acquisitions and investments of $174 million and capital expenditures of $140 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Financing Activities </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023, cash used in financing activities included a net decrease in commercial paper borrowings of $249 million, dividend payments of $146 million and debt repayments of $3 million, partially offset by  proceeds from stock issued under employee benefit plans of $36 million. In the first three months of 2022, cash used for financing activities included debt repayments of $404 million, dividend payments of $140 million, and a $45 million net repayment of short-term borrowings, partially offset by proceeds from stock issued under employee benefit plans of $66 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As authorized by our Board of Directors, we repurchase our stock depending upon our cash flows, net debt levels and market conditions. In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. We did not repurchase any shares under this authority in the first three months of 2023. We had $1.3 billion remaining available under this authorization as of March&#160;31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities and Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Facilities</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023, our U.S. dollar-denominated revolving credit facility and Euro-denominated revolving credit facility had a maximum capacity of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 billion and &#8364;200 million, respectively. There were no borrowings outstanding under these credit facilities as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or December&#160;31, 2022. Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we amended the credit agreements governing our U.S. dollar-denominated term loan credit facility and revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to amend the net leverage ratio covenant to increase the maximum net leverage ratio for the four fiscal quarters ending March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.  As of March&#160;31, 2023, we were in compliance with the financial covenants in these agreements. Based on our covenant calculations as of March&#160;31, 2023, we had capacity to draw approximately $2.2 billion under our credit facilities, less outstanding commercial paper borrowings, which were $50 million as of March&#160;31, 2023. The non-performance of any financial institution supporting either of the credit facilities would reduce the maximum capacity of these facilities by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the institution&#8217;s respective commitment. Additionally, a deterioration in our financial performance may further reduce our ability to draw on our credit facilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We intend to fund short-term and long-term obligations as they mature through cash on hand, future cash flows from operations or by issuing additional debt. We had $1.7 billion of cash and cash equivalents as of March&#160;31, 2023, with adequate cash available to meet operating requirements in each jurisdiction in which we operate. We invest our excess cash in money market and other funds and diversify the concentration of cash among different financial institutions. As of March&#160;31, 2023, we had approximately $16.4 billion of long-term debt and finance lease obligations, including current maturities, and short-term debt. Subject to market conditions, we regularly evaluate opportunities with respect to our capital structure.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate cash flows from operations, issue debt, including commercial paper, or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions. However, we believe we have sufficient financial flexibility to issue debt, enter into other financing arrangements and attract long-term capital on acceptable terms to support our growth objectives and reduce our post-acquisition debt levels as we take actions consistent with our capital allocation priorities. In January 2023, Fitch revised our senior debt credit rating outlook from negative to rating watch negative. There have been no changes to our investment grade credit ratings that we disclosed in our 2022 Annual Report. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LIBOR Reform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the United Kingdom&#8217;s Financial Conduct Authority announced that after 2021 it would no longer compel banks to submit the rates required to calculate the London Interbank Offered Rate (LIBOR) and other interbank offered rates, which have been widely used as reference rates for various securities and financial contracts, including loans, debt and derivatives. This announcement indicated that the continuation of LIBOR on the current basis was not guaranteed after 2021. Regulators in the U.S. and other jurisdictions have been working to replace these rates with alternative reference interest rates that are supported by transactions in liquid and observable markets, such as the Secured Overnight Financing Rate (SOFR). In 2020, it was announced that certain U.S. dollar LIBOR tenors would not cease until 2023. In September 2022, our $2.5 billion U.S. dollar-denominated revolving credit facility and our $4.0 billion Term Loan Credit Agreement were amended to reference SOFR-based rates. Currently, our &#8364;200 million Euro-denominated revolving credit facility references EURIBOR-based rates. A discontinuation would require this arrangement to be modified in order to replace EURIBOR with an alternative reference interest rate, which could impact our cost of funds. That credit facility agreement includes provisions related to the determination of a successor rate.</span></div><div id="ia96c30333efb48e3af554b764666aed6_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CRITICAL ACCOUNTING POLICIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and   judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 1 to our consolidated financial statements in our 2022 Annual Report. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our financial statements and require significant, difficult or complex judgments by us, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in our 2022 Annual Report. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of goodwill and intangible assets is one of our critical accounting policies and we recognized significant impairment charges during 2022. During the current year-to-date period, our Patient Support Systems reporting unit has been experiencing lower levels of customer orders for certain products than what we had previously expected. Certain of the products sold by that reporting unit are subject to our customers&#8217; capital budgets and we believe that many of those customers are delaying significant capital purchases due to uncertainty in the current economic environment. We currently expect that such capital spending constraints will likely continue throughout much of 2023. However, we have not reduced our longer-term outlook for that reporting unit as we currently expect that such capital spending constraints, which are often cyclical and closely aligned with broader economic conditions, will improve in the foreseeable future. Based on the excess of the reporting unit&#8217;s fair value over its carrying amount during our most recent annual impairment test in the fourth quarter of 2022 and our expectations for its performance over the forecast period, we determined that it is not more likely than not that the goodwill of that reporting unit was impaired as of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023. Therefore, we did not perform a trigger-based quantitative goodwill impairment test during the first quarter of 2023. However, we are continuing to closely monitor the performance of our Patient Support Systems reporting unit and if there is a significant adverse change in our outlook for that business in the future a goodwill impairment could arise at that time.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in the application of our critical accounting policies during the first three months of 2023.</span></div><div id="ia96c30333efb48e3af554b764666aed6_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no accounting standards issued but not yet effective that we believe will have a material impact on our condensed consolidated financial statements.</span></div><div id="ia96c30333efb48e3af554b764666aed6_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LEGAL CONTINGENCIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 5 within Item 1 for a discussion of our legal contingencies. Upon resolution of any of these uncertainties, we may incur charges in excess of presently established liabilities. While our liability in connection with certain claims cannot be estimated with any certainty, and although the resolution in any reporting period of one or more of these matters could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in these matters, litigation is inherently uncertain, excessive verdicts do occur, and we may in the future incur material judgments or enter into material settlements of claims.</span></div><div id="ia96c30333efb48e3af554b764666aed6_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTAIN REGULATORY MATTERS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, immediately prior to the closing of our acquisition of Claris Injectables Limited (Claris), the U.S. Food and Drug Administration (FDA) commenced an inspection of the Claris&#8217; facilities in Ahmedabad, India. FDA completed the inspection and subsequently issued a Warning Letter based on observations identified in the 2017 inspection (Claris Warning Letter).&#185; FDA re-inspected the facilities and issued a Form 483 on May 17, 2022. On September 1, 2022, FDA notified us that the inspection had been classified as voluntary action indicated (VAI). On January 19, 2023, FDA arrived to re-inspect the facilities and issued a Form 483 on January 27, 2023. On April 26, 2023, FDA notified us that the inspection had been classified as official action indicated (OAI). Since the issuance of the Claris Warning Letter, we have implemented corrective and preventive actions to address FDA's prior observations and other items we identified and management has begun working with other manufacturing locations, including contract manufacturing organizations, to support the production of new products for distribution in the U.S.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Available online at https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm613538.htm</span></div><div id="ia96c30333efb48e3af554b764666aed6_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FORWARD-LOOKING INFORMATION</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q includes forward-looking statements. Use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;evaluates,&#8221; &#8220;pursues,&#8221; &#8220;anticipates,&#8221; &#8220;continues,&#8221; &#8220;designs,&#8221; &#8220;impacts,&#8221; &#8220;affects,&#8221; &#8220;forecasts,&#8221; &#8220;target,&#8221; &#8220;outlook,&#8221; &#8220;initiative,&#8221; &#8220;objective,&#8221; &#8220;designed,&#8221; &#8220;priorities,&#8221; &#8220;goal,&#8221; or the negative of those words or other similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. These forward-looking statements may include statements with respect to plan to implement a simplified operating model, the proposed spinoff of our Renal Care and Acute Therapies product categories, review of strategic alternatives (including a potential sale) for our BPS product category and other potential portfolio management activities we may undertake in the future, accounting estimates and assumptions, global economic conditions and the impacts of the COVID-19 pandemic, litigation-related matters including outcomes, impacts of the internal investigation related to foreign exchange gains and losses, future regulatory filings and our R&amp;D pipeline, sales from new product offerings, credit exposure to foreign governments, the adequacy of cash flows and credit facilities, potential developments with respect to credit ratings, investment of foreign earnings, estimates of liabilities including those related to uncertain tax positions, contingent payments, future pension plan contributions, costs, discount rates and rates of return, our exposure to financial market volatility and foreign currency, interest rate and credit risks (including as a result of recent banking crises), the impact of inflation on our business, the impact of competition, future sales growth, business development activities, cost saving initiatives, future capital and R&amp;D expenditures, future debt issuances, the adequacy of tax provisions and reserves, the effective tax rate and all other statements that do not relate to historical facts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These forward-looking statements are based on certain assumptions and analyses made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate in the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. Whether actual future results and developments will conform to expectations and predictions is subject to a number of risks and uncertainties, including the following factors, many of which are beyond our control:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to execute and complete strategic initiatives, asset dispositions and other transactions, including the proposed spinoff of our Renal Care and Acute Therapies product categories, our plans to simplify our operating model and manufacturing footprint and our evaluation of strategic alternatives for our BPS product category, the timing for such transactions, the ability to satisfy any applicable conditions and the expected proceeds, consideration and benefits;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failure to accurately forecast or achieve our short-and long-term financial improvement performance and goals (including with respect to our strategic actions) and related impacts on our liquidity;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to execute on our capital allocation plans, including our debt repayment plans, the timing and amount of any dividends, share repurchases and divestiture proceeds and the capital structure of the public company that we expect to form as a result of the proposed spinoff (and the resulting capital structure for the remaining company);</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of global economic conditions (including, among other things, inflation levels, interest rates, financial market volatility, banking crises, the potential for a recession, the ongoing war in Ukraine, the related economic sanctions being imposed globally in response to the conflict and potential trade wars) and continuing public health crises, pandemics and epidemics, such as the ongoing COVID-19 pandemic, or the anticipation of any of the foregoing, on our operations and our employees, customers and suppliers, including foreign governments in countries in which we operate;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">downgrades to our credit ratings or ratings outlooks, and the related impact on our funding costs and liquidity;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">demand for and market acceptance risks for and competitive pressures related to new and existing products (including challenges with our ability to accurately predict changing customer preferences and future expenditures, which has led to and may continue to lead to increased inventory levels, and needs and advances in technology and the resulting impact on customer inventory levels and the impact of reduced hospital admission rates and elective surgery volumes), and the impact of those products on quality and patient safety concerns;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the continuity, availability and pricing of acceptable raw materials and component parts (and our ability to pass some or all of these costs to our customers through recent price increases), and the related continuity of our manufacturing and distribution and those of our suppliers;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">inability to create additional production capacity in a timely manner or the occurrence of other manufacturing, sterilization or supply difficulties (including as a result of natural disaster, public health crises and epidemics/pandemics, regulatory actions or otherwise);</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product development risks, including satisfactory clinical performance and obtaining and maintaining required regulatory approvals (including as a result of evolving regulatory requirements), the ability to manufacture at appropriate scale, and the general unpredictability associated with the product development cycle;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to finance and develop new products or enhancements on commercially acceptable terms or at all;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">loss of key employees, the occurrence of labor disruptions or the inability to identify and recruit new employees;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product quality or patient safety issues leading to product recalls, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation, or declining sales, including the focus on evaluating product portfolios for the potential presence or formation of nitrosamines;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">breaches or failures of our information technology systems or products, including by cyber-attack, data leakage, unauthorized access or theft (as a result of remote working arrangements or otherwise);</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of (or failures to act or delays in acting by) FDA, the European Medicines Agency or any other regulatory body or government authority (including the SEC, DOJ or the Attorney General of any State) that could delay, limit or suspend product development, manufacturing or sale or result in seizures, recalls, injunctions, monetary sanctions or criminal or civil liabilities, including the continued delay in lifting the warning letter at our Ahmedabad facility;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failures with respect to our quality, compliance or ethics programs;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of third parties, including third-party payers and our customers and distributors (including GPOs and IDNs), the impact of healthcare reform and its implementation, suspension, repeal, replacement, amendment, modification and other similar actions undertaken by the United States or foreign governments, including with respect to pricing, reimbursement, taxation and rebate policies; legislation, regulation and other governmental pressures in the United States or globally, including the cost of compliance and potential penalties for purported noncompliance thereof, all of which may affect pricing, reimbursement, taxation and rebate policies of government agencies and private payers or other elements of our business, including new or amended laws, rules and regulations (such as the California Consumer Privacy Act of 2018, the European Union&#8217;s General Data Protection Regulation and annual proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multi-year capital expenditures, which are difficult to estimate in advance);</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the outcome of pending or future litigation, including the opioid litigation and ethylene oxide litigation or other claims;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">global regulatory, trade and tax policies (including with respect to climate change and other sustainability matters);</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the ability to protect or enforce our owned or in-licensed patent or other proprietary rights (including trademarks, copyrights, trade secrets and know-how) or patents of third parties preventing or restricting our manufacture, sale or use of affected products or technology;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of any goodwill or other intangible asset impairments on our operating results;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fluctuations in foreign exchange and interest rates;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">any changes in law concerning the taxation of income (whether with respect to current or future tax reform);</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">actions by tax authorities in connection with ongoing tax audits;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other factors identified elsewhere in this report and other filings with the SEC, including those factors described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, all of which are available on our website.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Actual results may differ materially from those projected in the forward-looking statements. We do not undertake to update our forward-looking statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to revenues generated outside of the United States denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative financial instruments to further reduce the net exposure to foreign exchange. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and stockholders&#8217; equity volatility relating to foreign exchange. However, we don't hedge our entire foreign exchange exposure and are still subject to earnings and stockholders' equity volatility relating to foreign exchange risk.  Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily use forward contracts to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities denominated in foreign currencies. The maximum term over which we have cash flow hedge contracts in place related to foreign exchange risk on forecasted transactions as of March&#160;31, 2023 is 12 months. We also enter into derivative instruments to hedge foreign exchange risk on certain intra-company and third-party receivables and payables and debt denominated in foreign currencies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk-management program, we perform sensitivity analyses to assess potential changes in the fair value of our foreign exchange instruments relating to hypothetical and reasonably possible near-term movements in foreign exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of changes in the fair value of foreign exchange contracts outstanding as of March&#160;31, 2023, while not predictive in nature, indicated that if the U.S. Dollar uniformly weakened by 10% against all currencies, the net pre-tax balance of zero with respect to those contracts would change by $61 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity analysis model recalculates the fair value of the foreign exchange contracts outstanding as of March&#160;31, 2023 by replacing the actual exchange rates as of March&#160;31, 2023 with exchange rates that are 10% weaker compared to the actual exchange rates for each applicable currency. All other factors are held constant. These sensitivity analyses disregard the possibility that currency exchange rates can move in opposite directions and that gains from one currency may or may not be offset by losses from another currency. The analyses also disregard the offsetting change in value of the underlying hedged transactions and balances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the three-year cumulative inflation rate in Turkey exceeded 100 percent.  As a result, on April 1, 2022, we began reporting the results of our subsidiary in that jurisdiction using highly inflationary accounting, which requires that the functional currency of the entity be changed to the reporting currency of its parent.  As of March&#160;31, 2023, our subsidiary in Turkey had net monetary assets of $29 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate and Other Risks</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the caption &#8220;Interest Rate and Other Risks&#8221; in the &#8220;Financial Instrument Market Risk&#8221; section of the 2022 Annual Report. There were no significant changes during the quarter ended March&#160;31, 2023. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of March&#160;31, 2023. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March&#160;31, 2023. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Chan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es in Internal Control over Financial Reporting</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="ia96c30333efb48e3af554b764666aed6_121"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Part I, Item 1, Note 6 is incorporated herein by reference.</span></div><div id="ia96c30333efb48e3af554b764666aed6_124"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1A.  Risk Factors  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We do not believe that there have been any material changes to the risk factors previously disclosed in our 2022 Annual Report. </span></div><div id="ia96c30333efb48e3af554b764666aed6_127"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.574%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2012, we announced that our Board of Directors authorized us to repurchase up to $2.0 billion of our common stock on the open market or in private transactions. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. During the first quarter of 2023, we did not repurchase any shares under this authority. We had $1.3 billion remaining under this program as of March&#160;31, 2023. This program does not have an expiration date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">Baxter International Inc. Executive Officer Cash Severance Policy, effective February 13, 2023 (incorporated by reference to Exhibit 10.1 to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">Baxter In</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">ternational Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">.'</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">s Current Report on Form 8-K, filed on February 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000119312523039261/d465899dex101.htm">, 2023).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">Third Amendment, dated as of March 13, 2023, to the Credit Agreement, dated as of September 30, 2021, as amended by that certain First Amendment, dated as of September 28, 2022, and that certain Second Amendment, dated as of September 28, 2022, among Baxter International Inc. as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm"> (in</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">corporated by reference to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">Exhib</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">it 10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm"> to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">Baxter International Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">'s Current Report on Form 8-K, filed on March 13, 2023)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit101.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">Third Amendment, dated as of March 13, 2023, to the Five-Year Credit Agreement, dated as of September 30, 2021, as amended by that certain First Amendment, dated as of September 28, 2022, and that certain Second Amendment, dated as of September 28, 2022, among Baxter International Inc. as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm"> (incor</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">porated by reference to Exhibit 10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">.2 to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">Baxter International Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">'s Current Report on Form 8-K, filed on March 13, 2023)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit102.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">Second Guaranty Amendment, dated as of March 13, 2023, to the Amended and Restated Guaranty, dated as of October 1, 2021, as amended by that certain Second Amendment, dated as of September 28, 2022, among Baxter Healthcare SA and Baxter World Trade SRL, as Borrowers, J.P. Morgan SE, as Administrative Agent and certain other financial institutions named therein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm"> (incorporated by refer</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">ence to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">Exhibit 10.3 to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">Baxter I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">nternational Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">'s C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">urrent Report on Form 8-K, filed on March 13, 2023)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/10456/000162828023007718/bax-202303138kexhibit103.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20230331xex311.htm">Certification of Chief Executive Officer Pursuant to Rules 13a-14 (a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20230331xex312.htm">Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20230331ex321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20230331xex322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained within the Inline XBRL Instance Document in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith. This exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ia96c30333efb48e3af554b764666aed6_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BAXTER INTERNATIONAL INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 27, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro<br/>Executive Vice President and Chief Financial Officer<br/>(duly authorized officer and principal financial officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>bax-20230331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib3bc8e17cf1b4fffb27af5b0c9d630bf_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jos&#233; E. Almeida, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;27, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>bax-20230331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4832752f0f7641e99103a7f5ece24516_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James K. Saccaro, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Date&#58; April&#160;27, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>bax-20230331ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id013284004ec43f694ce928f10cb9b1f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jos&#233; E. Almeida, as Chairman of the Board and Chief Executive Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>bax-20230331xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i87cf41654c0a45beb60dbfb8e647f7e1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James K. Saccaro, as Executive Vice President and Chief Financial Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bax-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.baxter.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.baxter.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical">
        <link:definition>0000009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.baxter.com/role/BASISOFPRESENTATION">
        <link:definition>0000010 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>0000011 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNET" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET">
        <link:definition>0000012 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTS" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS">
        <link:definition>0000013 - Disclosure - FINANCING ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000016 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUES" roleURI="http://www.baxter.com/role/REVENUES">
        <link:definition>0000017 - Disclosure - REVENUES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGES" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES">
        <link:definition>0000018 - Disclosure - BUSINESS OPTIMIZATION CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS">
        <link:definition>0000019 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.baxter.com/role/INCOMETAXES">
        <link:definition>0000020 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.baxter.com/role/EARNINGSPERSHARE">
        <link:definition>0000021 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>0000022 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000023 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.baxter.com/role/SEGMENTINFORMATION">
        <link:definition>0000024 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>0000025 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONTables" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables">
        <link:definition>0000026 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETTables" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables">
        <link:definition>0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables">
        <link:definition>0000028 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESTables" roleURI="http://www.baxter.com/role/REVENUESTables">
        <link:definition>0000029 - Disclosure - REVENUES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESTables" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables">
        <link:definition>0000030 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables">
        <link:definition>0000031 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables">
        <link:definition>0000032 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>0000033 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables">
        <link:definition>0000035 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails">
        <link:definition>0000036 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails">
        <link:definition>0000037 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails">
        <link:definition>0000038 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails">
        <link:definition>0000039 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails">
        <link:definition>0000040 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
        <link:definition>0000041 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
        <link:definition>0000042 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails">
        <link:definition>0000043 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
        <link:definition>0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSDetails" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails">
        <link:definition>0000045 - Disclosure - FINANCING ARRANGEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>0000047 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails">
        <link:definition>0000048 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
        <link:definition>0000049 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails">
        <link:definition>0000050 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails_1" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1">
        <link:definition>0000050 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESContractAssetsandContractLiabilitiesDetails" roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails">
        <link:definition>0000051 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
        <link:definition>0000052 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESLeaseRevenueDetails" roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails">
        <link:definition>0000053 - Disclosure - REVENUES - Lease Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails">
        <link:definition>0000054 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
        <link:definition>0000055 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
        <link:definition>0000056 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
        <link:definition>0000057 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
        <link:definition>0000058 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.baxter.com/role/INCOMETAXESDetails">
        <link:definition>0000059 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails">
        <link:definition>0000060 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREAdditionalInformationDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails">
        <link:definition>0000061 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
        <link:definition>0000062 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
        <link:definition>0000063 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
        <link:definition>0000064 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails">
        <link:definition>0000065 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
        <link:definition>0000066 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>0000067 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>0000068 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
        <link:definition>0000069 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
        <link:definition>0000070 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
        <link:definition>0000071 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
        <link:definition>0000072 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bax_StockRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="StockRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BioPharmaSolutionsMember" abstract="true" name="BioPharmaSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_SurgicalSolutionsMember" abstract="true" name="SurgicalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_EMEASegmentMember" abstract="true" name="EMEASegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ManufacturingArrangementsMember" abstract="true" name="ManufacturingArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FrontLineCareMember" abstract="true" name="FrontLineCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" abstract="false" name="AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessOptimizationProgramsMember" abstract="true" name="BusinessOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityDeferredRevenue" abstract="false" name="ContractWithCustomerLiabilityDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_RevenueFromContractWithCustomerRollForward" abstract="true" name="RevenueFromContractWithCustomerRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_NewOperatingModelMember" abstract="true" name="NewOperatingModelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherProductOrServicesMember" abstract="true" name="OtherProductOrServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_HillromMember" abstract="true" name="HillromMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes04Due2024Member" abstract="true" name="GlobalNotes04Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_EnviromentalCleanUpMember" abstract="true" name="EnviromentalCleanUpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ClinicalNutritionMember" abstract="true" name="ClinicalNutritionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_MedicationDeliveryMember" abstract="true" name="MedicationDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueDisclosuresLineItems" abstract="true" name="FairValueDisclosuresLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_DerivativeFairValueTerminated" abstract="false" name="DerivativeFairValueTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_LossContingencyNumberOfLawsuits" abstract="false" name="LossContingencyNumberOfLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillTable" abstract="true" name="IntangibleAssetExcludingGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_RenalMember" abstract="true" name="RenalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ConsumableMedicalProductsMember" abstract="true" name="ConsumableMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_DerivativeNetInvestmentTerminated" abstract="false" name="DerivativeNetInvestmentTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AsiaPacificSegmentMember" abstract="true" name="AsiaPacificSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PatientSupportSystemsMember" abstract="true" name="PatientSupportSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" abstract="true" name="BundledEquipmentAndConsumableMedicalProductsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_AcuteTherapiesMember" abstract="true" name="AcuteTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_SeveranceAndOtherEmployeeRelatedCostsMember" abstract="true" name="SeveranceAndOtherEmployeeRelatedCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityTotalRevenueRecognized" abstract="false" name="ContractWithCustomerLiabilityTotalRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_GlobalNotes13Due2025Member" abstract="true" name="GlobalNotes13Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ContractTerminationAndOtherCostsMember" abstract="true" name="ContractTerminationAndOtherCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SiteContingencyNumberOfSites" abstract="false" name="SiteContingencyNumberOfSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityCurrencyTranslation" abstract="false" name="ContractWithCustomerLiabilityCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_DevelopedTechnologyIncludingPatentsMember" abstract="true" name="DevelopedTechnologyIncludingPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenueRecognizedContractPeriod" abstract="false" name="RevenueRecognizedContractPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_AssetImpairmentMember" abstract="true" name="AssetImpairmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PharmaceuticalsMember" abstract="true" name="PharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" abstract="false" name="ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_FairValueDisclosuresTable" abstract="true" name="FairValueDisclosuresTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_SoftwareArrangementsMember" abstract="true" name="SoftwareArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A04SeniorNotesDueMay2024Member" abstract="true" name="A04SeniorNotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IntegrationActivitiesMember" abstract="true" name="IntegrationActivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OriginalWeightedAverageTerm" abstract="false" name="OriginalWeightedAverageTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AmericasSegmentMember" abstract="true" name="AmericasSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessOptimizationChargeTableTextBlock" abstract="false" name="BusinessOptimizationChargeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_RevenuePerformanceObligationPaymentTerms" abstract="false" name="RevenuePerformanceObligationPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_AvailableForSaleDebtSecuritiesMember" abstract="true" name="AvailableForSaleDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A130SeniorNotesDueMay2025Member" abstract="true" name="A130SeniorNotesDueMay2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_A13SeniorNotesDueMay2029Member" abstract="true" name="A13SeniorNotesDueMay2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SuperfundSitesMember" abstract="true" name="SuperfundSitesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_CommonStock100PerValueMember" abstract="true" name="CommonStock100PerValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_AdvancedSurgeryMember" abstract="true" name="AdvancedSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillLineItems" abstract="true" name="IntangibleAssetExcludingGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_GlobalNotes13Due2029Member" abstract="true" name="GlobalNotes13Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bax-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4e1b39b3-7043-4cc5-9f6d-56c513b02862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4e1b39b3-7043-4cc5-9f6d-56c513b02862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1ea7f9d1-da24-4895-ae42-b9bdef1c183a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1ea7f9d1-da24-4895-ae42-b9bdef1c183a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d75d7d66-efe4-48ec-abc4-4154a3a8888f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:to="loc_us-gaap_CommonStockValue_d75d7d66-efe4-48ec-abc4-4154a3a8888f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6936c7c-0ad5-419b-926a-693f150ca532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6936c7c-0ad5-419b-926a-693f150ca532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_0aed9e8c-a102-4f31-a9f2-d01833895b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4db86de6-b544-43ec-9dc0-83b757c715b6" xlink:to="loc_us-gaap_TreasuryStockCommonValue_0aed9e8c-a102-4f31-a9f2-d01833895b0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_924f6411-6bc6-4cfb-8a93-9cca95f3519d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5fe16cb9-8216-4ab7-aff9-6472cbb3f7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_924f6411-6bc6-4cfb-8a93-9cca95f3519d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5fe16cb9-8216-4ab7-aff9-6472cbb3f7b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_70540d83-90bd-4b10-86f6-bff5eb13e3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_924f6411-6bc6-4cfb-8a93-9cca95f3519d" xlink:to="loc_us-gaap_AccountsPayableCurrent_70540d83-90bd-4b10-86f6-bff5eb13e3d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_90f52b7e-241d-4389-be62-1017e7502fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_924f6411-6bc6-4cfb-8a93-9cca95f3519d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_90f52b7e-241d-4389-be62-1017e7502fca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f40dd293-eb93-4b96-a222-60a167066d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_924f6411-6bc6-4cfb-8a93-9cca95f3519d" xlink:to="loc_us-gaap_ShortTermBorrowings_f40dd293-eb93-4b96-a222-60a167066d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e8d5f8d2-2bb5-42d6-b149-a1814986d9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b57e22c7-e3f8-4c76-88af-872d4e5d4dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e8d5f8d2-2bb5-42d6-b149-a1814986d9a4" xlink:to="loc_us-gaap_Liabilities_b57e22c7-e3f8-4c76-88af-872d4e5d4dcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6d98f391-9947-47e1-879a-9e18db022051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e8d5f8d2-2bb5-42d6-b149-a1814986d9a4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6d98f391-9947-47e1-879a-9e18db022051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e1b0d229-028f-4dce-aa93-baf4ae5e04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e8d5f8d2-2bb5-42d6-b149-a1814986d9a4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e1b0d229-028f-4dce-aa93-baf4ae5e04f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2cb0c0cd-08d1-406c-9c46-33b5e8f8d3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0afe0c71-bec4-40a9-9297-68ceeb93c56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2cb0c0cd-08d1-406c-9c46-33b5e8f8d3d9" xlink:to="loc_us-gaap_StockholdersEquity_0afe0c71-bec4-40a9-9297-68ceeb93c56f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4ebbaf30-58a3-4bd1-b82d-37add2e0fe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2cb0c0cd-08d1-406c-9c46-33b5e8f8d3d9" xlink:to="loc_us-gaap_MinorityInterest_4ebbaf30-58a3-4bd1-b82d-37add2e0fe4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e152e77-8b2d-45b9-9b9f-27ac6b28ac87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_AssetsCurrent_3e152e77-8b2d-45b9-9b9f-27ac6b28ac87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_070c5e80-e8e6-4e5d-bc16-83ca97059ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_070c5e80-e8e6-4e5d-bc16-83ca97059ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5f4d083a-5dc3-4059-b28c-2d7d3c4cfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_Goodwill_5f4d083a-5dc3-4059-b28c-2d7d3c4cfc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3fbafb5c-6f6a-4f1a-8b47-39d5d3e1e977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3fbafb5c-6f6a-4f1a-8b47-39d5d3e1e977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d5ceb9c0-75e3-4ea2-a12a-e4fcc813becf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d5ceb9c0-75e3-4ea2-a12a-e4fcc813becf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6b4a71cc-77ca-432f-8bf7-8b581ef69e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bfa5ac47-30d7-4886-8002-14548f9456b6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6b4a71cc-77ca-432f-8bf7-8b581ef69e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_931b50dc-3bc7-4ea5-85d4-4b056c332c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_847edcab-0d17-41c1-a063-827260e8e3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_931b50dc-3bc7-4ea5-85d4-4b056c332c0e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_847edcab-0d17-41c1-a063-827260e8e3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f05447e2-1c49-42dc-8514-d4b642074f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_931b50dc-3bc7-4ea5-85d4-4b056c332c0e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f05447e2-1c49-42dc-8514-d4b642074f75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_28c8db2d-63bd-4034-bcb1-b9d0606627e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_931b50dc-3bc7-4ea5-85d4-4b056c332c0e" xlink:to="loc_us-gaap_InventoryNet_28c8db2d-63bd-4034-bcb1-b9d0606627e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9842318b-930c-4f99-a440-96b9054af456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_931b50dc-3bc7-4ea5-85d4-4b056c332c0e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9842318b-930c-4f99-a440-96b9054af456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6daa2480-42ba-4fa3-8c65-7c4374291386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6f08c487-960e-409c-8f47-c143c5a12de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6daa2480-42ba-4fa3-8c65-7c4374291386" xlink:to="loc_us-gaap_LiabilitiesCurrent_6f08c487-960e-409c-8f47-c143c5a12de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9613671-c758-482e-bb2d-afbd134423d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6daa2480-42ba-4fa3-8c65-7c4374291386" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a9613671-c758-482e-bb2d-afbd134423d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e47c9293-aa20-4688-bc18-cf91181be123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6daa2480-42ba-4fa3-8c65-7c4374291386" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e47c9293-aa20-4688-bc18-cf91181be123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cf37b37b-0973-4d71-b831-a868780a33ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6daa2480-42ba-4fa3-8c65-7c4374291386" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cf37b37b-0973-4d71-b831-a868780a33ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofIncomeunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ad64963-daf1-4ec4-a86a-f26795576f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3a621b7c-ae1a-4993-8001-cccd5e158882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad64963-daf1-4ec4-a86a-f26795576f3b" xlink:to="loc_us-gaap_GrossProfit_3a621b7c-ae1a-4993-8001-cccd5e158882" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55920fa0-1dcf-4654-904c-53c1b8406b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad64963-daf1-4ec4-a86a-f26795576f3b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_55920fa0-1dcf-4654-904c-53c1b8406b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2d5fb930-8a78-4a63-a1df-fda816aa8ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad64963-daf1-4ec4-a86a-f26795576f3b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2d5fb930-8a78-4a63-a1df-fda816aa8ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_4ff468d7-db14-4e18-bdd5-8709902a2f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ad64963-daf1-4ec4-a86a-f26795576f3b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_4ff468d7-db14-4e18-bdd5-8709902a2f8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0bee6246-77da-4640-9135-293154beffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80924ee3-28db-4f73-8be6-7aed7dcb38f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0bee6246-77da-4640-9135-293154beffdb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80924ee3-28db-4f73-8be6-7aed7dcb38f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_af62b6a7-b3e2-4f2c-a285-566c4a2aa71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0bee6246-77da-4640-9135-293154beffdb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_af62b6a7-b3e2-4f2c-a285-566c4a2aa71b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_897c056f-39d8-4fc3-a41d-0910790c7770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_553f7bff-6bc7-4b3e-a0e3-01b0ed83d4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_897c056f-39d8-4fc3-a41d-0910790c7770" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_553f7bff-6bc7-4b3e-a0e3-01b0ed83d4a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d2e80366-4efd-40f0-a417-3a45ac9ee0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_897c056f-39d8-4fc3-a41d-0910790c7770" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d2e80366-4efd-40f0-a417-3a45ac9ee0bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7cc64cca-965f-47f7-a755-c8dc463b7c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ab3f154-7700-4564-87f2-17348736f99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc64cca-965f-47f7-a755-c8dc463b7c84" xlink:to="loc_us-gaap_ProfitLoss_1ab3f154-7700-4564-87f2-17348736f99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09162800-19c2-4448-8d39-03787a614876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7cc64cca-965f-47f7-a755-c8dc463b7c84" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09162800-19c2-4448-8d39-03787a614876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4cf4720f-5e61-4d4b-a126-0b9312bef0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_669b36be-9837-4a00-b3cd-164a0516d9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4cf4720f-5e61-4d4b-a126-0b9312bef0fe" xlink:to="loc_us-gaap_OperatingIncomeLoss_669b36be-9837-4a00-b3cd-164a0516d9f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4e690cb3-70a7-4b38-85d2-97107fc733ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4cf4720f-5e61-4d4b-a126-0b9312bef0fe" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4e690cb3-70a7-4b38-85d2-97107fc733ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_52d5b4a6-e75e-414a-b573-3a2a4fcd25de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4cf4720f-5e61-4d4b-a126-0b9312bef0fe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_52d5b4a6-e75e-414a-b573-3a2a4fcd25de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_915cb4e3-a910-4e71-8795-aa1d679cb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8543ff4a-e31e-4ea7-9317-66382e4f9de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_915cb4e3-a910-4e71-8795-aa1d679cb5a3" xlink:to="loc_us-gaap_ProfitLoss_8543ff4a-e31e-4ea7-9317-66382e4f9de7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65ad5f53-932b-4002-8ebf-f1106b1823bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_915cb4e3-a910-4e71-8795-aa1d679cb5a3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65ad5f53-932b-4002-8ebf-f1106b1823bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d36edf41-0d03-4182-b6b6-8e2c20137ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c5f142c8-1ab1-454a-89fc-ff03f05e4cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d36edf41-0d03-4182-b6b6-8e2c20137ec8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c5f142c8-1ab1-454a-89fc-ff03f05e4cb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bb640e66-fa1c-4ae2-88fe-97eab9a6d8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d36edf41-0d03-4182-b6b6-8e2c20137ec8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bb640e66-fa1c-4ae2-88fe-97eab9a6d8a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_272eebb1-46df-410d-b1ec-5707d186fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0cfc0d61-de92-4507-9837-c6a370cf45e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_272eebb1-46df-410d-b1ec-5707d186fc83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0cfc0d61-de92-4507-9837-c6a370cf45e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_420634fe-d512-45a4-ace8-41de7caeabd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_272eebb1-46df-410d-b1ec-5707d186fc83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_420634fe-d512-45a4-ace8-41de7caeabd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_02db3b3d-2ae1-4cf9-ace2-58d5b7e75ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_272eebb1-46df-410d-b1ec-5707d186fc83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_02db3b3d-2ae1-4cf9-ace2-58d5b7e75ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8cbc17d1-9738-4288-b525-bf93f790b171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_272eebb1-46df-410d-b1ec-5707d186fc83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8cbc17d1-9738-4288-b525-bf93f790b171" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d6fa2bc-c495-4395-86f0-c756b3649e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8c6d7966-391b-4521-967f-a282c10e6675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d6fa2bc-c495-4395-86f0-c756b3649e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8c6d7966-391b-4521-967f-a282c10e6675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30ee865a-4339-42e1-9915-fd3b2b23b866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d6fa2bc-c495-4395-86f0-c756b3649e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_30ee865a-4339-42e1-9915-fd3b2b23b866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9784f89d-f81e-4876-a742-96fe9e3c7151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d6fa2bc-c495-4395-86f0-c756b3649e67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9784f89d-f81e-4876-a742-96fe9e3c7151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a68e0b22-5b30-4490-bf6a-9fcb5ca9e34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1d6fa2bc-c495-4395-86f0-c756b3649e67" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_a68e0b22-5b30-4490-bf6a-9fcb5ca9e34d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_83678e48-3a3b-414c-bd70-8dbb031ac057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_83678e48-3a3b-414c-bd70-8dbb031ac057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c184980c-1c8f-4808-82f4-b90d7dce46ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c184980c-1c8f-4808-82f4-b90d7dce46ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_26ace91b-2e94-44d0-ad4e-53c1f36bf925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_26ace91b-2e94-44d0-ad4e-53c1f36bf925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f2a7dc59-6115-4731-86bd-3ec78c32d54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f2a7dc59-6115-4731-86bd-3ec78c32d54a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_881ae7c3-e7ad-48ef-a7ee-6bdf630b8310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b87586-c7d4-4854-b15f-a69efa401289" xlink:to="loc_us-gaap_RepaymentsOfDebt_881ae7c3-e7ad-48ef-a7ee-6bdf630b8310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa6d4439-27be-4614-b33a-40424b85e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_fec57ada-3a2d-41e5-a4db-6a6b31bdb50f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa6d4439-27be-4614-b33a-40424b85e2d8" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_fec57ada-3a2d-41e5-a4db-6a6b31bdb50f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2201b71b-f886-4bc0-b185-7ec2fde6d744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa6d4439-27be-4614-b33a-40424b85e2d8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2201b71b-f886-4bc0-b185-7ec2fde6d744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c5633e7-9aed-4633-b23b-9d802f60353a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa6d4439-27be-4614-b33a-40424b85e2d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c5633e7-9aed-4633-b23b-9d802f60353a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5551f702-a844-4529-aa75-fb7d6ad70525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5551f702-a844-4529-aa75-fb7d6ad70525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2ab50359-4229-489b-b1f9-82b1523f89b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_ShareBasedCompensation_2ab50359-4229-489b-b1f9-82b1523f89b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243fa8e7-7af3-4d3b-84c3-9b8b0e82132b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243fa8e7-7af3-4d3b-84c3-9b8b0e82132b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c8cec47b-be37-4653-80df-6e72b7d5922a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c8cec47b-be37-4653-80df-6e72b7d5922a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_9d2b21a5-cffa-474d-af10-1b337fd92546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_9d2b21a5-cffa-474d-af10-1b337fd92546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_6f00318b-8059-41f5-83b6-172618e750d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_6f00318b-8059-41f5-83b6-172618e750d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9716b157-41d4-45cb-8377-1b29f31aa588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9716b157-41d4-45cb-8377-1b29f31aa588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_076e2d62-4659-41ad-a964-6eba79d3ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_ProfitLoss_076e2d62-4659-41ad-a964-6eba79d3ac7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_bd5e4f8b-5823-4a47-aed4-373e768c9d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_bd5e4f8b-5823-4a47-aed4-373e768c9d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_446ef850-be1d-4363-81cb-b6f3018adedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_446ef850-be1d-4363-81cb-b6f3018adedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_5008f00e-dcd9-41d0-997f-71bc9d6e27a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_5008f00e-dcd9-41d0-997f-71bc9d6e27a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_047daf75-8460-46f6-aa24-086a1a592a6d" xlink:href="bax-20230331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2265d48-a1ef-4617-9591-718d23c79804" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_047daf75-8460-46f6-aa24-086a1a592a6d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b52720ff-d0e5-4170-8483-1580259a5e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_8e15c847-915a-4d6a-85d3-e58e37ef4972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b52720ff-d0e5-4170-8483-1580259a5e3f" xlink:to="loc_us-gaap_RestrictedCash_8e15c847-915a-4d6a-85d3-e58e37ef4972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d8005373-b90a-47df-9a13-78cd9f5cee92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b52720ff-d0e5-4170-8483-1580259a5e3f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d8005373-b90a-47df-9a13-78cd9f5cee92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0ddbcfb9-0708-4e4c-b4fd-a0934ef34d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_17a82416-0328-49bb-bb91-4084bcf37c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0ddbcfb9-0708-4e4c-b4fd-a0934ef34d33" xlink:to="loc_us-gaap_InventoryRawMaterials_17a82416-0328-49bb-bb91-4084bcf37c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_eb85a318-f8bf-4d41-b900-176e9a9d9c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0ddbcfb9-0708-4e4c-b4fd-a0934ef34d33" xlink:to="loc_us-gaap_InventoryWorkInProcess_eb85a318-f8bf-4d41-b900-176e9a9d9c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e61d92c5-3ae6-4e45-b265-07fea45ac02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0ddbcfb9-0708-4e4c-b4fd-a0934ef34d33" xlink:to="loc_us-gaap_InventoryFinishedGoods_e61d92c5-3ae6-4e45-b265-07fea45ac02f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f1217934-d247-4308-a733-0ae949fdc15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_51fcd025-cc60-4c8e-96f6-3dda24f2c3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f1217934-d247-4308-a733-0ae949fdc15a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_51fcd025-cc60-4c8e-96f6-3dda24f2c3fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cf02dc52-5f8e-4102-818a-75a4de576428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f1217934-d247-4308-a733-0ae949fdc15a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cf02dc52-5f8e-4102-818a-75a4de576428" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4d0baa3b-6c82-49e6-84c4-b771606ac326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ac9836c1-629e-4958-b4d1-f074f92f1298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_4d0baa3b-6c82-49e6-84c4-b771606ac326" xlink:to="loc_us-gaap_InterestExpense_ac9836c1-629e-4958-b4d1-f074f92f1298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_48d83d97-71ef-46f5-9642-c1dd97b9c550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_4d0baa3b-6c82-49e6-84c4-b771606ac326" xlink:to="loc_us-gaap_InterestIncomeOperating_48d83d97-71ef-46f5-9642-c1dd97b9c550" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_38a583b9-e1db-4358-aad6-4c90764cd4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b94c32ca-9723-4baa-8dcf-19454e18215d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_38a583b9-e1db-4358-aad6-4c90764cd4fe" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b94c32ca-9723-4baa-8dcf-19454e18215d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c8269752-cea1-4e8b-9587-5f4007ffec06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_38a583b9-e1db-4358-aad6-4c90764cd4fe" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c8269752-cea1-4e8b-9587-5f4007ffec06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_025ea639-1621-4f4c-80cf-0dfb44b07ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_38a583b9-e1db-4358-aad6-4c90764cd4fe" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_025ea639-1621-4f4c-80cf-0dfb44b07ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_2cdd565c-d28e-43bd-8cf8-c80725fe4192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_38a583b9-e1db-4358-aad6-4c90764cd4fe" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_2cdd565c-d28e-43bd-8cf8-c80725fe4192" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_690e0f9d-4300-47d8-9039-99d026213bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cec72088-6389-40b8-b64f-9d102c9ba250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_690e0f9d-4300-47d8-9039-99d026213bee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_cec72088-6389-40b8-b64f-9d102c9ba250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cafe0921-bb90-4859-a0de-2d80fdd907a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_690e0f9d-4300-47d8-9039-99d026213bee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cafe0921-bb90-4859-a0de-2d80fdd907a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55ec2196-bd91-4413-a77e-5ce384d803c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_48658159-864c-4a6d-a962-920be01d7087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55ec2196-bd91-4413-a77e-5ce384d803c7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_48658159-864c-4a6d-a962-920be01d7087" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_17bbf8c0-7280-4bee-9ff3-bfa1954af4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55ec2196-bd91-4413-a77e-5ce384d803c7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_17bbf8c0-7280-4bee-9ff3-bfa1954af4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3b27f053-12f9-4854-9895-052492a10aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5d591566-5aea-4593-8b9f-a32a139c9f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3b27f053-12f9-4854-9895-052492a10aec" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5d591566-5aea-4593-8b9f-a32a139c9f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b4c570d-d0fa-406e-9abb-d1d2f840c0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3b27f053-12f9-4854-9895-052492a10aec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b4c570d-d0fa-406e-9abb-d1d2f840c0d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESLeaseRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_1ec37b94-53d3-4466-be9e-90dc013d0703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_73a89be1-021b-498f-8bc5-1bf360af5e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_1ec37b94-53d3-4466-be9e-90dc013d0703" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_73a89be1-021b-498f-8bc5-1bf360af5e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_415a3a0c-335a-4c3e-ae40-56ecdba6411c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_1ec37b94-53d3-4466-be9e-90dc013d0703" xlink:to="loc_us-gaap_VariableLeaseIncome_415a3a0c-335a-4c3e-ae40-56ecdba6411c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_d499d12b-fef0-4333-bf27-a9980b6ae946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_1ec37b94-53d3-4466-be9e-90dc013d0703" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_d499d12b-fef0-4333-bf27-a9980b6ae946" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_346fb874-addd-44b0-86e6-262ffdb962e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_30c983eb-83a2-4a85-b777-b4c3f6384cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_346fb874-addd-44b0-86e6-262ffdb962e6" xlink:to="loc_us-gaap_RestructuringCharges_30c983eb-83a2-4a85-b777-b4c3f6384cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bb72ac1a-32fc-4131-ba70-852bf7e69d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_346fb874-addd-44b0-86e6-262ffdb962e6" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_bb72ac1a-32fc-4131-ba70-852bf7e69d19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27fdde21-1141-4d74-a6ce-83ae6b9a586b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a16d4b80-c7f6-4e75-a4ef-1c35c2698de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27fdde21-1141-4d74-a6ce-83ae6b9a586b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a16d4b80-c7f6-4e75-a4ef-1c35c2698de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_df2d6121-7909-456c-96bc-1eafa031daf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27fdde21-1141-4d74-a6ce-83ae6b9a586b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_df2d6121-7909-456c-96bc-1eafa031daf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6978ff85-9397-449f-9823-0a17d6d75be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27fdde21-1141-4d74-a6ce-83ae6b9a586b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6978ff85-9397-449f-9823-0a17d6d75be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8b7bae50-4077-44a2-8510-de8122edf0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27fdde21-1141-4d74-a6ce-83ae6b9a586b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8b7bae50-4077-44a2-8510-de8122edf0c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d32b7700-ac49-4937-9892-675555b7af38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2751b149-934f-4b1b-abc6-2877d1fcb936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d32b7700-ac49-4937-9892-675555b7af38" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2751b149-934f-4b1b-abc6-2877d1fcb936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2ff6b798-869f-4cd4-b5e1-f6f629eaf7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d32b7700-ac49-4937-9892-675555b7af38" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2ff6b798-869f-4cd4-b5e1-f6f629eaf7f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_398b15cf-8631-4d18-95c4-66029da6ead1" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_72ed6760-43a5-4e2a-b9c3-c3034d1bf34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_398b15cf-8631-4d18-95c4-66029da6ead1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_72ed6760-43a5-4e2a-b9c3-c3034d1bf34b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_01e483df-4117-4179-a9f7-399b95d6508c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_398b15cf-8631-4d18-95c4-66029da6ead1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_01e483df-4117-4179-a9f7-399b95d6508c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_77ac63a3-a35f-4dc7-99ee-f05782c9e27d" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_e0acbd88-5024-4b47-a8ab-7e271ee33164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_77ac63a3-a35f-4dc7-99ee-f05782c9e27d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_e0acbd88-5024-4b47-a8ab-7e271ee33164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_8f9958dc-399e-4799-89f8-731141b1f375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_77ac63a3-a35f-4dc7-99ee-f05782c9e27d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_8f9958dc-399e-4799-89f8-731141b1f375" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_753ee943-5b1f-4783-937b-c4eb6b015a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_2b307329-7ee7-4727-afd4-adca9ddbf79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_753ee943-5b1f-4783-937b-c4eb6b015a2a" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_2b307329-7ee7-4727-afd4-adca9ddbf79e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4ce44fa3-07ad-45a1-a79b-32f1eb987562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_753ee943-5b1f-4783-937b-c4eb6b015a2a" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4ce44fa3-07ad-45a1-a79b-32f1eb987562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11d20be4-04ed-41cb-b797-2033e321fcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_753ee943-5b1f-4783-937b-c4eb6b015a2a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11d20be4-04ed-41cb-b797-2033e321fcd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_067b3849-6ee3-4255-a7df-ad895f0f2844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_741db139-9221-4390-9b22-133c986f22a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_067b3849-6ee3-4255-a7df-ad895f0f2844" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_741db139-9221-4390-9b22-133c986f22a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cf70cdf3-d742-48c8-b75e-2fadf6e145c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_067b3849-6ee3-4255-a7df-ad895f0f2844" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cf70cdf3-d742-48c8-b75e-2fadf6e145c5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bax-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20230331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended" id="i6a5ff2659ae04a3d878c15f02ebbbeb9_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9f7e9da-33dc-4f73-9fb0-f93586e1fc5e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentType_d9f7e9da-33dc-4f73-9fb0-f93586e1fc5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4ea332d4-2103-42f3-b747-db9afe4ce83c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentQuarterlyReport_4ea332d4-2103-42f3-b747-db9afe4ce83c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9091b61f-017b-478a-9628-daffb8cffd85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentPeriodEndDate_9091b61f-017b-478a-9628-daffb8cffd85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_11e19211-78ff-4748-8e5d-7be1a34242f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentTransitionReport_11e19211-78ff-4748-8e5d-7be1a34242f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ce8636d8-d63a-4061-8eca-9b59f8b7ffef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityFileNumber_ce8636d8-d63a-4061-8eca-9b59f8b7ffef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_27589154-25b4-411a-9b45-882d150153fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityRegistrantName_27589154-25b4-411a-9b45-882d150153fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_82693408-a067-436b-a2de-bc7b801f8284" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_82693408-a067-436b-a2de-bc7b801f8284" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_accec10e-08df-4b9a-9d61-62a17805bb07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityTaxIdentificationNumber_accec10e-08df-4b9a-9d61-62a17805bb07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_396b9339-5b09-4ea6-af81-e62272df4497" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressAddressLine1_396b9339-5b09-4ea6-af81-e62272df4497" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ff87adb7-a887-499f-9cf9-1b2cd097f878" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressCityOrTown_ff87adb7-a887-499f-9cf9-1b2cd097f878" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_50fee72c-2d68-49c8-ad3f-b80968d54915" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressStateOrProvince_50fee72c-2d68-49c8-ad3f-b80968d54915" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1ec5990-227a-4ad8-9ef7-f52aa139624c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressPostalZipCode_c1ec5990-227a-4ad8-9ef7-f52aa139624c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_19bae842-9c08-4776-af7f-6b8855972b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_CityAreaCode_19bae842-9c08-4776-af7f-6b8855972b1c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_423a26bb-54db-46f6-8fb7-e37f4a42047b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_LocalPhoneNumber_423a26bb-54db-46f6-8fb7-e37f4a42047b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6d8e43af-a003-408d-b1e2-90db725f0b93" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_Security12bTitle_6d8e43af-a003-408d-b1e2-90db725f0b93" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3587cde0-e255-4459-912d-9a3cd019ceec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_TradingSymbol_3587cde0-e255-4459-912d-9a3cd019ceec" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa434c87-f1a5-49fd-8c65-0329a2b8c7e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_SecurityExchangeName_fa434c87-f1a5-49fd-8c65-0329a2b8c7e3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bb03a325-9eec-4a0b-b5bc-e729446ab533" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCurrentReportingStatus_bb03a325-9eec-4a0b-b5bc-e729446ab533" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b0fc57be-8372-4582-9616-c058641e5514" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityInteractiveDataCurrent_b0fc57be-8372-4582-9616-c058641e5514" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9dd29492-265d-4c8e-815d-0751690222ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityFilerCategory_9dd29492-265d-4c8e-815d-0751690222ed" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6eaf16ca-305f-4541-bd7e-f69ac5696928" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntitySmallBusiness_6eaf16ca-305f-4541-bd7e-f69ac5696928" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba16aca4-3790-4e3e-80cb-507eb17775e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba16aca4-3790-4e3e-80cb-507eb17775e5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a8300cb7-3fec-4ec2-9df4-074f9bedadbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityShellCompany_a8300cb7-3fec-4ec2-9df4-074f9bedadbc" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1ef249b0-d5bd-40e8-8971-3dfa68a04e6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1ef249b0-d5bd-40e8-8971-3dfa68a04e6d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1a61bddb-56f9-438c-b59f-7cee56700874" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_AmendmentFlag_1a61bddb-56f9-438c-b59f-7cee56700874" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_46eaa1e5-2995-43f7-b3ac-74f4a15dfbf4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentFiscalYearFocus_46eaa1e5-2995-43f7-b3ac-74f4a15dfbf4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_96f270f8-0afa-46a0-b97a-49afd8e58b25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_96f270f8-0afa-46a0-b97a-49afd8e58b25" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_af958595-cfd4-4af4-933d-ca11c98873d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCentralIndexKey_af958595-cfd4-4af4-933d-ca11c98873d0" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b19a391c-98db-44a9-b314-ddbf82d285e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_CurrentFiscalYearEndDate_b19a391c-98db-44a9-b314-ddbf82d285e5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_01622248-120c-470d-84e5-7888a13b6cbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:to="loc_us-gaap_ClassOfStockDomain_01622248-120c-470d-84e5-7888a13b6cbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:to="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_0447bb7a-28db-4548-9401-2b7069e76838" xlink:href="bax-20230331.xsd#bax_CommonStock100PerValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_CommonStock100PerValueMember_0447bb7a-28db-4548-9401-2b7069e76838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_dc5656a2-603a-43a3-8151-646f7bc8871c" xlink:href="bax-20230331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes04Due2024Member_dc5656a2-603a-43a3-8151-646f7bc8871c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_108905f0-1e65-4912-9ef9-77b9024999cc" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes13Due2025Member_108905f0-1e65-4912-9ef9-77b9024999cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_72e7ef66-091c-4af7-806a-f78f29d79d7d" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes13Due2029Member_72e7ef66-091c-4af7-806a-f78f29d79d7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:to="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_5ed2c3c8-0035-465c-8940-bec69066d7e0_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:to="loc_dei_ExchangeDomain_5ed2c3c8-0035-465c-8940-bec69066d7e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:to="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_b0edf1f0-93ec-4668-b953-5fb9efd58633" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:to="loc_exch_XNYS_b0edf1f0-93ec-4668-b953-5fb9efd58633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_fbe7f46c-cc6b-4162-99da-1ac978eb402c" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:to="loc_exch_XCHI_fbe7f46c-cc6b-4162-99da-1ac978eb402c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended" id="ibfd8eee387944b348a762ce7a1230dc5_CondensedConsolidatedStatementsofChangesinEquityunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5cd5a646-cb82-4ca4-8fa9-74a16bd0fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5cd5a646-cb82-4ca4-8fa9-74a16bd0fd65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_85068018-f9a8-4f1a-b2e8-4ee7f481fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_85068018-f9a8-4f1a-b2e8-4ee7f481fa41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6cf31c00-ed22-4658-b070-26eb9e9d478b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6cf31c00-ed22-4658-b070-26eb9e9d478b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e45dd3ec-117d-4cec-8e70-83faa3e1a0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_ProfitLoss_e45dd3ec-117d-4cec-8e70-83faa3e1a0ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6633a7e-9ea7-42be-a156-826a31f3ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6633a7e-9ea7-42be-a156-826a31f3ba0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5fdaab42-1226-4a31-b1d1-fe1615ec14db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5fdaab42-1226-4a31-b1d1-fe1615ec14db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d8fcf3c5-21b4-4a3a-a8bb-1f92894964f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d8fcf3c5-21b4-4a3a-a8bb-1f92894964f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_b3806d30-037a-4ff5-affe-f99db3d62bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_DividendsCommonStock_b3806d30-037a-4ff5-affe-f99db3d62bbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_30fafd9d-ae1a-49fd-9e96-bd6fec70d79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_30fafd9d-ae1a-49fd-9e96-bd6fec70d79f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f1d36d54-40c8-4bb7-b19c-f922f7234c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4e822c7-9eaa-44e6-995e-181ed3717be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:to="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72423295-5a7e-483c-ac43-ae23b436d359_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:to="loc_us-gaap_EquityComponentDomain_72423295-5a7e-483c-ac43-ae23b436d359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:to="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:to="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_733ca317-ee38-40ad-afcd-bc2b6fd4ce14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_CommonStockMember_733ca317-ee38-40ad-afcd-bc2b6fd4ce14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4f57b3ad-8147-4b0e-b25e-b606bb2b84a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4f57b3ad-8147-4b0e-b25e-b606bb2b84a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_51093089-b2b4-4883-8bb8-4b1cc5b1f982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_51093089-b2b4-4883-8bb8-4b1cc5b1f982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_752ba982-c490-4efb-884f-14a5ca62b39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_RetainedEarningsMember_752ba982-c490-4efb-884f-14a5ca62b39f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_341011f4-25d3-4c9c-ab73-ed9de215cb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_341011f4-25d3-4c9c-ab73-ed9de215cb8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_07c42308-b1c2-4d97-a58f-ae2df04c0c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:to="loc_us-gaap_NoncontrollingInterestMember_07c42308-b1c2-4d97-a58f-ae2df04c0c68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended" id="i7f45cf4b58c040ffbe43079961c9d2f3_SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dda02b93-3e9f-42aa-8d07-226714ca8e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dda02b93-3e9f-42aa-8d07-226714ca8e5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a639926d-bcf3-4748-ba46-176aa9b0f475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a639926d-bcf3-4748-ba46-176aa9b0f475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b91867b6-6d4e-4baf-878f-ab4a60e99b29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b91867b6-6d4e-4baf-878f-ab4a60e99b29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_52e148ac-ebbc-499c-a2a8-4e4491c15130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_52e148ac-ebbc-499c-a2a8-4e4491c15130" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended" id="i3dc511a8286d4a8e981c6c6b838ae673_GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:to="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c2cb87ec-a166-45d1-96ef-550b59407984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:to="loc_us-gaap_Goodwill_c2cb87ec-a166-45d1-96ef-550b59407984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2c04ac7f-03b7-4897-9ca7-9d3303255d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2c04ac7f-03b7-4897-9ca7-9d3303255d35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_031ecd8d-3e3a-4716-aaa0-c5144cc5e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:to="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f736366b-991d-4234-baaa-71cf5f4f5f1a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:to="loc_srt_SegmentGeographicalDomain_f736366b-991d-4234-baaa-71cf5f4f5f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:to="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_ef8c01d3-49f7-413a-bbb0-f2a2d312f816" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_srt_AmericasMember_ef8c01d3-49f7-413a-bbb0-f2a2d312f816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_56cdec0c-c9fd-42c2-8de1-a8baa099d1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_us-gaap_EMEAMember_56cdec0c-c9fd-42c2-8de1-a8baa099d1d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_7c381597-4136-41ac-a0e6-b7344f475882" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_srt_AsiaPacificMember_7c381597-4136-41ac-a0e6-b7344f475882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_49023b5b-261a-4777-a800-7bc06dfb809d" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_bax_HillromMember_49023b5b-261a-4777-a800-7bc06dfb809d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended" id="i8623fc9a22c84894a964639fdc4d96ea_GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f667470f-7369-4beb-a818-02996d43e8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f667470f-7369-4beb-a818-02996d43e8a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dd2fa11-e282-42d7-b83f-99749b40e3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dd2fa11-e282-42d7-b83f-99749b40e3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0c83dabd-c18f-41ea-af4b-c9e7b2979baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0c83dabd-c18f-41ea-af4b-c9e7b2979baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5eaa208a-ad49-4504-a2b6-7c76fc8510f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5eaa208a-ad49-4504-a2b6-7c76fc8510f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9ed33ca3-be4e-4950-9585-a9d2c4a90ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9ed33ca3-be4e-4950-9585-a9d2c4a90ef7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58dd3444-eff3-4e95-b4b9-3c59299bd076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58dd3444-eff3-4e95-b4b9-3c59299bd076" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ce962a4d-c288-45d5-8e66-4a0fc6097058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ce962a4d-c288-45d5-8e66-4a0fc6097058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_ae42b6cd-029c-49a2-96a9-6fee64c80aba" xlink:href="bax-20230331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_ae42b6cd-029c-49a2-96a9-6fee64c80aba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_11fb46a9-bc16-4e58-97d1-afc526e2ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_11fb46a9-bc16-4e58-97d1-afc526e2ebf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e6f97b14-0d7a-40a1-a412-ee1883ffd105_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e6f97b14-0d7a-40a1-a412-ee1883ffd105_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b9e3c247-b078-4a84-83ca-c88733e9a942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:to="loc_us-gaap_TradeNamesMember_b9e3c247-b078-4a84-83ca-c88733e9a942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_73884fcd-0dc1-4314-8010-6f85c6d0c9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_73884fcd-0dc1-4314-8010-6f85c6d0c9e8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended" id="ic34909e93f084463bd43b2ef6c900aaa_FINANCINGARRANGEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bfbec427-acbc-4e13-808d-5cd2cc520110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bfbec427-acbc-4e13-808d-5cd2cc520110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_26ef51e6-d761-4660-bafd-f176fb56f7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_RepaymentsOfDebt_26ef51e6-d761-4660-bafd-f176fb56f7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7e805836-8110-4407-9363-9aa1ba870c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7e805836-8110-4407-9363-9aa1ba870c74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_2fdc6a29-135f-4835-8c1b-847bde2a96f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_LineOfCredit_2fdc6a29-135f-4835-8c1b-847bde2a96f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_0251c782-102b-4c6f-b6f5-faa7d915ee4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_0251c782-102b-4c6f-b6f5-faa7d915ee4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_d4c441a4-5037-4376-9fd6-9820b1c83a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_d4c441a4-5037-4376-9fd6-9820b1c83a13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_2adcad12-07b2-471c-b20d-78886ce87c65" xlink:href="bax-20230331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_bax_OriginalWeightedAverageTerm_2adcad12-07b2-471c-b20d-78886ce87c65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99ce3691-46ab-4848-8c0f-f90b605b9d7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99ce3691-46ab-4848-8c0f-f90b605b9d7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_deb148e5-0403-4a0c-8334-492773bff8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:to="loc_us-gaap_CommercialPaperMember_deb148e5-0403-4a0c-8334-492773bff8b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:to="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bc373741-ef75-456b-be77-07c8878ad23f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:to="loc_us-gaap_CreditFacilityDomain_bc373741-ef75-456b-be77-07c8878ad23f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:to="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e7c8612c-b907-42ec-9f3d-05c6e5246ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e7c8612c-b907-42ec-9f3d-05c6e5246ae5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_6cc3a7d0-eff1-4dcb-bd8c-6be1b17393b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_6cc3a7d0-eff1-4dcb-bd8c-6be1b17393b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ia35b1d468b6d44b29d29f577e880c66d_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_035d0cbc-8208-461c-b76d-4d00a20acadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_us-gaap_LitigationReserve_035d0cbc-8208-461c-b76d-4d00a20acadf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_7780b4c4-edf6-49c0-8763-54e55ab61ad6" xlink:href="bax-20230331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_bax_SiteContingencyNumberOfSites_7780b4c4-edf6-49c0-8763-54e55ab61ad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_810b8e3f-78f5-4d1b-a99a-a186e5d79f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_810b8e3f-78f5-4d1b-a99a-a186e5d79f2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_6d18edd6-61e2-4155-b745-3eda152e20ff" xlink:href="bax-20230331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_6d18edd6-61e2-4155-b745-3eda152e20ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_12ecea58-ef89-4499-9ac9-97c7a7bdaa8e" xlink:href="bax-20230331.xsd#bax_SuperfundSitesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:to="loc_bax_SuperfundSitesMember_12ecea58-ef89-4499-9ac9-97c7a7bdaa8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_7f79e5b6-370b-4684-a889-8781dd9dec0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_7f79e5b6-370b-4684-a889-8781dd9dec0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_b7f606c2-2380-4efd-8a03-ed95c25ce8d2" xlink:href="bax-20230331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:to="loc_bax_EnviromentalCleanUpMember_b7f606c2-2380-4efd-8a03-ed95c25ce8d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails" xlink:type="extended" id="idd927af1aa3b44178ff67edd7474b4ba_ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2769270f-2683-448f-a59b-74e16cac4c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2769270f-2683-448f-a59b-74e16cac4c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_07eab2da-4c23-44b8-a57f-e0e76328fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_07eab2da-4c23-44b8-a57f-e0e76328fc65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ee4e8cd-ac69-4961-9555-cc971ca0b85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ee4e8cd-ac69-4961-9555-cc971ca0b85a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_123875a2-b48c-47e5-828d-2a6b7315800e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_123875a2-b48c-47e5-828d-2a6b7315800e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_166acc57-4319-4ee0-9369-072c1faabdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:to="loc_us-gaap_EquityComponentDomain_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:to="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7152969a-e986-40b9-86f9-8a9f03da30b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7152969a-e986-40b9-86f9-8a9f03da30b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67ca0873-7cbe-40b3-aedf-8ccb00ccd234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67ca0873-7cbe-40b3-aedf-8ccb00ccd234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c6d9754a-fcf2-4b4e-b40a-ffb3e080eb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c6d9754a-fcf2-4b4e-b40a-ffb3e080eb81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8190ba6c-1b3a-4fbf-b726-d25aa1554475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8190ba6c-1b3a-4fbf-b726-d25aa1554475" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_6918aee8-269e-4b18-97ba-e030c44cdeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_6918aee8-269e-4b18-97ba-e030c44cdeeb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended" id="i1e82605e2baf4b0f86910e4fdf8b573d_ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4d2f6999-2914-4432-b606-ef6b2a7cb7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4d2f6999-2914-4432-b606-ef6b2a7cb7e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c60ef472-4bcc-4488-84b1-e6f2a759c2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c60ef472-4bcc-4488-84b1-e6f2a759c2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_07c70db9-fef4-4e10-955e-e098a7961f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_07c70db9-fef4-4e10-955e-e098a7961f8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c1da8884-0385-4bee-90e8-6235747bd934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c1da8884-0385-4bee-90e8-6235747bd934" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289d00ab-5943-449f-a198-5a5a847e0291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289d00ab-5943-449f-a198-5a5a847e0291" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14e965fd-16ff-4461-8df4-ed50df50b0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_NetIncomeLoss_14e965fd-16ff-4461-8df4-ed50df50b0e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1ce8c385-fd7d-483c-ac18-ed0ce41c8130_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1ce8c385-fd7d-483c-ac18-ed0ce41c8130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b620abc6-9a64-40f2-a67c-9420cda83d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b620abc6-9a64-40f2-a67c-9420cda83d4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_809aa164-46eb-4246-817c-2f0cf837a24a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:to="loc_us-gaap_EquityComponentDomain_809aa164-46eb-4246-817c-2f0cf837a24a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:to="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f1a71aa-4e86-4d89-8d5d-d979b6d8de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f1a71aa-4e86-4d89-8d5d-d979b6d8de1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4497fb4b-e232-46ce-8929-fda7a7dbd8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4497fb4b-e232-46ce-8929-fda7a7dbd8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c229964f-3cad-4c57-816b-1d2c4fcde08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c229964f-3cad-4c57-816b-1d2c4fcde08e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1053fe42-5107-4278-b6bd-8ce8f69629f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1053fe42-5107-4278-b6bd-8ce8f69629f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_642e7b6b-0dfd-4b2c-93a3-793c1b03a578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:to="loc_us-gaap_ForeignExchangeContractMember_642e7b6b-0dfd-4b2c-93a3-793c1b03a578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_6cc204d2-b78f-41c9-9a83-4badd4e9f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:to="loc_us-gaap_InterestRateContractMember_6cc204d2-b78f-41c9-9a83-4badd4e9f30e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended" id="i067f595e3fec45acb2684dffcdca341c_REVENUESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:href="bax-20230331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:href="bax-20230331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2bfce245-2ba4-4d52-aa5d-5958067bd5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2bfce245-2ba4-4d52-aa5d-5958067bd5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:to="loc_srt_RangeMember_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:to="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_148fde4a-76fc-46f9-a99b-033c31e7f9a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_148fde4a-76fc-46f9-a99b-033c31e7f9a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:href="bax-20230331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended" id="i2cf3198319a14f358e5ef02c9c6ecdd8_REVENUESAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:href="bax-20230331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:href="bax-20230331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:to="loc_srt_RangeMember_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:to="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_148fde4a-76fc-46f9-a99b-033c31e7f9a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_148fde4a-76fc-46f9-a99b-033c31e7f9a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:href="bax-20230331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended" id="i4e3861429c0e4958a80809914c561f68_REVENUESContractAssetsandContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_80717242-6004-45e5-9136-0a7e806e9cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_80717242-6004-45e5-9136-0a7e806e9cd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2b3667d1-d2bd-4057-94b2-1943c757b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2b3667d1-d2bd-4057-94b2-1943c757b32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:href="bax-20230331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_07107c88-32d8-426b-8ab4-7ea3cb233cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_5ddb6468-1582-404c-b443-76ffdbccd81c" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_5ddb6468-1582-404c-b443-76ffdbccd81c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_869a7dca-18f2-4a4e-a930-c6dd750acfdb" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_869a7dca-18f2-4a4e-a930-c6dd750acfdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_958293fe-d5ac-4267-9bba-9b97c0f600b3" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_958293fe-d5ac-4267-9bba-9b97c0f600b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f4aa7ef0-7573-418d-82ab-50db40a5482b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_48972bcb-39f7-4a56-8ff2-0e6755c73a09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_48972bcb-39f7-4a56-8ff2-0e6755c73a09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_ea720f06-25ac-4450-8ef7-0c44565fc52c" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_ManufacturingArrangementsMember_ea720f06-25ac-4450-8ef7-0c44565fc52c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_93d0eb1f-aa51-4ad4-9325-a2c3f42e1d41" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_SoftwareArrangementsMember_93d0eb1f-aa51-4ad4-9325-a2c3f42e1d41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_b0bc7dc7-6c00-4d2a-a5a8-b05e27e7704e" xlink:href="bax-20230331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_b0bc7dc7-6c00-4d2a-a5a8-b05e27e7704e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2aa1c176-e30d-4bf2-8c44-3c611797671f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2aa1c176-e30d-4bf2-8c44-3c611797671f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c5186839-0bbe-4d77-bcef-d92eaa8bed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c5186839-0bbe-4d77-bcef-d92eaa8bed7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_07aa96b5-0e41-47aa-901a-fe8707143991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_07aa96b5-0e41-47aa-901a-fe8707143991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_9993425e-347d-443f-8fe1-ff08b2f9df91" xlink:href="bax-20230331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_9993425e-347d-443f-8fe1-ff08b2f9df91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ee59ab04-0853-4127-a7b2-180f6d356d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ee59ab04-0853-4127-a7b2-180f6d356d83" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended" id="i48cb8f85fb2648a8a9f455fa38d1e9b4_REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62322ab3-8060-4821-9131-6154a21b2565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62322ab3-8060-4821-9131-6154a21b2565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:to="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec67639e-7436-4198-8839-fe6416b6a88f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:to="loc_srt_ProductsAndServicesDomain_ec67639e-7436-4198-8839-fe6416b6a88f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:to="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_291fa763-b9d1-4c2c-bb79-c2ebe8db6d68" xlink:href="bax-20230331.xsd#bax_RenalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_RenalMember_291fa763-b9d1-4c2c-bb79-c2ebe8db6d68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_43f51f9d-12ed-47d4-b092-344bc275df3d" xlink:href="bax-20230331.xsd#bax_MedicationDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_MedicationDeliveryMember_43f51f9d-12ed-47d4-b092-344bc275df3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_8e18835e-3f15-48ba-89ce-44be864ef14b" xlink:href="bax-20230331.xsd#bax_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_PharmaceuticalsMember_8e18835e-3f15-48ba-89ce-44be864ef14b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_21745f4d-5930-4c3b-a68d-6ed16208615f" xlink:href="bax-20230331.xsd#bax_ClinicalNutritionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_ClinicalNutritionMember_21745f4d-5930-4c3b-a68d-6ed16208615f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_8347507f-a5ad-419e-88c8-565e73868060" xlink:href="bax-20230331.xsd#bax_AdvancedSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_AdvancedSurgeryMember_8347507f-a5ad-419e-88c8-565e73868060" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_e9daf7cd-8dc7-4495-a8bf-c4f7fd59c190" xlink:href="bax-20230331.xsd#bax_AcuteTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_AcuteTherapiesMember_e9daf7cd-8dc7-4495-a8bf-c4f7fd59c190" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_7bf4a48b-c1d1-4da8-987d-20dc717da538" xlink:href="bax-20230331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_BioPharmaSolutionsMember_7bf4a48b-c1d1-4da8-987d-20dc717da538" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_67bb3a33-6057-48bd-ab72-4c1f36e185c5" xlink:href="bax-20230331.xsd#bax_PatientSupportSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_PatientSupportSystemsMember_67bb3a33-6057-48bd-ab72-4c1f36e185c5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_c0748d8a-e77b-4379-b725-9c923e744d56" xlink:href="bax-20230331.xsd#bax_FrontLineCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_FrontLineCareMember_c0748d8a-e77b-4379-b725-9c923e744d56" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_a7b3ebae-bfb4-4c6d-a669-83b5ed2a1600" xlink:href="bax-20230331.xsd#bax_SurgicalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_SurgicalSolutionsMember_a7b3ebae-bfb4-4c6d-a669-83b5ed2a1600" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_09ceedac-5559-40e1-9d42-7d4178637439" xlink:href="bax-20230331.xsd#bax_OtherProductOrServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_OtherProductOrServicesMember_09ceedac-5559-40e1-9d42-7d4178637439" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:to="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:to="loc_srt_SegmentGeographicalDomain_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:to="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8058023e-02f4-4f85-bee3-4750c47ae631" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:to="loc_country_US_8058023e-02f4-4f85-bee3-4750c47ae631" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a2773907-f906-498d-8933-682ab429fe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:to="loc_us-gaap_NonUsMember_a2773907-f906-498d-8933-682ab429fe14" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="extended" id="id1a416755be2466aacbd9a543d2c305c_BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_90b04862-5b2d-441a-afd5-c85574d3c08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_90b04862-5b2d-441a-afd5-c85574d3c08d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_74dae872-de58-4aa1-8483-4e837fd2fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_74dae872-de58-4aa1-8483-4e837fd2fba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_0b8ae9aa-b8d4-4537-b538-511b77ce34db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringCharges_0b8ae9aa-b8d4-4537-b538-511b77ce34db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a495aa4-2992-43cb-83fe-1f962ceac877_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a495aa4-2992-43cb-83fe-1f962ceac877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_9fe06ddd-06d0-46f5-b169-9bba47ed99ed" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:to="loc_bax_HillromMember_9fe06ddd-06d0-46f5-b169-9bba47ed99ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_3ed89028-50a1-411b-ab8d-02c8931b411e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_3ed89028-50a1-411b-ab8d-02c8931b411e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntegrationActivitiesMember_c94d036b-4223-43cb-ab5d-23e78606d468" xlink:href="bax-20230331.xsd#bax_IntegrationActivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_IntegrationActivitiesMember_c94d036b-4223-43cb-ab5d-23e78606d468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_77f34699-cfcb-4469-9171-90adee4c28b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_us-gaap_EmployeeSeveranceMember_77f34699-cfcb-4469-9171-90adee4c28b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_9cb9ff10-cfa4-435b-8b86-d09c3a6fb834" xlink:href="bax-20230331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_9cb9ff10-cfa4-435b-8b86-d09c3a6fb834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_871bf3ed-b84b-458c-801e-d5788218e538" xlink:href="bax-20230331.xsd#bax_AssetImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_AssetImpairmentMember_871bf3ed-b84b-458c-801e-d5788218e538" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ca228657-7c8b-483f-a220-e2aea23bea20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:to="loc_us-gaap_RestructuringPlanDomain_ca228657-7c8b-483f-a220-e2aea23bea20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:to="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_NewOperatingModelMember_2c213869-4fcc-4fea-a634-d47704df291b" xlink:href="bax-20230331.xsd#bax_NewOperatingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:to="loc_bax_NewOperatingModelMember_2c213869-4fcc-4fea-a634-d47704df291b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended" id="i1a08942c1e434ab7ae528184aa38de2c_BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_58894c1b-1ef9-4b2c-aed0-0ddaad38c2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringCharges_58894c1b-1ef9-4b2c-aed0-0ddaad38c2cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fee02387-8464-4a42-b8cf-feb831a522b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fee02387-8464-4a42-b8cf-feb831a522b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_2c23524b-0847-4679-8a4d-26c96edaf316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringCosts_2c23524b-0847-4679-8a4d-26c96edaf316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:to="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_86e2be0c-bf5f-483a-bf59-84ae239d4cdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:to="loc_us-gaap_RestructuringPlanDomain_86e2be0c-bf5f-483a-bf59-84ae239d4cdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:to="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_c98db2ae-bc24-45f8-b85a-9ef922d6bf91" xlink:href="bax-20230331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:to="loc_bax_BusinessOptimizationProgramsMember_c98db2ae-bc24-45f8-b85a-9ef922d6bf91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended" id="ib6f27071ecc047f6a9c66f6a44dc1296_BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5d20634f-4a29-403d-83a1-af5618fe1bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:to="loc_us-gaap_RestructuringCharges_5d20634f-4a29-403d-83a1-af5618fe1bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_cb63b19e-77d7-4766-83b1-9b888b690428_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_cb63b19e-77d7-4766-83b1-9b888b690428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_cb2e0595-945c-4746-b889-5e23682a35c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_us-gaap_EmployeeSeveranceMember_cb2e0595-945c-4746-b889-5e23682a35c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_1111d17f-20a4-43ae-988b-49b3fbd54523" xlink:href="bax-20230331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_1111d17f-20a4-43ae-988b-49b3fbd54523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_6143e41a-c9d0-4718-8955-b1b81db7d64e" xlink:href="bax-20230331.xsd#bax_AssetImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_bax_AssetImpairmentMember_6143e41a-c9d0-4718-8955-b1b81db7d64e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98f831e0-6221-45d5-bda2-c8e25f764458_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98f831e0-6221-45d5-bda2-c8e25f764458_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_016a09a3-5586-4c53-a306-767d60b99f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_CostOfSalesMember_016a09a3-5586-4c53-a306-767d60b99f29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f796d23-5187-43fe-b7a9-79d5ce702016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f796d23-5187-43fe-b7a9-79d5ce702016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_90664d9c-1d8b-45db-9899-696171bb1900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_90664d9c-1d8b-45db-9899-696171bb1900" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended" id="if260d9b789e842c3aec67096583fa7e0_BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:to="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e6d4cb06-66b6-4f7a-b11c-523324d2d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserve_e6d4cb06-66b6-4f7a-b11c-523324d2d92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ebea7431-d28e-4f45-8503-46b2fc18e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringCharges_ebea7431-d28e-4f45-8503-46b2fc18e0b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_70112682-dca5-4469-ab41-b43da3c49f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_PaymentsForRestructuring_70112682-dca5-4469-ab41-b43da3c49f48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_435cfa14-9ba2-4346-b7ec-c38355469f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_435cfa14-9ba2-4346-b7ec-c38355469f97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_1916fccd-a753-4f6c-b813-9a47944f2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_1916fccd-a753-4f6c-b813-9a47944f2bb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5e6c61bb-67dc-4f98-98d9-4b594343cc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_25939eb4-9389-4196-bf70-4c6d99def691_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_25939eb4-9389-4196-bf70-4c6d99def691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_c5cf6968-e5d5-47e7-b1cc-b51986823c24" xlink:href="bax-20230331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_c5cf6968-e5d5-47e7-b1cc-b51986823c24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended" id="i6740832886794d939eb0eb0dd85e9094_PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6d3b29f0-dc7a-4d91-900e-3b98dbd6278d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6d3b29f0-dc7a-4d91-900e-3b98dbd6278d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cd246446-c60f-4a2e-8c97-8ae88f61b84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cd246446-c60f-4a2e-8c97-8ae88f61b84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_07782bfb-a13c-47f4-ba01-d2b4ff924925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_07782bfb-a13c-47f4-ba01-d2b4ff924925" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_56a6c2cb-d485-448a-b834-851755e16bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_56a6c2cb-d485-448a-b834-851755e16bf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ba674136-c392-4d98-b8dd-6307bce67783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ba674136-c392-4d98-b8dd-6307bce67783" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8925a938-8249-4afd-adf6-7585789815e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8925a938-8249-4afd-adf6-7585789815e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c51e9766-d43c-48e4-91fd-be728b46c5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c51e9766-d43c-48e4-91fd-be728b46c5de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b00650f0-1412-4b28-9091-ac90fc632087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b00650f0-1412-4b28-9091-ac90fc632087" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended" id="i938a621f50444d9a8c8287e3e816823f_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0f9b8477-b5f0-4613-938a-e217c9274d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0f9b8477-b5f0-4613-938a-e217c9274d2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2e04a143-6f8c-475b-be47-ef4388b0f785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2e04a143-6f8c-475b-be47-ef4388b0f785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c76c1c8b-8034-461e-8de8-07d605159d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c76c1c8b-8034-461e-8de8-07d605159d4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_44c1244a-2521-4f8f-bcd1-f8a1688bb4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_44c1244a-2521-4f8f-bcd1-f8a1688bb4bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6eb69b-7086-4a42-949a-b43cb3107e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6eb69b-7086-4a42-949a-b43cb3107e29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_63ba3fcd-9b5c-44e0-94d7-f9507999aef5" xlink:href="bax-20230331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_bax_DerivativeFairValueTerminated_63ba3fcd-9b5c-44e0-94d7-f9507999aef5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_4b092cfc-61a5-4583-955f-2e141f471ec7" xlink:href="bax-20230331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_4b092cfc-61a5-4583-955f-2e141f471ec7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b2ac3f50-3807-472c-a00e-a6c7b6db523d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b2ac3f50-3807-472c-a00e-a6c7b6db523d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_58fbbdbb-a19e-48bd-aa3a-f643df9cd4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_58fbbdbb-a19e-48bd-aa3a-f643df9cd4e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_bd5c1d51-f432-4314-b4cd-c1f1d3a4007c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_InterestRateContractMember_bd5c1d51-f432-4314-b4cd-c1f1d3a4007c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_515a2862-4c8d-4258-bb7e-9a635cb2e306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_InterestRateSwapMember_515a2862-4c8d-4258-bb7e-9a635cb2e306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ff38b234-da79-4075-8c84-84c9e716d413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ff38b234-da79-4075-8c84-84c9e716d413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member_3c87ee47-a386-4b2b-a2af-377b57d813bc" xlink:href="bax-20230331.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A130SeniorNotesDueMay2025Member_3c87ee47-a386-4b2b-a2af-377b57d813bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member_d1e8b6b4-943d-4086-b37a-bbfdc35a1f15" xlink:href="bax-20230331.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A04SeniorNotesDueMay2024Member_d1e8b6b4-943d-4086-b37a-bbfdc35a1f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member_3e3968fe-f2f7-4b57-801a-b10058e8cd69" xlink:href="bax-20230331.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A13SeniorNotesDueMay2029Member_3e3968fe-f2f7-4b57-801a-b10058e8cd69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_062deb58-a5f6-4172-a202-45946cddf9e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_062deb58-a5f6-4172-a202-45946cddf9e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_21bf3e55-ccab-4ab1-b318-461f512fd1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_21bf3e55-ccab-4ab1-b318-461f512fd1f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9b95e77d-73b7-44c3-b3f6-51dd7f2ef6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:to="loc_us-gaap_NondesignatedMember_9b95e77d-73b7-44c3-b3f6-51dd7f2ef6af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended" id="ifacb5581ef694c56b40925e9e706f604_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_773dbb42-307d-4e4a-8105-aa682bbe1d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_773dbb42-307d-4e4a-8105-aa682bbe1d72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8d1cd2d5-28b6-49c3-adc2-d9564c6617b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8d1cd2d5-28b6-49c3-adc2-d9564c6617b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_306e837b-63ca-4ced-8a8d-eedd3760be92" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_306e837b-63ca-4ced-8a8d-eedd3760be92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_23fe3376-c65e-4a2a-b420-0beea11afb19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_23fe3376-c65e-4a2a-b420-0beea11afb19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_134ace99-46d8-45df-881f-f788ca4474f7" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_134ace99-46d8-45df-881f-f788ca4474f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_eb1d16bc-ade6-47b2-833e-fcb52929ee27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_eb1d16bc-ade6-47b2-833e-fcb52929ee27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f5adab7a-8553-4499-9342-dcceac4120bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f5adab7a-8553-4499-9342-dcceac4120bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_9041832a-f9ee-49e7-b03b-0879138bcbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:to="loc_us-gaap_InterestRateContractMember_9041832a-f9ee-49e7-b03b-0879138bcbe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_30d08751-525c-4b66-b6de-4e60e48bde24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_30d08751-525c-4b66-b6de-4e60e48bde24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_06cccc7a-5df6-44da-ac72-1a32195c7b7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_06cccc7a-5df6-44da-ac72-1a32195c7b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26cc8b01-64ce-4fef-818c-4eb4074eb845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:to="loc_us-gaap_CashFlowHedgingMember_26cc8b01-64ce-4fef-818c-4eb4074eb845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_64d51ae9-8d03-4909-808f-8516dc3f13ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_64d51ae9-8d03-4909-808f-8516dc3f13ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d8df560a-6e76-4ba3-b5da-63440b852af1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d8df560a-6e76-4ba3-b5da-63440b852af1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_63324275-c7ed-4ee9-abba-f4697678f59a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_InterestExpenseMember_63324275-c7ed-4ee9-abba-f4697678f59a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_59f62647-973e-41b9-ba69-1d18c6a9580f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_CostOfSalesMember_59f62647-973e-41b9-ba69-1d18c6a9580f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b4b14252-f53f-4304-bfb7-b44299e3185a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b4b14252-f53f-4304-bfb7-b44299e3185a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended" id="ibd6252a234a9456c822c7f093af428af_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_87d98ee9-c37a-4c92-830b-ab18c78174a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_87d98ee9-c37a-4c92-830b-ab18c78174a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87c82053-5279-4cc4-a796-66859ce2683e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87c82053-5279-4cc4-a796-66859ce2683e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_614277de-2124-46b6-9d40-b380ae2982bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:to="loc_us-gaap_HedgingDesignationDomain_614277de-2124-46b6-9d40-b380ae2982bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:to="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f071c23-489b-4879-a9b8-65e8c946d4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f071c23-489b-4879-a9b8-65e8c946d4ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9f893a29-a85b-4784-a47b-4bd91dc564b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:to="loc_us-gaap_NondesignatedMember_9f893a29-a85b-4784-a47b-4bd91dc564b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_79a5a75b-0112-4354-bdf6-4cb0167f9e73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_79a5a75b-0112-4354-bdf6-4cb0167f9e73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ec09378b-40b8-44ac-976f-d1b529f78735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ec09378b-40b8-44ac-976f-d1b529f78735" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_35b006d0-06f3-41c1-8f5a-1ab754ece8ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_35b006d0-06f3-41c1-8f5a-1ab754ece8ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_01ace3d7-68ef-4c18-a283-bd9fad39ffa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_01ace3d7-68ef-4c18-a283-bd9fad39ffa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_bb90dfc6-30db-4834-a027-97c18a8346e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_bb90dfc6-30db-4834-a027-97c18a8346e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended" id="i476b45034c62468185ecadee96e799f8_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_c6907c76-44ac-464f-9655-2ef9316e8607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_c6907c76-44ac-464f-9655-2ef9316e8607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f3654a84-abd9-4c78-aace-370b19daa958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f3654a84-abd9-4c78-aace-370b19daa958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:to="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94d2c43f-4dd6-4b27-832f-e11c9761d2e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94d2c43f-4dd6-4b27-832f-e11c9761d2e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1476dc7f-d4d1-41b1-b016-0812db786ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:to="loc_us-gaap_LongTermDebtMember_1476dc7f-d4d1-41b1-b016-0812db786ceb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ib2b380c60786424489175f385ec91521_FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_37275e97-2908-43f3-be94-5a229eb26f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_37275e97-2908-43f3-be94-5a229eb26f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b3deb01-bde9-4901-87ac-b28685526911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b3deb01-bde9-4901-87ac-b28685526911" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b69a010b-f1d5-4893-8c33-a5a3fc83d20c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b69a010b-f1d5-4893-8c33-a5a3fc83d20c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_80f8bd8b-d68b-4424-b175-9395b8fab38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_80f8bd8b-d68b-4424-b175-9395b8fab38a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_994067d0-ed76-48d0-9d78-d550773a93b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_994067d0-ed76-48d0-9d78-d550773a93b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_994e622d-ed1f-4a65-8588-f94dd63a7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_994e622d-ed1f-4a65-8588-f94dd63a7da4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_9bee201d-ddcb-4e6d-87ae-f467f3c9699f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_9bee201d-ddcb-4e6d-87ae-f467f3c9699f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_769a81a7-f658-4620-81e8-7ede4d7f0073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_769a81a7-f658-4620-81e8-7ede4d7f0073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_174e2af1-5b82-4d18-add4-85dab854b367_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_174e2af1-5b82-4d18-add4-85dab854b367_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a0a7a570-7156-4d55-b5b4-056f49553ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a0a7a570-7156-4d55-b5b4-056f49553ea5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cbf1ae36-767c-44bd-9312-a87070d6646e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cbf1ae36-767c-44bd-9312-a87070d6646e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_135d8beb-2ac9-4734-bbb6-6628ac489844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_135d8beb-2ac9-4734-bbb6-6628ac489844" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="ib503cf3e1cc94af99ebd54552242fbf8_FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d95433b-7d4d-4c00-a499-8a2ab664161d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d95433b-7d4d-4c00-a499-8a2ab664161d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e198ce7b-7f19-45f7-ae37-ebee1c037ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e198ce7b-7f19-45f7-ae37-ebee1c037ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_e520106b-6888-4744-a0bb-bc605baf3996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_e520106b-6888-4744-a0bb-bc605baf3996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_208b80e6-addf-4847-ae3c-5872cc7906cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_208b80e6-addf-4847-ae3c-5872cc7906cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8326f789-2c88-459e-abe1-1596830ca28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8326f789-2c88-459e-abe1-1596830ca28f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_44067246-ac12-4c61-8937-4363059300bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_44067246-ac12-4c61-8937-4363059300bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_2ff29bb4-fecc-4628-8896-80eb49884a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:to="loc_us-gaap_OtherAssetsMember_2ff29bb4-fecc-4628-8896-80eb49884a02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_371af24d-9fdb-404e-91d0-b462a4570b4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_371af24d-9fdb-404e-91d0-b462a4570b4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_2de609f2-4d57-4af4-9e1a-757cf14b79f9" xlink:href="bax-20230331.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_2de609f2-4d57-4af4-9e1a-757cf14b79f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended" id="ie4645d7e1f324a67a4a953c0b9925087_FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_106f362e-fb9a-4190-997a-2dffacd58fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_106f362e-fb9a-4190-997a-2dffacd58fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b1a21d6b-7c17-4a06-881a-02a29f9cfa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b1a21d6b-7c17-4a06-881a-02a29f9cfa0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3440e2a0-dbcc-4c30-9a86-a66e1d130e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3440e2a0-dbcc-4c30-9a86-a66e1d130e92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_8f031afa-4b13-4d3c-aa2d-ce82a7819535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_8f031afa-4b13-4d3c-aa2d-ce82a7819535" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_04623473-2e14-4635-8f47-f649d5c346f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_04623473-2e14-4635-8f47-f649d5c346f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f61d8faa-c683-485f-bbb4-612ec596e9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f61d8faa-c683-485f-bbb4-612ec596e9e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ac0289d5-7682-420f-b9de-27a421ad5055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b312b408-f71b-4d90-9c31-811449c671e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b312b408-f71b-4d90-9c31-811449c671e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_229e52eb-14f0-49db-93e2-e260b1a57f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_229e52eb-14f0-49db-93e2-e260b1a57f1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_b9cf7df3-9b70-4ddd-bfa0-f1131b4e693a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_b9cf7df3-9b70-4ddd-bfa0-f1131b4e693a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_881937a1-a412-4a3d-ac67-607cbc7db1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_881937a1-a412-4a3d-ac67-607cbc7db1fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c60e7870-7893-41e2-a9e1-3b1834cbe7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c60e7870-7893-41e2-a9e1-3b1834cbe7e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_6b1a870d-5b0d-484c-a34e-0e5f4862549f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_6b1a870d-5b0d-484c-a34e-0e5f4862549f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_01591640-e891-46c1-b09e-8875bdd3b4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:to="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a01490b-c0e2-4c30-b579-c06d3be68ba7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a01490b-c0e2-4c30-b579-c06d3be68ba7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_1fd13530-8198-4538-849f-62166c5a6cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_1fd13530-8198-4538-849f-62166c5a6cc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_a489b6f1-f71e-4cc9-8644-8d97ca070f76" xlink:href="bax-20230331.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_a489b6f1-f71e-4cc9-8644-8d97ca070f76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended" id="i837cbb02b45143bbb5e0e42227490429_FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_6000977f-0883-4671-a6a3-53eb2506a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_us-gaap_ShorttermDebtFairValue_6000977f-0883-4671-a6a3-53eb2506a6ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_36b184c5-ad2b-4516-aa7c-56c30dc32c2b" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_36b184c5-ad2b-4516-aa7c-56c30dc32c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_2834dfc0-d537-4581-8b87-cad9a44125f6" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_2834dfc0-d537-4581-8b87-cad9a44125f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_07c008e5-1534-46eb-9b90-d8cf84bbba6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_07c008e5-1534-46eb-9b90-d8cf84bbba6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_cb871aba-9a8b-49d2-89bf-c10f3af6025e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_cb871aba-9a8b-49d2-89bf-c10f3af6025e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6677c5b3-64e1-476d-94bd-9b8d0e90c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6677c5b3-64e1-476d-94bd-9b8d0e90c10e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended" id="i803798ffdbbd45b6be5c7471b4aa881b_SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_53ab5fea-6ddd-4e88-a2fb-ce51a04d2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_NumberOfOperatingSegments_53ab5fea-6ddd-4e88-a2fb-ce51a04d2b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaa1833c-ed6c-4a9f-b844-df29f6abc203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaa1833c-ed6c-4a9f-b844-df29f6abc203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_67adcdf2-cd46-40b4-b609-0fdf1724c9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_OperatingIncomeLoss_67adcdf2-cd46-40b4-b609-0fdf1724c9de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:to="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:to="loc_srt_ConsolidationItemsDomain_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:to="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a4738a24-2eed-44ca-9f30-fceb97c8f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:to="loc_us-gaap_OperatingSegmentsMember_a4738a24-2eed-44ca-9f30-fceb97c8f3e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1a0dde9-74f5-450c-92ef-7c53f7369ab9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:to="loc_us-gaap_SegmentDomain_b1a0dde9-74f5-450c-92ef-7c53f7369ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:to="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_28ad3cbe-1655-4c05-a3d3-ad733d285e35" xlink:href="bax-20230331.xsd#bax_AmericasSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_AmericasSegmentMember_28ad3cbe-1655-4c05-a3d3-ad733d285e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_1e930901-f2e8-4c96-aad2-f899609d16a9" xlink:href="bax-20230331.xsd#bax_EMEASegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_EMEASegmentMember_1e930901-f2e8-4c96-aad2-f899609d16a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_0c4fc957-9276-4d0a-8796-4ab14eccb1e6" xlink:href="bax-20230331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_AsiaPacificSegmentMember_0c4fc957-9276-4d0a-8796-4ab14eccb1e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_6d85d3c8-24b3-424a-8346-511e7a17f136" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_HillromMember_6d85d3c8-24b3-424a-8346-511e7a17f136" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended" id="i5bd90315fa6747fbba310c55a9311998_SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d8e8ccbd-e668-4299-bc08-4247f4c096d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_OperatingIncomeLoss_d8e8ccbd-e668-4299-bc08-4247f4c096d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6b54ce66-ebfd-426f-967a-016a883096ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6b54ce66-ebfd-426f-967a-016a883096ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d725d114-3843-4daf-b9da-3fbc9c13c98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d725d114-3843-4daf-b9da-3fbc9c13c98e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bc4c88d9-8714-433a-b4f2-b0e08c9163c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bc4c88d9-8714-433a-b4f2-b0e08c9163c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:to="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4bbe0233-6299-44d6-932d-e78d56d737c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:to="loc_srt_ConsolidationItemsDomain_4bbe0233-6299-44d6-932d-e78d56d737c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:to="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d8330c3a-bca4-4aa1-ad2d-1d09f7adb9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:to="loc_us-gaap_OperatingSegmentsMember_d8330c3a-bca4-4aa1-ad2d-1d09f7adb9d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e5916d3c-8d95-4180-9c29-72b6d8b53f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e5916d3c-8d95-4180-9c29-72b6d8b53f12" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bax-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f69f5e6a-3eb8-4f32-a46e-758249ea842c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_f1a6341e-c37e-4088-8a5e-6c62d8f8686e_terseLabel_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="bax-20230331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_43c39885-7599-4b29-9215-29a646086b0f_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_f88249b9-3b44-401d-8764-d1e9fddfc9e7_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_label_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosure Line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresLineItems" xlink:to="lab_bax_FairValueDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_5a000625-8ef7-4292-a403-a2bc5c50bd68_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00f81e7a-79e2-48b5-8271-d4cf1d2997be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_93febf50-1f58-470a-8dfa-cdb74aadadb0_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_959b9095-4101-4b58-8a01-5932d15eb35f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_e84b9452-351f-4957-90fd-4aed50f29eb6_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_569111f3-c693-42d0-93c6-c552c81d69d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c7d929fe-5ba4-4b01-a1bc-983cbec278ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_83ed6446-8446-47d4-ac15-9c9efcbf6e80_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_label_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member" xlink:href="bax-20230331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes04Due2024Member" xlink:to="lab_bax_GlobalNotes04Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_90b55f52-db61-41ac-83e1-cccc0046b7ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_a4f90819-0e62-4b85-b2fa-376807c3975b_terseLabel_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology, including patents</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_label_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Including Patents [Member]</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_documentation_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology including patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:href="bax-20230331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:to="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_8478a768-e065-4920-adf6-fd5395f6ae5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_ccd24f4f-b5c5-400d-a331-f9452cf236c8_terseLabel_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and Other Employee Related Costs</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_label_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance And Other Employee Related Costs [Member]</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_documentation_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and other employee related costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:href="bax-20230331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:to="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_a0a0c980-fa4f-4d10-9963-45644b624cca_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and carrying value by balance sheet grouping.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7fd68bff-511e-424e-aedb-d0343bbef382_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_fbd177d3-3da0-47d1-a359-76f5829ea760_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_4c182293-4c39-4be8-bd72-2c63ec2a09c9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_2f131574-3a0f-4882-8f71-58be668d15b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1e194f95-bb6c-44fd-9922-4ce05ea8ffdd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_ecc25531-b6c2-4efd-879d-4473d76098c4_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_43d8715b-6862-4383-9b39-772f13d390da_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_14518e48-873a-49f8-9637-b0a03c7f5edf_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseIncome_cea493aa-f515-4b9e-93ae-8a4e5c87d764_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease revenue</link:label>
    <link:label id="lab_us-gaap_LeaseIncome_label_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseIncome" xlink:to="lab_us-gaap_LeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_272f45eb-a52b-42cb-8ed4-66987cd13695_terseLabel_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled equipment and consumable medical products contracts</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_label_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts [Member]</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_documentation_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:href="bax-20230331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:to="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_f0fb15ac-697f-4dd9-b756-9bb9661d92e8_terseLabel_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, additional authorized amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program additional authorized amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="bax-20230331.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_9e47682b-8848-432a-9ce6-cc9e98f28a53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income) Expense, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1392a164-fa7c-4f0d-a826-86a49c458dcf_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_86ef4180-3011-40bf-8216-45fde7af4bd9_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:href="bax-20230331.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:to="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7f09aae9-36a6-48af-9e13-d090c96310e5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_86120749-c034-41b7-a297-6a2212b0b3f6_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce745f32-2ba8-4c75-b9ef-ffb4bc02a81f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_a510991c-9893-48f1-8c5f-6b09403a37d3_terseLabel_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original weighted-average term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_label_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_documentation_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm" xlink:href="bax-20230331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OriginalWeightedAverageTerm" xlink:to="lab_bax_OriginalWeightedAverageTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ca9c5afb-6dbb-4ccc-86b4-c36aa91528a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gains and Losses on Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_469a8dcc-fefb-434b-97ab-d86a057a7faa_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_08fb998f-4ab6-4a79-a923-bdebb9e8067e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a11c9676-3818-410b-90b2-d722d1129895_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f3027b6e-de04-4112-a23b-82edd90be0d3_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_1c6f4f3d-4a16-40ac-a02d-3b0d73bb3d2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b0da7bcf-08a2-4f40-911c-905ed7b7ebb1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3763e604-f139-4ca4-83cf-be3cc2f0e433_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_28626f6e-1fd1-47c9-b168-5cee7c5464a3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_41d1874f-d0e1-4f10-b478-f667b19aa9f4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2ab075e2-4cbd-4515-8bc3-604fd3d816e2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_a7833d40-3468-49f3-98d0-1325bab3eea6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99b572fc-7415-4f7c-9086-1d9c05b871c6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AmericasSegmentMember_aef33810-d910-4822-b543-5675e83672be_terseLabel_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_label_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment [Member]</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_documentation_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember" xlink:href="bax-20230331.xsd#bax_AmericasSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AmericasSegmentMember" xlink:to="lab_bax_AmericasSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_bd551012-3e33-460f-81a1-65b3d9b7730a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other amortized intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_a07d691b-59fd-46a0-8bb9-db77a4d75978_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_d26c3964-ebb6-46a9-b813-9e8171ea723f_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntegrationActivitiesMember_6a30810f-2bc2-436a-9fd2-cb4a526f1b3f_terseLabel_en-US" xlink:label="lab_bax_IntegrationActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration Activities</link:label>
    <link:label id="lab_bax_IntegrationActivitiesMember_label_en-US" xlink:label="lab_bax_IntegrationActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration Activities [Member]</link:label>
    <link:label id="lab_bax_IntegrationActivitiesMember_documentation_en-US" xlink:label="lab_bax_IntegrationActivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntegrationActivitiesMember" xlink:href="bax-20230331.xsd#bax_IntegrationActivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntegrationActivitiesMember" xlink:to="lab_bax_IntegrationActivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_860cfe52-9e43-44c7-b570-299e03f4451f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_52123a8a-d7a4-4d3a-bc1b-8bb3636768e8_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_15f45efa-522e-465e-88f2-bf75849c252c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2554d01b-8dd5-4ef6-b14f-a42514a778de_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_f87d9364-a764-425d-aa0f-9ed7b4aafe81_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_0a72ab79-4745-4bc7-9460-c998fb5cb8e9_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury, at cost,177,658,649 shares in 2023 and 179,062,594 shares in 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_09f5568d-dfa8-48fb-b6ea-4364ce496aaf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_8a4d06a0-a267-4a85-911c-48c6a03d89e2_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2029Member" xlink:to="lab_bax_GlobalNotes13Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6c193b68-64a7-49ce-94df-1d2738ba96b1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_01e04d96-d819-41a4-9f2f-3bf0331eff7c_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_3e0883f3-ba65-41c3-8715-dfbf82dc9deb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_0555064a-8c7d-4519-91b9-20ccd1f98d4a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_cf0a005c-3389-4a13-908c-51fce46c56ce_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_1abad164-ff88-4312-b77b-6306c17696d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_c3e70f42-1817-4a5b-9b4d-d9c53bc27199_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6a0bca2b-c52d-4aa6-b666-fe29fb1e8163_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_66b41304-2c40-4939-9a88-a9bb0261a711_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active markets for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_ebabf2cc-cc4a-45e6-8688-d6568697143d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_86047f35-75fb-464a-84a3-929fddd70a1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_4222e901-8427-411a-8b07-735a7ab7b6da_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9e4ebd3c-a58d-4651-8888-f8bcfe4aece8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_6f55e363-b682-44d4-a9ff-5b06c9ca4b67_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total business optimization charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseIncome_0c90d651-8fbf-4071-b4ef-bfb84023ba70_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease revenue</link:label>
    <link:label id="lab_us-gaap_VariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseIncome" xlink:to="lab_us-gaap_VariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a1c1acf4-7647-47e9-a585-eb12fb24bf6d_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_852dc9fe-ac6a-403a-9afe-e1559a79480f_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_e8f3d192-8c0f-4154-96ce-b19fdfd76fc6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_c2170a97-6802-41b7-ba96-4f31eadf307c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected additional pre-tax costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_0928f9fd-d4dd-44f0-9e0b-91fcd58dba7e_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_67790c66-1c0d-40a1-b6f9-03230e7e20eb_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9d632a52-1cf4-4b65-afd8-2bafe7121ae8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_fe00f5d8-576e-4814-8f59-d53a8d5b7a57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_4812e2ef-d2dd-420f-ab2a-1c37727796d5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_971a3f96-fec5-4627-98da-5095fb252c8b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_f5324e9b-6f9f-4d17-a144-3852f2588562_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Reclassification from AOCI to Net Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6998dbac-08c9-406f-879a-93d8c7d106f6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fdc79859-7790-4e63-b50e-e5b71a27c3ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_3a347657-4b50-4db1-bcee-f5b32b036aa4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_235e48ed-be44-465a-8c77-7db13bb8a38f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6972c555-17fe-4df9-834d-97fd6ff69b9a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_96987f1f-3ec8-4737-9c1b-cfae167dd0c3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_eb632d2c-b8ea-4c04-a2c4-427f8a41e8bf_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_19e1edb2-44c3-4ec0-8033-e73bf1ccc153_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_56cf28d9-4e6f-46ab-854b-7261efaf3a32_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5af6f54f-9b35-4179-ac53-14f340d5ab45_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_b07aba59-0452-46cd-b577-8b5bb160f5da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_c9bd5e82-c96d-4e7d-979d-a116b493e4e6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_a4bb7152-ef07-471c-b857-c90135df183d_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c91eec17-1a28-481f-a1f1-2999135ef1bb_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cf1f5b40-17ab-46ab-bad6-8ad78dc6817a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9ff6aae7-a7fa-4ed1-9770-3e6e361dd1e3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_87b92ed3-39b7-482c-96a0-222d2f2c733b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_6bf88203-e0b4-41d1-9e7d-26146c2e10e2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48bb5616-7241-4d95-ba67-5fcbf456c929_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_136afeef-ed41-4f00-a699-ad5ee4ed9574_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_60a5fe0c-0d3e-4584-a28e-59153139527a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_63826dc2-366f-47ad-862b-01038dd6ea05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in AOCI by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1d760bb6-92e5-4601-9dd7-c63edef9455e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_0fafe915-8625-49cc-8360-2c73edd76d7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8b9914ef-39c6-40c4-8101-d5ab64708201_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_08d241fb-ad2a-49c2-8875-3e331ab0ed86_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_f451df05-2523-4034-be1c-22253bbf91c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_4dc42f39-21ca-424d-8d48-043ef2c28441_terseLabel_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_label_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognized Contract Period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_documentation_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod" xlink:href="bax-20230331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueRecognizedContractPeriod" xlink:to="lab_bax_RevenueRecognizedContractPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_896cb2fe-f40b-4dcd-9dc6-5e3b10aeb9ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_bc9e37a7-56de-4622-9517-192086dfafa4_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_328926f3-b7fb-491f-92f0-66602fd3531d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e5983cc8-03da-45ff-95e6-f792d21cce30_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_e6de09bf-3907-4965-a472-80851c5f8c6c_totalLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ba07d489-f0e0-4665-bebc-067bc5a3db27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_4c85e5da-fed3-4d4e-aa38-d8fc8e163a63_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b00a1df-b349-4be2-b8a4-ed888f9092d6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_26f3f33e-e2f4-44b7-ba90-b28cc20ba6f2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1c40dff9-039c-4c77-aca6-f35a88a1a3a2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a5e4e5f-0a0b-4fd9-acb6-3d7271a2f046_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb4ec0db-0e18-4935-be1d-e5d9e0fb8485_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1e65603f-507d-4842-bf21-ab0cac86d38c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_cd698c6f-9940-44c9-8565-f45f462b4292_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_8eda3b02-b1bc-4c39-b762-a7b5c1e1391e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_dcdcbc29-1b6b-4009-a7d4-f22dcd5653ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_057be035-9704-4952-9109-d279b729e357_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_01bfd571-7bba-43bc-85d3-ef8a02f9ea13_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_be93b342-4350-4728-a157-fb4939440f7f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CTA</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_d2c55559-2ea5-4d66-8fa0-bb9f36cceba1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_dc29d171-6f01-4591-b1a6-9fb13a414751_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31020027-05de-4e5f-9f42-3c054cdb2af1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_828fa3b8-8bb1-4f1f-933e-318ec982bf3d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7c8c8c9d-cada-4c86-ae34-535e027c2f5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and Fair Values of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_09bbb7ee-3979-4d5f-aa96-d7c469daeb89_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, less current portion</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long -Term Debt and Finance Lease Obligations, Noncurrent</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_18192cd3-fd95-4036-9c0a-a8d12f159822_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SurgicalSolutionsMember_257c85ac-4dfd-4f64-bf43-111e0a6f47fc_terseLabel_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_label_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions [Member]</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_documentation_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember" xlink:href="bax-20230331.xsd#bax_SurgicalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SurgicalSolutionsMember" xlink:to="lab_bax_SurgicalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e7a75633-67b7-447b-abc6-31733f536b82_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a3e33a94-f8b2-4df1-92fd-fa5fb2924bc4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_48ab24f9-2a2b-4ce2-8803-a8a5b611c9f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Values and Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a43fb1e8-8ae8-4837-91c8-c6b78d0e9445_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_281ccd4a-53ee-48b6-aa18-66a5bf858169_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_ae883645-04a3-4253-b1f9-58c88bda793e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_89a403e5-d698-4acf-9c25-409186c7a0ad_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e5bb2277-a0a8-4955-bdc6-bf97202c0964_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_05fb0139-dcf5-4fe8-809a-583b2e034fb0_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum length of time hedge in cash flow hedge</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e7700418-4abf-4030-a3d7-2a8e4239c42f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_0c5d356e-98f2-495d-92c7-13614bbfe1b0_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_62a63865-f107-418e-95e4-cbfbe1141011_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_ecce8b13-dc77-4b62-b473-a9262b7e7a3f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_32e54387-9249-401e-bce3-a1cdd72d1668_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_47708a98-87d8-4a4b-898b-6b40ac94958f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_883c43ab-33a6-4bdc-a3a2-7936c470ffde_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4f8b9648-9d4c-4c78-9dc3-9577e73f2999_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_46bf7e04-e047-4caf-b781-16abc355a799_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8e1a532a-7a9f-4811-9dff-8f91cd1d9045_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_6b993e15-bbf5-41aa-8278-a88b02ee1553_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6b21f96f-4fc1-4ac6-b211-d18b2b91389c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c5ec044-c3b9-4975-83e7-20370f27e6c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff0797aa-0805-4ff6-bab6-59127dcd4133_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_cac4bea8-7914-4023-990d-222fbc7d2bc4_terseLabel_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, net investment terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_label_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated" xlink:href="bax-20230331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeNetInvestmentTerminated" xlink:to="lab_bax_DerivativeNetInvestmentTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f357c0fd-02be-4ecd-82a8-d06ab67434fd_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ClinicalNutritionMember_37f28474-c6fa-47c1-80ea-b718f7b19e51_terseLabel_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_label_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition [Member]</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_documentation_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical nutrition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember" xlink:href="bax-20230331.xsd#bax_ClinicalNutritionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ClinicalNutritionMember" xlink:to="lab_bax_ClinicalNutritionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3896b7b4-7d7b-4450-9f05-11b62be4d269_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_04f8f93f-1f4e-476f-af19-37d433c8635f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_22413893-0057-4cec-8583-094769c344f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_38ef9d69-df89-4a68-a129-8fcf326c2684_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_398a181b-d779-4f44-97ce-2399276ca540_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_937687b2-0bf2-4863-9739-3d99b264139f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1ee60faf-8a61-4179-a6a3-5260ac2d1bfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_fdf6df3c-a9db-41a1-8222-3cc5715ea4f8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_94413677-b53b-403b-8a7f-7ac38610ac7a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b34574b2-ce9a-49b9-a03f-697cdb37f383_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7fb6ad1d-e035-464e-8121-14381b308134_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8938f9d4-a0c6-43d9-bec6-cc9f61b01fe5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_e8204af7-278c-4709-bcb2-1301b405ac00_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_f53c4905-ec9f-4d0c-8530-078802d788dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8bc6876f-9321-4864-8013-a829b4cef3ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_ef5623e3-3025-4b62-8d33-c9d27caf6df5_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7bbe0c88-ad24-428a-ab9a-dd0ef77ff597_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d1b98a23-88fc-484a-bb7f-a1a5a6ac3ef6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_29a444a0-a2b5-43ec-9564-35342d79369e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_75b74398-5b02-41cf-81a9-2100238783aa_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_4a106393-0f85-42d8-85b7-1a15175c28d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_b2ccb3da-62ae-451b-bc2c-b0107157d93e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_3935d108-0ceb-409d-b963-487ef1223971_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_6e47590a-b158-4499-9356-74a2ee5979a8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1815de80-58a3-4117-89de-e73a72a65480_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a1ff38af-db00-4332-b643-9b43e4caddd0_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e4691405-8c58-4cf5-9212-b4c6065c6670_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, net of tax expense (benefit) of ($1) for the three months ended March 31, 2023 and 2022.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_1758ef93-3921-44e2-bfe2-e006264e2118_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative pre-tax costs incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_5f5a37ef-339d-4fc6-bbad-8a34951d9e3b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_7b38cb3d-44c9-4ec5-bcc1-3089e6eafcae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_3672cbc4-9fbc-4a56-9e13-8e45baab6a64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_36cdc3ce-2f32-47dc-bc21-e880bf48a92f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c6ae2f6b-0e64-4f17-8f1c-614891e59f11_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d073e6b5-3fb4-4ec5-8d78-3c3c28747e59_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_238504d2-b091-40cb-82cb-74a136f5c8ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_20c874ef-8cbd-4d04-8b4b-6116205896e0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_c934a7ae-90f0-4267-9f23-24f74ac2352e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_1d64d19f-40a7-4b50-b3d1-1de95b7fb98c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_78a2f78e-2e03-4f95-b0b2-3884ed42f251_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcuteTherapiesMember_28db28b4-35ce-4f1d-914f-e3f3a7e6b710_terseLabel_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_label_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies [Member]</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_documentation_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember" xlink:href="bax-20230331.xsd#bax_AcuteTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcuteTherapiesMember" xlink:to="lab_bax_AcuteTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_83b86928-795a-488e-8825-f027bd2c37b4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_30e4b172-60d4-42f4-a81b-8e3f4234ff3b_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Finance Lease Obligations, Current Fair Value Disclosure</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, current, fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_a95ae73b-8a08-475d-a607-088a326b475a_terseLabel_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_label_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_documentation_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:href="bax-20230331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:to="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ac3eebc1-4d7f-4d08-828a-ed5b888656d6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b4212d48-51bb-43b2-b005-591c7cf40fd0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_45b19f99-b87c-428b-9753-5902d8fd34f0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommonStock100PerValueMember_db0c7f2d-6796-45f0-bbb4-b6b761d9889b_terseLabel_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 par value</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_label_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value [Member]</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_documentation_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember" xlink:href="bax-20230331.xsd#bax_CommonStock100PerValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommonStock100PerValueMember" xlink:to="lab_bax_CommonStock100PerValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_65b0e986-b308-4ea2-a29b-3284c8394a91_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, average outstanding</link:label>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_label_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Average Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:to="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_0ae55e4e-db65-4643-8acb-e4a1378ae5c0_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_ec853f52-bc02-4a21-a68a-61516affc528_terseLabel_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_label_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency Number Of Sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_documentation_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site contingency, number of sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites" xlink:href="bax-20230331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SiteContingencyNumberOfSites" xlink:to="lab_bax_SiteContingencyNumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_fdb9e584-1f8e-4fbd-a21f-03f131dd6f7b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_545f7564-0ba0-42d5-a681-b67b08f5cd47_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a6ec4791-4de4-4881-987e-0357d0db7a32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_687a3772-7a74-456c-9411-d3f861ec3ce4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3b2b290b-d6d0-42c6-9c52-643cd0838267_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_4fd77af8-6f6e-4eaa-b12d-6c7880bddaf2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f0106d87-ee7d-4a54-88ea-883a289dfc8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in balance sheet items:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ManufacturingArrangementsMember_b5f2882d-c49c-472d-86b6-88f083f04f1f_terseLabel_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract manufacturing services</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_label_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Arrangements [Member]</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_documentation_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ManufacturingArrangementsMember" xlink:to="lab_bax_ManufacturingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f4d8f0f1-737f-4cbd-abfd-3e4039532c68_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_6ab52fdc-fa94-4508-aa37-b0b9b62bc1ba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_ea947e82-53bd-4d8c-a3c1-2b0c5e3a96bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_751de2b7-12d6-4273-bdba-a1d9c371c570_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_a2c24ee0-a200-4a00-b959-aa7ae1585260_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds, at carrying value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_35917779-0a1d-4182-89fa-55348213f7bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_da7117c4-14ae-491f-8d29-3740fbff8d4b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_e210792c-cea2-4db7-96b9-b937605b1e31_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_52f98205-b1c0-4cb1-a0b3-f70f60b28a36_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_0e4fddce-1e04-45aa-97f0-62d159e05ce1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3cd715cc-caee-416f-8b0c-4b199c05db0b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_44071890-de03-4472-a6df-bee1103db134_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_4fa7e5a9-2ba7-4110-8b59-67f97043ce28_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_5995d7a5-245a-48db-b642-08ad03f4ecad_negatedTerseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized upon satisfaction of performance obligations</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Total Revenue Recognized</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Total Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:to="lab_bax_ContractWithCustomerLiabilityTotalRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2fd77311-66d5-4637-9033-336349b8055f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_541ffd26-c0ae-403b-b17f-bca93db608fc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bdcdc670-e4eb-4d06-9dbd-725a405f88e9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5c693a48-23aa-4491-b226-7c3130a75200_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b3a63a5c-c07a-40ec-a0b1-bb09bf2c89bc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_47551d97-6760-4461-9ed5-6406f628e006_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_be69ed64-9306-4923-bc5f-fc8356d592a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_77888b70-a9a2-4a10-bc44-4e2fdb8aa401_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $122 in 2023 and $114 in 2022</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_d310732e-38f8-4d2f-b755-5693255a4d3d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_8b1c8f5e-2d42-4d08-bd09-deeb8a0a99aa_negatedTerseLabel_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:href="bax-20230331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_9ec6f235-3e81-458d-bb81-308dc76ff7b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_345706a6-01d9-4edf-95a3-f610d4f6275a_terseLabel_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_label_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Termination And Other Costs [Member]</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_documentation_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember" xlink:href="bax-20230331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractTerminationAndOtherCostsMember" xlink:to="lab_bax_ContractTerminationAndOtherCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ba322c35-9850-404e-9af9-2dde77a02956_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_b4510af8-8ce7-45a6-9085-d690e67f6392_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b2343a5e-e5ea-42df-8c40-070e332fec7b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03c5931d-970b-4c96-a8f1-213bb90d263f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ec75c089-307b-447d-92f7-0c500eabda31_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c96046c1-be03-48d0-9461-bd52125d7a29_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6691cd8f-2c42-4ee7-87af-8ac4205a466b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AssetImpairmentMember_236b4348-8f25-4b03-9655-a65cb8b84a31_terseLabel_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_label_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment [Member]</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_documentation_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember" xlink:href="bax-20230331.xsd#bax_AssetImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AssetImpairmentMember" xlink:to="lab_bax_AssetImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8fc1aca4-c315-4ab6-9af3-c2dd5787a14a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_11c2ab48-0009-47ee-ac58-2d83618289f8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_70bea4cb-95ff-4e3e-889c-da5fd4dec835_negatedTerseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Currency Translation</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:to="lab_bax_ContractWithCustomerLiabilityCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0b95e2d0-b146-469f-a01d-c077d9e5d5fa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_9e41ed6c-9be9-428e-a6f4-5a43e002cf05_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension and other postretirement costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_218b0dff-a0bc-4baf-8bcd-9176bb7cbb28_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8df806ce-6d0c-45e8-8807-f54dcbc3c4b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_189416ac-adae-4417-a7e9-38422d07ea6f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_4961f8aa-aaee-4843-87f3-0b700c0c2e12_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_dfaf82da-610c-4d0e-94f0-e49a525caa48_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_72649de1-c7fc-4980-8add-c13a057f56e6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_571cc278-caef-4b32-8179-a5fc65f13d85_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_16c13ff7-a722-496c-9be9-29db29969c74_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_554b12e2-25ab-4801-a6b0-50540426eb3d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3075777e-c98f-456f-8ab9-ca8bf324a986_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_45d487db-e2eb-4a79-8a58-4e6a1f335613_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_8caa2b0f-1f08-477b-9d0f-b9a058afc088_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_6086a022-ceda-4871-897c-df01a418e786_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_14c2f9f9-a237-43d3-ab81-bef244f0bc7f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_cb53d064-2e83-49e7-9b6b-6302b5fd34a2_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_72e39fac-8d74-4f48-b4c4-ceea659be545_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6db63168-8b25-437c-bec1-b1a6ddfa3166_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b3440604-155d-4841-aa08-c63f91f010fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_799e97b5-d5a7-48d0-8f56-f1144038d2f6_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_efba532c-d298-4454-942f-450b837b5a39_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_46976f20-cc75-4225-b25d-814b03d5c5a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_b18c1fe6-c4e8-437a-a913-8ad81f089e15_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value, total</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Security Sold under Agreement to Repurchase, and Security Loaned, Subject to Master Netting Arrangement, after Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:to="lab_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RenalMember_d78a837d-8cc9-4cf0-a899-f41df0ba8b83_terseLabel_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care</link:label>
    <link:label id="lab_bax_RenalMember_label_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal [Member]</link:label>
    <link:label id="lab_bax_RenalMember_documentation_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember" xlink:href="bax-20230331.xsd#bax_RenalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RenalMember" xlink:to="lab_bax_RenalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_973b698c-6161-4e40-ad41-7a65e0971ca1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ae488fbe-8326-4650-a84a-858e2edc924d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_3dafd6bd-db96-4052-af9c-f2d122430475_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_833b9df7-008f-4268-b455-5a5421b69074_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_1b14ff3f-c80b-4316-997a-8c2e67b569bf_terseLabel_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_label_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_documentation_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits" xlink:href="bax-20230331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LossContingencyNumberOfLawsuits" xlink:to="lab_bax_LossContingencyNumberOfLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ded86cb1-80ee-4d07-a276-a77e36895826_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash flows from operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BioPharmaSolutionsMember_e596ea9d-431c-40c2-9e82-158bda52f5e2_terseLabel_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_label_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions [Member]</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_documentation_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember" xlink:href="bax-20230331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BioPharmaSolutionsMember" xlink:to="lab_bax_BioPharmaSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_59810015-120a-4f40-9929-f5d409f0762e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bbe38239-a9fa-48e2-af65-1d2815697301_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f333b428-cb69-438c-a0fa-c662360cf699_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_531e311a-dc04-4e8a-9273-2a6788feb341_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_NewOperatingModelMember_36843487-d218-474b-b5d4-f15d8b4b4034_terseLabel_en-US" xlink:label="lab_bax_NewOperatingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Operating Model</link:label>
    <link:label id="lab_bax_NewOperatingModelMember_label_en-US" xlink:label="lab_bax_NewOperatingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Operating Model [Member]</link:label>
    <link:label id="lab_bax_NewOperatingModelMember_documentation_en-US" xlink:label="lab_bax_NewOperatingModelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Operating Model</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_NewOperatingModelMember" xlink:href="bax-20230331.xsd#bax_NewOperatingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_NewOperatingModelMember" xlink:to="lab_bax_NewOperatingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_e9a1e151-b4d9-4877-9cdd-b752c14f004d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_80afd079-1feb-42f8-9ae0-ebc3156001fa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresTable_34ba6790-eba4-4490-9047-57b5b3da968b_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_label_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosures table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresTable" xlink:to="lab_bax_FairValueDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d9327465-5996-4dfc-9eb8-91ed594957d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_dc852ee7-e74a-4dad-9d77-2bfc145ccd11_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f4bdc20b-a18f-42fb-8491-ec57d8e49d49_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SuperfundSitesMember_9d51a7dd-79ef-4db4-98e4-8b214d6c6e32_terseLabel_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_label_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites [Member]</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_documentation_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember" xlink:href="bax-20230331.xsd#bax_SuperfundSitesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SuperfundSitesMember" xlink:to="lab_bax_SuperfundSitesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_e71f8766-2f44-4d83-aafe-29055bea5c23_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8eaa5271-856a-4c6e-ac5e-98530c6bae2c_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4d073cb-cadb-4ecf-9b40-909ce3a1269e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ae783c77-130c-4d8d-89ed-3c3badd2c20e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eeb9acc7-a1ee-48df-b3f6-3abe8112fa44_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_421e3984-9540-49b2-a96e-f2aa286b7fd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_654f2f52-64eb-4b50-bd93-d1d91228d2e6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_47b1a2f9-7322-46cf-992c-4cb3097ab63d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_7e51c04f-e510-41e3-8d41-fd605c79d6a1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_4aab3099-421e-4a3e-854f-ed60a3fff69e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_3b1f2e65-ebf7-4cff-839f-4df8a8e62b09_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b76dc527-c1b7-4a36-863a-e23d9c0e98f8_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book values</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_33b669fd-cb67-4ca8-a85a-d2e474f583fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_288f2f28-131a-4658-84e3-579c8e4f4bd3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_b15e769f-3926-4bab-b597-2881076b0996_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseRevenue" xlink:to="lab_us-gaap_SalesTypeLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_5996b7b8-e165-4953-88ab-393d518414d0_terseLabel_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Senior Notes Due May 2024</link:label>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_label_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Senior Notes Due May 2024 [Member]</link:label>
    <link:label id="lab_bax_A04SeniorNotesDueMay2024Member_documentation_en-US" xlink:label="lab_bax_A04SeniorNotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero point four percentage senior notes due May two thousand twenty four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member" xlink:href="bax-20230331.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A04SeniorNotesDueMay2024Member" xlink:to="lab_bax_A04SeniorNotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_bfde5f97-d53c-4150-be54-010d02b2bb8c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_fb70760a-aff9-4589-919a-bbb0488bd77c_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3be99c0f-e080-457a-9b90-2ebd034abb20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_92f9d5ed-f5f0-482d-9fd5-25a43b46f039_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d941972a-bd93-4afd-8001-64bbe8c96c28_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred, net after-tax gains on derivative instruments</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_03973e0b-437f-4b47-bbe8-a46b47bbbfb4_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_f36b2289-c6a8-49ba-85df-b12faf126d0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of marketable equity securities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6e59c229-fcd6-4f42-87a5-eb88d2d13ef0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3425e120-23e0-410d-b6fd-dc9523011128_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa5b9345-91df-4358-9149-4b8d15195cea_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d840ba5b-ab79-4252-b532-ab817248db83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, net of tax expense (benefit) of ($13) and $(11) for the three months ended March 31, 2023 and 2022, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_9c70baf9-da76-4fb3-ae4d-db7236c3f260_terseLabel_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Senior Notes Due May 2029</link:label>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_label_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Senior Notes Due May 2029 [Member]</link:label>
    <link:label id="lab_bax_A13SeniorNotesDueMay2029Member_documentation_en-US" xlink:label="lab_bax_A13SeniorNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One point three percentage senior notes due May two thousand twenty nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member" xlink:href="bax-20230331.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A13SeniorNotesDueMay2029Member" xlink:to="lab_bax_A13SeniorNotesDueMay2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b09cc23d-58a6-4819-b846-cce65f740148_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ce3c440a-5f31-446d-92b6-2bac1a4f1be1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d30e580f-fc43-4a16-b653-dfa9ebaa59bf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f32159c2-bd8e-4b01-992f-ae9db528c6c4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_4694f004-0607-435b-92b9-4dbd91b3b18f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1da2d26d-4b98-485e-8dfb-14a6cceac5fc_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures incurred but not yet paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_218fdf15-a61f-4da5-9697-27c4d510f9b0_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders' equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_c9d5e8cf-fd4d-4dd7-b7ed-b063a94cf786_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_ac1b3c29-a0bd-4b1e-a817-f1b423d94b27_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8497c6f7-1f70-46fa-8a77-ee3df781df53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_cfa51ca6-8cd8-496a-bc34-f823f8c092b0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_4bf6b26d-9e76-4e8f-87ba-47f32a0b0784_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34c4398f-ad13-4642-8593-e55c6a2f61b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PharmaceuticalsMember_3cd14181-5f84-42f8-92f3-5881f0104880_terseLabel_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_label_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_documentation_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember" xlink:href="bax-20230331.xsd#bax_PharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PharmaceuticalsMember" xlink:to="lab_bax_PharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_369e41f4-82bf-449f-a235-22e4e5ee3984_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9e9b44a2-3308-4d1d-ac09-ef8ef40d2548_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_e71d5cae-d211-498e-8531-fc0626b8192d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, total</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:to="lab_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SoftwareArrangementsMember_7a0e44ae-885d-4ce6-87d1-bfaf6c0c465c_terseLabel_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software sales</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_label_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Arrangements [Member]</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_documentation_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SoftwareArrangementsMember" xlink:to="lab_bax_SoftwareArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_e8724681-1822-40e3-9882-5d38ac0c0bb9_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_5325ceef-d1c9-4969-99a8-1333f407084c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_42957b5e-b770-43c2-8686-4783032ae9d7_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_512a0e6b-02ef-4353-aa44-81ecddb3b507_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_96e725dd-7172-432c-8328-a265cc7aa408_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherProductOrServicesMember_05b79c67-4eb2-44d2-bfe4-246e9020f553_terseLabel_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_label_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Product Or Services [Member]</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_documentation_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other product or services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember" xlink:href="bax-20230331.xsd#bax_OtherProductOrServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherProductOrServicesMember" xlink:to="lab_bax_OtherProductOrServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_968580cb-1b29-44c0-8e65-95252b0fcc9c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock issued under employee benefit plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_55f924b7-6ccd-4618-9d50-b88db08ef82a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information for Our Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_39c4c428-2f2c-45cc-a0b7-790615001cf4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated pre-tax unrealized translation gain in AOCI</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_3d1dab67-0669-4a59-84e0-91265fbb9dad_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_cbf5a799-bfb7-40c5-9433-89db757d2265_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_20d0c8bb-5746-47e0-b6c1-aa698e7b63a2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_64002c36-16eb-4b61-9210-107181de6697_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_ef9f562d-b0c5-451a-b136-3181f30b32a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeFairValueTerminated_c6727eda-1352-4579-b0ac-8e42a16cd8e7_terseLabel_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_label_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated" xlink:href="bax-20230331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeFairValueTerminated" xlink:to="lab_bax_DerivativeFairValueTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_883caf61-e4b5-4a57-ae50-575b451ec709_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Business Optimization Charges</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_label_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Charge [Table Text Block]</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business optimization charge.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:href="bax-20230331.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:to="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_621d0bfc-3b13-4565-8ebe-dbf8275ecb9c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_MedicationDeliveryMember_215d13b7-8661-4ec8-a69e-fc20fb123a13_terseLabel_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_label_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery [Member]</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_documentation_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication delivery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember" xlink:href="bax-20230331.xsd#bax_MedicationDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_MedicationDeliveryMember" xlink:to="lab_bax_MedicationDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_9e7a1389-17c1-4774-b3ce-105ffad0ef57_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decreases in debt with original maturities of three months or less</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_b271e717-6e21-4feb-8a90-614c49ead68a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type leases, receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_332ab259-c033-4de5-8278-f85a336c6266_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_97b8e991-96cc-4f13-959b-cc55a282c3ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_96cb9ba9-53c3-4bae-88f1-23dd8b5bf336_terseLabel_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy [Policy Text Block]</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="bax-20230331.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_53bda9a0-9762-421f-bb35-93871a6fb458_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_07e8101d-5730-4b53-b5af-0ab097fa736f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8fca9917-82b4-493f-8adc-74b2a76b5882_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_45292d58-1cbc-4a1d-9355-33b4b88e0d93_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_bd8a0f33-ab96-4565-985b-69243cc19311_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1c12e70e-ea40-4d85-9616-d650f9f95e3e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4ebd9897-eac9-475b-80cb-fdc791054b17_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4ad553dd-d880-43b7-80c4-ac7b5387984a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_33a0794c-4cd5-4d0b-af74-658d9729013f_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b7305446-bdb6-4119-b505-1feed373dd68_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_6c6097ed-379c-4748-b1a6-705be48ea853_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_7242b8f7-f371-4f83-b6fb-213846fccef0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EnviromentalCleanUpMember_eec07f8f-4d60-4c5a-853c-7995e9e5c802_terseLabel_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Clean-up</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_label_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental Clean Up [Member]</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_documentation_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental clean-up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember" xlink:href="bax-20230331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EnviromentalCleanUpMember" xlink:to="lab_bax_EnviromentalCleanUpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_30f12b8c-16d3-44e3-b6b8-8e57fbafeb53_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2023 and 2022, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_4cfe9892-20bc-4dbc-83b4-979d62e18cab_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_b5eab335-9fe7-4f60-a103-2424ba3624a1_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_label_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs [Member]</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember" xlink:href="bax-20230331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationProgramsMember" xlink:to="lab_bax_BusinessOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b45c85c3-b3f2-42d9-a247-674f3f5e90ec_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_94a3e5e6-935d-46e1-b72f-6eb9662a40d1_terseLabel_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global payment terms (in days)</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_label_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_documentation_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:href="bax-20230331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:to="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_682e93e0-b61b-4cc5-bd07-4b3b2731f39c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5fe267c0-c77e-47d7-b2c2-20cf13e9af31_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_7e66f0af-a119-4738-b539-6c43f09e714c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_360a1fd7-cd44-4c78-94a9-76ef0ef0cc25_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3836780d-5d5c-4cd9-b989-df93f4821053_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities, net of tax expense of zero and $1 for the three months ended March 31, 2023 and 2022, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_4558ec34-91c3-41d9-a438-30fb0c1c22b7_totalLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_37724bf6-608f-4e18-a5ff-9fcd776c3d12_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS OPTIMIZATION CHARGES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d3e546de-e613-4917-9d2b-beaf7c4fa6e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_eb6b3fbd-15b0-4d59-9050-70c81f82d47e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in income, undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_2b5a5252-ea25-44bc-8c3d-65dc0dc6ec9c_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c9067ff5-181e-430b-8bcc-dcce474de3ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_188cfd8e-2b74-4e8c-874d-3aa45bb41646_terseLabel_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_label_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products [Member]</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_documentation_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable medical products [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember" xlink:href="bax-20230331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ConsumableMedicalProductsMember" xlink:to="lab_bax_ConsumableMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a14e8216-c367-4309-bef1-17068bfd007a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_815c0f08-ce1c-411e-86b5-0b0abbbdf3aa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_bb7afc8a-4f5b-4131-9567-4dc73f93b49d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales from Contracts with Customers by Global Business Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c634bcca-10cf-4cd2-98ef-eeac2e3ff86d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_125a612c-9331-41e5-89ae-d0245b3c9c55_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_36d7a7b5-f87e-4e26-8f4a-5b8bbb9d0fa7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_65107a5a-afad-46ac-ad1a-ef0ba7f0d609_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e6dbb81e-7695-4c8b-9c6a-bf53ba5d19ea_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments designated as hedges</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_9c6c20ea-96d4-4929-b667-247f3e2fc955_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7249d81a-fd6c-4852-968a-cea814efe129_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized upon satisfaction of performance obligations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_7ffc78d4-52b3-4478-9505-b36f65afb087_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8e4921fd-616c-46d7-af67-8fec3989f170_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_22d4aa9a-eb85-436c-bc2d-78be64786932_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_af14f87b-c014-4148-beca-50a89a67db3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_9881f982-945d-4283-9cbd-ed6850acd59a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_22187058-5bec-4864-a3ba-2a93b4866657_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net, finite-lived</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_948ee744-a813-4110-919e-0904c2f37dfa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_fb9a62f6-6a6c-45c8-afb7-742db991718f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_80d7fac1-6b13-4eeb-96b8-e28f6d08de43_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9d63ca94-bef1-4ec9-9212-35d87230a3d2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_50e375cf-c454-440d-a34a-a024aeae1520_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_56693525-2bcf-4e48-b1d4-ce82faa099dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0b79a0a5-4df7-4ded-9196-31626c58156e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a1ee9af3-2cc7-47a7-a6d8-1e5104e6dd2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5cdce8aa-a7dd-43bf-9798-fda9f4e105e4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_be893689-1169-4cb6-9d98-45dafec12fb6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_89b75267-1664-49e7-9e92-6a8793f468b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_508b3f07-9752-4b35-adbe-8ddc7fb063f1_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_72bbdc18-1213-4a9c-b890-6dbbe1edf9ab_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4aa788d8-4760-4322-8ced-c826734e9617_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_234dafec-a01a-4c1e-9406-dc4b4f74cb47_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair values</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_969e514d-7671-4408-8427-01c2535658f8_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Stock Exchange</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9f7d5af0-9678-41f2-a146-92c39bf6c2e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d020e6b9-c5a7-4000-bf9b-362bd1aad4b7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9403e279-9952-4afc-81f7-87e1167d3929_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_21143957-c858-4230-8ce0-5a56e73b0f3d_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_156edb02-948b-4be3-9899-6ffde7a532e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_3a16bede-c025-471f-8d0b-c2364d43ee10_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_7178c1b0-da84-45e2-8b87-ed14b10538cf_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_01af0bc3-248a-4ae2-a17d-884c79532b8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental reserves</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_a662cecb-eedb-4f04-b80f-e2541b85bfbd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_9ac85d6e-9da9-4541-99e6-c0920833a164_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_bea87db9-e67c-477a-b37b-ecd2866d9469_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc974ebe-686f-4bc4-bbd0-964fcf839404_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_57196a06-f4a5-400d-850f-527ab0a2f6ad_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b428c28-11fb-4be9-a515-5419c501ba22_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_28e9facf-748c-4cd0-a151-da704249d032_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_161b13c5-6b9c-46bc-b2f7-8da0be44c51c_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2025Member" xlink:to="lab_bax_GlobalNotes13Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_ebc2ea5c-09aa-4705-92cc-41a2b38a855a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XCHI_3e750988-5aed-4077-afc6-53001fc24be6_terseLabel_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago Stock Exchange</link:label>
    <link:label id="lab_exch_XCHI_label_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NYSE CHICAGO, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XCHI" xlink:to="lab_exch_XCHI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_66f3b64b-d66d-420d-8fc7-e3965a791861_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b218840d-b52f-45b1-b03b-1e38ee8c9e2f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_a4a9e7e4-9ad6-405d-b389-18de36b7d9fa_negatedLabel_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:href="bax-20230331.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:to="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_HillromMember_f08fbc56-bd4d-4438-b8fd-f2334e542daa_terseLabel_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom</link:label>
    <link:label id="lab_bax_HillromMember_label_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom [Member]</link:label>
    <link:label id="lab_bax_HillromMember_documentation_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_HillromMember" xlink:to="lab_bax_HillromMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_a411a292-4b1f-4237-9362-65a36b1aafcb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_61138428-34e2-4042-b356-8364232a8765_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_40adc742-7ca8-4d6a-8897-21d1593ff68f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cec9aeec-8989-42f8-9a12-b2345207aebc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fedb3787-fc55-406a-a8c4-f32ed060635f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_9e60c638-b02c-4c68-a7ba-e1a4008d6fce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_6c7f3e00-5de1-4852-90f7-6e66beaa21c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_064692fa-43cd-4423-9548-f26d32f8c9e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5d968295-4b88-4665-8065-70b851b5cb6f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f813c66d-7195-4a81-a3b9-1ac1935deb84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_6e987c60-8fe7-4570-b5cc-e919eaf398a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_cfbbb24a-fcac-4eb1-b13a-929987545e58_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_731450aa-185e-4cd5-959c-e6f53449ff5a_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_d55a658d-f4f9-4249-b9ea-cdb6878d4ea0_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_23015eac-25ae-400f-af1e-cf96e394c90d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9bd4d989-f5b0-4213-b654-b6a9eea0827a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_0b5115de-92a0-4151-9e2e-d14c8a8a89c0_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Positions Presented On Net Basis</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of derivative positions presented on net basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:href="bax-20230331.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:to="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7ee9de12-e024-4938-96a3-ead9d0bce73e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_fb5ed023-cfac-462a-ae4d-30889a59bc4c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs to implement business optimization programs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_ab6f773c-5b24-4d35-bdf3-20b6c8cc26eb_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease, net of investment in lease</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_ba83bc79-6f13-4b89-bc19-a64633399cf3_terseLabel_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025</link:label>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_label_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025 [Member]</link:label>
    <link:label id="lab_bax_A130SeniorNotesDueMay2025Member_documentation_en-US" xlink:label="lab_bax_A130SeniorNotesDueMay2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes Due May 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member" xlink:href="bax-20230331.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_A130SeniorNotesDueMay2025Member" xlink:to="lab_bax_A130SeniorNotesDueMay2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_2297a874-7fc8-4dcf-af6e-99542c8722d0_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_097f0bc0-56dc-4a55-aca5-5edb0266fe74_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_91c7b01d-a1dc-4dbe-9825-1bc8a13856da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1cc3d978-55bd-4e8f-9d57-ac86c2ee18a6_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net losses and prior service costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2e5528d6-3598-46f1-bb2e-363d178a6d9f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FrontLineCareMember_a0046e90-3000-4f23-99cb-00cb1dbe2899_terseLabel_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care</link:label>
    <link:label id="lab_bax_FrontLineCareMember_label_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care [Member]</link:label>
    <link:label id="lab_bax_FrontLineCareMember_documentation_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Line Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember" xlink:href="bax-20230331.xsd#bax_FrontLineCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FrontLineCareMember" xlink:to="lab_bax_FrontLineCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_ec097bc0-fbd8-43db-8a0d-18e02281e4c8_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gains) losses, net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_8452b5ea-5a0b-468b-befd-9451bef72f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0fc3e3a8-8c0d-487a-9db7-38431ee023cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_b2ca7277-5ff0-4598-a44f-b3698d38c3ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b6a439a1-a7e2-4cac-8203-aa84aad65c18_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining value available under stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_cf3d30ac-d488-4947-9924-905d747cb307_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_9229d425-b06b-454e-8708-3abc2f56e0e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3da08853-79c9-45d6-b574-9eee47e792bf_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_4d8a1e73-be2d-4534-b142-889a6be942cd_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_05eab459-e343-40dd-b742-6baf3103f117_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired, and investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_98d34f3f-f0b1-4565-8cea-054bf79464ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8c7eddbf-0b71-4e4f-834e-17237b5b5173_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_c4f41060-7f59-4c74-8da0-b492b20abc3f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income to Income Before Income Taxes Reconciliation</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_0f61b5fd-ed49-4e9f-973e-05df6ba0556e_terseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New revenue deferrals</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:to="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c534f1ea-cec1-4af1-901f-e638800d303b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_50a16178-0402-4080-8fb8-6f721ece09ed_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_59e50253-a4b7-483e-b7da-31d0cf4a659f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_76ac894f-7a50-4d61-86f9-33c4e82a5512_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_b8e98815-4bc2-48bd-bbd7-56e0c8733868_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PatientSupportSystemsMember_e3164dd8-dde0-41d3-a3e0-b33123202f20_terseLabel_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_label_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems [Member]</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_documentation_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Support Systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember" xlink:href="bax-20230331.xsd#bax_PatientSupportSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PatientSupportSystemsMember" xlink:to="lab_bax_PatientSupportSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AsiaPacificSegmentMember_932621df-c0bb-4238-9d6f-c5a6473c9151_terseLabel_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_label_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment [Member]</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_documentation_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember" xlink:href="bax-20230331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AsiaPacificSegmentMember" xlink:to="lab_bax_AsiaPacificSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_fd750128-e8ce-48af-bc91-4d5f49f30fba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EMEASegmentMember_44f0b834-5441-4986-bd57-de876434039b_terseLabel_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_bax_EMEASegmentMember_label_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment [Member]</link:label>
    <link:label id="lab_bax_EMEASegmentMember_documentation_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember" xlink:href="bax-20230331.xsd#bax_EMEASegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EMEASegmentMember" xlink:to="lab_bax_EMEASegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_9474f4d7-9199-40de-b0f2-970366d64ff0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_63b3d9c7-0de5-4765-88df-4052e0f6d869_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_aee6ac2b-f64a-4494-b0f1-e24c14e2dbb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:to="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_b0dc6972-6d30-46ef-a40f-9dd192ae6a67_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_38f335fc-9498-4f41-8532-80e0d583a2f3_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_5719111a-9896-4dbf-b68a-025325ddfc8c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6e18e657-7777-4d1c-b88f-b4ef7d59e8a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_be9e76e5-c291-436f-9351-d925a168a0bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_18a78a53-2025-4db8-9920-3061b2a32459_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_0d46863b-c0ab-4b1f-bfcb-612cb13deb74_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a5843f42-666d-408e-be89-1cbc9413c75a_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e7309b70-7691-43f7-a68c-269e11870fd2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_fa59fd6a-7f47-4d43-b713-3c710bc11c2c_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_41e48558-4bed-4257-be4c-81ff795679bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_03ac0d9a-948d-4838-b954-f296632ccccc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_69791fe8-95d3-443a-8330-5fa45efb090e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_223e884f-cbd0-4030-9563-43b02f0080d7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_67dc8d85-1f29-4ce0-8732-f65af8ce499e_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1f4e231f-ace3-4166-8cd8-d4e00a38bf4c_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_a1a38e72-eedd-440d-9f1f-02a679fbe271_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d32b79bd-4c4f-4679-a7dd-f5b3fc16a313_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c7235bba-2705-47a2-9f74-900ea528428d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_209fd900-803d-46ed-8977-63f322d897d5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_861e3d81-7f69-4c31-8f91-4312958d59df_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_46febb32-9a26-4202-a5e8-2c6237b557b3_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_b6a38a94-d252-49da-a824-2cecb141c82a_terseLabel_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_label_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale, Debt Securities [Member]</link:label>
    <link:label id="lab_bax_AvailableForSaleDebtSecuritiesMember_documentation_en-US" xlink:label="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale, Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember" xlink:href="bax-20230331.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AvailableForSaleDebtSecuritiesMember" xlink:to="lab_bax_AvailableForSaleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9898e9eb-4e3c-4061-8e70-7861a246a1d0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_5ef95eff-7418-4b77-bf7f-c9303b09eb4d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_55a6b818-0de0-4258-9763-11dfa8cb0cca_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_e3c29763-3670-42bb-9c61-379fdc47eefb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_42f08624-4de8-4312-bfb2-11ccb37848fb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8595ec3c-28e3-4692-8784-dc54ef4afbbe_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_a9f1985f-47ad-4279-b9aa-8f43eb7f2da8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_30797e08-8d48-4249-a579-ca872249ed75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_4e77c5a0-99ba-4e82-9162-3f4ef48eeea5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_8f0e0d5d-a5c6-435b-aa95-ae9cd2f6fa39_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7dd2079b-f064-44ac-bd22-c3de508410b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4022f983-9317-41eb-9861-0028ce32e32e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9d4d594c-8b97-458f-93ea-fe807210be1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity in Reserves Related to Restructuring Initiatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ff33c1bc-eb86-4ea9-98c9-8a71b0498a88_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_23763c28-c8d1-438d-be7e-a42649952da7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_9dae3ab2-3f22-4815-a1ca-48f12317d3ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_11f25141-d471-4c9d-a819-dcdaba89b65a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_35242053-724f-4cb9-b6fd-208488d4337e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_597d9ff3-70da-411a-82fb-cdf62b26728d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_2f404e03-dc8d-403e-a50e-3a8155d5cd15_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_0c0f7af8-8545-4cf4-bc3d-184c47109406_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserve</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_37798d66-585d-4079-a241-8d6b4488bf64_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AdvancedSurgeryMember_319da6c0-edc3-4041-a0d6-ae38a65316c1_terseLabel_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_label_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery [Member]</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_documentation_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced surgery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember" xlink:href="bax-20230331.xsd#bax_AdvancedSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AdvancedSurgeryMember" xlink:to="lab_bax_AdvancedSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_39e749fe-3805-4307-b42b-d44d4144f890_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_860516b0-0396-4574-9570-68f8d9b5da28_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fd1d56e1-bb57-4abf-8276-1858a25223eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a44a8111-f745-42d0-a901-e75c112e2d45_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_510c7665-f23f-49bb-9c26-79911bb5e427_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_ed8db59a-4730-4eed-a80c-c50a031edd4f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining revenue performance obligation, percentage of revenue expected to be recognized</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e4ebc8-5d54-4c26-b4c2-2e943a7ef57c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_78cc581c-db8c-4e60-baa3-b72fbf3be23c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_17dac031-602b-45f8-8f66-3f9851590483_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_3011eefe-9826-4732-8acb-de5805aa0817_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b787b190-d2a4-479c-b70e-bb1636cae20c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_311eac5e-7220-4030-8c2b-53dbf685373a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_fdafce05-b0b0-455d-8d0b-acd6a28cd368_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4c2e4bea-3edf-410f-a397-8dc26188ee30_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_c36a9f4a-7cc8-41b6-a4d0-9114443e0acd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COGS</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_bc5fddfc-01eb-4902-87cc-456052060d54_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_216a8d7d-2998-4970-9854-c882f3e41a8b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPEB</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bax-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c36d7f4-89e9-4e55-84c8-a75c2c133f83,g:b8428c9f-f8d2-40b0-bcb5-e849d3219252-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_81a836f2-5878-45c0-905d-5ace58ca2268" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_81a836f2-5878-45c0-905d-5ace58ca2268" xlink:to="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_01622248-120c-470d-84e5-7888a13b6cbc" xlink:to="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_0447bb7a-28db-4548-9401-2b7069e76838" xlink:href="bax-20230331.xsd#bax_CommonStock100PerValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_CommonStock100PerValueMember_0447bb7a-28db-4548-9401-2b7069e76838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_dc5656a2-603a-43a3-8151-646f7bc8871c" xlink:href="bax-20230331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes04Due2024Member_dc5656a2-603a-43a3-8151-646f7bc8871c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_108905f0-1e65-4912-9ef9-77b9024999cc" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes13Due2025Member_108905f0-1e65-4912-9ef9-77b9024999cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_72e7ef66-091c-4af7-806a-f78f29d79d7d" xlink:href="bax-20230331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a4ad2f39-6bf9-4a0e-a2f9-dee346d735b6" xlink:to="loc_bax_GlobalNotes13Due2029Member_72e7ef66-091c-4af7-806a-f78f29d79d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:to="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_5ed2c3c8-0035-465c-8940-bec69066d7e0" xlink:to="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_b0edf1f0-93ec-4668-b953-5fb9efd58633" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:to="loc_exch_XNYS_b0edf1f0-93ec-4668-b953-5fb9efd58633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_fbe7f46c-cc6b-4162-99da-1ac978eb402c" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XCHI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_4f697720-3b52-4525-8f71-3d1e86bdf622" xlink:to="loc_exch_XCHI_fbe7f46c-cc6b-4162-99da-1ac978eb402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_dbc80957-5d21-48e2-be39-9c97546eecdb" xlink:to="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9f7e9da-33dc-4f73-9fb0-f93586e1fc5e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentType_d9f7e9da-33dc-4f73-9fb0-f93586e1fc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4ea332d4-2103-42f3-b747-db9afe4ce83c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentQuarterlyReport_4ea332d4-2103-42f3-b747-db9afe4ce83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9091b61f-017b-478a-9628-daffb8cffd85" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentPeriodEndDate_9091b61f-017b-478a-9628-daffb8cffd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_11e19211-78ff-4748-8e5d-7be1a34242f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentTransitionReport_11e19211-78ff-4748-8e5d-7be1a34242f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ce8636d8-d63a-4061-8eca-9b59f8b7ffef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityFileNumber_ce8636d8-d63a-4061-8eca-9b59f8b7ffef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_27589154-25b4-411a-9b45-882d150153fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityRegistrantName_27589154-25b4-411a-9b45-882d150153fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_82693408-a067-436b-a2de-bc7b801f8284" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_82693408-a067-436b-a2de-bc7b801f8284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_accec10e-08df-4b9a-9d61-62a17805bb07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityTaxIdentificationNumber_accec10e-08df-4b9a-9d61-62a17805bb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_396b9339-5b09-4ea6-af81-e62272df4497" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressAddressLine1_396b9339-5b09-4ea6-af81-e62272df4497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ff87adb7-a887-499f-9cf9-1b2cd097f878" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressCityOrTown_ff87adb7-a887-499f-9cf9-1b2cd097f878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_50fee72c-2d68-49c8-ad3f-b80968d54915" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressStateOrProvince_50fee72c-2d68-49c8-ad3f-b80968d54915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1ec5990-227a-4ad8-9ef7-f52aa139624c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityAddressPostalZipCode_c1ec5990-227a-4ad8-9ef7-f52aa139624c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_19bae842-9c08-4776-af7f-6b8855972b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_CityAreaCode_19bae842-9c08-4776-af7f-6b8855972b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_423a26bb-54db-46f6-8fb7-e37f4a42047b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_LocalPhoneNumber_423a26bb-54db-46f6-8fb7-e37f4a42047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6d8e43af-a003-408d-b1e2-90db725f0b93" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_Security12bTitle_6d8e43af-a003-408d-b1e2-90db725f0b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3587cde0-e255-4459-912d-9a3cd019ceec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_TradingSymbol_3587cde0-e255-4459-912d-9a3cd019ceec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa434c87-f1a5-49fd-8c65-0329a2b8c7e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_SecurityExchangeName_fa434c87-f1a5-49fd-8c65-0329a2b8c7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bb03a325-9eec-4a0b-b5bc-e729446ab533" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCurrentReportingStatus_bb03a325-9eec-4a0b-b5bc-e729446ab533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b0fc57be-8372-4582-9616-c058641e5514" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityInteractiveDataCurrent_b0fc57be-8372-4582-9616-c058641e5514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9dd29492-265d-4c8e-815d-0751690222ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityFilerCategory_9dd29492-265d-4c8e-815d-0751690222ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6eaf16ca-305f-4541-bd7e-f69ac5696928" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntitySmallBusiness_6eaf16ca-305f-4541-bd7e-f69ac5696928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba16aca4-3790-4e3e-80cb-507eb17775e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba16aca4-3790-4e3e-80cb-507eb17775e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a8300cb7-3fec-4ec2-9df4-074f9bedadbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityShellCompany_a8300cb7-3fec-4ec2-9df4-074f9bedadbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1ef249b0-d5bd-40e8-8971-3dfa68a04e6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1ef249b0-d5bd-40e8-8971-3dfa68a04e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1a61bddb-56f9-438c-b59f-7cee56700874" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_AmendmentFlag_1a61bddb-56f9-438c-b59f-7cee56700874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_46eaa1e5-2995-43f7-b3ac-74f4a15dfbf4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentFiscalYearFocus_46eaa1e5-2995-43f7-b3ac-74f4a15dfbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_96f270f8-0afa-46a0-b97a-49afd8e58b25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_96f270f8-0afa-46a0-b97a-49afd8e58b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_af958595-cfd4-4af4-933d-ca11c98873d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_EntityCentralIndexKey_af958595-cfd4-4af4-933d-ca11c98873d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b19a391c-98db-44a9-b314-ddbf82d285e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9df40259-326b-4e1a-92fd-447432cc59fb" xlink:to="loc_dei_CurrentFiscalYearEndDate_b19a391c-98db-44a9-b314-ddbf82d285e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd681172-c892-48ee-a271-96ac164b8196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd681172-c892-48ee-a271-96ac164b8196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0248f8bc-69e6-45fb-8796-1d6fe45c2493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0248f8bc-69e6-45fb-8796-1d6fe45c2493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_74e8660a-ccee-467d-8a53-bb77ef51645a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:to="loc_us-gaap_InventoryNet_74e8660a-ccee-467d-8a53-bb77ef51645a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2256577c-eb10-4eb2-bd36-5661249af271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2256577c-eb10-4eb2-bd36-5661249af271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_438b496b-e14b-41d5-99bc-5a3aad735d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b181313-aebe-47e0-b9d0-cbf7c76a7f43" xlink:to="loc_us-gaap_AssetsCurrent_438b496b-e14b-41d5-99bc-5a3aad735d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3d5ba007-dbb1-4acd-b05a-09954cbedddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3d5ba007-dbb1-4acd-b05a-09954cbedddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9fe836f-b4fc-4605-ba02-bac4d9d71f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_Goodwill_c9fe836f-b4fc-4605-ba02-bac4d9d71f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9c64f0c-8dcb-4e61-9c61-7e85db8786d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9c64f0c-8dcb-4e61-9c61-7e85db8786d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6cb87c28-bf90-4d4e-8a31-4918a16d17ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6cb87c28-bf90-4d4e-8a31-4918a16d17ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_38793467-2054-4d44-ad28-8f809dbb03a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_38793467-2054-4d44-ad28-8f809dbb03a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_29d704a0-2a5b-4e15-b54a-60d0384193fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_Assets_29d704a0-2a5b-4e15-b54a-60d0384193fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2134ce67-3f25-4367-a431-474991a9f5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:to="loc_us-gaap_ShortTermBorrowings_2134ce67-3f25-4367-a431-474991a9f5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2c172c60-6b48-4d27-9384-6808622b0f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2c172c60-6b48-4d27-9384-6808622b0f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d0718f1a-1ace-4c3a-85a4-724d98cb9349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:to="loc_us-gaap_AccountsPayableCurrent_d0718f1a-1ace-4c3a-85a4-724d98cb9349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_79f83974-cae8-4849-94dd-0625af4f8315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_79f83974-cae8-4849-94dd-0625af4f8315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c14c3fe5-79c0-4071-aa9d-8ba8303a0c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d376f4f4-a2b9-466c-ad66-806bac6a7710" xlink:to="loc_us-gaap_LiabilitiesCurrent_c14c3fe5-79c0-4071-aa9d-8ba8303a0c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cbb42060-46c1-45a0-b1eb-ef8080d7c8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cbb42060-46c1-45a0-b1eb-ef8080d7c8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ff4c278e-fa9f-4df0-ae4d-58f07c426727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ff4c278e-fa9f-4df0-ae4d-58f07c426727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cce11584-f167-4cff-87f9-93376133600c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cce11584-f167-4cff-87f9-93376133600c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cdb17f69-f8a7-4a7d-b173-8749670251b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_Liabilities_cdb17f69-f8a7-4a7d-b173-8749670251b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2ed0beae-223a-4c7b-8469-bd7c77198200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2ed0beae-223a-4c7b-8469-bd7c77198200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_779f7eac-af99-47d6-9ec3-c451bed34bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_CommonStockValue_779f7eac-af99-47d6-9ec3-c451bed34bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_8d327c9d-be4e-4380-881f-fafb12fadfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_TreasuryStockCommonValue_8d327c9d-be4e-4380-881f-fafb12fadfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_72b67e32-489c-4cc4-9735-77848c0b14cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_72b67e32-489c-4cc4-9735-77848c0b14cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f6874d51-9a08-44d0-82c5-dd391924a303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f6874d51-9a08-44d0-82c5-dd391924a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6c947b4-1d51-4e75-bb5c-77c23fb82d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6c947b4-1d51-4e75-bb5c-77c23fb82d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3e61bebc-3c59-4985-abcd-8be7d124d2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_StockholdersEquity_3e61bebc-3c59-4985-abcd-8be7d124d2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ced43632-2bd1-47ee-b282-9ec0876143a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_MinorityInterest_ced43632-2bd1-47ee-b282-9ec0876143a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a64de53-a906-4999-b0e3-f254553186aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_2b2e4749-257b-44c5-a2c2-87c3952064cd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a64de53-a906-4999-b0e3-f254553186aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_66b7d20a-78bb-4043-994a-84441efc0d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_06eda3e8-be82-49d9-bd09-293ba713de19" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_66b7d20a-78bb-4043-994a-84441efc0d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d104cb3c-e3db-4b4c-b19c-6f47f674a05e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d104cb3c-e3db-4b4c-b19c-6f47f674a05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_abb0e408-6532-4b57-8b7b-daae5e23e2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_abb0e408-6532-4b57-8b7b-daae5e23e2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0ace3f0b-6c35-440c-aba9-96cb7181834c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0ace3f0b-6c35-440c-aba9-96cb7181834c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d637b2c8-6128-4c80-8e36-23188a613a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:to="loc_us-gaap_CommonStockSharesIssued_d637b2c8-6128-4c80-8e36-23188a613a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1e890dd6-8967-4644-b1ed-d5014bbed447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b77defb-59e4-403f-973b-1cc17598fc79" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1e890dd6-8967-4644-b1ed-d5014bbed447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d9418e44-1237-4622-aa44-2a3324038afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d9418e44-1237-4622-aa44-2a3324038afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ebf4873c-0651-4d51-a119-f066dff1e749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ebf4873c-0651-4d51-a119-f066dff1e749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9f7159a2-4751-43e1-8527-7c6b0a3ced8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_GrossProfit_9f7159a2-4751-43e1-8527-7c6b0a3ced8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_950ad039-175b-4377-8fe3-f76a43ea9b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_950ad039-175b-4377-8fe3-f76a43ea9b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7d9f68dd-552e-49b9-8922-9643985ddde3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7d9f68dd-552e-49b9-8922-9643985ddde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_fbd6d24a-28a5-4c1a-8176-dd46a763d11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_fbd6d24a-28a5-4c1a-8176-dd46a763d11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7d0816ad-b5c8-4017-aec1-880774a1392c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_OperatingIncomeLoss_7d0816ad-b5c8-4017-aec1-880774a1392c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_2b7ea785-5ddf-4b23-a872-b2f281888484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_2b7ea785-5ddf-4b23-a872-b2f281888484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3bbabfa0-0071-44d4-b7c9-4b782762ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3bbabfa0-0071-44d4-b7c9-4b782762ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_641cb532-1b83-40b4-9218-55d2e10a4736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_641cb532-1b83-40b4-9218-55d2e10a4736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d9b7994e-c81b-40c1-9824-3614d9d46e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d9b7994e-c81b-40c1-9824-3614d9d46e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_962eea6e-da1c-45b9-b64d-496f143457f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_ProfitLoss_962eea6e-da1c-45b9-b64d-496f143457f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_79e48276-009c-4868-a273-02d5bbd487b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_79e48276-009c-4868-a273-02d5bbd487b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c6b3d76-e4c3-4919-8424-fbec30049ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_NetIncomeLoss_4c6b3d76-e4c3-4919-8424-fbec30049ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2af5967c-d77f-48b7-a75b-6a0b3b02c577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2af5967c-d77f-48b7-a75b-6a0b3b02c577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_69b9d6c2-4f41-41d5-b710-d293520569c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2af5967c-d77f-48b7-a75b-6a0b3b02c577" xlink:to="loc_us-gaap_EarningsPerShareBasic_69b9d6c2-4f41-41d5-b710-d293520569c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_42de1c78-8727-46b7-a110-8fd43863e087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2af5967c-d77f-48b7-a75b-6a0b3b02c577" xlink:to="loc_us-gaap_EarningsPerShareDiluted_42de1c78-8727-46b7-a110-8fd43863e087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a10abef8-8d33-4f0c-9361-a82208df6238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c7613f0e-8aa9-4cec-bb72-ed7274d7eb82" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a10abef8-8d33-4f0c-9361-a82208df6238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b31aeb8d-9fd9-4535-9d60-f165e310f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a10abef8-8d33-4f0c-9361-a82208df6238" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b31aeb8d-9fd9-4535-9d60-f165e310f5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28085453-aa37-4a4f-a9d0-5ade3778cf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a10abef8-8d33-4f0c-9361-a82208df6238" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_28085453-aa37-4a4f-a9d0-5ade3778cf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4203ab8c-7c75-48d2-80d0-60e4cff38bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:to="loc_us-gaap_ProfitLoss_4203ab8c-7c75-48d2-80d0-60e4cff38bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9762b30-c39d-47b5-adf2-107d614583ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9762b30-c39d-47b5-adf2-107d614583ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d694ee0-081f-46b6-8963-50b2a1690aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9d694ee0-081f-46b6-8963-50b2a1690aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1da65360-d10a-4cd7-9128-98ba08a04193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1da65360-d10a-4cd7-9128-98ba08a04193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_838be7f5-0d73-452d-8536-4552ebd8a9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_838be7f5-0d73-452d-8536-4552ebd8a9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_009b2e0d-0eb5-4261-8fb0-14f63db9ed4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_439c369c-8aa6-4995-88cd-a227783033e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_009b2e0d-0eb5-4261-8fb0-14f63db9ed4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_09455f8f-fb9c-4e68-8d05-95e2b35e4976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_09455f8f-fb9c-4e68-8d05-95e2b35e4976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f90f810e-d7a1-43cc-afc3-894e79ed57e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f90f810e-d7a1-43cc-afc3-894e79ed57e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5daa8c6b-2c42-4dd4-8725-9ece8400af61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d0a41e52-2463-4910-95fd-4526cd885d17" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5daa8c6b-2c42-4dd4-8725-9ece8400af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32eb32ed-475f-44b7-b993-646d282d3e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_84718b83-9c34-4e4d-91da-3fc8c8df0765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32eb32ed-475f-44b7-b993-646d282d3e64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_84718b83-9c34-4e4d-91da-3fc8c8df0765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_ff2363de-1fbc-45a7-98af-af43751c8a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32eb32ed-475f-44b7-b993-646d282d3e64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_ff2363de-1fbc-45a7-98af-af43751c8a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_24ff8a86-8b6a-4101-8e99-23f80327b5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32eb32ed-475f-44b7-b993-646d282d3e64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_24ff8a86-8b6a-4101-8e99-23f80327b5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_87baa8ba-dda8-4c41-9473-7a3327d245be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_32eb32ed-475f-44b7-b993-646d282d3e64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_87baa8ba-dda8-4c41-9473-7a3327d245be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7057e362-d8a2-4210-85e4-d76e918c2c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7057e362-d8a2-4210-85e4-d76e918c2c83" xlink:to="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72423295-5a7e-483c-ac43-ae23b436d359" xlink:to="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:to="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_733ca317-ee38-40ad-afcd-bc2b6fd4ce14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_CommonStockMember_733ca317-ee38-40ad-afcd-bc2b6fd4ce14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4f57b3ad-8147-4b0e-b25e-b606bb2b84a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4f57b3ad-8147-4b0e-b25e-b606bb2b84a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_51093089-b2b4-4883-8bb8-4b1cc5b1f982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_51093089-b2b4-4883-8bb8-4b1cc5b1f982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_752ba982-c490-4efb-884f-14a5ca62b39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_RetainedEarningsMember_752ba982-c490-4efb-884f-14a5ca62b39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_341011f4-25d3-4c9c-ab73-ed9de215cb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5a29fb64-b18c-4960-ac1e-8808b2b928d1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_341011f4-25d3-4c9c-ab73-ed9de215cb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_07c42308-b1c2-4d97-a58f-ae2df04c0c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf9100e8-e5aa-4c5a-bf92-f0bf53b5e781" xlink:to="loc_us-gaap_NoncontrollingInterestMember_07c42308-b1c2-4d97-a58f-ae2df04c0c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_026f67df-d8db-4c34-bd15-f5fc448ef341" xlink:to="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b69d1ee3-40ab-4e83-9023-f986ee38e6ab" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5cd5a646-cb82-4ca4-8fa9-74a16bd0fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5cd5a646-cb82-4ca4-8fa9-74a16bd0fd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_85068018-f9a8-4f1a-b2e8-4ee7f481fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_85068018-f9a8-4f1a-b2e8-4ee7f481fa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6cf31c00-ed22-4658-b070-26eb9e9d478b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6cf31c00-ed22-4658-b070-26eb9e9d478b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e45dd3ec-117d-4cec-8e70-83faa3e1a0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_ProfitLoss_e45dd3ec-117d-4cec-8e70-83faa3e1a0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6633a7e-9ea7-42be-a156-826a31f3ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6633a7e-9ea7-42be-a156-826a31f3ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5fdaab42-1226-4a31-b1d1-fe1615ec14db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5fdaab42-1226-4a31-b1d1-fe1615ec14db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d8fcf3c5-21b4-4a3a-a8bb-1f92894964f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d8fcf3c5-21b4-4a3a-a8bb-1f92894964f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_b3806d30-037a-4ff5-affe-f99db3d62bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_DividendsCommonStock_b3806d30-037a-4ff5-affe-f99db3d62bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_30fafd9d-ae1a-49fd-9e96-bd6fec70d79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_30fafd9d-ae1a-49fd-9e96-bd6fec70d79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f1d36d54-40c8-4bb7-b19c-f922f7234c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f1d36d54-40c8-4bb7-b19c-f922f7234c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4e822c7-9eaa-44e6-995e-181ed3717be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b432b935-6ef9-4a63-a921-5cfe0cb04638" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4e822c7-9eaa-44e6-995e-181ed3717be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7528a67c-ebe3-4dec-91d1-22b18b9a935e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7528a67c-ebe3-4dec-91d1-22b18b9a935e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a67ae65e-8f4c-4db2-b40a-2602d0cbfb04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7528a67c-ebe3-4dec-91d1-22b18b9a935e" xlink:to="loc_us-gaap_ProfitLoss_a67ae65e-8f4c-4db2-b40a-2602d0cbfb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7528a67c-ebe3-4dec-91d1-22b18b9a935e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3ec3f7e2-fd8d-40bb-a6a9-3e5947b25542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3ec3f7e2-fd8d-40bb-a6a9-3e5947b25542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4951b411-8f19-4c34-ab01-d741f7ef310c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4951b411-8f19-4c34-ab01-d741f7ef310c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8c71cf51-bdb3-4c2a-a85e-d0da0b77b14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_ShareBasedCompensation_8c71cf51-bdb3-4c2a-a85e-d0da0b77b14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_027066af-58bd-4def-b6cf-4a059f68e939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_027066af-58bd-4def-b6cf-4a059f68e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_03ea1910-9f37-4446-af50-0f87b8b49a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_03ea1910-9f37-4446-af50-0f87b8b49a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_641580e2-d706-41aa-8063-3d25e223d3f2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bcc6ad3d-54e0-4064-8713-8099b3e5ca9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bcc6ad3d-54e0-4064-8713-8099b3e5ca9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c8708837-db53-47f6-996c-782b1faf4f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c8708837-db53-47f6-996c-782b1faf4f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3beecfb6-bf96-43b7-b484-95fc9232ecf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3beecfb6-bf96-43b7-b484-95fc9232ecf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1d48fb76-a238-427d-a539-75c9fb867113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1d48fb76-a238-427d-a539-75c9fb867113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_017127c0-e2f5-469c-9de3-1d156c40e21e" xlink:href="bax-20230331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_017127c0-e2f5-469c-9de3-1d156c40e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dd8c96c0-fd65-433c-8073-ed8687ab5d14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4413c6f-792c-45c8-8bec-de9cc766f370" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dd8c96c0-fd65-433c-8073-ed8687ab5d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d18908c7-d2eb-4688-9a01-bc2795c58cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7528a67c-ebe3-4dec-91d1-22b18b9a935e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d18908c7-d2eb-4688-9a01-bc2795c58cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_9e12e428-c233-434c-b233-db541751fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_9e12e428-c233-434c-b233-db541751fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b3d0a710-da8d-4803-aaf7-111ce3e8af6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b3d0a710-da8d-4803-aaf7-111ce3e8af6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1e0b522c-57c6-4ac7-b173-a95e51c42bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1e0b522c-57c6-4ac7-b173-a95e51c42bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c6bba1c3-c43c-4462-a5aa-ef9e4c6f3fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_07917ced-a54d-4374-bb46-c3fe7b5f9108" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c6bba1c3-c43c-4462-a5aa-ef9e4c6f3fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_8f024133-42bf-4ea5-bb04-2211e2f801db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_RepaymentsOfDebt_8f024133-42bf-4ea5-bb04-2211e2f801db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_06d2750b-5982-4ecb-9d41-a956dee3f9af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_06d2750b-5982-4ecb-9d41-a956dee3f9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_431fb0a0-0a26-41eb-8529-9c775f245c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_431fb0a0-0a26-41eb-8529-9c775f245c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bce47ad1-2ef7-4cb9-bed9-c05b5181c337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bce47ad1-2ef7-4cb9-bed9-c05b5181c337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc22c0ea-b7af-48fe-9400-fe3abdb1b307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bc22c0ea-b7af-48fe-9400-fe3abdb1b307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c69f047-a408-4c7a-a9c1-1ce45bf56158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_33baf638-d357-42cf-91aa-83dd89dce641" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c69f047-a408-4c7a-a9c1-1ce45bf56158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3ba251e5-c159-4eec-8ee0-680670df2c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3ba251e5-c159-4eec-8ee0-680670df2c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_98d2a950-13c2-4464-9cd4-e7f2b292a233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_98d2a950-13c2-4464-9cd4-e7f2b292a233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea092153-612d-4af7-9f35-62ea2560c087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea092153-612d-4af7-9f35-62ea2560c087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cef27cd-4d50-4322-a597-5f616f0f8548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2d54cbb3-ca24-4482-b93b-2d0a860acbb0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cef27cd-4d50-4322-a597-5f616f0f8548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical" xlink:type="simple" xlink:href="bax-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_48f82fa7-8cc8-4007-b9a4-33b20c6fa6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6fa6974e-cedd-4e9e-b232-45869aac0dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_48f82fa7-8cc8-4007-b9a4-33b20c6fa6aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6fa6974e-cedd-4e9e-b232-45869aac0dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_032fb2e8-8bc0-45c0-bc98-8ac6143847ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_48f82fa7-8cc8-4007-b9a4-33b20c6fa6aa" xlink:to="loc_us-gaap_RestrictedCash_032fb2e8-8bc0-45c0-bc98-8ac6143847ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12cd0508-5e96-48b0-bded-ec8c34098a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_48f82fa7-8cc8-4007-b9a4-33b20c6fa6aa" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12cd0508-5e96-48b0-bded-ec8c34098a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="bax-20230331.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_287f9614-8340-4da9-9813-33a748991ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8b5181d9-079a-42a2-856a-fa33857c7c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_287f9614-8340-4da9-9813-33a748991ee8" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8b5181d9-079a-42a2-856a-fa33857c7c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82b90d31-4ac0-44df-b752-4886bf0b321d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_de02237a-b95c-41c2-961d-416582d43b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82b90d31-4ac0-44df-b752-4886bf0b321d" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_de02237a-b95c-41c2-961d-416582d43b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNET"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8e6ffb5-a01f-4736-a83e-13cc2d79820f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d572a681-6b6a-4468-b8a5-2b702e956462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8e6ffb5-a01f-4736-a83e-13cc2d79820f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d572a681-6b6a-4468-b8a5-2b702e956462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="simple" xlink:href="bax-20230331.xsd#FINANCINGARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0717daa5-591f-4af4-8b56-939e788b0032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_347cf28a-fc45-4c63-9799-0b3c2b537d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0717daa5-591f-4af4-8b56-939e788b0032" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_347cf28a-fc45-4c63-9799-0b3c2b537d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bax-20230331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f6319f2-5195-43c6-83fe-1c0c035981a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_38f72070-9cf9-4176-b42a-0ae1567b57e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f6319f2-5195-43c6-83fe-1c0c035981a1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_38f72070-9cf9-4176-b42a-0ae1567b57e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bax-20230331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6929003a-aa90-459e-9b79-8032ec73f2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_33c334bb-934c-40c7-8e41-ebf2be6fcb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6929003a-aa90-459e-9b79-8032ec73f2b5" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_33c334bb-934c-40c7-8e41-ebf2be6fcb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_611eb221-e2dc-4ca4-98a7-0f2098369298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_9301e797-7e01-4973-b44d-b4e8f69edd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_611eb221-e2dc-4ca4-98a7-0f2098369298" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_9301e797-7e01-4973-b44d-b4e8f69edd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUES" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3522e75e-83fe-47cd-b5e6-846ca995b325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7221339c-546f-4918-8cab-e56e0b7b1086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3522e75e-83fe-47cd-b5e6-846ca995b325" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7221339c-546f-4918-8cab-e56e0b7b1086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1c8dc4f6-91af-422b-93c0-e7ce48a2390d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f92774e3-8206-4d0a-8525-07731aff047b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1c8dc4f6-91af-422b-93c0-e7ce48a2390d" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f92774e3-8206-4d0a-8525-07731aff047b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="simple" xlink:href="bax-20230331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a387382a-6b1f-49c7-a012-943bda93f000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_54726981-07ba-4e48-ba25-0aaed708b6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a387382a-6b1f-49c7-a012-943bda93f000" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_54726981-07ba-4e48-ba25-0aaed708b6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bax-20230331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_915ab78b-1da8-441f-86f0-f97cae39394b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_982631d0-2f51-44c3-a6f1-3c27e4bcefd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_915ab78b-1da8-441f-86f0-f97cae39394b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_982631d0-2f51-44c3-a6f1-3c27e4bcefd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bax-20230331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dad1ff64-4986-4af9-aa72-1abe5530cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_061c3d56-ad7d-4171-97e0-7b542f35432c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dad1ff64-4986-4af9-aa72-1abe5530cfe9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_061c3d56-ad7d-4171-97e0-7b542f35432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_046eb116-2443-4a91-9107-229bcfb4ba2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d247d214-0526-4c44-9470-05188b500570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_046eb116-2443-4a91-9107-229bcfb4ba2c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d247d214-0526-4c44-9470-05188b500570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d502324e-57d1-475b-bd55-c6e509c36d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_e77e7b6e-6ed5-43ce-b031-f66df1cc1398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d502324e-57d1-475b-bd55-c6e509c36d0a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_e77e7b6e-6ed5-43ce-b031-f66df1cc1398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0922e9c4-6936-414b-91b6-9afcdc162913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_efa82b78-9de5-4497-930b-497683a455b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0922e9c4-6936-414b-91b6-9afcdc162913" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_efa82b78-9de5-4497-930b-497683a455b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="bax-20230331.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_80bb4af8-dc37-4ac0-8087-3cc1451721bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_75ea03d2-3c27-47a9-a093-568fd949c304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_80bb4af8-dc37-4ac0-8087-3cc1451721bf" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_75ea03d2-3c27-47a9-a093-568fd949c304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_b92c209c-e979-4519-baea-b0841f7ba63a" xlink:href="bax-20230331.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_80bb4af8-dc37-4ac0-8087-3cc1451721bf" xlink:to="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_b92c209c-e979-4519-baea-b0841f7ba63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_de25690a-edf4-4663-82c2-7dbec3f7db64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_de25690a-edf4-4663-82c2-7dbec3f7db64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dc6ce377-0403-4b7d-b01f-d447b8b12af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dc6ce377-0403-4b7d-b01f-d447b8b12af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_90ac5dc5-0809-4e45-a429-a8116657b4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_90ac5dc5-0809-4e45-a429-a8116657b4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_1eb7e8d6-ab93-499e-b741-77d66c7dfad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_1eb7e8d6-ab93-499e-b741-77d66c7dfad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_65047fad-f111-4e3d-a084-d4e9119d9ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_edf62779-7b9a-4992-a6c1-89f2c3d2e89d" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_65047fad-f111-4e3d-a084-d4e9119d9ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_67c4c950-172a-4471-9423-79b52d7cf57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_feafa6c6-2176-4392-b370-558cb3c3b83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_67c4c950-172a-4471-9423-79b52d7cf57f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_feafa6c6-2176-4392-b370-558cb3c3b83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_f4c8f0e8-be85-47e9-8db5-44fea2cfc34e" xlink:href="bax-20230331.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_67c4c950-172a-4471-9423-79b52d7cf57f" xlink:to="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_f4c8f0e8-be85-47e9-8db5-44fea2cfc34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_26aac0e3-3dbc-4e35-b515-8e60a4de3c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8f88a049-f430-4e92-82ba-ef1154dc22d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_26aac0e3-3dbc-4e35-b515-8e60a4de3c85" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8f88a049-f430-4e92-82ba-ef1154dc22d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_bc007b4e-4ce7-44d0-8afc-ff6f4fd2aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_26aac0e3-3dbc-4e35-b515-8e60a4de3c85" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_bc007b4e-4ce7-44d0-8afc-ff6f4fd2aa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESTables" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f56e22f9-8d83-4ddd-9554-37f1f84cc7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e0f32975-e979-4bbe-af3d-0939309ec4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f56e22f9-8d83-4ddd-9554-37f1f84cc7ce" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e0f32975-e979-4bbe-af3d-0939309ec4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_236e5de7-ea04-498f-a1d3-ede9570c03cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f56e22f9-8d83-4ddd-9554-37f1f84cc7ce" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_236e5de7-ea04-498f-a1d3-ede9570c03cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_93d7367c-d1a5-4656-90cd-8d76bc421bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f56e22f9-8d83-4ddd-9554-37f1f84cc7ce" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_93d7367c-d1a5-4656-90cd-8d76bc421bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_48866eed-f854-43b2-bd57-22d086f5f80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f56e22f9-8d83-4ddd-9554-37f1f84cc7ce" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_48866eed-f854-43b2-bd57-22d086f5f80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_daef4cf3-531f-46d2-8c3e-49fdf945e72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock_edffd856-b878-4990-90db-a073b857f25f" xlink:href="bax-20230331.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_daef4cf3-531f-46d2-8c3e-49fdf945e72c" xlink:to="loc_bax_BusinessOptimizationChargeTableTextBlock_edffd856-b878-4990-90db-a073b857f25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_f95523fa-04d3-495b-8fdb-b4a3898dfcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_daef4cf3-531f-46d2-8c3e-49fdf945e72c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_f95523fa-04d3-495b-8fdb-b4a3898dfcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8e309f86-ae53-48da-82c3-231431378104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_daef4cf3-531f-46d2-8c3e-49fdf945e72c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8e309f86-ae53-48da-82c3-231431378104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="simple" xlink:href="bax-20230331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4552204d-236b-485a-84dc-689c48985f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_80b73954-a508-4ba2-8a83-5ed3e8bdcd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4552204d-236b-485a-84dc-689c48985f55" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_80b73954-a508-4ba2-8a83-5ed3e8bdcd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bax-20230331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c8f4292d-4783-4004-a557-04c546681413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cf9acd26-d562-40ac-b6bc-a229636b64ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c8f4292d-4783-4004-a557-04c546681413" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cf9acd26-d562-40ac-b6bc-a229636b64ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f20fa46-6546-4993-bef6-416a39740e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a6626e06-25d7-428d-b8e1-9ff3fc47ff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f20fa46-6546-4993-bef6-416a39740e11" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a6626e06-25d7-428d-b8e1-9ff3fc47ff0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5b19ece4-fc65-46b4-bc8d-7918b0b3bb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f20fa46-6546-4993-bef6-416a39740e11" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5b19ece4-fc65-46b4-bc8d-7918b0b3bb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_8e7b9f7b-968b-425d-b54b-edaaf9b0f453" xlink:href="bax-20230331.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f20fa46-6546-4993-bef6-416a39740e11" xlink:to="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_8e7b9f7b-968b-425d-b54b-edaaf9b0f453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1dd84c46-b13c-49a2-a141-11998d9b3886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f20fa46-6546-4993-bef6-416a39740e11" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1dd84c46-b13c-49a2-a141-11998d9b3886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1624d873-d8a5-4ffb-85f4-056af1d930ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_bdc2b9ce-d1da-4210-83c6-ff6519376f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1624d873-d8a5-4ffb-85f4-056af1d930ad" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_bdc2b9ce-d1da-4210-83c6-ff6519376f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_303629c4-a0d3-4f7b-b5bb-2c4f455da854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1624d873-d8a5-4ffb-85f4-056af1d930ad" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_303629c4-a0d3-4f7b-b5bb-2c4f455da854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_fa190da9-e4c2-4751-8c0d-9bf96a2bccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1624d873-d8a5-4ffb-85f4-056af1d930ad" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_fa190da9-e4c2-4751-8c0d-9bf96a2bccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b447aa6d-855b-4930-8168-7f130650d0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5f9df990-5c67-4689-848e-dc267ebcdb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b447aa6d-855b-4930-8168-7f130650d0b3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5f9df990-5c67-4689-848e-dc267ebcdb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a2573d47-8bb0-4744-97cf-c0aac6fd9451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b447aa6d-855b-4930-8168-7f130650d0b3" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a2573d47-8bb0-4744-97cf-c0aac6fd9451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ad30682-75a4-49b2-b56a-e3895cc654ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ad30682-75a4-49b2-b56a-e3895cc654ca" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecbc93ed-bf0b-45e8-8421-4f13902251e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ecbc93ed-bf0b-45e8-8421-4f13902251e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_f50a2141-1100-4eb5-89df-10ff9391bb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_f50a2141-1100-4eb5-89df-10ff9391bb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_fc71b4cf-2632-4b9a-b9d0-f45052760f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_fc71b4cf-2632-4b9a-b9d0-f45052760f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_79c4ea71-39bb-42eb-964a-3395c979afaa" xlink:href="bax-20230331.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:to="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_79c4ea71-39bb-42eb-964a-3395c979afaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a748c8d4-b7d0-48d7-9885-3f4e7407b26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e34835b8-bc2a-4bd5-a071-9904133278ff" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_a748c8d4-b7d0-48d7-9885-3f4e7407b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14f16972-894f-4f89-8b3c-2fdda92daa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_ad429782-d9fa-4935-8023-b4eaa598ede4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14f16972-894f-4f89-8b3c-2fdda92daa1b" xlink:to="loc_us-gaap_InventoryRawMaterials_ad429782-d9fa-4935-8023-b4eaa598ede4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_258360b8-7d82-4d9d-9534-a8daf77aabd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14f16972-894f-4f89-8b3c-2fdda92daa1b" xlink:to="loc_us-gaap_InventoryWorkInProcess_258360b8-7d82-4d9d-9534-a8daf77aabd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_5cc8d49c-0394-43a6-a288-386a0055bc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14f16972-894f-4f89-8b3c-2fdda92daa1b" xlink:to="loc_us-gaap_InventoryFinishedGoods_5cc8d49c-0394-43a6-a288-386a0055bc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_54970184-b2b9-4035-801b-3c56ccc67f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14f16972-894f-4f89-8b3c-2fdda92daa1b" xlink:to="loc_us-gaap_InventoryNet_54970184-b2b9-4035-801b-3c56ccc67f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_727fb8f7-c3fa-4cce-bc98-cc0c086d6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6fa0ba2a-80f7-4619-9bd3-63c16d318601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_727fb8f7-c3fa-4cce-bc98-cc0c086d6513" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6fa0ba2a-80f7-4619-9bd3-63c16d318601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b9c5ba20-1d79-4f31-84db-058744929b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_727fb8f7-c3fa-4cce-bc98-cc0c086d6513" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b9c5ba20-1d79-4f31-84db-058744929b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_db447144-0453-475a-8d0c-45d37bfc7155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_727fb8f7-c3fa-4cce-bc98-cc0c086d6513" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_db447144-0453-475a-8d0c-45d37bfc7155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d8b9afdc-cdd1-46f3-a784-5b310da4531d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_75cf0e65-e2c3-47b2-afb3-5718f5c611a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d8b9afdc-cdd1-46f3-a784-5b310da4531d" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_75cf0e65-e2c3-47b2-afb3-5718f5c611a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dc564c17-d7ca-4b06-943f-146d7e9887f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_75cf0e65-e2c3-47b2-afb3-5718f5c611a5" xlink:to="loc_us-gaap_InterestExpense_dc564c17-d7ca-4b06-943f-146d7e9887f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_d890a56b-4f3d-4443-9dde-862f77bec8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_75cf0e65-e2c3-47b2-afb3-5718f5c611a5" xlink:to="loc_us-gaap_InterestIncomeOperating_d890a56b-4f3d-4443-9dde-862f77bec8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_be92073f-0a4b-4771-8d21-772783c895f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_75cf0e65-e2c3-47b2-afb3-5718f5c611a5" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_be92073f-0a4b-4771-8d21-772783c895f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fee23cb8-5597-4893-b7e9-5c253a55ab97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fee23cb8-5597-4893-b7e9-5c253a55ab97" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0c1eaf1a-5ef8-4596-b6e9-79ef1a58e7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_0c1eaf1a-5ef8-4596-b6e9-79ef1a58e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c83dd7ab-b87b-4746-b694-c207af9c069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c83dd7ab-b87b-4746-b694-c207af9c069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_6dac9eed-422c-4955-be89-08acd9d7fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_6dac9eed-422c-4955-be89-08acd9d7fff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_131558e2-df61-4ece-9678-ccd60f280e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_131558e2-df61-4ece-9678-ccd60f280e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_98f9334b-6c7c-4a8c-8206-24225c4ca52b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3ac916d9-79a6-43e4-9fbc-2d2844b4f844" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_98f9334b-6c7c-4a8c-8206-24225c4ca52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d4c6d625-fb79-460f-b9aa-617563a69987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d4c6d625-fb79-460f-b9aa-617563a69987" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b91867b6-6d4e-4baf-878f-ab4a60e99b29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_52e148ac-ebbc-499c-a2a8-4e4491c15130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f5fcd7e-08e8-4a86-8e89-c33b5bbf0753" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_52e148ac-ebbc-499c-a2a8-4e4491c15130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f3cef567-255c-45c0-8a9f-883e04ac68a0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dda02b93-3e9f-42aa-8d07-226714ca8e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dda02b93-3e9f-42aa-8d07-226714ca8e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a639926d-bcf3-4748-ba46-176aa9b0f475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b499afe1-e714-40f9-a8c6-81ee81e2c20f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a639926d-bcf3-4748-ba46-176aa9b0f475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba8c1ce7-7cbe-4563-9a86-c0cc9f12b266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba8c1ce7-7cbe-4563-9a86-c0cc9f12b266" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:to="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f736366b-991d-4234-baaa-71cf5f4f5f1a" xlink:to="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_ef8c01d3-49f7-413a-bbb0-f2a2d312f816" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_srt_AmericasMember_ef8c01d3-49f7-413a-bbb0-f2a2d312f816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_56cdec0c-c9fd-42c2-8de1-a8baa099d1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_us-gaap_EMEAMember_56cdec0c-c9fd-42c2-8de1-a8baa099d1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_7c381597-4136-41ac-a0e6-b7344f475882" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_srt_AsiaPacificMember_7c381597-4136-41ac-a0e6-b7344f475882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_49023b5b-261a-4777-a800-7bc06dfb809d" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c713a6b4-7153-4229-87ca-c554403b6879" xlink:to="loc_bax_HillromMember_49023b5b-261a-4777-a800-7bc06dfb809d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_243eec32-4b70-47e3-802c-740cfd032e67" xlink:to="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e01278aa-1a9e-461a-b86e-99de645738ce" xlink:to="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c2cb87ec-a166-45d1-96ef-550b59407984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:to="loc_us-gaap_Goodwill_c2cb87ec-a166-45d1-96ef-550b59407984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2c04ac7f-03b7-4897-9ca7-9d3303255d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2c04ac7f-03b7-4897-9ca7-9d3303255d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_031ecd8d-3e3a-4716-aaa0-c5144cc5e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_b4ed0b47-7891-4726-963c-64744b03714b" xlink:to="loc_us-gaap_Goodwill_031ecd8d-3e3a-4716-aaa0-c5144cc5e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97637260-b10f-4078-9c88-e6789f12deda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_67a3b9f0-382b-4bb2-8f13-ba649d26b663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97637260-b10f-4078-9c88-e6789f12deda" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_67a3b9f0-382b-4bb2-8f13-ba649d26b663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7e2e0dae-b37e-4ad2-8d20-45312e37721f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97637260-b10f-4078-9c88-e6789f12deda" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7e2e0dae-b37e-4ad2-8d20-45312e37721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c3fe1117-8d4f-4021-8b7d-68496c8ceceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c3fe1117-8d4f-4021-8b7d-68496c8ceceb" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f449a438-81b2-4c1c-b7ba-dcd03de8ddc2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ce962a4d-c288-45d5-8e66-4a0fc6097058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ce962a4d-c288-45d5-8e66-4a0fc6097058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_ae42b6cd-029c-49a2-96a9-6fee64c80aba" xlink:href="bax-20230331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_ae42b6cd-029c-49a2-96a9-6fee64c80aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_11fb46a9-bc16-4e58-97d1-afc526e2ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef00a9f-fbb7-4f43-a4ab-5351937f88e3" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_11fb46a9-bc16-4e58-97d1-afc526e2ebf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6f97b14-0d7a-40a1-a412-ee1883ffd105" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b9e3c247-b078-4a84-83ca-c88733e9a942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:to="loc_us-gaap_TradeNamesMember_b9e3c247-b078-4a84-83ca-c88733e9a942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_73884fcd-0dc1-4314-8010-6f85c6d0c9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f94dd2e-aa33-4013-9f4f-3e890cdfb574" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_73884fcd-0dc1-4314-8010-6f85c6d0c9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:href="bax-20230331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_4c55f0a3-3cbf-4142-b481-262d31ab1223" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f667470f-7369-4beb-a818-02996d43e8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f667470f-7369-4beb-a818-02996d43e8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dd2fa11-e282-42d7-b83f-99749b40e3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dd2fa11-e282-42d7-b83f-99749b40e3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0c83dabd-c18f-41ea-af4b-c9e7b2979baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0c83dabd-c18f-41ea-af4b-c9e7b2979baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5eaa208a-ad49-4504-a2b6-7c76fc8510f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5eaa208a-ad49-4504-a2b6-7c76fc8510f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9ed33ca3-be4e-4950-9585-a9d2c4a90ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9ed33ca3-be4e-4950-9585-a9d2c4a90ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58dd3444-eff3-4e95-b4b9-3c59299bd076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_f4b3be46-c451-4f09-ac01-39053cfe0215" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58dd3444-eff3-4e95-b4b9-3c59299bd076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cf314f81-e24e-4c6f-a5ca-fd1c5bd6f371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cf314f81-e24e-4c6f-a5ca-fd1c5bd6f371" xlink:to="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99ce3691-46ab-4848-8c0f-f90b605b9d7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_deb148e5-0403-4a0c-8334-492773bff8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6e57ee6c-de75-4410-b531-9786d97241a4" xlink:to="loc_us-gaap_CommercialPaperMember_deb148e5-0403-4a0c-8334-492773bff8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:to="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_bc373741-ef75-456b-be77-07c8878ad23f" xlink:to="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e7c8612c-b907-42ec-9f3d-05c6e5246ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e7c8612c-b907-42ec-9f3d-05c6e5246ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_6cc3a7d0-eff1-4dcb-bd8c-6be1b17393b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3bc62d2b-c2f9-455a-99a9-339e0ee10d0c" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_6cc3a7d0-eff1-4dcb-bd8c-6be1b17393b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f477e2a3-6c61-4112-88a9-57a9650afe61" xlink:to="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bfbec427-acbc-4e13-808d-5cd2cc520110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bfbec427-acbc-4e13-808d-5cd2cc520110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_26ef51e6-d761-4660-bafd-f176fb56f7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_RepaymentsOfDebt_26ef51e6-d761-4660-bafd-f176fb56f7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7e805836-8110-4407-9363-9aa1ba870c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7e805836-8110-4407-9363-9aa1ba870c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_2fdc6a29-135f-4835-8c1b-847bde2a96f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_LineOfCredit_2fdc6a29-135f-4835-8c1b-847bde2a96f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_0251c782-102b-4c6f-b6f5-faa7d915ee4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_0251c782-102b-4c6f-b6f5-faa7d915ee4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_d4c441a4-5037-4376-9fd6-9820b1c83a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_d4c441a4-5037-4376-9fd6-9820b1c83a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_2adcad12-07b2-471c-b20d-78886ce87c65" xlink:href="bax-20230331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59e9b2fe-92ce-4beb-b61e-6de853dbbb29" xlink:to="loc_bax_OriginalWeightedAverageTerm_2adcad12-07b2-471c-b20d-78886ce87c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_034b5f50-4d0f-416c-8854-91f3546d05b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_034b5f50-4d0f-416c-8854-91f3546d05b3" xlink:to="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_6e856ffe-a5ec-4dff-a4ae-ab0ef67d8bbb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_12ecea58-ef89-4499-9ac9-97c7a7bdaa8e" xlink:href="bax-20230331.xsd#bax_SuperfundSitesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_c5722a91-0e32-4178-ba83-1e31decc0764" xlink:to="loc_bax_SuperfundSitesMember_12ecea58-ef89-4499-9ac9-97c7a7bdaa8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_7f79e5b6-370b-4684-a889-8781dd9dec0c" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_b7f606c2-2380-4efd-8a03-ed95c25ce8d2" xlink:href="bax-20230331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_8eda0d09-0484-4d85-935e-843479178d87" xlink:to="loc_bax_EnviromentalCleanUpMember_b7f606c2-2380-4efd-8a03-ed95c25ce8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e03a6530-ba76-443c-8b86-7d1c94a5a363" xlink:to="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_035d0cbc-8208-461c-b76d-4d00a20acadf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_us-gaap_LitigationReserve_035d0cbc-8208-461c-b76d-4d00a20acadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_7780b4c4-edf6-49c0-8763-54e55ab61ad6" xlink:href="bax-20230331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_bax_SiteContingencyNumberOfSites_7780b4c4-edf6-49c0-8763-54e55ab61ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_810b8e3f-78f5-4d1b-a99a-a186e5d79f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_810b8e3f-78f5-4d1b-a99a-a186e5d79f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_6d18edd6-61e2-4155-b745-3eda152e20ff" xlink:href="bax-20230331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9d1c0c55-23bb-4dc1-8ad9-1a871db228bd" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_6d18edd6-61e2-4155-b745-3eda152e20ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e89563a-8f95-4d18-842f-721ff19ab48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1a2b3b48-3d0b-4e88-85cd-6ea58a28724b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e89563a-8f95-4d18-842f-721ff19ab48b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1a2b3b48-3d0b-4e88-85cd-6ea58a28724b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_adb5a850-40aa-4752-a5d6-fbc660634a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e89563a-8f95-4d18-842f-721ff19ab48b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_adb5a850-40aa-4752-a5d6-fbc660634a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_33727018-c02e-4798-b608-4384f5688dfb" xlink:href="bax-20230331.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e89563a-8f95-4d18-842f-721ff19ab48b" xlink:to="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_33727018-c02e-4798-b608-4384f5688dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a1cffc03-e279-4693-94ce-2ec700c03e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e89563a-8f95-4d18-842f-721ff19ab48b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a1cffc03-e279-4693-94ce-2ec700c03e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_044fdbfa-0d62-44b1-91bd-5cc5a070a591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_044fdbfa-0d62-44b1-91bd-5cc5a070a591" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e62492f-dfd5-4ce5-a62b-0b9c409dd6e1" xlink:to="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7152969a-e986-40b9-86f9-8a9f03da30b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7152969a-e986-40b9-86f9-8a9f03da30b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67ca0873-7cbe-40b3-aedf-8ccb00ccd234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67ca0873-7cbe-40b3-aedf-8ccb00ccd234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c6d9754a-fcf2-4b4e-b40a-ffb3e080eb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c6d9754a-fcf2-4b4e-b40a-ffb3e080eb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8190ba6c-1b3a-4fbf-b726-d25aa1554475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8190ba6c-1b3a-4fbf-b726-d25aa1554475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_6918aee8-269e-4b18-97ba-e030c44cdeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3de5f4d3-4822-4830-9946-9ae7446067d0" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_6918aee8-269e-4b18-97ba-e030c44cdeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c5a56920-7859-4504-a891-3052ac0a1f89" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7f5257a7-51d0-4e61-9e24-7fd6157d50e5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2769270f-2683-448f-a59b-74e16cac4c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2769270f-2683-448f-a59b-74e16cac4c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_07eab2da-4c23-44b8-a57f-e0e76328fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_07eab2da-4c23-44b8-a57f-e0e76328fc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ee4e8cd-ac69-4961-9555-cc971ca0b85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ee4e8cd-ac69-4961-9555-cc971ca0b85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_123875a2-b48c-47e5-828d-2a6b7315800e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_123875a2-b48c-47e5-828d-2a6b7315800e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_166acc57-4319-4ee0-9369-072c1faabdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_16a4bea9-207d-4c01-a7e1-515367698bb5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_166acc57-4319-4ee0-9369-072c1faabdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ec9a5dac-80ff-46a0-ba3d-3368c5ed6447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ec9a5dac-80ff-46a0-ba3d-3368c5ed6447" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1ce8c385-fd7d-483c-ac18-ed0ce41c8130" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b620abc6-9a64-40f2-a67c-9420cda83d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_ac5e787e-003a-4435-ab73-5ded7bf8d98c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_b620abc6-9a64-40f2-a67c-9420cda83d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_809aa164-46eb-4246-817c-2f0cf837a24a" xlink:to="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f1a71aa-4e86-4d89-8d5d-d979b6d8de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f1a71aa-4e86-4d89-8d5d-d979b6d8de1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4497fb4b-e232-46ce-8929-fda7a7dbd8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4497fb4b-e232-46ce-8929-fda7a7dbd8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c229964f-3cad-4c57-816b-1d2c4fcde08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf9148a-bc35-43eb-8493-729ffd61e60c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_c229964f-3cad-4c57-816b-1d2c4fcde08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1053fe42-5107-4278-b6bd-8ce8f69629f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_642e7b6b-0dfd-4b2c-93a3-793c1b03a578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:to="loc_us-gaap_ForeignExchangeContractMember_642e7b6b-0dfd-4b2c-93a3-793c1b03a578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_6cc204d2-b78f-41c9-9a83-4badd4e9f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4d94e20e-913e-4166-be3a-a37187b21a20" xlink:to="loc_us-gaap_InterestRateContractMember_6cc204d2-b78f-41c9-9a83-4badd4e9f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_098d93a3-e6fb-43dd-96c7-8192d6487077" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4d2f6999-2914-4432-b606-ef6b2a7cb7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4d2f6999-2914-4432-b606-ef6b2a7cb7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c60ef472-4bcc-4488-84b1-e6f2a759c2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c60ef472-4bcc-4488-84b1-e6f2a759c2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_07c70db9-fef4-4e10-955e-e098a7961f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_07c70db9-fef4-4e10-955e-e098a7961f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c1da8884-0385-4bee-90e8-6235747bd934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c1da8884-0385-4bee-90e8-6235747bd934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289d00ab-5943-449f-a198-5a5a847e0291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289d00ab-5943-449f-a198-5a5a847e0291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14e965fd-16ff-4461-8df4-ed50df50b0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a79e4529-5e70-4c95-ab61-cbc51ebd4b7d" xlink:to="loc_us-gaap_NetIncomeLoss_14e965fd-16ff-4461-8df4-ed50df50b0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e7b7cdf-72db-454f-8622-0cd07aba4be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e7b7cdf-72db-454f-8622-0cd07aba4be6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2bfce245-2ba4-4d52-aa5d-5958067bd5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2bfce245-2ba4-4d52-aa5d-5958067bd5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a5d0e9b5-2af5-4c2c-bb18-978a406b0d08" xlink:to="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MinimumMember_0061bae6-001d-46b6-8cea-7b58671c27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5723a598-b946-4aa3-a7fa-936d143b55b9" xlink:to="loc_srt_MaximumMember_08b619b7-8998-4049-91f1-d5a92ba76540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_148fde4a-76fc-46f9-a99b-033c31e7f9a4" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ManufacturingArrangementsMember_42f6f0b5-45a9-439f-a726-60287934b8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_SoftwareArrangementsMember_58b21212-b86c-45a6-bd4d-aa26064d83f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:href="bax-20230331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_05707f0a-a52b-4aca-b2a2-35d205ec0de9" xlink:to="loc_bax_ConsumableMedicalProductsMember_5372ddb6-44aa-418f-9d37-1b7fb2bc8962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a43a7f63-5df2-480c-a74f-7f26d8f047aa" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:href="bax-20230331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_e9115da0-b14e-4b5a-8dc0-43f5e1694f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_500eb3a3-d1be-4546-bbb8-94872da813fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b2c8e6ac-b815-4bdf-af5e-a4c811863919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_AccountsReceivableNet_b1d8741e-ac3b-4e4b-88ed-1350e98816c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:href="bax-20230331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_bax_RevenueRecognizedContractPeriod_fee96bda-8f5a-45a9-814d-690b049321f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_52dfa396-ef78-4c91-aa13-db5d5b35576c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_7f861d66-b2f4-4e93-b5ea-4f5726e29a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_18053e95-de62-4377-bb6c-9d14129174d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_10afae4d-3300-4c08-95ab-0940f96fc80a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_13282067-08dc-4c5e-bd10-561464c81e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e78669b1-234b-4857-96d9-a4a3d082aa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e78669b1-234b-4857-96d9-a4a3d082aa28" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_48972bcb-39f7-4a56-8ff2-0e6755c73a09" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_ea720f06-25ac-4450-8ef7-0c44565fc52c" xlink:href="bax-20230331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_ManufacturingArrangementsMember_ea720f06-25ac-4450-8ef7-0c44565fc52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_93d0eb1f-aa51-4ad4-9325-a2c3f42e1d41" xlink:href="bax-20230331.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_SoftwareArrangementsMember_93d0eb1f-aa51-4ad4-9325-a2c3f42e1d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_b0bc7dc7-6c00-4d2a-a5a8-b05e27e7704e" xlink:href="bax-20230331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_0ed06b99-45cc-436f-9f0b-8e1c9c275278" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_b0bc7dc7-6c00-4d2a-a5a8-b05e27e7704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2aa1c176-e30d-4bf2-8c44-3c611797671f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c5186839-0bbe-4d77-bcef-d92eaa8bed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c5186839-0bbe-4d77-bcef-d92eaa8bed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_07aa96b5-0e41-47aa-901a-fe8707143991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_07aa96b5-0e41-47aa-901a-fe8707143991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_9993425e-347d-443f-8fe1-ff08b2f9df91" xlink:href="bax-20230331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_9993425e-347d-443f-8fe1-ff08b2f9df91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ee59ab04-0853-4127-a7b2-180f6d356d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70e29e0b-20d7-433e-9ff1-89e290786f07" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ee59ab04-0853-4127-a7b2-180f6d356d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc704e45-6889-48f4-90d7-a127199087b5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_80717242-6004-45e5-9136-0a7e806e9cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_80717242-6004-45e5-9136-0a7e806e9cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2b3667d1-d2bd-4057-94b2-1943c757b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2b3667d1-d2bd-4057-94b2-1943c757b32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:href="bax-20230331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_095ccef3-0b7b-4bed-be67-e701b073b761" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_07107c88-32d8-426b-8ab4-7ea3cb233cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_07107c88-32d8-426b-8ab4-7ea3cb233cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_5ddb6468-1582-404c-b443-76ffdbccd81c" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_5ddb6468-1582-404c-b443-76ffdbccd81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_869a7dca-18f2-4a4e-a930-c6dd750acfdb" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityTotalRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityTotalRevenueRecognized_869a7dca-18f2-4a4e-a930-c6dd750acfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_958293fe-d5ac-4267-9bba-9b97c0f600b3" xlink:href="bax-20230331.xsd#bax_ContractWithCustomerLiabilityCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_bax_ContractWithCustomerLiabilityCurrencyTranslation_958293fe-d5ac-4267-9bba-9b97c0f600b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f4aa7ef0-7573-418d-82ab-50db40a5482b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_917c03c7-0509-4caa-824c-eb4888d68f8a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_f4aa7ef0-7573-418d-82ab-50db40a5482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_868c1a39-a293-4a38-abc3-44b5bde0cbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_868c1a39-a293-4a38-abc3-44b5bde0cbe1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:to="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ec67639e-7436-4198-8839-fe6416b6a88f" xlink:to="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_291fa763-b9d1-4c2c-bb79-c2ebe8db6d68" xlink:href="bax-20230331.xsd#bax_RenalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_RenalMember_291fa763-b9d1-4c2c-bb79-c2ebe8db6d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_43f51f9d-12ed-47d4-b092-344bc275df3d" xlink:href="bax-20230331.xsd#bax_MedicationDeliveryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_MedicationDeliveryMember_43f51f9d-12ed-47d4-b092-344bc275df3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_8e18835e-3f15-48ba-89ce-44be864ef14b" xlink:href="bax-20230331.xsd#bax_PharmaceuticalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_PharmaceuticalsMember_8e18835e-3f15-48ba-89ce-44be864ef14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_21745f4d-5930-4c3b-a68d-6ed16208615f" xlink:href="bax-20230331.xsd#bax_ClinicalNutritionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_ClinicalNutritionMember_21745f4d-5930-4c3b-a68d-6ed16208615f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_8347507f-a5ad-419e-88c8-565e73868060" xlink:href="bax-20230331.xsd#bax_AdvancedSurgeryMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_AdvancedSurgeryMember_8347507f-a5ad-419e-88c8-565e73868060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_e9daf7cd-8dc7-4495-a8bf-c4f7fd59c190" xlink:href="bax-20230331.xsd#bax_AcuteTherapiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_AcuteTherapiesMember_e9daf7cd-8dc7-4495-a8bf-c4f7fd59c190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_7bf4a48b-c1d1-4da8-987d-20dc717da538" xlink:href="bax-20230331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_BioPharmaSolutionsMember_7bf4a48b-c1d1-4da8-987d-20dc717da538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_67bb3a33-6057-48bd-ab72-4c1f36e185c5" xlink:href="bax-20230331.xsd#bax_PatientSupportSystemsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_PatientSupportSystemsMember_67bb3a33-6057-48bd-ab72-4c1f36e185c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_c0748d8a-e77b-4379-b725-9c923e744d56" xlink:href="bax-20230331.xsd#bax_FrontLineCareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_FrontLineCareMember_c0748d8a-e77b-4379-b725-9c923e744d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_a7b3ebae-bfb4-4c6d-a669-83b5ed2a1600" xlink:href="bax-20230331.xsd#bax_SurgicalSolutionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_SurgicalSolutionsMember_a7b3ebae-bfb4-4c6d-a669-83b5ed2a1600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_09ceedac-5559-40e1-9d42-7d4178637439" xlink:href="bax-20230331.xsd#bax_OtherProductOrServicesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f3a2ed8e-b92c-4336-b13d-ca3d7313b843" xlink:to="loc_bax_OtherProductOrServicesMember_09ceedac-5559-40e1-9d42-7d4178637439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:to="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_368fdfb6-c5ca-472c-b8b7-c0bf6433f5e4" xlink:to="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8058023e-02f4-4f85-bee3-4750c47ae631" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:to="loc_country_US_8058023e-02f4-4f85-bee3-4750c47ae631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_a2773907-f906-498d-8933-682ab429fe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f887b3fd-7fc2-48c9-94dd-86408700aaf8" xlink:to="loc_us-gaap_NonUsMember_a2773907-f906-498d-8933-682ab429fe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b365dafd-8617-4fe4-9267-ae8565095b5d" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62322ab3-8060-4821-9131-6154a21b2565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b766574-fba1-4161-aa97-4aad83630cfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62322ab3-8060-4821-9131-6154a21b2565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#REVENUESLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8bb60d2c-d211-4373-9b76-7bd01bdd5827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_2f7d5978-e3fb-4878-889d-5c64d05e4347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8bb60d2c-d211-4373-9b76-7bd01bdd5827" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_2f7d5978-e3fb-4878-889d-5c64d05e4347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_cfe40824-68d6-4985-9cf5-91fa75cb675c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8bb60d2c-d211-4373-9b76-7bd01bdd5827" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_cfe40824-68d6-4985-9cf5-91fa75cb675c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_871fe86c-1235-4749-b759-6bbfe271c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8bb60d2c-d211-4373-9b76-7bd01bdd5827" xlink:to="loc_us-gaap_VariableLeaseIncome_871fe86c-1235-4749-b759-6bbfe271c0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_46704411-e27f-4330-a5d9-13affdc364dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8bb60d2c-d211-4373-9b76-7bd01bdd5827" xlink:to="loc_us-gaap_LeaseIncome_46704411-e27f-4330-a5d9-13affdc364dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5c73835f-f231-409b-91a9-bfed3df42552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5c73835f-f231-409b-91a9-bfed3df42552" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4a495aa4-2992-43cb-83fe-1f962ceac877" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_9fe06ddd-06d0-46f5-b169-9bba47ed99ed" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fab98578-0057-402d-8f5d-4323491cecca" xlink:to="loc_bax_HillromMember_9fe06ddd-06d0-46f5-b169-9bba47ed99ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_3ed89028-50a1-411b-ab8d-02c8931b411e" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntegrationActivitiesMember_c94d036b-4223-43cb-ab5d-23e78606d468" xlink:href="bax-20230331.xsd#bax_IntegrationActivitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_IntegrationActivitiesMember_c94d036b-4223-43cb-ab5d-23e78606d468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_77f34699-cfcb-4469-9171-90adee4c28b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_us-gaap_EmployeeSeveranceMember_77f34699-cfcb-4469-9171-90adee4c28b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_9cb9ff10-cfa4-435b-8b86-d09c3a6fb834" xlink:href="bax-20230331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_9cb9ff10-cfa4-435b-8b86-d09c3a6fb834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_871bf3ed-b84b-458c-801e-d5788218e538" xlink:href="bax-20230331.xsd#bax_AssetImpairmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c21437f-ec1e-4b9a-b369-3411241c1335" xlink:to="loc_bax_AssetImpairmentMember_871bf3ed-b84b-458c-801e-d5788218e538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ca228657-7c8b-483f-a220-e2aea23bea20" xlink:to="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_NewOperatingModelMember_2c213869-4fcc-4fea-a634-d47704df291b" xlink:href="bax-20230331.xsd#bax_NewOperatingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9233f05f-de56-4648-b6bf-f8da0089d614" xlink:to="loc_bax_NewOperatingModelMember_2c213869-4fcc-4fea-a634-d47704df291b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ba2615-cfea-4042-aa50-3ad8ea3ec38d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_90b04862-5b2d-441a-afd5-c85574d3c08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_90b04862-5b2d-441a-afd5-c85574d3c08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_74dae872-de58-4aa1-8483-4e837fd2fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_74dae872-de58-4aa1-8483-4e837fd2fba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_0b8ae9aa-b8d4-4537-b538-511b77ce34db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4c603d48-e3b6-47a7-8b6c-9b8ad09bd6ca" xlink:to="loc_us-gaap_RestructuringCharges_0b8ae9aa-b8d4-4537-b538-511b77ce34db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ba280495-e932-4a26-a3f9-55ce9899e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ba280495-e932-4a26-a3f9-55ce9899e8b1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:to="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_86e2be0c-bf5f-483a-bf59-84ae239d4cdb" xlink:to="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_c98db2ae-bc24-45f8-b85a-9ef922d6bf91" xlink:href="bax-20230331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_951e296e-be78-46e1-86ce-eeceab34a225" xlink:to="loc_bax_BusinessOptimizationProgramsMember_c98db2ae-bc24-45f8-b85a-9ef922d6bf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6ab67be2-0af2-412d-963e-ff7a384e0473" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_58894c1b-1ef9-4b2c-aed0-0ddaad38c2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringCharges_58894c1b-1ef9-4b2c-aed0-0ddaad38c2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fee02387-8464-4a42-b8cf-feb831a522b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_fee02387-8464-4a42-b8cf-feb831a522b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_2c23524b-0847-4679-8a4d-26c96edaf316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d90b3470-18f0-4f5b-8fe6-293db55c3fed" xlink:to="loc_us-gaap_RestructuringCosts_2c23524b-0847-4679-8a4d-26c96edaf316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1cc04a43-54d8-48c7-95b0-8abea3b8f38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1cc04a43-54d8-48c7-95b0-8abea3b8f38d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cb63b19e-77d7-4766-83b1-9b888b690428" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_cb2e0595-945c-4746-b889-5e23682a35c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_us-gaap_EmployeeSeveranceMember_cb2e0595-945c-4746-b889-5e23682a35c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_1111d17f-20a4-43ae-988b-49b3fbd54523" xlink:href="bax-20230331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_1111d17f-20a4-43ae-988b-49b3fbd54523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_6143e41a-c9d0-4718-8955-b1b81db7d64e" xlink:href="bax-20230331.xsd#bax_AssetImpairmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_edf45edd-4d69-4c30-856d-f52478b48bda" xlink:to="loc_bax_AssetImpairmentMember_6143e41a-c9d0-4718-8955-b1b81db7d64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98f831e0-6221-45d5-bda2-c8e25f764458" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_016a09a3-5586-4c53-a306-767d60b99f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_CostOfSalesMember_016a09a3-5586-4c53-a306-767d60b99f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f796d23-5187-43fe-b7a9-79d5ce702016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9f796d23-5187-43fe-b7a9-79d5ce702016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_90664d9c-1d8b-45db-9899-696171bb1900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d9fe6a2d-b0bc-476e-9b5e-3a71603ef6ab" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_90664d9c-1d8b-45db-9899-696171bb1900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f750bc49-453f-43a3-ae7c-9251c56ba2d3" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5d20634f-4a29-403d-83a1-af5618fe1bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8c5ad2e3-2cbd-4a73-aa20-ce53d3f4509a" xlink:to="loc_us-gaap_RestructuringCharges_5d20634f-4a29-403d-83a1-af5618fe1bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7083d794-5fd2-4fde-9555-827f4eefbd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7083d794-5fd2-4fde-9555-827f4eefbd14" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_25939eb4-9389-4196-bf70-4c6d99def691" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_c5cf6968-e5d5-47e7-b1cc-b51986823c24" xlink:href="bax-20230331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d410c8c5-4a36-46a0-925a-6d12762724ed" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_c5cf6968-e5d5-47e7-b1cc-b51986823c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1367c849-d38b-4deb-9157-bfc0521ccbb2" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ce1a2936-cf5f-4c7d-b1d2-4e541d4ddf63" xlink:to="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e6d4cb06-66b6-4f7a-b11c-523324d2d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserve_e6d4cb06-66b6-4f7a-b11c-523324d2d92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ebea7431-d28e-4f45-8503-46b2fc18e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringCharges_ebea7431-d28e-4f45-8503-46b2fc18e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_70112682-dca5-4469-ab41-b43da3c49f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_PaymentsForRestructuring_70112682-dca5-4469-ab41-b43da3c49f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_435cfa14-9ba2-4346-b7ec-c38355469f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_435cfa14-9ba2-4346-b7ec-c38355469f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_1916fccd-a753-4f6c-b813-9a47944f2bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_1916fccd-a753-4f6c-b813-9a47944f2bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5e6c61bb-67dc-4f98-98d9-4b594343cc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_fd135763-458e-4997-8a08-464dfcf68121" xlink:to="loc_us-gaap_RestructuringReserve_5e6c61bb-67dc-4f98-98d9-4b594343cc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e58d6f6f-9c0f-4dcb-87db-6383cb364524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e58d6f6f-9c0f-4dcb-87db-6383cb364524" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8925a938-8249-4afd-adf6-7585789815e0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c51e9766-d43c-48e4-91fd-be728b46c5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c51e9766-d43c-48e4-91fd-be728b46c5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b00650f0-1412-4b28-9091-ac90fc632087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7f0d951d-9f8d-4fcd-9d3e-9c560ae47644" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b00650f0-1412-4b28-9091-ac90fc632087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a7c452f2-dd53-48f4-937e-5aff6301e8db" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_255ca04c-4b0b-4f8f-92a7-9926cd27469e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6d3b29f0-dc7a-4d91-900e-3b98dbd6278d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6d3b29f0-dc7a-4d91-900e-3b98dbd6278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cd246446-c60f-4a2e-8c97-8ae88f61b84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cd246446-c60f-4a2e-8c97-8ae88f61b84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_07782bfb-a13c-47f4-ba01-d2b4ff924925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_07782bfb-a13c-47f4-ba01-d2b4ff924925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_56a6c2cb-d485-448a-b834-851755e16bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_56a6c2cb-d485-448a-b834-851755e16bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ba674136-c392-4d98-b8dd-6307bce67783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_508f7cc5-d988-45db-b677-e76d49b270bb" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ba674136-c392-4d98-b8dd-6307bce67783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4cde2fd3-7f5c-4107-b865-0ce083f7cf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_44a20a9d-4579-4b33-875a-4949c90808d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4cde2fd3-7f5c-4107-b865-0ce083f7cf36" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_44a20a9d-4579-4b33-875a-4949c90808d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f97922c0-d02d-4220-b3ac-870582b6120a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4cde2fd3-7f5c-4107-b865-0ce083f7cf36" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f97922c0-d02d-4220-b3ac-870582b6120a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_75e7e647-925e-4e50-a4d9-7e59017c209a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_282b1082-be31-4e25-bc4d-e33175ac2c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75e7e647-925e-4e50-a4d9-7e59017c209a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_282b1082-be31-4e25-bc4d-e33175ac2c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bb03d653-5b2b-4cb8-851d-e8378643da3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_282b1082-be31-4e25-bc4d-e33175ac2c5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bb03d653-5b2b-4cb8-851d-e8378643da3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f9a8d64e-da83-45a2-9491-eb792c600a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_282b1082-be31-4e25-bc4d-e33175ac2c5c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f9a8d64e-da83-45a2-9491-eb792c600a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aced91d3-697f-4e6c-9770-7f2c7192c291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_282b1082-be31-4e25-bc4d-e33175ac2c5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aced91d3-697f-4e6c-9770-7f2c7192c291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#EARNINGSPERSHAREAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_909754f3-af22-4699-ba3f-6ade0da62a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fb30f01a-e1a5-48f9-bc58-b4bb8e587619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_909754f3-af22-4699-ba3f-6ade0da62a94" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fb30f01a-e1a5-48f9-bc58-b4bb8e587619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_eda5d7a3-afcc-4a83-a83d-86cd754b125f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_eda5d7a3-afcc-4a83-a83d-86cd754b125f" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6a05d8cc-4418-45ca-8fc7-9c6454bf1dc0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_58fbbdbb-a19e-48bd-aa3a-f643df9cd4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_58fbbdbb-a19e-48bd-aa3a-f643df9cd4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_bd5c1d51-f432-4314-b4cd-c1f1d3a4007c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_InterestRateContractMember_bd5c1d51-f432-4314-b4cd-c1f1d3a4007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_515a2862-4c8d-4258-bb7e-9a635cb2e306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d527938d-e3c4-44a5-870a-9a6ba5df041d" xlink:to="loc_us-gaap_InterestRateSwapMember_515a2862-4c8d-4258-bb7e-9a635cb2e306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff38b234-da79-4075-8c84-84c9e716d413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A130SeniorNotesDueMay2025Member_3c87ee47-a386-4b2b-a2af-377b57d813bc" xlink:href="bax-20230331.xsd#bax_A130SeniorNotesDueMay2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A130SeniorNotesDueMay2025Member_3c87ee47-a386-4b2b-a2af-377b57d813bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A04SeniorNotesDueMay2024Member_d1e8b6b4-943d-4086-b37a-bbfdc35a1f15" xlink:href="bax-20230331.xsd#bax_A04SeniorNotesDueMay2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A04SeniorNotesDueMay2024Member_d1e8b6b4-943d-4086-b37a-bbfdc35a1f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_A13SeniorNotesDueMay2029Member_3e3968fe-f2f7-4b57-801a-b10058e8cd69" xlink:href="bax-20230331.xsd#bax_A13SeniorNotesDueMay2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c33a8893-dbc6-4351-8d19-9a256245f2e8" xlink:to="loc_bax_A13SeniorNotesDueMay2029Member_3e3968fe-f2f7-4b57-801a-b10058e8cd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_062deb58-a5f6-4172-a202-45946cddf9e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_21bf3e55-ccab-4ab1-b318-461f512fd1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_066de50a-1fa0-4c6d-9070-596abaf27aa9" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_21bf3e55-ccab-4ab1-b318-461f512fd1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a5e4d3d6-93a8-4283-9f83-fb7ddb5d85c2" xlink:to="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9b95e77d-73b7-44c3-b3f6-51dd7f2ef6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_98bed6f1-1914-4939-a214-512338564e9d" xlink:to="loc_us-gaap_NondesignatedMember_9b95e77d-73b7-44c3-b3f6-51dd7f2ef6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b39ed5c1-cddc-4c55-ba71-f2f276903342" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0f9b8477-b5f0-4613-938a-e217c9274d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0f9b8477-b5f0-4613-938a-e217c9274d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2e04a143-6f8c-475b-be47-ef4388b0f785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_2e04a143-6f8c-475b-be47-ef4388b0f785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c76c1c8b-8034-461e-8de8-07d605159d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c76c1c8b-8034-461e-8de8-07d605159d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_44c1244a-2521-4f8f-bcd1-f8a1688bb4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_44c1244a-2521-4f8f-bcd1-f8a1688bb4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6eb69b-7086-4a42-949a-b43cb3107e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5e6eb69b-7086-4a42-949a-b43cb3107e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_63ba3fcd-9b5c-44e0-94d7-f9507999aef5" xlink:href="bax-20230331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_bax_DerivativeFairValueTerminated_63ba3fcd-9b5c-44e0-94d7-f9507999aef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_4b092cfc-61a5-4583-955f-2e141f471ec7" xlink:href="bax-20230331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_4b092cfc-61a5-4583-955f-2e141f471ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b2ac3f50-3807-472c-a00e-a6c7b6db523d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f89b2b3a-e003-4c97-89c0-3d17b08f7579" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b2ac3f50-3807-472c-a00e-a6c7b6db523d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_726f95d8-814e-4b6f-9e53-2fb62c439eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_726f95d8-814e-4b6f-9e53-2fb62c439eac" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f5adab7a-8553-4499-9342-dcceac4120bb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_9041832a-f9ee-49e7-b03b-0879138bcbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:to="loc_us-gaap_InterestRateContractMember_9041832a-f9ee-49e7-b03b-0879138bcbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_30d08751-525c-4b66-b6de-4e60e48bde24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b0fe8e3-569a-4fe2-9235-e5303b73975f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_30d08751-525c-4b66-b6de-4e60e48bde24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06cccc7a-5df6-44da-ac72-1a32195c7b7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26cc8b01-64ce-4fef-818c-4eb4074eb845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:to="loc_us-gaap_CashFlowHedgingMember_26cc8b01-64ce-4fef-818c-4eb4074eb845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_64d51ae9-8d03-4909-808f-8516dc3f13ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_65db7c19-c084-4b00-aa46-24a87b83cfec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_64d51ae9-8d03-4909-808f-8516dc3f13ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d8df560a-6e76-4ba3-b5da-63440b852af1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_63324275-c7ed-4ee9-abba-f4697678f59a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_InterestExpenseMember_63324275-c7ed-4ee9-abba-f4697678f59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_59f62647-973e-41b9-ba69-1d18c6a9580f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_CostOfSalesMember_59f62647-973e-41b9-ba69-1d18c6a9580f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b4b14252-f53f-4304-bfb7-b44299e3185a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a22b91fa-3634-46ae-be40-c02aaa2fe72d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b4b14252-f53f-4304-bfb7-b44299e3185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_56376439-d0f6-4827-a3e1-c5367dbd90aa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_773dbb42-307d-4e4a-8105-aa682bbe1d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_773dbb42-307d-4e4a-8105-aa682bbe1d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8d1cd2d5-28b6-49c3-adc2-d9564c6617b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8d1cd2d5-28b6-49c3-adc2-d9564c6617b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_306e837b-63ca-4ced-8a8d-eedd3760be92" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_306e837b-63ca-4ced-8a8d-eedd3760be92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_23fe3376-c65e-4a2a-b420-0beea11afb19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_23fe3376-c65e-4a2a-b420-0beea11afb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_134ace99-46d8-45df-881f-f788ca4474f7" xlink:href="bax-20230331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_134ace99-46d8-45df-881f-f788ca4474f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_eb1d16bc-ade6-47b2-833e-fcb52929ee27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c0e891e9-6afe-428d-b870-b09779531c87" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_eb1d16bc-ade6-47b2-833e-fcb52929ee27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_91ad560c-bc67-4937-9964-3a8ab5352d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_91ad560c-bc67-4937-9964-3a8ab5352d2b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_614277de-2124-46b6-9d40-b380ae2982bc" xlink:to="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f071c23-489b-4879-a9b8-65e8c946d4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4f071c23-489b-4879-a9b8-65e8c946d4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9f893a29-a85b-4784-a47b-4bd91dc564b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ad7dd416-c003-4da4-ad4c-c7b45d77946c" xlink:to="loc_us-gaap_NondesignatedMember_9f893a29-a85b-4784-a47b-4bd91dc564b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_79a5a75b-0112-4354-bdf6-4cb0167f9e73" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ec09378b-40b8-44ac-976f-d1b529f78735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5de91989-921b-470e-ac51-a48ed1bdae20" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ec09378b-40b8-44ac-976f-d1b529f78735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35b006d0-06f3-41c1-8f5a-1ab754ece8ce" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_01ace3d7-68ef-4c18-a283-bd9fad39ffa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_01ace3d7-68ef-4c18-a283-bd9fad39ffa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_bb90dfc6-30db-4834-a027-97c18a8346e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65881255-50ad-482e-8a2c-d36e373ec8a7" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_bb90dfc6-30db-4834-a027-97c18a8346e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0b806b1f-a9d9-4ce9-8af6-a95c0c7df1e5" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_87d98ee9-c37a-4c92-830b-ab18c78174a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_87d98ee9-c37a-4c92-830b-ab18c78174a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87c82053-5279-4cc4-a796-66859ce2683e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b8607325-d7ad-4f84-ae5d-87913d176912" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87c82053-5279-4cc4-a796-66859ce2683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88d2452e-6aa4-4b20-88d1-e976b777bb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_b7ce6536-2857-4f6d-b118-b7d8380af760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88d2452e-6aa4-4b20-88d1-e976b777bb6a" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_b7ce6536-2857-4f6d-b118-b7d8380af760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_00d5a126-cb57-4dc0-85b0-dab1cf7dd860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b7ce6536-2857-4f6d-b118-b7d8380af760" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_00d5a126-cb57-4dc0-85b0-dab1cf7dd860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_27f1dbe8-795c-47d2-9330-94e23111bac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b7ce6536-2857-4f6d-b118-b7d8380af760" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_27f1dbe8-795c-47d2-9330-94e23111bac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9d85cc18-03a6-4b7b-a352-0e6cdb02fbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b7ce6536-2857-4f6d-b118-b7d8380af760" xlink:to="loc_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection_9d85cc18-03a6-4b7b-a352-0e6cdb02fbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_a5928aab-8aa8-4231-aeec-8717556abda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88d2452e-6aa4-4b20-88d1-e976b777bb6a" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_a5928aab-8aa8-4231-aeec-8717556abda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_bcd14bce-f0dc-46c3-82b2-43779a75ae5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a5928aab-8aa8-4231-aeec-8717556abda2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_bcd14bce-f0dc-46c3-82b2-43779a75ae5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_4f129d26-6130-447f-9720-6e9aeb13ccc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a5928aab-8aa8-4231-aeec-8717556abda2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_4f129d26-6130-447f-9720-6e9aeb13ccc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_948a8aa8-4052-454f-bb21-0ea0861d3347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_a5928aab-8aa8-4231-aeec-8717556abda2" xlink:to="loc_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement_948a8aa8-4052-454f-bb21-0ea0861d3347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a5573b04-b422-4edf-b5f9-c0c3428e5732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a5573b04-b422-4edf-b5f9-c0c3428e5732" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:to="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_94d2c43f-4dd6-4b27-832f-e11c9761d2e2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1476dc7f-d4d1-41b1-b016-0812db786ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2739c87c-3c7d-406d-903a-1a4047aa6273" xlink:to="loc_us-gaap_LongTermDebtMember_1476dc7f-d4d1-41b1-b016-0812db786ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_00a1ac50-00a4-4fe8-a8cd-fc04eab3c642" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_c6907c76-44ac-464f-9655-2ef9316e8607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_c6907c76-44ac-464f-9655-2ef9316e8607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f3654a84-abd9-4c78-aace-370b19daa958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_47319812-ddf1-497f-8027-e08b72c64145" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f3654a84-abd9-4c78-aace-370b19daa958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_db0f2a63-89e9-40ff-8579-47e22483f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_db0f2a63-89e9-40ff-8579-47e22483f52e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b1e78077-bed6-4cfb-bd3e-e2383aad3dc8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_769a81a7-f658-4620-81e8-7ede4d7f0073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9b06a519-706d-4a8f-9165-1e2bcd19a4af" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_769a81a7-f658-4620-81e8-7ede4d7f0073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_174e2af1-5b82-4d18-add4-85dab854b367" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a0a7a570-7156-4d55-b5b4-056f49553ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a0a7a570-7156-4d55-b5b4-056f49553ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cbf1ae36-767c-44bd-9312-a87070d6646e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cbf1ae36-767c-44bd-9312-a87070d6646e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_135d8beb-2ac9-4734-bbb6-6628ac489844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3b44f93-aa42-48e7-907c-16cbad42fe42" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_135d8beb-2ac9-4734-bbb6-6628ac489844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8253a785-67d8-4ea4-93b9-039363503cc6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_37275e97-2908-43f3-be94-5a229eb26f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_37275e97-2908-43f3-be94-5a229eb26f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b3deb01-bde9-4901-87ac-b28685526911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b3deb01-bde9-4901-87ac-b28685526911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b69a010b-f1d5-4893-8c33-a5a3fc83d20c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b69a010b-f1d5-4893-8c33-a5a3fc83d20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_80f8bd8b-d68b-4424-b175-9395b8fab38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9c2f2b3e-4864-4577-a535-cef594803f2e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_80f8bd8b-d68b-4424-b175-9395b8fab38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9619c280-02a1-4839-bf27-a7d944853eb7" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_994067d0-ed76-48d0-9d78-d550773a93b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_994067d0-ed76-48d0-9d78-d550773a93b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_994e622d-ed1f-4a65-8588-f94dd63a7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_994e622d-ed1f-4a65-8588-f94dd63a7da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_9bee201d-ddcb-4e6d-87ae-f467f3c9699f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7aae22bf-f4f8-406c-a71c-d825765c4570" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_9bee201d-ddcb-4e6d-87ae-f467f3c9699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c2ba4510-0739-4337-ad21-457f99ff7ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c2ba4510-0739-4337-ad21-457f99ff7ee1" xlink:to="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_208b80e6-addf-4847-ae3c-5872cc7906cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8326f789-2c88-459e-abe1-1596830ca28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_295f6b5f-e02f-40d8-a9ab-42a0d0ff1327" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8326f789-2c88-459e-abe1-1596830ca28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44067246-ac12-4c61-8937-4363059300bc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_2ff29bb4-fecc-4628-8896-80eb49884a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a1398fe4-84f8-4195-a03e-8b562c1d0dee" xlink:to="loc_us-gaap_OtherAssetsMember_2ff29bb4-fecc-4628-8896-80eb49884a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_371af24d-9fdb-404e-91d0-b462a4570b4a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_2de609f2-4d57-4af4-9e1a-757cf14b79f9" xlink:href="bax-20230331.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f45195e-0fd3-404e-8a34-331596453847" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_2de609f2-4d57-4af4-9e1a-757cf14b79f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_9e858a29-87da-448a-bc88-6df3bbe974c4" xlink:to="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d95433b-7d4d-4c00-a499-8a2ab664161d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d95433b-7d4d-4c00-a499-8a2ab664161d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e198ce7b-7f19-45f7-ae37-ebee1c037ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e198ce7b-7f19-45f7-ae37-ebee1c037ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_e520106b-6888-4744-a0bb-bc605baf3996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_5a754326-618f-4e2a-b12e-06f07964e7f8" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_e520106b-6888-4744-a0bb-bc605baf3996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bd34f7d1-2865-4c48-b1f9-0cffebc584a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bd34f7d1-2865-4c48-b1f9-0cffebc584a6" xlink:to="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a01490b-c0e2-4c30-b579-c06d3be68ba7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_1fd13530-8198-4538-849f-62166c5a6cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_1fd13530-8198-4538-849f-62166c5a6cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AvailableForSaleDebtSecuritiesMember_a489b6f1-f71e-4cc9-8644-8d97ca070f76" xlink:href="bax-20230331.xsd#bax_AvailableForSaleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c07efb6-4a04-4188-8077-067ad4e0d558" xlink:to="loc_bax_AvailableForSaleDebtSecuritiesMember_a489b6f1-f71e-4cc9-8644-8d97ca070f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:href="bax-20230331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_59ecff3a-5b8d-4f46-9c6a-bc7eeaa3de6d" xlink:to="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_106f362e-fb9a-4190-997a-2dffacd58fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_106f362e-fb9a-4190-997a-2dffacd58fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b1a21d6b-7c17-4a06-881a-02a29f9cfa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_b1a21d6b-7c17-4a06-881a-02a29f9cfa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3440e2a0-dbcc-4c30-9a86-a66e1d130e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3440e2a0-dbcc-4c30-9a86-a66e1d130e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_8f031afa-4b13-4d3c-aa2d-ce82a7819535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_8f031afa-4b13-4d3c-aa2d-ce82a7819535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_04623473-2e14-4635-8f47-f649d5c346f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_04623473-2e14-4635-8f47-f649d5c346f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f61d8faa-c683-485f-bbb4-612ec596e9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f61d8faa-c683-485f-bbb4-612ec596e9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ac0289d5-7682-420f-b9de-27a421ad5055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_42cfad05-50ea-4335-8244-61d43dc37eeb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ac0289d5-7682-420f-b9de-27a421ad5055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_f211ebbb-e376-46a9-8bc9-e6537a2cb3a5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b312b408-f71b-4d90-9c31-811449c671e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b312b408-f71b-4d90-9c31-811449c671e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_229e52eb-14f0-49db-93e2-e260b1a57f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_229e52eb-14f0-49db-93e2-e260b1a57f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_b9cf7df3-9b70-4ddd-bfa0-f1131b4e693a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_b9cf7df3-9b70-4ddd-bfa0-f1131b4e693a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_881937a1-a412-4a3d-ac67-607cbc7db1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_881937a1-a412-4a3d-ac67-607cbc7db1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c60e7870-7893-41e2-a9e1-3b1834cbe7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c60e7870-7893-41e2-a9e1-3b1834cbe7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_6b1a870d-5b0d-484c-a34e-0e5f4862549f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_6b1a870d-5b0d-484c-a34e-0e5f4862549f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_01591640-e891-46c1-b09e-8875bdd3b4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5d9e1bb5-9b6e-460c-971e-7cbfff2e0f98" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_01591640-e891-46c1-b09e-8875bdd3b4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_454cf260-04d7-4f98-8cc3-82a5f4e4d329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_454cf260-04d7-4f98-8cc3-82a5f4e4d329" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_07c008e5-1534-46eb-9b90-d8cf84bbba6f" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_cb871aba-9a8b-49d2-89bf-c10f3af6025e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_cb871aba-9a8b-49d2-89bf-c10f3af6025e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6677c5b3-64e1-476d-94bd-9b8d0e90c10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ae22b6a0-d607-474f-996d-af3167596189" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6677c5b3-64e1-476d-94bd-9b8d0e90c10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:href="bax-20230331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_3a39fec2-12f5-4160-859d-19372c72805a" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_6000977f-0883-4671-a6a3-53eb2506a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_us-gaap_ShorttermDebtFairValue_6000977f-0883-4671-a6a3-53eb2506a6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_36b184c5-ad2b-4516-aa7c-56c30dc32c2b" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_36b184c5-ad2b-4516-aa7c-56c30dc32c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_2834dfc0-d537-4581-8b87-cad9a44125f6" xlink:href="bax-20230331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_91326b14-ffea-4a7c-b148-78e3425f6518" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_2834dfc0-d537-4581-8b87-cad9a44125f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9b5b3944-28a2-451f-a263-69a064219695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9b5b3944-28a2-451f-a263-69a064219695" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:to="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4c37b7d5-0a5d-406e-b8b6-ae5e0953c67b" xlink:to="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a4738a24-2eed-44ca-9f30-fceb97c8f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_81b133db-d934-4294-9844-73fbb0328784" xlink:to="loc_us-gaap_OperatingSegmentsMember_a4738a24-2eed-44ca-9f30-fceb97c8f3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1a0dde9-74f5-450c-92ef-7c53f7369ab9" xlink:to="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_28ad3cbe-1655-4c05-a3d3-ad733d285e35" xlink:href="bax-20230331.xsd#bax_AmericasSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_AmericasSegmentMember_28ad3cbe-1655-4c05-a3d3-ad733d285e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_1e930901-f2e8-4c96-aad2-f899609d16a9" xlink:href="bax-20230331.xsd#bax_EMEASegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_EMEASegmentMember_1e930901-f2e8-4c96-aad2-f899609d16a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_0c4fc957-9276-4d0a-8796-4ab14eccb1e6" xlink:href="bax-20230331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_AsiaPacificSegmentMember_0c4fc957-9276-4d0a-8796-4ab14eccb1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_6d85d3c8-24b3-424a-8346-511e7a17f136" xlink:href="bax-20230331.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aac449dc-fb19-4aa6-97f8-8514c5e2f5a9" xlink:to="loc_bax_HillromMember_6d85d3c8-24b3-424a-8346-511e7a17f136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73cb6ec3-74e1-4dab-93b9-68a456e78d29" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_53ab5fea-6ddd-4e88-a2fb-ce51a04d2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_NumberOfOperatingSegments_53ab5fea-6ddd-4e88-a2fb-ce51a04d2b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaa1833c-ed6c-4a9f-b844-df29f6abc203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eaa1833c-ed6c-4a9f-b844-df29f6abc203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_67adcdf2-cd46-40b4-b609-0fdf1724c9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f1b77c35-76d5-4b0a-bb5b-0ec2b10a2cfa" xlink:to="loc_us-gaap_OperatingIncomeLoss_67adcdf2-cd46-40b4-b609-0fdf1724c9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20230331.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_db7b5c20-1815-4484-8aef-50cc8db09b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_db7b5c20-1815-4484-8aef-50cc8db09b6c" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:to="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4bbe0233-6299-44d6-932d-e78d56d737c3" xlink:to="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d8330c3a-bca4-4aa1-ad2d-1d09f7adb9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:to="loc_us-gaap_OperatingSegmentsMember_d8330c3a-bca4-4aa1-ad2d-1d09f7adb9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e5916d3c-8d95-4180-9c29-72b6d8b53f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a2ddd780-9600-45ca-88f3-b579cfb7374f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e5916d3c-8d95-4180-9c29-72b6d8b53f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_b25f7ec6-d69c-4349-a611-c57dea509082" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d8e8ccbd-e668-4299-bc08-4247f4c096d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_OperatingIncomeLoss_d8e8ccbd-e668-4299-bc08-4247f4c096d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6b54ce66-ebfd-426f-967a-016a883096ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6b54ce66-ebfd-426f-967a-016a883096ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d725d114-3843-4daf-b9da-3fbc9c13c98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d725d114-3843-4daf-b9da-3fbc9c13c98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bc4c88d9-8714-433a-b4f2-b0e08c9163c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_a95ef01f-15ef-47e1-b710-20f1a35e1bb8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bc4c88d9-8714-433a-b4f2-b0e08c9163c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403611084160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BAXTER INTERNATIONAL INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">224.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948.2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,850,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | Chicago Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member', window );">0.4% Global Notes due 2024 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.4% Global Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member', window );">1.3% Global Notes due 2025 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member', window );">1.3% Global Notes due 2029 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610822480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,673<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $122 in 2023 and $114 in 2022</a></td>
<td class="nump">2,547<span></span>
</td>
<td class="nump">2,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,922<span></span>
</td>
<td class="nump">2,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">957<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,099<span></span>
</td>
<td class="nump">8,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">4,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,868<span></span>
</td>
<td class="nump">6,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,640<span></span>
</td>
<td class="nump">6,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">28,291<span></span>
</td>
<td class="nump">28,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">1,103<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">1,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">2,317<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,760<span></span>
</td>
<td class="nump">4,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">15,278<span></span>
</td>
<td class="nump">15,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">458<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,854<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">22,350<span></span>
</td>
<td class="nump">22,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Common stock in treasury, at cost,177,658,649 shares in 2023 and 179,062,594 shares in 2022</a></td>
<td class="num">(11,324)<span></span>
</td>
<td class="num">(11,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional contributed capital</a></td>
<td class="nump">6,312<span></span>
</td>
<td class="nump">6,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">13,947<span></span>
</td>
<td class="nump">14,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(3,739)<span></span>
</td>
<td class="num">(3,833)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Baxter stockholders&#8217; equity</a></td>
<td class="nump">5,879<span></span>
</td>
<td class="nump">5,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">5,941<span></span>
</td>
<td class="nump">5,895<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 28,291<span></span>
</td>
<td class="nump">$ 28,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403611046960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for accounts receivable, current</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">683,494,944<span></span>
</td>
<td class="nump">683,494,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">177,658,649<span></span>
</td>
<td class="nump">179,062,594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610897104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,649<span></span>
</td>
<td class="nump">$ 3,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,302<span></span>
</td>
<td class="nump">2,359<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income, net</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Baxter stockholders</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613522512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments, net of tax expense (benefit) of ($13) and $(11) for the three months ended March 31, 2023 and 2022, respectively.</a></td>
<td class="nump">102<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2023 and 2022, respectively.</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Hedging activities, net of tax expense (benefit) of ($1) for the three months ended March 31, 2023 and 2022.</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Available-for-sale debt securities, net of tax expense of zero and $1 for the three months ended March 31, 2023 and 2022, respectively.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">94<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Baxter stockholders</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403611055552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Currency translation adjustments, tax</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and other postretirement benefits, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Hedging activities, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Debt securities, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612207456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Baxter stockholders' equity</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Common stock in treasury</div></th>
<th class="th"><div>Additional contributed capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Noncontrolling interests</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2021</a></td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">$ 9,077<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,488)<span></span>
</td>
<td class="nump">$ 6,197<span></span>
</td>
<td class="nump">$ 17,065<span></span>
</td>
<td class="num">$ (3,380)<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Mar. 31, 2022</a></td>
<td class="nump">$ 9,119<span></span>
</td>
<td class="nump">9,075<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,422)<span></span>
</td>
<td class="nump">6,207<span></span>
</td>
<td class="nump">16,994<span></span>
</td>
<td class="num">(3,387)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">179,062,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2022</a></td>
<td class="nump">$ 5,895<span></span>
</td>
<td class="nump">5,833<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,389)<span></span>
</td>
<td class="nump">6,322<span></span>
</td>
<td class="nump">14,050<span></span>
</td>
<td class="num">(3,833)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Mar. 31, 2023</a></td>
<td class="nump">$ 5,941<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,324)<span></span>
</td>
<td class="nump">$ 6,312<span></span>
</td>
<td class="nump">$ 13,947<span></span>
</td>
<td class="num">$ (3,739)<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">177,658,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610908816">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operations</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash flows from operations:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">319<span></span>
</td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Net periodic pension and other postretirement costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in balance sheet items:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">157<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">479<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired, and investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows from investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Net decreases in debt with original maturities of three months or less</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(249)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends on common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock issued under employee benefit plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">36<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(372)<span></span>
</td>
<td class="num">(548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,722<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="nump">$ 2,299<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2023, December&#160;31, 2022, and March&#160;31, 2022 (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses And Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615037856">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,673<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
<td class="nump">$ 2,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash included in prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="nump">$ 1,722<span></span>
</td>
<td class="nump">$ 2,299<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2023, December&#160;31, 2022, and March&#160;31, 2022 (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615640848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we, our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 Annual Report).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we announced our intention to separate our Renal Care and Acute Therapies product categories into a new, publicly traded company. While the completion of the proposed spinoff is subject to satisfaction of customary conditions, we are targeting completion of the planned separation by July 2024 or earlier. Additionally, we announced that we are pursuing strategic alternatives (including a potential sale) for our BioPharma Solutions product category. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supply Constraints and Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the challenges caused by global economic conditions, among other factors, may continue to have an adverse effect on our business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615834544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">SUPPLEMENTAL FINANCIAL INFORMATION</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Income, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2023 and 2022 were $26 million and $14&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div>Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2023 and 2022 were $70 million and $53 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403698738176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS, NET<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,991&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods ended March&#160;31, 2023 and 2022, there were no reductions in goodwill relating to impairment losses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $162 million and $217 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403698462112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">FINANCING ARRANGEMENTS</a></td>
<td class="text">FINANCING ARRANGEMENTS <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we amended the credit agreements governing our U.S. dollar-denominated term loan credit facility and revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to amend the net leverage ratio covenant to increase the maximum net leverage ratio for the four fiscal quarters ending March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2.5&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of March&#160;31, 2023 or December&#160;31, 2022.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. Based on our covenant calculations as of March&#160;31, 2023 we have capacity to draw approximately $2.2&#160;billion under our credit facilities, less commercial paper borrowings which were $50 million as of March&#160;31, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $50 million of commercial paper outstanding with a weighted-average interest rate of 5.42% and an original weighted-average term of 28 days. As of December&#160;31, 2022, we had $299 million of commercial paper outstanding with a weighted-average interest rate of 4.75% and an original weighted-average term of 32 days.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615751968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2023 and December&#160;31, 2022, our total recorded reserves with respect to legal and environmental matters were $29 million and $28 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2023 and December&#160;31, 2022, our environmental reserves, which are measured on an undiscounted basis, were $17 million and $19 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. On December 16, 2022, we filed a motion to dismiss and for a more definite statement. In response, Plaintiffs filed a First Amended Complaint on January 6, 2023. We answered the First Amended Complaint on January 27, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We acquired Hill-Rom Holdings, Inc. (Hillrom) on December 13, 2021. In July 2021, Hill-Rom, Inc., a wholly-owned subsidiary of Hillrom, received a subpoena from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. In October 2022, the DOJ issued a separate Civil Investigative Demand (CID) addressed to Hillrom, requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Baxter is cooperating fully with the DOJ in responding to the CID. The DHHS and DOJ often issue these types of requests when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an </span></div>answer to the complaint on January 28, 2022 and filed a motion challenging certain aspects of plaintiff's case on May 27, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615748112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three months ended March&#160;31, 2023 and 2022 were $0.29 and $0.28, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div>In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first quarter of 2023 and 2022, we did not repurchase any shares under this authority. We had $1.3 billion remaining available under the authorization as of March&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615691568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income, cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans, gains and losses on cash flow hedges and unrealized gains and losses on available-for-sale debt securities.</span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,833)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,284)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,739)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div>Refer to Note 10 for additional information regarding the amortization of pension and OPEB items and Note 13 for additional information regarding hedging activity<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403616822640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES</a></td>
<td class="text">REVENUES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had $9.9 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 25% of this amount as revenue over the remainder of 2023, 35% in 2024, 20% in 2025, 10% in 2026 and 10% thereafter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in  accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2023 and 2022 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3&#160;billion and $2.4 billion as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5Nw_058c585b-8103-4c06-82dd-1458b96650eb">one</span> to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA4NQ_0ec20cf7-5fe4-4e5f-af12-88aff4a5d833">one</span> to seven years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March&#160;31, 2023 and 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, $68 million and $50 million of revenue was recognized that was included in contract liabilities as of December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Global Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease medical equipment, such as smart beds, renal dialysis equipment and infusion pumps, to customers, often in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.137%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $82 million as of March&#160;31, 2023, of which $24 million originated in 2019 and prior, $21 million in 2020, $20&#160;million in 2021, $14 million in 2022, and $3&#160;million in 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615731360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">BUSINESS OPTIMIZATION CHARGES</a></td>
<td class="text">BUSINESS OPTIMIZATION CHARGES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2023, we have incurred cumulative pre-tax costs of $1.6 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $24 million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three months ended March&#160;31, 2023 and 2022, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, $78&#160;million of the restructuring charges reflected in the table above, consisting of employee termination costs, were related to the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, $56&#160;million of the restructuring charges reflected in the table above were related to integration activities for the Hillrom acquisition, consisting of $38&#160;million of employee termination costs, $12&#160;million of contract termination and other costs and $6&#160;million of asset impairments.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of March&#160;31, 2023 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615751968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</a></td>
<td class="text">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615702656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 35.7% and 22.3% for the three months ended March 31, 2023 and 2022, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances, increases or decreases in liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to tax shortfalls on stock compensation awards and an increase in our liabilities for uncertain tax positions, partially offset by a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none were individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615604704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes 17 million and 4 million shares issuable under equity awards for the three months ended March&#160;31, 2023 and 2022, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615675200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $386 million and $398 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at March&#160;31, 2023 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;600 million of senior notes due May 2025. In May 2019, we issued &#8364;750 million of senior notes due May 2024 and &#8364;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2023, we had an accumulated pre-tax unrealized translation gain in AOCI of $47 million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no cash flow hedge dedesignations in the first three months of 2023 or 2022 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first three months of 2023 or 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gain or loss recognized in AOCI is not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first three months of 2023 or 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $632&#160;million as of March&#160;31, 2023 and $753 million as of December&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, $3 million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2023.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615698928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, cash and cash equivalents of $1.7 billion, respectively, included money market and other short-term funds of approximately $369 million and $341 million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,232&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,657&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of equity investments without readily determinable fair values that we measure at cost, less impairment were $103 million as of March&#160;31, 2023 and $104 million as of December&#160;31, 2022. When applicable, we also adjust the measurement of such equity investments for observable prices in orderly transactions for an identical </span></div>or similar investment of the same issuer. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615675200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a global segment for our Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are implementing a new operating model intended to simplify and streamline our operations and we expect that our reportable segments will be changed to align with that new operating model when it is fully implemented, which is currently expected in the second half of 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403616606768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we, our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Supply Constraints and Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the challenges caused by global economic conditions, among other factors, may continue to have an adverse effect on our business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks and Uncertainties Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403617375808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Interest Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Other (Income) Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Income, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615622240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,991&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock', window );">Other Intangible Assets, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">In process Research and Development</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615928944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Changes in AOCI by Component</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,833)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,284)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,739)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains (losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Summary of Reclassification from AOCI to Net Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610414944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Contract Asset</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March&#160;31, 2023 and 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, $68 million and $50 million of revenue was recognized that was included in contract liabilities as of December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Net Sales from Contracts with Customers by Global Business Unit</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Global Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock', window );">Sales-type Lease, Lease Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403616687136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_BusinessOptimizationChargeTableTextBlock', window );">Summary of Business Optimization Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Components of Restructuring Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Activity in Reserves Related to Restructuring Initiatives</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessOptimizationChargeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business optimization charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessOptimizationChargeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610831536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615702656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Basic Shares to Diluted Shares</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613495200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Gains and Losses on Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2023 and 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Classification and Fair Values of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2023.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock', window );">Derivative Positions Presented On Net Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of derivative positions presented on net basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615882064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Book Values and Fair Values of Financial Instruments</a></td>
<td class="text">For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2023 and December&#160;31, 2022.<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,232&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,657&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612324720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Information for Our Segments</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Operating Income to Income Before Income Taxes Reconciliation</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403607070240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Charged to costs and expenses</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments', window );">Currency translation adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610854320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 812<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,922<span></span>
</td>
<td class="nump">$ 2,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612266512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 11,622<span></span>
</td>
<td class="nump">$ 11,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(6,622)<span></span>
</td>
<td class="num">(6,442)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615023936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income Expense Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of capitalized interest</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403607069872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange (gains) losses, net</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Pension and other postretirement benefit plans</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Change in fair value of marketable equity securities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613004080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset obtained in exchange for operating lease liability</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures incurred but not yet paid</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610733968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 6,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">6,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">APAC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 3,991<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612234336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613356144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">$ 9,415<span></span>
</td>
<td class="nump">$ 9,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2,775)<span></span>
</td>
<td class="num">(2,593)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,640<span></span>
</td>
<td class="nump">6,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">1,571<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">3,454<span></span>
</td>
<td class="nump">3,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(529)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">2,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember', window );">Developed technology, including patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">3,862<span></span>
</td>
<td class="nump">3,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="num">(1,888)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">1,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other amortized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets, finite-lived</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(246)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net, finite-lived</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IntangibleAssetExcludingGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Asset Excluding Goodwill [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IntangibleAssetExcludingGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610203200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 404,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaperAverageOutstanding', window );">Commercial paper, average outstanding</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OriginalWeightedAverageTerm', window );">Original weighted-average term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">32 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit, current borrowing capacity</a></td>
<td class="nump">2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember', window );">Domestic Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit, current borrowing capacity</a></td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">5.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">5.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OriginalWeightedAverageTerm', window );">Original weighted-average term</a></td>
<td class="text">28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OriginalWeightedAverageTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original Weighted-Average Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OriginalWeightedAverageTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaperAverageOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average amount outstanding of commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaperAverageOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613460112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>site</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>lawsuit</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserve</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LossContingencyNumberOfLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember', window );">Superfund Sites | Environmental Clean-up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_SiteContingencyNumberOfSites', window );">Number of sites | site</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Environmental reserves</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LossContingencyNumberOfLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LossContingencyNumberOfLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_SiteContingencyNumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Site contingency, number of sites.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_SiteContingencyNumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13703-110860<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610243104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Jul. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount', window );">Stock repurchase program, additional authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining value available under stock repurchase programs</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock repurchase program additional authorized amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_StockRepurchaseProgramAdditionalAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610510064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="nump">$ 5,895<span></span>
</td>
<td class="nump">$ 9,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">99<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">94<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">5,941<span></span>
</td>
<td class="nump">9,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">CTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(3,386)<span></span>
</td>
<td class="num">(2,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">102<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">102<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(3,284)<span></span>
</td>
<td class="num">(2,922)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(331)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(337)<span></span>
</td>
<td class="num">(338)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedging activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(3,833)<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">$ (3,739)<span></span>
</td>
<td class="num">$ (3,387)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610475232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(2,302)<span></span>
</td>
<td class="num">(2,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Pension and OPEB items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities | Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI | Gains (losses) on hedging activities | Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403611127792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">$ 9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Net trade accounts receivable</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized upon satisfaction of performance obligations</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Sales-type lease, net of investment in lease</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable', window );">Sales-type leases, receivables</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms (in days)</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms (in days)</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenuePerformanceObligationPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenuePerformanceObligationPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueRecognizedContractPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue recognized contract period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueRecognizedContractPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403613404688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Contract Assets and Contract Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityDeferredRevenue', window );">New revenue deferrals</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityTotalRevenueRecognized', window );">Revenue recognized upon satisfaction of performance obligations</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityCurrencyTranslation', window );">Currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember', window );">Accrued Expenses And Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember', window );">Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember', window );">Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember', window );">Bundled equipment and consumable medical products contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with Customer, Asset, after Allowance for Credit Loss</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityTotalRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability, Total Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityTotalRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403611992256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,649<span></span>
</td>
<td class="nump">$ 3,707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,734<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">892<span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">687<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient Support Systems | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front Line Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_RenalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_RenalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_MedicationDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_ClinicalNutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AcuteTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_FrontLineCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610264944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Lease Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Sales-type lease revenue</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseIncome', window );">Variable lease revenue</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseIncome', window );">Total lease revenue</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610215536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cumulative pre-tax costs incurred</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected additional pre-tax costs</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | New Operating Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom | Integration Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom | Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom | Contract termination and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom | Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bax_NewOperatingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bax_NewOperatingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_IntegrationActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_IntegrationActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403616637200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember', window );">Business Optimization Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Costs to implement business optimization programs</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Total business optimization charges</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610534752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610195056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember', window );">Severance and Other Employee Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, beginning balance</a></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Reserve adjustments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, ending balance</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403617353968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">OPEB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost (income)</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403698445552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">35.70%<span></span>
</td>
<td class="nump">22.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403617249088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Reconciliation of Basic Shares to Diluted Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612275744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403609563728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DerivativeFairValueTerminated', window );">Derivative, fair value, terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_DerivativeNetInvestmentTerminated', window );">Derivative, net investment terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Deferred, net after-tax gains on derivative instruments</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">632,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 753,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Accumulated pre-tax unrealized translation gain in AOCI</a></td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member', window );">1.30% Senior Notes Due May 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member', window );">0.4% Senior Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member', window );">1.3% Senior Notes Due May 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 386,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum length of time hedge in cash flow hedge</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeFairValueTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Fair Value, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeFairValueTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeNetInvestmentTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Net Investment Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeNetInvestmentTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A130SeniorNotesDueMay2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A04SeniorNotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_A13SeniorNotesDueMay2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610913792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</a></td>
<td class="num">$ (48)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax', window );">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="num">(48)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts | Cash Flow Hedging | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) recognized in income, undesignated derivative instruments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Cash Flow Hedging | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403615055024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610480000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection', window );">Derivative asset, fair value, total</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement', window );">Derivative liability, fair value, total</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of master netting arrangement, of derivative liability, security sold under agreement to repurchase, and security loaned. Includes financial instrument subject to master netting arrangement not elected or qualified to offset. Excludes liability not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403698516656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details) - Long-term debt - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Carrying amount of hedged item</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610118320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted prices in active markets for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610722592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,673<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
<td class="nump">$ 2,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue', window );">Other equity investments without readily determinable fair values</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds, at carrying value</a></td>
<td class="nump">$ 369<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value disclosure Line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 820<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35710923&amp;loc=d3e45360-110995<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403612284640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Contingent payments related to acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Contingent payments related to acquisitions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning of period</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in earnings</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Change in fair value recognized in AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at end of period</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Available-for-sale debt securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at beginning of period</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Change in fair value recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Change in fair value recognized in AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at end of period</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bax_AvailableForSaleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403610517168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Book values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">1,103<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">15,278<span></span>
</td>
<td class="nump">15,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">$ 14,011<span></span>
</td>
<td class="nump">$ 13,657<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value and carrying value by balance sheet grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations, current, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403609570752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">$ 3,649<span></span>
</td>
<td class="nump">$ 3,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">3,649<span></span>
</td>
<td class="nump">3,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">852<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140403607109424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">852<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="num">$ (666)<span></span>
</td>
<td class="num">$ (917)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>bax-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bax-20230331.xsd" xlink:type="simple"/>
    <context id="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1722827f9deb4a7c96da1d99bfa95a6a_I20230420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2023-04-20</instant>
        </period>
    </context>
    <context id="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0940ea73b3b94072b07c67b32d418ff6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01ba7452daab4c4b92575193d9e5f92b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c666c1fd3384543a02c18e41beb10c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia504d0c0578e43abb57742fcbac04df9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fbb9d28165848e7b735c76a24f97442_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i569f70b56e6e4546a2b0440c1c1b4dd6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i78a604e834034d2e80798d244359c92e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i086a01f241704bcaba8f2f58797f4896_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i903a903783024d0c822c638260089e91_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c67e5be4a9c454b9d1c77df627b3423_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c4edd866db741baa51307eb018f3d9f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i68252ad5814845d2b86cdb16badea3ea_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibe84036cbe4d4876bfc384531e6ff350_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bd566d2dac84388a0dc10cf986cbde7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iefe188762f1241fa87f6153d43d125bf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40418177dcd1484c97237105cd4eacb8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i594c4d36a82e4345a1148e4403700728_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1adea57705bd4eb780aaa0eaaec735f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48f43fae8a584013afd3637231c43053_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie465403042354662a73d63fe8476ff82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7990853ab5584403a5cbfd42f7d394b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff3416cbddea4d21a603a12d26373af8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63fca21e0f0c47a6803f298e2ba68799_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1cfa36d74d3d45f69917cc8c0e03163d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i549981689c2d46afb3aab51cfc3c1fa2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52c1210990e74a9b95fe24b71553ad83_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d202d13044e48c6b29936c91e8c157b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ecdb3fe5d0e4b8e827b13f44d1963b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3a4799c9ebd14c07b2231243699099b4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i745ad501a79c44d6aec90e097e8047c9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if0e5d98eeff04b8996adc2d0bb0ff481_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8aefd6cba0d4106847bb6b58cb837e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8ac1583fbba246859aa51f7df3cee508_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i74b8716ad88248e28c4c5356153e3a7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25d5af7f312e4865be66979f792580ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31b93924f957421ba38aa7f8e31ae06b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81f07e528dbe484f982e220a41fa1577_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4cf6a305b9149389378aa6125813d6e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5fa64dff379543ff9a0e870c10d36e3b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibdd748bfd4df44c5b9b7a1d75b53c8cd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9122ce6ade864b9f939af3570b2a12d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ba1d1d1ab4a4b58bbc7c4edd43217e8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd5b28bd50b747f58909a56b3ce1d3cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ief1ede9bd1eb4a41881ac35ef3560275_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica9f83b89e384e909e618e9f0fc79b8c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18c60cecc4dd4674a79048e6dec4f65c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic8750ae5d3034349b54eb62120194f7c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5ea658ef4e8a4402a8e9549a454537cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9691d0cc94e2490085471645d739eab9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id92dec25d7c34b37b1430e2c4a7835d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib369cfb36a82482b8db8a6063f7d16d8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ebf6db10af94658bfb39f075c42d0ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie473cdb19c1847169b73a323e42bd39a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8a56dbdd4ff14331a905150029de9251_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50e14096fdd04423a5333d25f12d89a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb2809f872c14e8ebe75278e58f5b315_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5251aea994574c9583ba547d9a6bac1f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie998dbec09874c54aeb8ff608dc85931_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8a129980c2e0429f900251c40212bfea_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83ac75103174457caa01d60ace762a52_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia6f5b61f71de4b578b8f219e50d9e242_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia18ed76e0fa040a8aac24e70b8c0d1b2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icb1e1e86edba409592faffa2c09656e7_I20120731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2012-07-31</instant>
        </period>
    </context>
    <context id="i54acfe1b3c9e4d72a0d864d5c38acb28_I20161130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2016-11-30</instant>
        </period>
    </context>
    <context id="i4dcdbf9afbfe48f697caa407b52ea2a9_I20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="i82b54d14b4714bb8909d97f501750950_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i3cda740eb170402f8aecbd918a7cb4dc_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id7a3e16bcba5455287abc55ac7a72c7b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f4bdbd9802f43e4b40fdb623ef4c6b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38a1fa71e8d34f8f8b550e41ec2f74b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia34a05a406da4126b9897e999764cf3b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iddc00ddfcf9a4d538640cf78c5d1745c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i614575b7558142db88b525cd20152c5e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if1731323823d48a9ad85ad284c1026de_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9e585fdb356847ee95bef768d6c8f6fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iabbe53c3b4844245a71aa4170a3d6951_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7fe94c791c144fb3901d9ccada083e46_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i891fc74d6b294098b52b2dbacb9d8244_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4974271eca4848daac4ef6f3c0268466_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ba818d615df44fa9ab8dc663c356b0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc59f5aaa04945a290aa672855b1c1ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i573b5203abe64eee9fc6bd8d764b6765_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i154a7b3c49ee48b38613d9dec8d98845_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icc57a64dfa914805848eec366284d706_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5b3a5ddf7f0b4ea8ad0c518d49a70509_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i86fbdd6384f94375a9f88c4a431213fb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1b60f9d6630f49ffa53859e738234d11_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibab71210a8c94981891c3847d80b517f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if5d70874f80c482cb0e5b8513c4530c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id2eb0cff5ab142898e3663ceebe5e867_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic023f2fc593e4fd29470ad3b703a07c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i16554c4f2d744cd9a29f4b0265752f73_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91aae7c820be40a39dc2a16e37f937df_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide752f889a824123acdfc488ef4c92da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48c4b44d7aaf45f6a6e5c398103bc5cb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21b2d8e97e8244178d692d6892f4a85a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5610c9c40f1541588c111ed258e20b5b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb101e2dce6d4a8da899e7f908565f3f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i91e5bce880e748fa8fd4e3630bd445ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61cf97becb9c4e1a9b859df1e52905f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib69465f840b74ac28588c55cf8bf2541_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if002ac6e967144bd96115173fc7cf29a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5b4886e6fb2e496c92895c5e21b2ca46_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib95b5cb2f8e647f6a99def589a703561_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i94cea0cc9a13461d932c6e9ca4283393_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i934c0cc8c80045549e4782969e1e7b84_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia6b196d8914241ada05ff36938bc292e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3e73cac1b5c4796a4109810e816823d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iabeea204152c4e01befa7939da13274f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieab095ac3325476aa40d27526c3ce9d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idfc44eeeb3fe4cf8a2fa2850b25dbd4f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i830f0bf194924d0e87c143bb795d1c61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ec046897a2946cd93ab85a15ee56c94_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie1bd13a49b7d429e82c8bdf69b96e60b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30142c94438942e98469e05b1af863d8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3508ca5e5c14a48b24d540f5319e20b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51119038860e46bab77a4b1e87a97094_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i23951dd4106e4790ac61468e0c4ec8df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i341560a16fc74ca08d74ea499cbe59d7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib97450461ad646f683e7377c9387239a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieed79c5aca8f438cb35994e6accb8277_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i32733260a4bf466da30a8f6e7a69dc20_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb9352b2578b4ff8af90d6737f465636_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie7dff2da3bb745e083dfc8efbc4a6a2d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ffe0a066678436faeb952bbc5692853_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50262bb8dfd6483883e178e4d08c0ce7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12de3de1a9974944bc8378eba2c65c03_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i79bf91abd1634761a2195c7f9d8d118a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia7a0d7a1030b4a098fc24e15ad2a801d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i820a760c47924ab98c99c4b2a9096d78_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idc6075f06dbd490298097b3ed5cd4821_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idf1bbc48b59745a293d43e19e9033459_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idac2f4acb21d4eda95086e8322451c06_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id093cc65fe2e41f685c58769f4731abe_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b1f8777b66c4f1abea702af4a4f50d8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ae97fbb983b4c339641d89166090167_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d21ce85e8b546008235897f9720292f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5a674bd62d60412dae3e15bda3d6fd5d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18171446335341e6972e6ad0f0855341_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d7450c4c4ea47f395399141fae391aa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i32eccbe2241e419fbbbba27ba8251c58_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f4f3a644eb645e3b6ffb4f9285599fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i326ca958c6174cbd9f53bd4911788519_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ffdd9abc5b147d1b6b3131424e764b8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48702d534ce34e3d895104c00a42f7b9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i77f8be4d668c436690b8ef4eaa3b1289_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i37ecf3e2ffa240ab97ef06571c436317_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae75aad13a8b4f4a9d28f6c2a411306e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i36331106af6b44069480b11afb1c4eb7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id70635d3e9e24de284e21b0565f0a12c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a994bb1351d426e972cb4ab45bf9e31_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if15645b93aa34aadb9ab25d167667aa4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e5c3586df22467d826986ca298658b2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifddaa3fea1ec401fb23364d3c78814ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i70a9ffd20fe44b3494b57e15f7d91ccb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie7a56542c97d47a0b0f0459e24442e08_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4237b6bc47b47e3be8d39761a9c6aa6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2481cb453dff4f67b82d44e30bd6d0fb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7cff1006b2cd4700a226e1343371d967_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f9f21fee0414681bd88793126bd2d5d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib0865a1d47314456a3bf5d603919e3aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i65045dd2524b4052a661a980309aee0e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i65a6dd9348044feb8a8e67e815565350_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i58acde9af12d40e88ea03e411ef7469a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8bcd8e837bc4dc08f1912d660ad261c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae2ec3cee867481bae76001f58c40302_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic8332d3c37964860a2fa8f6c0f6e8183_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b5d26e5e396479bb46016c7624c2225_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1c506923a318493ea4d9c20cbab2421a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7f1768ac76934e2091b109112b486b74_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id0ac9d56de7f4427a9059c8e448f30f0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie54c320fa8384fc9acd727cd9b93cb52_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88faf063570c4244819342e4932cf151_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic892496e521b4b4180628d9710fcfde4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i639893b243a5412089b13acbee4be7d8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0e5f7268c6da45c28b4cc8a8092641d4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8c3ca618644448a69e18c4788006dcfb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c4c6783bfa6492680542b292f98ef46_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d7bcb4770d143ccb5cf3653c8dbd7ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i04066796b2e844dd9677b2763ae8e6ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie43580480246408d913ffd6f7571c3c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i700fd4a0950a4c45b9412d578fea8869_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i406d564a78fd4100975bf9f358114ad6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4ed76db4cef84a44b19a64f1d1833488_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50189ca1ce5346128884acb2fd951604_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i556f482c728a4e6abc7fcb69f24c8e79_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34e11ed2205046a495eb41670b8242bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d5191430d4c4fa5b3ea2beb1699b836_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i61f02dbb147d48a7be36808b0e938d20_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i42fee9757d10432cb8ae120e6b418ddd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd5a84bea14647598fb6658816f37588_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd5848326be84436ade2b47357ffcccf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i38f1c5a1ba7442d1a6b301c41e26e0bd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92e9e48c329d4d63aa8ed4f54c4d2d61_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8d7f02b816254b8aa330323c3a69a6f8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50a9fd6731664971b019d860f06b8d7a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaf58d18ba69645c388a1b80e92a29a6a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i857194e9005945168ca557c8b9cd6cf6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i080f246a03434c36b738f2ab73889cb7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i723a8f8cd90d40c5b923bb953965b6f0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45cdbf59bba942c799174d71fc78424f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7480c0baf3ef4031958b631683211304_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8ace030c17a84199b8a58d5de02660b0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibcb0c4c8a0364ddab4ced3d467f03536_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie9afb4c625184a3f99e2cb5a2e3d5eaf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3c8d9d2e13254a4a851b924c07c94850_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibcdaac085a184fd991190127986b186a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icd11f2b19d644626913c68555b6a3ed3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba969a96aa1a4d5c9b9694620c56457c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd088a28be84475899676efd77df7fb1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0844e0faf2924757a27a663c5f70585f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iafe3d35593ef467a942d74f57b0d973f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iee715c6013774f86871bc93f1f3c5581_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ded499efde348f38db33fa32a02f9c7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf53b679288243c4b2c60ffa46acdbc7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1ebac333e6b4b7e824140ded41ed412_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i360dc4f66e284c169a8571d8f06cfb23_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i27eafd0032b54ff9b789fb388acb51f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i301ed7692b8f4861bf3943d034b41d27_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8dbd6d4f17c1483890abb77740b35017_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d39b8e7b0d742918fa14009236396be_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf871b9974004097959095e896164ea5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ef6dc9c2a204c7eb7bd1ef80318af8e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:NewOperatingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icbd8645e550c4ed8952d05182e882159_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:IntegrationActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5c12720ec2d4657b11334d2f5c03900_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab2e3d03af0e4a9d8b80b6d36fc10ad6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie7cece8bf1314a0bb7e3af8e0b6c6632_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ff73073d6be424295feaeb2acc57d80_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if47e22ae3131468e92ac7e7b3405265d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9538dd5f2a2244a9adcb80fb4dd92160_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id4f02046af9547bf90a5a5fecea5c89e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4c66e4f9c56742b18ccfe453072a0567_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8f7c52bc902e4958a1aa1af5261b13dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98bfbbe989f94db8a2f6860f5daea064_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd110d5b3b474fb9a4243053206a4b98_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8bc91ff6eb4746318f5c648bd8d956ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0ae9704eed9e408f85ac8af9ab07b959_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A130SeniorNotesDueMay2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i747bc7554666414992b2b24bb2e4b2b9_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A04SeniorNotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="ic5cedfb9fb234c4fa8f05974b6a48de8_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:A13SeniorNotesDueMay2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="id9faaf9a5d1d4dc39fc43d27a01f474a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8be3a0f43b6f4f4697b04212b8b81e2d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i496040ce8ccb46e6bb87e3ad9f95ec52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cc935ff843a4dc29ec8c895720e3066_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id7a795c4b1fb4e3084ef17809809118d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib752bbb3f58f4422b1f965bc7c89f074_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iea2285dfc1a7402a99c067a6e802ca97_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i189d98535fb942c99329457fb43522d1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c25693c2f1b4a5f9dfc483f5ca0a8b2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifab0be122c59428e9024680a862f2c0d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibaad8a6fd0bd4705ab16d4fb5b21406c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66a9ab3f00c6441596fadb7fc37919f1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8118589f429a4a0ca38950943ac2978a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91cf39a12b99429d8289596966b89fe2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i17ecdd9ca5f54679995d5d378c4d06ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i46477fce4d7049aab502d6b4eb1ab53b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c1f79300409417e829d19d1e521ffde_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i671ceedc0954414bbc1ef559a31dc3b0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8311fb17141a43e08936804f2663ce41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifc0855e415a24ea2bbed65f9964a98ca_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifa6620927c944ffab75861c764f15bbf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9582e8bab32a4622a5341a018568c9a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56e1d124500c4886b5441bdd89954116_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d40aa82836d4e5d80dbeabff53e5546_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6b248d3ee7c433a940949503db3e3fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d5a655bb88c41bfb5152c5fc3f19595_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i607c52fdcfa04c428b2116b4f6436aa0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifad00739353c4b57be82940bf374498e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf5014e9c356493ea281263e29225f8c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id86b1f179ffa42a495a950dfaa16e4ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8107d66cdfef47cc96732db00726b56e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i60f96dbbad654789adba4c76777fb89d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a401be8e879440883b9309dd7cd46eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05af2841efd44956a910f7e3b2175557_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37ecc9bb48ea468fbe53ecaa9574ab83_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ff491835ffe4fdf8c4b26233dcb9a9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1672a644c104e0cba0f5a365004ec05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37ead0a6833745b5a2c9a8c87f3eb359_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c61a0314afd43cd8e3a9aaaf26630eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icda293782fa046d38a077f41e8d52047_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f90874bfa6d48fba1bed7ac9573fcf6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f96fffbf70b48c3af05ddc881ed1a92_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5885ecc04c124fd88f7d20f0411c5299_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i39589615eba84af88bd227d8332e4d0b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bax:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3bc8aeefbd654849815b65f8dedd082d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibe45285509d54b74948837ef32da5fb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4465ac79533347819eb60404998c9a41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9fb955fb2b1749fa979c87c9f7a93003_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id39e31f62b29442da1752786dc58134e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8411fdd837b543e6b9186cdf5182839f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bd21c5a704642b7add19a18376900db_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if10723145fec4c039ea5033c9599406a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2931aa2efeee464695085541f236afb5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i353419505f7f47a39847c9b26776c895_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22bd1d9d744b4e77b5508602e287cf98_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="site">
        <measure>bax:site</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bax:lawsuit</measure>
    </unit>
    <unit id="segment">
        <measure>bax:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N18yLTEtMS0xLTE0MjYyNA_009b9f5a-ac36-4d10-9fc6-de70f609ba50">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N18zLTEtMS0xLTE0MjYyNA_c0d4a575-3148-4421-823c-4d807580da54">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N180LTEtMS0xLTE0MjYyNA_6f43ed4a-9293-43cb-850f-a2bd91c3ff00">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N181LTEtMS0xLTE0MjYyNA_92c3dd4b-0638-4f7e-8837-c2784f175d23">0000010456</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80L2ZyYWc6MWExYzUwMzhkM2JmNGEwYmE2Mjk3NTgyOTlmYjE2MzAvdGFibGU6NTZiZWJiNThhOTgxNGIyNmI5MWExNDBjN2QwYzllNTcvdGFibGVyYW5nZTo1NmJlYmI1OGE5ODE0YjI2YjkxYTE0MGM3ZDBjOWU1N182LTEtMS0xLTE0MjYyNA_d55f7047-d836-4772-84a2-480a3313b45f">--12-31</dei:CurrentFiscalYearEndDate>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i5b4886e6fb2e496c92895c5e21b2ca46_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5Nw_058c585b-8103-4c06-82dd-1458b96650eb">P1Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i94cea0cc9a13461d932c6e9ca4283393_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA4NQ_0ec20cf7-5fe4-4e5f-af12-88aff4a5d833">P1Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i5610c9c40f1541588c111ed258e20b5b_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfNC0xLTEtMS0xNDI2MjQ_d6d893fc-8438-4923-a849-d968822074f7">P3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ifb101e2dce6d4a8da899e7f908565f3f_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfOC0xLTEtMS0xNDI2MjQ_be44d27a-b5dc-44a9-a881-152d9306c990">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i91e5bce880e748fa8fd4e3630bd445ad_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMTItMS0xLTEtMTQyNjI0_54ac5a69-e474-4299-8398-6e75810761e9">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i61cf97becb9c4e1a9b859df1e52905f9_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMTYtMS0xLTEtMTQyNjI0_5caf3791-870c-486c-a5b1-c3adba882b54">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib69465f840b74ac28588c55cf8bf2541_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82NC9mcmFnOmJlZDJhY2Y0YmE5YjQ0YzJhNDI2MmYzMDljOTNlNjNlL3RhYmxlOjAxNGFiNzkyOWQ0NzQ4ZDhiODdjNGI5NzdhNzYwNjk3L3RhYmxlcmFuZ2U6MDE0YWI3OTI5ZDQ3NDhkOGI4N2M0Yjk3N2E3NjA2OTdfMjAtMS0xLTEtMTQyNjI0_0da06f34-6c7f-47e2-988d-ed38182147ae"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xNjY_7808a1fe-8345-42ea-b9a6-f563e763f6d3">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ODZhMmE3MGUyMjRhNDM3MGFlNWUzNjczMGMwMzNiMGYvdGFibGVyYW5nZTo4NmEyYTcwZTIyNGE0MzcwYWU1ZTM2NzMwYzAzM2IwZl8wLTAtMS0xLTE0MjYyNA_b51712fb-2a28-4323-87e2-a5c7169723c1">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yODM_ad699735-5677-492c-bafd-1dbf3457d480">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6OTk2MjJkYjk1ZDE4NDk5MGIyYmQ0OWJiNzJkN2M4MzUvdGFibGVyYW5nZTo5OTYyMmRiOTVkMTg0OTkwYjJiZDQ5YmI3MmQ3YzgzNV8wLTAtMS0xLTE0MjYyNA_62c09e87-40d8-4830-9c1f-c2d55fa414c6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8zNzA_edba1689-9800-4068-8f12-47b953bdc6ad">1-4448</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF80NTU_20551448-9ce1-4f64-ab45-98e7df146924">BAXTER INTERNATIONAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8wLTAtMS0xLTE0MjYyNA_1935d321-0786-4c1c-b773-cec3b8f991ae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8wLTQtMS0xLTE0MjYyNA_65b97f54-4241-446f-8165-dc34171c6d2d">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTAtMS0xLTE0MjYyNA_cf85c8bb-ef46-422d-aa81-14fe1feeda00">One Baxter Parkway,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTEtMS0xLTE0MjYyNA_b5d0033a-9ae4-41b7-8c0e-7008f1d6d735">Deerfield,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTItMS0xLTE0MjYyNA_c9dc8abb-ed46-48c3-a209-a47592d1c3ab">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZTY2ODZhOTRhNWY0NDAyNWFlZjFlMmUyMGUwMWY1NjUvdGFibGVyYW5nZTplNjY4NmE5NGE1ZjQ0MDI1YWVmMWUyZTIwZTAxZjU2NV8zLTQtMS0xLTE0MjYyNA_e8bf704f-8310-4bce-aa3c-aa6b81d6cff8">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZWQyNDYzYTNiNmY2NGViZjhkMDg2MjYxNTYxNTBjODcvdGFibGVyYW5nZTplZDI0NjNhM2I2ZjY0ZWJmOGQwODYyNjE1NjE1MGM4N18wLTItMS0xLTE0MjYyNA_e5e2cced-e5df-4346-b45e-8b955410396d">224.</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZWQyNDYzYTNiNmY2NGViZjhkMDg2MjYxNTYxNTBjODcvdGFibGVyYW5nZTplZDI0NjNhM2I2ZjY0ZWJmOGQwODYyNjE1NjE1MGM4N18wLTMtMS0xLTE0MjYyNA_820d34b2-9fe3-4f3c-95b1-b65622dad758">948.2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTAtMS0xLTE0MjYyNA_a5a3130d-40e3-4483-ba54-8408e7d0a310">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTAtMS0xLTE0MjYyNA_cc8436b6-67cf-453a-b979-d5c44fc79e5c">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTItMS0xLTE0MjYyNA_14e4ce3e-d3ac-4438-a25a-f372e25b3c5f">BAX (NYSE)</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTItMS0xLTE0MjYyNA_8db624b9-0dab-44ff-9f8c-776da28a44b3">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib7557576737e4a55876f3f1f309f6d5d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18xLTQtMS0xLTE0MjYyNA_fb011bd4-9441-4960-a8e9-5e5ab528d7fb">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="ib48efcd26bb048a9b880ede32eb646dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18yLTQtMS0xLTE0MjYyNA_8cbaeba3-df51-47bf-a875-2ef6f6fad407">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTAtMS0xLTE0MjYyNA_4b2d2968-a8c5-4926-a3ed-1ef98ea0caf4">0.4% Global Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTItMS0xLTE0MjYyNA_677b63e5-aae5-47d0-98a2-31ceb8068b04">BAX 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i632d1638e54549c1bc873a01dc44ff5e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y18zLTQtMS0xLTE0MjYyNA_db8ab794-c72a-4b46-b8b5-81b3a26ac959">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTAtMS0xLTE0MjYyNA_3958224b-b3bc-4d5a-9cdb-be3192049b40">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTItMS0xLTE0MjYyNA_54eac8cc-53b9-438a-b523-faf75faf4c53">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7345d36a671a4a0f9c7ff6ce3054b355_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y180LTQtMS0xLTE0MjYyNA_bc859006-9531-48b6-b7e2-ed7ccc5038d1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTAtMS0xLTE0MjYyNA_15f658a1-1b56-47fa-80ba-e7ba5ea8166f">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTItMS0xLTE0MjYyNA_57b0375d-08be-4be7-99d9-8621bda8a16e">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i79f3e5fc0fa444e98610f4f85301774b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6ZDczOTc0M2RlZWE0NGM5ZjhhNzk0MmZiMTU0OTVjNWMvdGFibGVyYW5nZTpkNzM5NzQzZGVlYTQ0YzlmOGE3OTQyZmIxNTQ5NWM1Y181LTQtMS0xLTE0MjYyNA_d806be2a-be3e-4c7c-b2dd-9a2fab316c02">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xMDg2_14ea5591-d84f-4d00-baad-250280aa4df0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8xMzc4_83b1737f-38e5-4f30-a7dc-62615917894b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8wLTAtMS0xLTE0MjYyNA_c990ef1e-c391-4ad9-8bd5-9aa5c1265c0f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8xLTQtMS0xLTE0MjYyNA_7cc18a2d-f549-4f19-bea1-3ea618f04dec">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGFibGU6NTcxNDY4ZGQ2ZGFlNDdiM2JhZDc5NzE4MjBhNjUyZWQvdGFibGVyYW5nZTo1NzE0NjhkZDZkYWU0N2IzYmFkNzk3MTgyMGE2NTJlZF8yLTEtMS0xLTE0MjYyNA_4e4cf0e8-63d9-4182-8025-c56d3b2f8a05">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yMjM3_ea8086ba-b5a1-42f6-b790-f96f95893bf3">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1722827f9deb4a7c96da1d99bfa95a6a_I20230420"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xL2ZyYWc6M2Q2Y2VhMzI1YzkxNDhiMDg3Nzc4OTBiY2Y5ZWJmZjgvdGV4dHJlZ2lvbjozZDZjZWEzMjVjOTE0OGIwODc3Nzg5MGJjZjllYmZmOF8yMjI2_e8685d82-fea4-4524-a44a-91a8e1625b38"
      unitRef="shares">505850082</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMi0xLTEtMS0xNDI2MjQ_c39df3ac-458d-4b97-8258-1afdc85cb014"
      unitRef="usd">1673000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMi0yLTEtMS0xNDI2MjQ_99db5387-e9c9-4433-b894-583f83ce285b"
      unitRef="usd">1718000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo0ZGUxOTFkNWY4OWM0NzMzOGNlNGQzYWM3NWM0NDUwMV80Ng_2bd9a226-d0d5-478e-82e2-e1b748b73497"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo0ZGUxOTFkNWY4OWM0NzMzOGNlNGQzYWM3NWM0NDUwMV81OQ_3904a800-7354-4515-b852-d47b427ebb1c"
      unitRef="usd">114000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0xLTEtMS0xNDI2MjQ_1fac8903-3f69-4888-8abe-b433ed21b823"
      unitRef="usd">2547000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMy0yLTEtMS0xNDI2MjQ_61428fb0-6dbc-4a98-b03d-9b57697699b0"
      unitRef="usd">2659000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNC0xLTEtMS0xNDI2MjQ_4eef2a5d-5aa3-4366-bbba-f9f0c687333c"
      unitRef="usd">2922000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNC0yLTEtMS0xNDI2MjQ_ad06e582-d10d-43ec-82cc-fee64bd5a261"
      unitRef="usd">2718000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNS0xLTEtMS0xNDI2MjQ_7a2df1bf-2ca7-4a3a-b5d9-87c69f55dc0c"
      unitRef="usd">957000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNS0yLTEtMS0xNDI2MjQ_e11b1d1d-7d71-4131-b82c-1eaf4dfa16ab"
      unitRef="usd">916000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNi0xLTEtMS0xNDI2MjQ_781317f5-014d-4e45-a22b-41448c9ca022"
      unitRef="usd">8099000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNi0yLTEtMS0xNDI2MjQ_6de68f34-588c-4cfb-8904-4e83fbf3950b"
      unitRef="usd">8011000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNy0xLTEtMS0xNDI2MjQ_106edac5-9843-4d8e-bba5-396a1fdd3b8f"
      unitRef="usd">5000000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfNy0yLTEtMS0xNDI2MjQ_184c26d6-844e-415f-923e-5a044df40610"
      unitRef="usd">4979000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOC0xLTEtMS0xNDI2MjQ_13da78e6-3d4b-46e3-ba9d-e7bfe98d6dc4"
      unitRef="usd">6868000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOC0yLTEtMS0xNDI2MjQ_412786d4-6cad-4e77-b6aa-b543f3534270"
      unitRef="usd">6843000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOS0xLTEtMS0xNDI2MjQ_f1d832f5-7c11-4d94-8e69-b74e2a861a15"
      unitRef="usd">6640000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfOS0yLTEtMS0xNDI2MjQ_a2f53b6d-4fa0-4ffe-93b1-adcf6cb96f87"
      unitRef="usd">6793000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTAtMS0xLTEtMTQyNjI0_6400ef8f-f59f-4801-bcd9-be5c661f88a0"
      unitRef="usd">554000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTAtMi0xLTEtMTQyNjI0_a62478a3-4305-408a-8c14-7205238d3f8e"
      unitRef="usd">550000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTEtMS0xLTEtMTQyNjI0_d3bf10ed-652f-4fb3-b363-9ca25a9afd56"
      unitRef="usd">1130000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTEtMi0xLTEtMTQyNjI0_7e8033bb-c823-4b13-bfc5-2b88e9c3b3db"
      unitRef="usd">1111000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTItMS0xLTEtMTQyNjI0_c4d55631-1ddc-4a0a-a3e4-014c2b3f7450"
      unitRef="usd">28291000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTItMi0xLTEtMTQyNjI0_8b5eade0-5189-448b-b7c8-c9f63241be2a"
      unitRef="usd">28287000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTQtMS0xLTEtMTQyNjI0_a73b27bb-577f-48ab-99f6-664aa4be75a0"
      unitRef="usd">50000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTQtMi0xLTEtMTQyNjI0_6cb4ab8a-5f14-4f35-a5e3-62ad55371901"
      unitRef="usd">299000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTUtMS0xLTEtMTQyNjI0_a2d90a6e-7e2f-4719-a793-5b384b548b1b"
      unitRef="usd">1103000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTUtMi0xLTEtMTQyNjI0_313284d0-00ae-4ba4-b13c-82c911b9528c"
      unitRef="usd">1105000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTYtMS0xLTEtMTQyNjI0_63dbe87f-92af-4578-9255-d0fed2ad01f2"
      unitRef="usd">1290000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTYtMi0xLTEtMTQyNjI0_736260fc-87df-4488-b5fc-9bfe07353c88"
      unitRef="usd">1139000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTctMS0xLTEtMTQyNjI0_dfa93b6f-1fe1-440c-b895-221187e219e6"
      unitRef="usd">2317000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTctMi0xLTEtMTQyNjI0_c91c33b5-dd7e-4c29-a352-4141e4ff9e84"
      unitRef="usd">2202000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTgtMS0xLTEtMTQyNjI0_43d09323-b64f-43a2-9dd3-1a977a4be31f"
      unitRef="usd">4760000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTgtMi0xLTEtMTQyNjI0_551a67b5-e089-43e8-aec7-01d0be9010b6"
      unitRef="usd">4745000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTktMS0xLTEtMTQyNjI0_4a5f2742-303b-4d49-82c5-10e0c06a9874"
      unitRef="usd">15278000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMTktMi0xLTEtMTQyNjI0_cfa80c3e-f9a8-4181-9293-2213a1cc60f0"
      unitRef="usd">15232000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjAtMS0xLTEtMTQyNjI0_b1fbe88f-05f3-4f9e-acb9-832902bbfe0b"
      unitRef="usd">458000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjAtMi0xLTEtMTQyNjI0_056b5697-98e3-4ec3-9637-8eaeaa3d35ba"
      unitRef="usd">456000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjEtMS0xLTEtMTQyNjI0_20a4af9b-b560-46f2-b659-f0b71dc13b64"
      unitRef="usd">1854000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjEtMi0xLTEtMTQyNjI0_1b38d624-c74e-4f49-ac29-2f857d8c78d5"
      unitRef="usd">1959000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjItMS0xLTEtMTQyNjI0_fa3e04e1-b450-4b66-97d3-d7047904d316"
      unitRef="usd">22350000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjItMi0xLTEtMTQyNjI0_ed06ac6c-a8e0-4e3f-bfa1-42fbd4afbe52"
      unitRef="usd">22392000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjMtMS0xLTEtMTQyNjI0_6f1e8413-c540-4583-a79d-f0c1180ac91d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjMtMi0xLTEtMTQyNjI0_391bba79-9d14-47b9-b4f8-131ec443e309"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfMTg_2ba36db3-93a2-4d8f-ba60-3114a5c5cdb1"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfMTg_ce6ca01e-d692-46c5-99a3-44fef6fb5be0"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNDM_adf244bd-0b2d-46dc-a29e-10c5db8aaf05"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNDM_dee51893-d735-44ff-8227-ab27df466f19"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNjE_07d3cea7-2886-4db9-ad81-9e140b775cc1"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246NWY4YjEyNDc2YmM2NDQ4Njg3NzI1YTJjNGJlMzFhOThfNjE_879f1668-65e5-4288-82a0-1fd92352bdbd"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMS0xLTEtMTQyNjI0_3c97f181-62be-414b-bf37-fd2438f7a38a"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjUtMi0xLTEtMTQyNjI0_67cf9ac5-465c-4747-9c3f-a063efde7681"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246OGRhZDU2ZTZmNjMxNDJjZTk1NzAwMzYxMDVhMDJlYWNfMzg_49bf6c43-c769-4bcb-9fdc-0146dcbd5de6"
      unitRef="shares">177658649</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMC0xLTEtMTQyNjI0L3RleHRyZWdpb246OGRhZDU2ZTZmNjMxNDJjZTk1NzAwMzYxMDVhMDJlYWNfNTg_e7eceab7-9130-4f13-8ea1-aa3922933885"
      unitRef="shares">179062594</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMS0xLTEtMTQyNjI0_4a10bff6-dd2e-4019-ae29-62db308a2a33"
      unitRef="usd">11324000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjYtMi0xLTEtMTQyNjI0_ef83ea97-e877-476a-bdf8-8088666ec209"
      unitRef="usd">11389000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjctMS0xLTEtMTQyNjI0_963f3772-d65b-4996-97f0-45be33e880c2"
      unitRef="usd">6312000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjctMi0xLTEtMTQyNjI0_b7d18290-db5c-4686-ab41-6913c3c15e1f"
      unitRef="usd">6322000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjgtMS0xLTEtMTQyNjI0_78d61afb-c733-48ae-ae1e-4a2e9733d731"
      unitRef="usd">13947000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjgtMi0xLTEtMTQyNjI0_dc1a0763-ef7e-48e1-a201-85a92e03735a"
      unitRef="usd">14050000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjktMS0xLTEtMTQyNjI0_8306bdec-57c6-4e37-8d87-dbdf932784cc"
      unitRef="usd">-3739000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMjktMi0xLTEtMTQyNjI0_1cd863b6-6d80-4e57-be81-774ae83abbb4"
      unitRef="usd">-3833000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzAtMS0xLTEtMTQyNjI0_e18ea181-2805-4ac2-a5ea-5d58335d9580"
      unitRef="usd">5879000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzAtMi0xLTEtMTQyNjI0_7a1c0b24-0caa-410f-81b4-2e0a887bfbc1"
      unitRef="usd">5833000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzEtMS0xLTEtMTQyNjI0_9b3a4655-e8d4-48b1-88c0-314fb279160c"
      unitRef="usd">62000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzEtMi0xLTEtMTQyNjI0_ae074f9d-f742-4bea-b827-c5fe068e101e"
      unitRef="usd">62000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzItMS0xLTEtMTQyNjI0_6a6c14a5-9908-47c8-889c-b5bc8dbecf93"
      unitRef="usd">5941000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzItMi0xLTEtMTQyNjI0_fec218f6-6af0-4132-a45f-2fb1793dcc89"
      unitRef="usd">5895000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzMtMS0xLTEtMTQyNjI0_a218c0c9-51e1-4fd1-9f7d-d2961e2022bd"
      unitRef="usd">28291000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xNi9mcmFnOjc5YjY4MTVhZGYzNTQwNGE5YWM4OTAyOGZmZDU1ZTk2L3RhYmxlOjVkNDVjMmRkYzczYzRkMDZiNTY4YmIzODdmZDAzZGI5L3RhYmxlcmFuZ2U6NWQ0NWMyZGRjNzNjNGQwNmI1NjhiYjM4N2ZkMDNkYjlfMzMtMi0xLTEtMTQyNjI0_afa9a29d-cd95-4738-8735-e0b09cf47616"
      unitRef="usd">28287000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMi0xLTEtMS0xNDI2MjQ_0e8704b8-b063-4aba-8248-8eca3bac3208"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMi0yLTEtMS0xNDI2MjQ_714d95c2-60f4-460d-aa6c-e1d6ec0de86e"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMy0xLTEtMS0xNDI2MjQ_735e4a92-9a5d-47cc-899f-fc1a7b93a7e5"
      unitRef="usd">2302000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMy0yLTEtMS0xNDI2MjQ_d6b99cfb-abc4-4852-9bed-d1702fe298b0"
      unitRef="usd">2359000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNC0xLTEtMS0xNDI2MjQ_e15d2b06-6053-4d6f-a5e3-f5925e70afec"
      unitRef="usd">1347000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNC0yLTEtMS0xNDI2MjQ_63405dae-4e68-42b1-85dc-da352116c715"
      unitRef="usd">1348000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNS0xLTEtMS0xNDI2MjQ_9856f3ad-e459-4000-967a-c0bc89a36808"
      unitRef="usd">1010000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNS0yLTEtMS0xNDI2MjQ_4c173892-d7a4-4cf2-aca1-8af0d4841b72"
      unitRef="usd">1052000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNi0xLTEtMS0xNDI2MjQ_83ce9e62-9f06-496f-834f-2a731cbaaa6a"
      unitRef="usd">164000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfNi0yLTEtMS0xNDI2MjQ_389b1ec9-ddc9-4ad9-b93f-919343ba861c"
      unitRef="usd">150000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOC0xLTEtMS0xNDI2MjQ_0f977b6c-cd75-4362-bc3b-14425e7df1e9"
      unitRef="usd">13000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOC0yLTEtMS0xNDI2MjQ_aa7f10f7-ba5c-4f13-8050-d52c19dbc0bf"
      unitRef="usd">17000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOS0xLTEtMS0xNDI2MjQ_547bb0b2-2804-4a80-a043-122327b88482"
      unitRef="usd">186000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfOS0yLTEtMS0xNDI2MjQ_aecba5e4-74cf-41bb-998d-b0d5f3559a1a"
      unitRef="usd">163000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTAtMS0xLTEtMTQyNjI0_d5363b04-38de-41b2-8192-f03d4e55a5e1"
      unitRef="usd">-117000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTAtMi0xLTEtMTQyNjI0_630c48e0-03b8-4ede-93ab-15f2d7ac5be2"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTEtMS0xLTEtMTQyNjI0_0a204982-20cf-41ac-aa11-f2d0a60b8be0"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTEtMi0xLTEtMTQyNjI0_4b77026d-522e-4f61-8294-c7098a097ea5"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTItMS0xLTEtMTQyNjI0_a2474c57-e400-430d-8200-8f19444db67d"
      unitRef="usd">70000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTItMi0xLTEtMTQyNjI0_d5254488-0a6e-4754-83c4-f84bdd1f699d"
      unitRef="usd">94000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTMtMS0xLTEtMTQyNjI0_5bffe7e0-fccc-4edd-aa9a-e6bd5016d409"
      unitRef="usd">25000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTMtMi0xLTEtMTQyNjI0_2b1fe4d6-9a3c-440d-ab4e-2d7a1ef13013"
      unitRef="usd">21000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTQtMS0xLTEtMTQyNjI0_ea2aa02f-ef64-40b5-ad4d-90c985b6167d"
      unitRef="usd">45000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTQtMi0xLTEtMTQyNjI0_2dee814c-8aae-4569-9c6c-e7140330f2aa"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTUtMS0xLTEtMTQyNjI0_456e79e9-1a30-410d-9e20-f8ae68af2aa5"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTUtMi0xLTEtMTQyNjI0_6f259a06-b485-4936-ba2a-879de294274e"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTYtMS0xLTEtMTQyNjI0_f3d16d5a-5a41-4fbd-b2ae-8e55b41f598e"
      unitRef="usd">44000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTYtMi0xLTEtMTQyNjI0_aac5743f-2ae3-43f7-8452-cb977c3ac3a5"
      unitRef="usd">71000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTgtMS0xLTEtMTQyNjI0_4703179c-508d-48b8-891f-5b6aee846c80"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTgtMi0xLTEtMTQyNjI0_de9d9d2b-849b-4265-b155-66b83f750ed4"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTktMS0xLTEtMTQyNjI0_a789b6b2-745e-4817-a0d0-c7dc2b1c4279"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMTktMi0xLTEtMTQyNjI0_b63cfcb4-e1dc-4d2f-b7d3-bb7d5d10e35f"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjEtMS0xLTEtMTQyNjI0_0f0a8063-605c-4569-93ad-f890105cfc17"
      unitRef="shares">505000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjEtMi0xLTEtMTQyNjI0_994e0b0b-0c5b-4d1a-b084-5a44a3778470"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjItMS0xLTEtMTQyNjI0_e946a5d8-50ab-473e-a8b7-dbaf08fc751e"
      unitRef="shares">507000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8xOS9mcmFnOjg1NzYxNjI0MzFkYzRmODg4MmYzMDIwNmRhNDViMjcxL3RhYmxlOjVjMmIwODQ3OTQxMTRlNjI4Yjg3NmI5MTRkZjUwYTRlL3RhYmxlcmFuZ2U6NWMyYjA4NDc5NDExNGU2MjhiODc2YjkxNGRmNTBhNGVfMjItMi0xLTEtMTQyNjI0_3d8791e6-df2e-4c07-ba2e-fa697366ffaa"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMi0xLTEtMS0xNDI2MjQ_6b78bf4b-169b-48e7-bbd3-17a5c20d1d55"
      unitRef="usd">45000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMi0yLTEtMS0xNDI2MjQ_dfc7735e-dac5-4ebb-8a40-fd173d85a9d1"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjoxNjkxOTUzMGExN2M0MTM1YmM1MWFhY2M2N2U3ZjM1NV83MA_27c2ad07-b340-4bef-907c-afc9204d192c"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjoxNjkxOTUzMGExN2M0MTM1YmM1MWFhY2M2N2U3ZjM1NV83Nw_0017eaae-45ae-4dc0-986e-10bb88593952"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0xLTEtMS0xNDI2MjQ_90c7ef21-8794-41a4-8fc1-8fa8281391a0"
      unitRef="usd">102000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNC0yLTEtMS0xNDI2MjQ_eb04c039-9013-4fd1-abc0-96554c0d35f0"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjpmZmFlMjM0MzZhMTY0ZWUwOGVhY2JmNzg5YzkzM2FhZV82OQ_c7a5a456-83b8-434d-ad78-8241e6da008a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjpmZmFlMjM0MzZhMTY0ZWUwOGVhY2JmNzg5YzkzM2FhZV83Ng_039a760e-8e83-4a76-a55d-af9d1f85ca94"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0xLTEtMS0xNDI2MjQ_1859105d-f81c-4688-9b8c-377059ab7b74"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNS0yLTEtMS0xNDI2MjQ_79753db2-bc1a-4a6b-8775-398aa2c6f9ec"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjozMDk3MGRlMWFmNjQ0ZjI5YTk3ZjQ3MGE0ZTdlZGE2MF80Ng_7703d46c-b3cd-488e-b9b8-63f3c7c01de8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjozMDk3MGRlMWFmNjQ0ZjI5YTk3ZjQ3MGE0ZTdlZGE2MF80Ng_9cb369fd-acf7-4691-b548-c3851c3701f3"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0xLTEtMS0xNDI2MjQ_78c396bf-cc56-4ce1-a226-5689bb77711d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNi0yLTEtMS0xNDI2MjQ_27c3992d-b2ab-4531-af68-e06f07521c20"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo2OTRlMTY4NDFkZjg0ZjU4OTYwMWNlOWZiMTg5YTlhNF81NDk3NTU4MTQxODk_850c6c17-50b5-464c-af87-25b649522297"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0wLTEtMS0xNDI2MjQvdGV4dHJlZ2lvbjo2OTRlMTY4NDFkZjg0ZjU4OTYwMWNlOWZiMTg5YTlhNF82Mg_6990331a-d733-4055-baa1-5a61ef35ce2d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0xLTEtMS0xNDI2MjQ_ce8a0333-c901-4716-bc23-7bebdd02290e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfNy0yLTEtMS0xNDI2MjQ_bcb187d7-9d9b-4533-aff7-e2349d4aa8ab"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOC0xLTEtMS0xNDI2MjQ_005ea97b-aafa-4eae-a859-3837f6e1dd82"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOC0yLTEtMS0xNDI2MjQ_11a6f7a3-d9a1-4598-9d48-ae0c448a0c49"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOS0xLTEtMS0xNDI2MjQ_8235cc66-ffea-4026-ba3c-c15fa26fc8bf"
      unitRef="usd">139000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfOS0yLTEtMS0xNDI2MjQ_ebce60cd-86e4-4ef0-a141-b7bbc838131f"
      unitRef="usd">66000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTAtMS0xLTEtMTQyNjI0_f1dc0c48-bc43-465e-97db-385420b789d7"
      unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTAtMi0xLTEtMTQyNjI0_a988c929-fb6b-4ed2-9ba1-0c7d914fbf64"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTEtMS0xLTEtMTQyNjI0_a39d543d-4718-4152-9ff2-47bbb342ea19"
      unitRef="usd">138000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yMi9mcmFnOmI2ODEzN2ZkMGRjNTQ5OGU4NzkwMDdlNDFhNTU2ZjM5L3RhYmxlOmY2MzA0ZjFjMTgxYTRkYzg5MjNlYzFkOWYxNzM2MWVlL3RhYmxlcmFuZ2U6ZjYzMDRmMWMxODFhNGRjODkyM2VjMWQ5ZjE3MzYxZWVfMTEtMi0xLTEtMTQyNjI0_5b2ece8b-d949-43fa-8969-d05cc84505a9"
      unitRef="usd">64000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0xLTEtMS0xNDI2MjQ_f578c812-54c6-4a9d-b3f9-a60a6c15086a"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43353d40d47f4c3cb34055b17a7dd0bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0yLTEtMS0xNDI2MjQ_329fff48-2da1-4cf0-8172-7fd690e3f199"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0940ea73b3b94072b07c67b32d418ff6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0zLTEtMS0xNDI2MjQ_05b54c94-fafa-4aaf-b437-6895569910d4"
      unitRef="shares">179000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0940ea73b3b94072b07c67b32d418ff6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy00LTEtMS0xNDI2MjQ_84f074c1-dcbb-483d-ab38-645b49feef9f"
      unitRef="usd">-11389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01ba7452daab4c4b92575193d9e5f92b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy01LTEtMS0xNDI2MjQ_48f31b44-fdd7-4b2c-a365-e878cf101fe5"
      unitRef="usd">6322000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c666c1fd3384543a02c18e41beb10c8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy02LTEtMS0xNDI2MjQ_4d02b34f-d5eb-4aef-9463-e37860fe6f6b"
      unitRef="usd">14050000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia504d0c0578e43abb57742fcbac04df9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy03LTEtMS0xNDI2MjQ_431fb5fd-4b47-4ff5-959f-7202714c8d35"
      unitRef="usd">-3833000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fbb9d28165848e7b735c76a24f97442_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy04LTEtMS0xNDI2MjQ_2e9f865b-21e1-4210-b2d4-0cb017ec7584"
      unitRef="usd">5833000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i569f70b56e6e4546a2b0440c1c1b4dd6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy05LTEtMS0xNDI2MjQ_45b9c526-0dbf-43cc-a1ef-5189c309f73c"
      unitRef="usd">62000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMy0xMC0xLTEtMTQyNjI0_e580f513-0905-4e3f-88b7-9de3bb9c76e1"
      unitRef="usd">5895000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS02LTEtMS0xNDI2MjQ_ea3acd3f-7112-46ce-a61f-ec39b75687c6"
      unitRef="usd">44000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS04LTEtMS0xNDI2MjQ_ed1a9898-8ac0-4652-aa33-868c7a0c6870"
      unitRef="usd">44000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS05LTEtMS0xNDI2MjQ_dfb72f94-d0e0-47d9-812d-b3b88c362bef"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNS0xMC0xLTEtMTQyNjI0_0f8a1101-5edc-4ffe-89b1-7faa48042554"
      unitRef="usd">45000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i78a604e834034d2e80798d244359c92e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi03LTEtMS0xNDI2MjQ_67fabb19-2e52-40b8-a0a1-ddc479e66952"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi04LTEtMS0xNDI2MjQ_d7da6f8f-bb4d-4fe1-a1c6-5bc5a9ca8010"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfNi0xMC0xLTEtMTQyNjI0_61b828fb-7125-4a4e-91e0-991be45616e4"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC0zLTEtMS0xNDI2MjQ_a1ecd3bf-530a-4cc5-8344-853d7bd37df6"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9d49b2b5d3124f6ba58d9325b97a0fa9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC00LTEtMS0xNDI2MjQ_f1f30a03-8ac7-4497-baec-dafe6625d753"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i086a01f241704bcaba8f2f58797f4896_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC01LTEtMS0xNDI2MjQ_ec2f48ca-86da-4cd0-9fc2-c4237818520a"
      unitRef="usd">-10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC04LTEtMS0xNDI2MjQ_4fd8ed1b-4726-4bdd-8517-873f25d360f3"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOC0xMC0xLTEtMTQyNjI0_90b4e02a-3719-42e3-a4c4-561cec75f137"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i0eb480ebc47f4fc29d5cd2433112e67f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS02LTEtMS0xNDI2MjQ_a11be9b5-f5ba-4965-bbd8-0810bc91baf0"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i2a8e79faf3a142768d5a6a27ffcf13ce_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS04LTEtMS0xNDI2MjQ_364375cc-3f2d-40a8-a511-5b53396310cc"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfOS0xMC0xLTEtMTQyNjI0_5d11673d-6dd5-42cc-874e-a5d930cf9034"
      unitRef="usd">147000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i87ea4c4b14a74b0a837757099f165b29_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTAtOS0xLTEtMTQyNjI0_b34173eb-6fef-49e3-9c5c-eb16f86821d6"
      unitRef="usd">-1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTAtMTAtMS0xLTE0MjYyNA_bc8059be-add9-4e92-8dd7-1016511f0470"
      unitRef="usd">-1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i903a903783024d0c822c638260089e91_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMS0xLTEtMTQyNjI0_6b079395-22c7-412c-92e6-b41699bdb4d5"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i903a903783024d0c822c638260089e91_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMi0xLTEtMTQyNjI0_3a83dcbe-1b58-4d13-b9dd-08f9d6e774ef"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i7c67e5be4a9c454b9d1c77df627b3423_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMy0xLTEtMTQyNjI0_1fcaa6aa-2cc1-43d3-84c0-ae36afd55382"
      unitRef="shares">178000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c67e5be4a9c454b9d1c77df627b3423_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNC0xLTEtMTQyNjI0_083edb58-85a7-4dbc-ac29-fc6e46c5445c"
      unitRef="usd">-11324000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c4edd866db741baa51307eb018f3d9f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNS0xLTEtMTQyNjI0_bfdbbcf8-6d64-4d7c-91c1-cfe5ebf3fb66"
      unitRef="usd">6312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68252ad5814845d2b86cdb16badea3ea_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNi0xLTEtMTQyNjI0_e283abb1-b4e3-4f42-bc73-358a1434e900"
      unitRef="usd">13947000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe84036cbe4d4876bfc384531e6ff350_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtNy0xLTEtMTQyNjI0_90d5d201-161f-4a51-a888-94007a993cb0"
      unitRef="usd">-3739000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bd566d2dac84388a0dc10cf986cbde7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtOC0xLTEtMTQyNjI0_7aa91b5c-38a1-4afb-a8e5-3235a9314220"
      unitRef="usd">5879000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefe188762f1241fa87f6153d43d125bf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtOS0xLTEtMTQyNjI0_ae465050-13bc-4c3e-b601-f20bc69ac45a"
      unitRef="usd">62000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjdmOTA0ZTY4N2M5ZTQyMGI5ZjBhYWZkZWNjMzY2ZWNlL3RhYmxlcmFuZ2U6N2Y5MDRlNjg3YzllNDIwYjlmMGFhZmRlY2MzNjZlY2VfMTEtMTAtMS0xLTE0MjYyNA_2a979ab0-d6d9-48ad-8dc9-de10977414d0"
      unitRef="usd">5941000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0xLTEtMS0xNDI2MjQ_b8fba7ab-6f81-4363-9982-9cb390bd84fa"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1084f3c2a7f04ebeb03f6f5c55dbc975_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0yLTEtMS0xNDI2MjQ_45744762-9c0e-4e86-a7c1-2de75c1175b3"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i40418177dcd1484c97237105cd4eacb8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0zLTEtMS0xNDI2MjQ_134812ac-36bf-4faa-9632-c24779455fc6"
      unitRef="shares">182000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40418177dcd1484c97237105cd4eacb8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy00LTEtMS0xNDI2MjQ_33c68d7b-a5a0-4ecc-a52e-31a632015a43"
      unitRef="usd">-11488000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i594c4d36a82e4345a1148e4403700728_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy01LTEtMS0xNDI2MjQ_3a9bcd4d-358e-4d0f-b238-4bc57ae12137"
      unitRef="usd">6197000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1adea57705bd4eb780aaa0eaaec735f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy02LTEtMS0xNDI2MjQ_c6579eb8-7eab-4066-bdcc-e32052aa5771"
      unitRef="usd">17065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48f43fae8a584013afd3637231c43053_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy03LTEtMS0xNDI2MjQ_c41f4117-060b-4225-bd4b-22e61e0860b7"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie465403042354662a73d63fe8476ff82_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy04LTEtMS0xNDI2MjQ_ebe92896-16c0-4f10-8b5b-c8391e60a186"
      unitRef="usd">9077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7990853ab5584403a5cbfd42f7d394b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy05LTEtMS0xNDI2MjQ_6c9a93ca-4f00-40fa-909f-bfe47314dcfd"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMy0xMC0xLTEtMTQyNjI0_732e31bf-b8a9-4496-be67-cd92594ebeaf"
      unitRef="usd">9121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS02LTEtMS0xNDI2MjQ_ba1089fb-7db5-484b-aae9-a0299a126566"
      unitRef="usd">71000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS04LTEtMS0xNDI2MjQ_b9e05ce7-2427-49cf-8fa3-c6d1134e36a4"
      unitRef="usd">71000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS05LTEtMS0xNDI2MjQ_6b445495-a885-4f19-a847-c07ced2e2ad3"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNS0xMC0xLTEtMTQyNjI0_6f3f5f2d-d1c5-41e1-aaac-10b10516a14e"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i63fca21e0f0c47a6803f298e2ba68799_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi03LTEtMS0xNDI2MjQ_fbb975e8-7a64-458a-b83f-788bbbc41455"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi04LTEtMS0xNDI2MjQ_db881846-cba8-43fe-a6b4-3140525b96c1"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfNi0xMC0xLTEtMTQyNjI0_cc28c4f4-194f-4e3e-ae50-bd4337ced6d5"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC0zLTEtMS0xNDI2MjQ_a9ff906d-4f25-4312-8c70-282f3b31d400"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia3ee4f2fd0ef4123af193e184cab1752_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC00LTEtMS0xNDI2MjQ_76510c42-3452-406c-b086-17bd090d7385"
      unitRef="usd">66000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1cfa36d74d3d45f69917cc8c0e03163d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC01LTEtMS0xNDI2MjQ_9246425a-9426-41e4-972e-20e960b78aaa"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC04LTEtMS0xNDI2MjQ_6f38faca-6f16-43f6-b5e8-01edc1f34f07"
      unitRef="usd">76000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOC0xMC0xLTEtMTQyNjI0_61b63708-309c-470c-8f89-17dc44d39324"
      unitRef="usd">76000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="iabc86627fc5349f1916f6448b87231fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS02LTEtMS0xNDI2MjQ_8364d7d0-5b85-4782-9bfe-6fd7c9a660ed"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i79ed7cd0b1bd4a438622e4382bca4838_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS04LTEtMS0xNDI2MjQ_a3a570cb-b8ba-4f3d-9822-3aa58bfaee3c"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfOS0xMC0xLTEtMTQyNjI0_2f2311e3-6a5b-49de-9827-401ce21d2c39"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i3ebd30c221cc4502a43e10e6b78784a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTAtOS0xLTEtMTQyNjI0_589a8864-3f6e-48c2-8565-1336305c0134"
      unitRef="usd">-2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTAtMTAtMS0xLTE0MjYyNA_2bbe5cb0-7db8-4d7d-9189-bb4bfe9f9e72"
      unitRef="usd">-2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i549981689c2d46afb3aab51cfc3c1fa2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMS0xLTEtMTQyNjI0_5294cebc-2338-469a-8ea2-5aeda7c8cf22"
      unitRef="shares">683000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i549981689c2d46afb3aab51cfc3c1fa2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMi0xLTEtMTQyNjI0_1a83beef-9fe4-499b-acf2-67a672319b26"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i52c1210990e74a9b95fe24b71553ad83_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMy0xLTEtMTQyNjI0_b6b1b528-7f7e-44a3-9944-23dea487efc5"
      unitRef="shares">180000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52c1210990e74a9b95fe24b71553ad83_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNC0xLTEtMTQyNjI0_5cc520d8-7949-4b3c-a935-d44d527ef79c"
      unitRef="usd">-11422000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d202d13044e48c6b29936c91e8c157b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNS0xLTEtMTQyNjI0_4051ce81-5507-4c23-b3c2-84e0b67b9c95"
      unitRef="usd">6207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ecdb3fe5d0e4b8e827b13f44d1963b1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNi0xLTEtMTQyNjI0_4d3df59f-6e0a-4725-b2bd-f7dfc62d34b3"
      unitRef="usd">16994000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a4799c9ebd14c07b2231243699099b4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtNy0xLTEtMTQyNjI0_76f50f7d-8d9a-4a35-a5f9-96208bf4c8cc"
      unitRef="usd">-3387000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i745ad501a79c44d6aec90e097e8047c9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtOC0xLTEtMTQyNjI0_b03fd037-cf9f-4b0c-a7f8-44cdf21a1abb"
      unitRef="usd">9075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0e5d98eeff04b8996adc2d0bb0ff481_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtOS0xLTEtMTQyNjI0_d17b098f-0113-4c51-a3fc-f28158ded4c5"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yNS9mcmFnOjAzNDczODE0ODJiNjQ1OWZiM2UwNGMzNzMyNmY4Mjk4L3RhYmxlOjRiNzRlNzgwZWE0ODRhZWY5NDhmYjczMzFjYzk5N2I2L3RhYmxlcmFuZ2U6NGI3NGU3ODBlYTQ4NGFlZjk0OGZiNzMzMWNjOTk3YjZfMTEtMTAtMS0xLTE0MjYyNA_67a4a374-0bed-482f-868d-ec1fc306c4c7"
      unitRef="usd">9119000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMy0xLTEtMS0xNDI2MjQ_f946a4b9-e6bb-4d6d-aba4-a3ba92bb445e"
      unitRef="usd">45000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMy0yLTEtMS0xNDI2MjQ_fd3f237d-6fa0-463d-915c-2af3673333c2"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNS0xLTEtMS0xNDI2MjQ_5c844527-89a2-42bc-bdec-46b5cb8ea171"
      unitRef="usd">319000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNS0yLTEtMS0xNDI2MjQ_456d82c5-0928-43b8-992f-fa1aa9369056"
      unitRef="usd">380000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNi0xLTEtMS0xNDI2MjQ_234658ac-f1c5-4cd7-9a88-663fcf826110"
      unitRef="usd">-50000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNi0yLTEtMS0xNDI2MjQ_ede14fb2-fe6a-4d10-b1f1-58a2c9bc4579"
      unitRef="usd">-55000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNy0xLTEtMS0xNDI2MjQ_5ea67b2b-912f-4020-9370-7cb200726b5a"
      unitRef="usd">25000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNy0yLTEtMS0xNDI2MjQ_b1a3caf6-3e79-4be8-ac06-aad7ea9cbc9d"
      unitRef="usd">32000000</us-gaap:ShareBasedCompensation>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfOC0xLTEtMS0xNDI2MjQ_92a81969-2abf-473f-a76b-8a8faf517567"
      unitRef="usd">-4000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfOC0yLTEtMS0xNDI2MjQ_bdd6592d-dee0-4c6e-8599-6bed6f168aa9"
      unitRef="usd">14000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTMtMS0xLTEtMTQyNjI0_eafb0c84-0e58-4cab-87dc-44da3e886417"
      unitRef="usd">-14000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTMtMi0xLTEtMTQyNjI0_4e1ba81b-7856-4d38-b6b2-0973603199d7"
      unitRef="usd">12000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTUtMS0xLTEtMTQyNjI0_721c3001-505f-4abb-8b4c-6546cafd8b16"
      unitRef="usd">-136000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTUtMi0xLTEtMTQyNjI0_01763aa2-c07c-4ac8-ba95-b6203f4e43f9"
      unitRef="usd">-153000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTYtMS0xLTEtMTQyNjI0_cab7666f-9ce6-464d-a61c-2d8f618fdd0c"
      unitRef="usd">181000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTYtMi0xLTEtMTQyNjI0_0cf4efb7-0dde-4bac-97ee-9db95c0f4b13"
      unitRef="usd">105000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTctMS0xLTEtMTQyNjI0_ad6d8027-b7ca-48a1-a10d-8bcd2d9abb04"
      unitRef="usd">39000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTctMi0xLTEtMTQyNjI0_2c8d13be-06e0-4ce8-807e-1bcd8f436b84"
      unitRef="usd">13000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTgtMS0xLTEtMTQyNjI0_d8516559-358c-42ee-8ed8-231aeae9595c"
      unitRef="usd">157000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTgtMi0xLTEtMTQyNjI0_067a88bb-c8fc-47f8-9ea6-7fb61ac2c40b"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTktMS0xLTEtMTQyNjI0_bbc1db13-2f33-4e63-a667-74b1095091c4"
      unitRef="usd">-93000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMTktMi0xLTEtMTQyNjI0_a34bf0a4-e642-4c66-8229-84ecccc50d70"
      unitRef="usd">221000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjAtMS0xLTEtMTQyNjI0_8226a77f-56b8-4c53-8187-7ed312583d1a"
      unitRef="usd">-36000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjAtMi0xLTEtMTQyNjI0_6d4551cd-3933-402a-814e-c974b2c1c898"
      unitRef="usd">-43000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjMtMS0xLTEtMTQyNjI0_a6ad418e-dd38-40b7-b844-6523584f860a"
      unitRef="usd">479000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjMtMi0xLTEtMTQyNjI0_cbe49a60-8d64-4588-ba31-10928410a6a8"
      unitRef="usd">208000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjUtMS0xLTEtMTQyNjI0_b715a77c-014c-4471-8c1e-59150e06ed5b"
      unitRef="usd">172000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjUtMi0xLTEtMTQyNjI0_2214ac3f-a589-42b2-bade-269b82210644"
      unitRef="usd">140000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjYtMS0xLTEtMTQyNjI0_0ef438c2-ea7b-4af4-abe3-04ee411b3075"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjYtMi0xLTEtMTQyNjI0_8885a5c9-788b-4770-85a1-75f9d09f5ef3"
      unitRef="usd">174000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjctMS0xLTEtMTQyNjI0_e6ae2ae2-06b8-471e-8b50-413eb8e78007"
      unitRef="usd">-5000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjctMi0xLTEtMTQyNjI0_b4e29906-cc62-4580-b061-83a9a5c97cc3"
      unitRef="usd">-10000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjgtMS0xLTEtMTQyNjI0_559ef970-3b40-4b6f-8a00-8a80f3d202fc"
      unitRef="usd">-170000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMjgtMi0xLTEtMTQyNjI0_41bbdd64-f160-44f7-bd17-0f2c79f7d38d"
      unitRef="usd">-304000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzAtMS0xLTEtMTQyNjI0_62feb418-4ff6-4e80-b42f-d96bfaf69373"
      unitRef="usd">3000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzAtMi0xLTEtMTQyNjI0_cda3fdad-8472-481f-a62c-a392ea951275"
      unitRef="usd">404000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzItMS0xLTEtMTQyNjI0_cdddacf8-f1d4-4acc-beb8-ead28413af7a"
      unitRef="usd">-249000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzItMi0xLTEtMTQyNjI0_9b9fcfcd-4bd3-4af3-b30a-366af4603e96"
      unitRef="usd">-45000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzMtMS0xLTEtMTQyNjI0_1efcc5be-d1c6-4540-815a-2c909f26e611"
      unitRef="usd">146000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzMtMi0xLTEtMTQyNjI0_c4919858-1f84-4f6a-b0db-29572433d773"
      unitRef="usd">140000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzQtMS0xLTEtMTQyNjI0_b35dfd56-efd7-4b10-a9ee-86d99c1644fc"
      unitRef="usd">36000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzQtMi0xLTEtMTQyNjI0_3516afb9-d64a-4c20-9aad-d49e6bf71523"
      unitRef="usd">66000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzctMS0xLTEtMTQyNjI0_d3424785-24d1-45a4-88c0-b6d9a12e483c"
      unitRef="usd">-10000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzctMi0xLTEtMTQyNjI0_83f01273-ebe3-400f-bc2a-85ebaad400b5"
      unitRef="usd">-25000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzgtMS0xLTEtMTQyNjI0_fa08b882-689c-432a-83b2-95eb19e47091"
      unitRef="usd">-372000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzgtMi0xLTEtMTQyNjI0_660c47d6-ad4b-4fa4-bbc8-81a9ffbc1732"
      unitRef="usd">-548000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzktMS0xLTEtMTQyNjI0_e0016120-7944-42dd-81f2-fd1ac67d698a"
      unitRef="usd">18000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfMzktMi0xLTEtMTQyNjI0_c0c844cd-971b-4fe4-9f3b-9e187efa573e"
      unitRef="usd">-13000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDAtMS0xLTEtMTQyNjI0_1bc4bc17-7e59-455a-b17d-1f588bab2372"
      unitRef="usd">-45000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDAtMi0xLTEtMTQyNjI0_596342ea-f9e5-4fd1-8a4e-e5f76efb5c1e"
      unitRef="usd">-657000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f"
      unitRef="usd">1722000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d"
      unitRef="usd">2956000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d"
      unitRef="usd">1677000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96"
      unitRef="usd">2299000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0xLTEtMS0xNDI2MjQ_cd7eb4e8-fc6e-4023-bcd7-26087fc51c3a"
      unitRef="usd">1673000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0yLTEtMS0xNDI2MjQ_84ecd203-2199-40f4-b1ff-0270bf59b81e"
      unitRef="usd">1718000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMS0zLTEtMS0xNDI2MjQ_fe13988e-a277-41ac-9862-f7e1a9949a50"
      unitRef="usd">2294000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0xLTEtMS0xNDI2MjQ_ea000005-c2db-45b4-af76-a6d89ea02ae9"
      unitRef="usd">4000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0yLTEtMS0xNDI2MjQ_61fe613c-3bbf-4c2e-8ee6-3d4bec2df6b5"
      unitRef="usd">4000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMi0zLTEtMS0xNDI2MjQ_fbdee8e7-f2b7-4fc0-8bdc-4e241997f555"
      unitRef="usd">5000000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0xLTEtMS0xNDI2MjQ_9441da64-b35f-476c-939c-e84bdd504979"
      unitRef="usd">1677000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0yLTEtMS0xNDI2MjQ_9d16268f-33d3-4821-bd5c-c87fded69269"
      unitRef="usd">1722000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOjc0NWQ3NmQ0YjhmZjQwNDQ5ZDQxNGZhYTQ5NWQxZmJlL3RhYmxlcmFuZ2U6NzQ1ZDc2ZDRiOGZmNDA0NDlkNDE0ZmFhNDk1ZDFmYmVfMy0zLTEtMS0xNDI2MjQ_a1f2201d-27b2-4394-80bf-b2abe633783a"
      unitRef="usd">2299000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxMg_1069e69d-c537-4b83-8b55-c0a84fb4a280">BASIS OF PRESENTATION&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we, our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 Annual Report).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, we announced our intention to separate our Renal Care and Acute Therapies product categories into a new, publicly traded company. While the completion of the proposed spinoff is subject to satisfaction of customary conditions, we are targeting completion of the planned separation by July 2024 or earlier. Additionally, we announced that we are pursuing strategic alternatives (including a potential sale) for our BioPharma Solutions product category. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Supply Constraints and Global Economic Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect that the challenges caused by global economic conditions, among other factors, may continue to have an adverse effect on our business.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxOQ_8e01b762-59f2-4d66-895b-e27cc06922b1">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we, our or Baxter) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</us-gaap:ConsolidationPolicyTextBlock>
    <bax:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8zNC9mcmFnOmI4OWMwNjI3YTg1NzQ1MmNiZTIzMTRlNTRmMjY4YzRjL3RleHRyZWdpb246Yjg5YzA2MjdhODU3NDUyY2JlMjMxNGU1NGYyNjhjNGNfNDYxNQ_20cae7c1-a069-4c7c-b72f-3230402c9679">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Supply Constraints and Global Economic Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have experienced significant challenges to our global supply chain in recent periods, including production delays and interruptions, increased costs and shortages of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, resulting from the pandemic and other exogenous factors including significant weather events, elevated inflation levels, disruptions to certain ports of call around the world, the war in Ukraine and other geopolitical events. We expect to experience some of these and other challenges related to our supply chain in future periods. These challenges, including the unavailability of certain raw materials and component parts, have also had a negative impact on our sales for certain product categories due to our inability to fully satisfy demand and may continue to have a negative impact on our sales in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect that the challenges caused by global economic conditions, among other factors, may continue to have an adverse effect on our business.&lt;/span&gt;&lt;/div&gt;</bax:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMw_73910736-84da-464b-b2f3-cddc40817d6a">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other Income, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Non-Cash Operating and Investing Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2023 and 2022 were $26 million and $14&#160;million, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2023 and 2022 were $70 million and $53 million, respectively.</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNA_2e1081ce-b821-4e91-a25b-3440212c31ff">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfMi0xLTEtMS0xNDI2MjQ_ba07f21c-d8f6-4a75-a000-7102cbc53c62"
      unitRef="usd">114000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfMi0yLTEtMS0xNDI2MjQ_ff2f1118-4ec3-4b72-9e1a-f02a468193cd"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNC0xLTEtMS0xNDI2MjQ_a91d8e47-0115-4ec7-b349-22eb4d337a2b"
      unitRef="usd">7000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNC0yLTEtMS0xNDI2MjQ_6d880137-caf4-4590-abb8-155137eadb08"
      unitRef="usd">6000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNS0xLTEtMS0xNDI2MjQ_551fc6e4-7ee6-4ed1-adc9-3c36d2d3932f"
      unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNS0yLTEtMS0xNDI2MjQ_3569ae46-0153-42b4-b9c6-1548beb70a65"
      unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNi0xLTEtMS0xNDI2MjQ_9ac9ec1a-956b-4b27-8376-7a9f1ca598b5"
      unitRef="usd">-2000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNi0yLTEtMS0xNDI2MjQ_db4ef58b-0ed7-4aba-997c-1fa62ce854c3"
      unitRef="usd">-2000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNy0xLTEtMS0xNDI2MjQ_4479dec6-446f-41cf-a66d-e88625967812"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjllYThhMjIwYmQzYzRkMjc4NDZkNWE0YmE3N2I1MTg1L3RhYmxlcmFuZ2U6OWVhOGEyMjBiZDNjNGQyNzg0NmQ1YTRiYTc3YjUxODVfNy0yLTEtMS0xNDI2MjQ_eaa4a47f-ca62-4ddf-ae3c-456f082a1ea8"
      unitRef="usd">129000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNQ_c58a73e4-9afb-4e58-b3cb-f63b77b31a07">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMS0xLTEtMS0xNDI2MjQ_3b426d4f-39b1-451e-a913-54414b778807"
      unitRef="usd">812000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMS0yLTEtMS0xNDI2MjQ_17c859c2-87bc-41f7-8879-fc65dd807de1"
      unitRef="usd">738000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMi0xLTEtMS0xNDI2MjQ_13a20903-e368-4a7f-a8a8-d7158b9955e1"
      unitRef="usd">316000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMi0yLTEtMS0xNDI2MjQ_e5e7ece4-3d97-42be-8a5c-05ca79256e96"
      unitRef="usd">293000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMy0xLTEtMS0xNDI2MjQ_bdee2d68-c063-4840-8688-64c57fe2cd6c"
      unitRef="usd">1794000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfMy0yLTEtMS0xNDI2MjQ_2142e8a2-4b94-457d-a6bd-d7a85c6238bb"
      unitRef="usd">1687000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfNC0xLTEtMS0xNDI2MjQ_29d22bdb-d448-4bfc-95f9-b3be1a9971f7"
      unitRef="usd">2922000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmI5MWUzZGQ2ZDA5YjQyNmJhMDQ5MDVlYWE3YzdjZDI1L3RhYmxlcmFuZ2U6YjkxZTNkZDZkMDliNDI2YmEwNDkwNWVhYTdjN2NkMjVfNC0yLTEtMS0xNDI2MjQ_2feb4f3f-329f-4af8-b24f-d13ffba5638f"
      unitRef="usd">2718000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwNg_b86105fa-e83e-4268-9ab0-c38a60d37729">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMS0xLTEtMS0xNDI2MjQ_d152904a-bef9-489e-a06d-44f6d5deedae"
      unitRef="usd">11622000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMS0yLTEtMS0xNDI2MjQ_7b67a7fd-e99f-43d3-aed1-3cb5bf5ac581"
      unitRef="usd">11421000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMi0xLTEtMS0xNDI2MjQ_c58cb848-d09e-4e0c-a676-b38fb0e5e67f"
      unitRef="usd">6622000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMi0yLTEtMS0xNDI2MjQ_37da9933-c8de-43e7-8841-62877f5a36d3"
      unitRef="usd">6442000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMy0xLTEtMS0xNDI2MjQ_9cf538ad-da88-4617-8189-43711beb1a6c"
      unitRef="usd">5000000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmE4N2QyNjg4MjY4ZTRjYTliM2M5MDRlNzY4MWMwZWMyL3RhYmxlcmFuZ2U6YTg3ZDI2ODgyNjhlNGNhOWIzYzkwNGU3NjgxYzBlYzJfMy0yLTEtMS0xNDI2MjQ_c6b7cd2c-0dde-4b94-a422-d463c00f0f33"
      unitRef="usd">4979000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMA_ea47e932-c0f4-49cc-b6b6-5cec55312600">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMi0xLTEtMS0xNDI2MjQ_8a997748-0940-4fe2-9840-9e765db0c1db"
      unitRef="usd">127000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMi0yLTEtMS0xNDI2MjQ_b30a70a2-d651-4c3a-9246-c6f4ba71ce68"
      unitRef="usd">88000000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeOperating
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMy0xLTEtMS0xNDI2MjQ_c35ac96d-1004-411e-9702-8a75353e13b2"
      unitRef="usd">10000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfMy0yLTEtMS0xNDI2MjQ_32c01011-531d-4c8b-9ca5-0d91d6ec60de"
      unitRef="usd">3000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfNC0xLTEtMS0xNDI2MjQ_34fa9e44-19c6-4205-96c6-f3bca40da63d"
      unitRef="usd">-117000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOmRiZjM0NDg1NTRlZjRhODg5NzIzOTMwMjVhY2IyODkwL3RhYmxlcmFuZ2U6ZGJmMzQ0ODU1NGVmNGE4ODk3MjM5MzAyNWFjYjI4OTBfNC0yLTEtMS0xNDI2MjQ_db651e63-b659-453c-bd44-1a3ee92b712d"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTYwMQ_8ad090bf-daac-4e56-a543-d3010c3ccfca">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other Income, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMi0xLTEtMS0xNDI2MjQ_9295f747-a622-458f-94cd-5f87110c3283"
      unitRef="usd">-14000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMi0yLTEtMS0xNDI2MjQ_586c34c7-0c4b-4ec6-b728-ab54e0446ad5"
      unitRef="usd">11000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMy0xLTEtMS0xNDI2MjQ_88a7a15c-bb9c-45df-8dd3-cf6bb8d173b1"
      unitRef="usd">-10000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfMy0yLTEtMS0xNDI2MjQ_d88637c3-481f-4bbc-ad3b-c87241f4d0b1"
      unitRef="usd">-5000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNS0xLTEtMS0xNDI2MjQ_152e5f5d-85e9-4ce5-991b-02b2c544b3ca"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNS0yLTEtMS0xNDI2MjQ_5dbbb57d-aac8-4a75-aa77-b7ce59a384dd"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNy0xLTEtMS0xNDI2MjQ_da64059c-d1f4-43c3-847d-7a15625b1583"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfNy0yLTEtMS0xNDI2MjQ_7c2f37b6-42f9-4ef7-b974-8c6445707c1f"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfOC0xLTEtMS0xNDI2MjQ_e75e22b3-e1c9-4328-ba3a-37ad75eb7d6b"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RhYmxlOjAxNjJkYmIzM2M4NjQzZmI4MzJlNTlkMGFjNjZlOTk2L3RhYmxlcmFuZ2U6MDE2MmRiYjMzYzg2NDNmYjgzMmU1OWQwYWM2NmU5OTZfOC0yLTEtMS0xNDI2MjQ_dd4aaf4a-9ab5-47b4-9863-8ac7c6f2667b"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTQ1Ng_71caf30f-599f-4de4-9c0c-3b2dacd14d1f"
      unitRef="usd">26000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTQ2Mw_2fb3d8de-c26a-40cc-bb6f-1b0a3bd1bab3"
      unitRef="usd">14000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if8aefd6cba0d4106847bb6b58cb837e9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTU3Ng_57e240ba-b37b-41e7-82d6-673d9a93a70e"
      unitRef="usd">70000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8ac1583fbba246859aa51f7df3cee508_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80MC9mcmFnOmEzNDZkYmU0M2E0MjQyNDE5YmFlNzFiNzMxNGY0NjIwL3RleHRyZWdpb246YTM0NmRiZTQzYTQyNDI0MTliYWU3MWI3MzE0ZjQ2MjBfMTU4Mw_7520c119-d13a-48b7-9f45-e31123e8fd62"
      unitRef="usd">53000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzcyOQ_53167a86-da2b-4685-b7f4-1849e917056b">GOODWILL AND OTHER INTANGIBLE ASSETS, NET&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the periods ended March&#160;31, 2023 and 2022, there were no reductions in goodwill relating to impairment losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;In process Research and Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense was $162 million and $217 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzczMA_2a2707d7-3906-49c5-bcb7-8e18f8502f54">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i74b8716ad88248e28c4c5356153e3a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0xLTEtMS0xNDI2MjQ_6e7ca70d-e00d-4880-9b10-10b34499911d"
      unitRef="usd">2356000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i25d5af7f312e4865be66979f792580ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0yLTEtMS0xNDI2MjQ_203d186c-9fa3-43c0-bed4-03a5672581ea"
      unitRef="usd">289000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i31b93924f957421ba38aa7f8e31ae06b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS0zLTEtMS0xNDI2MjQ_49945d1c-c89b-4bbc-9915-9eee8029674d"
      unitRef="usd">210000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i81f07e528dbe484f982e220a41fa1577_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS00LTEtMS0xNDI2MjQ_385b2e05-b0ae-4c97-95f4-48f66a591344"
      unitRef="usd">3988000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfMS01LTEtMS0xNDI2MjQ_e373e7b2-1ed8-4d3f-86ae-5b7537222db6"
      unitRef="usd">6843000000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib4cf6a305b9149389378aa6125813d6e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0xLTEtMS0xNDI2MjQ_9214e87d-2bf5-48a4-aa5e-e06b0b11bec7"
      unitRef="usd">18000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5fa64dff379543ff9a0e870c10d36e3b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0yLTEtMS0xNDI2MjQ_7f9bb666-1007-4560-9009-3ca970894ad3"
      unitRef="usd">2000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibdd748bfd4df44c5b9b7a1d75b53c8cd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi0zLTEtMS0xNDI2MjQ_1f6f17c1-1b18-47b5-9318-9c6ecb1a6c0c"
      unitRef="usd">2000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9122ce6ade864b9f939af3570b2a12d5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi00LTEtMS0xNDI2MjQ_af8e7006-6fa2-4124-b2eb-035e01e6f381"
      unitRef="usd">3000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNi01LTEtMS0xNDI2MjQ_b79b3654-eba8-448b-a030-7916338334c2"
      unitRef="usd">25000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i3ba1d1d1ab4a4b58bbc7c4edd43217e8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0xLTEtMS0xNDI2MjQ_72261a38-7d9b-48ce-ab78-fb7e7e6abf95"
      unitRef="usd">2374000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icd5b28bd50b747f58909a56b3ce1d3cb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0yLTEtMS0xNDI2MjQ_64c366ee-ef10-48a6-a37d-362ab2ad6228"
      unitRef="usd">291000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ief1ede9bd1eb4a41881ac35ef3560275_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy0zLTEtMS0xNDI2MjQ_7cfe1c70-8095-4de9-9779-fc0a11b7f73e"
      unitRef="usd">212000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica9f83b89e384e909e618e9f0fc79b8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy00LTEtMS0xNDI2MjQ_90c60c24-dd6b-44cd-b11d-01211ce1eb70"
      unitRef="usd">3991000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOjdlNTk5ZDA3NTk2ZDRiNWE4NmY5OTUzYWI1ZWRhMTNkL3RhYmxlcmFuZ2U6N2U1OTlkMDc1OTZkNGI1YTg2Zjk5NTNhYjVlZGExM2RfNy01LTEtMS0xNDI2MjQ_a54f6c31-e6ad-4fd4-9abb-be4b18682f54"
      unitRef="usd">6868000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjE5OTAyMzI2OTE3OQ_2a4ed85a-f229-4440-870a-95c16f6a3512"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMzczMg_ddae0a08-bc43-4253-9a7f-6f6b672b0fd5">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;In process Research and Development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0xLTEtMS0xNDI2MjQ_26cb527b-364e-4a73-894b-480965a0618b"
      unitRef="usd">3454000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0yLTEtMS0xNDI2MjQ_012561a7-a7ab-43a3-9f1b-26fc0960f9a8"
      unitRef="usd">3862000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy0zLTEtMS0xNDI2MjQ_fa6a58ea-92d6-449f-b5de-deb742ced415"
      unitRef="usd">326000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9691d0cc94e2490085471645d739eab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy00LTEtMS0xNDI2MjQ_03afba3e-28b1-48ce-a280-37d783b7e63e"
      unitRef="usd">1571000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy01LTEtMS0xNDI2MjQ_2581a171-5acc-45f4-981a-2ddfa94d4716"
      unitRef="usd">202000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfMy02LTEtMS0xNDI2MjQ_ace2c503-70b6-4afe-ab07-b01bc78be290"
      unitRef="usd">9415000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0xLTEtMS0xNDI2MjQ_4794258b-11a3-4bc1-aa85-904b3f435c7e"
      unitRef="usd">529000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0yLTEtMS0xNDI2MjQ_16804a25-427c-4f4d-9aa0-a071d0eb043f"
      unitRef="usd">2000000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC0zLTEtMS0xNDI2MjQ_0e0e9a84-6108-4887-bb93-4baaf148cd3d"
      unitRef="usd">246000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNC02LTEtMS0xNDI2MjQ_2c9ff652-9b5c-4530-a63f-d4ada03464b1"
      unitRef="usd">2775000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i18c60cecc4dd4674a79048e6dec4f65c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0xLTEtMS0xNDI2MjQ_e961e0fb-0607-4263-90d8-e1dce64bb2b1"
      unitRef="usd">2925000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic8750ae5d3034349b54eb62120194f7c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0yLTEtMS0xNDI2MjQ_448e02b9-81a8-4acd-acc7-86440e63ecb7"
      unitRef="usd">1862000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5ea658ef4e8a4402a8e9549a454537cf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS0zLTEtMS0xNDI2MjQ_4f39bc7e-d838-4f04-a414-5c7fbafe6c99"
      unitRef="usd">80000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9691d0cc94e2490085471645d739eab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS00LTEtMS0xNDI2MjQ_4b4a43d0-1ae3-474e-a3fb-de09d816fdea"
      unitRef="usd">1571000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i38352f3f327e4115bf1938d7c2d9ebe0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS01LTEtMS0xNDI2MjQ_891540ef-3dcc-4d4b-9de5-601ef8245524"
      unitRef="usd">202000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNS02LTEtMS0xNDI2MjQ_79b3a232-7e56-4810-938c-59efd77afd6f"
      unitRef="usd">6640000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0xLTEtMS0xNDI2MjQ_60c5c62d-fb34-491a-bcb7-65cda2b76b77"
      unitRef="usd">3452000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0yLTEtMS0xNDI2MjQ_7ac4ef52-b661-4f4f-8bf4-575f5d75e32a"
      unitRef="usd">3836000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy0zLTEtMS0xNDI2MjQ_f390a25e-2237-4ea5-a8ad-169c8f6fa0fb"
      unitRef="usd">325000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i8ebf6db10af94658bfb39f075c42d0ba_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy00LTEtMS0xNDI2MjQ_1b68fcea-7d44-4bb3-9752-521b1dc2d956"
      unitRef="usd">1571000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie473cdb19c1847169b73a323e42bd39a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy01LTEtMS0xNDI2MjQ_e9a676f2-f217-49d0-a14d-bc57a414443b"
      unitRef="usd">202000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfNy02LTEtMS0xNDI2MjQ_c6bac4af-00d0-4013-8438-9c89e38b59bd"
      unitRef="usd">9386000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0xLTEtMS0xNDI2MjQ_281696a1-013c-47d1-8a1f-cf2239a2c711"
      unitRef="usd">470000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0yLTEtMS0xNDI2MjQ_7ff0935f-dd71-499f-a9bc-43bdad1a0706"
      unitRef="usd">1888000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC0zLTEtMS0xNDI2MjQ_cc561f87-9a10-483d-b18a-5d0d3b43166b"
      unitRef="usd">235000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOC02LTEtMS0xNDI2MjQ_8392fe94-53d8-4750-a258-4c687de148c8"
      unitRef="usd">2593000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id92dec25d7c34b37b1430e2c4a7835d3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0xLTEtMS0xNDI2MjQ_b674efdb-be5c-43e7-a101-89f744abacf1"
      unitRef="usd">2982000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3f7fbf25e6ef426ba0f2ddb9ef9816a1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0yLTEtMS0xNDI2MjQ_972b65de-676c-4635-80ee-fa3d3d424a74"
      unitRef="usd">1948000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib369cfb36a82482b8db8a6063f7d16d8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS0zLTEtMS0xNDI2MjQ_9cb17c1b-c075-47e1-9d86-580d1525e426"
      unitRef="usd">90000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i8ebf6db10af94658bfb39f075c42d0ba_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS00LTEtMS0xNDI2MjQ_fe3721f5-c7d2-4fa7-ba15-a0501f372dd3"
      unitRef="usd">1571000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie473cdb19c1847169b73a323e42bd39a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS01LTEtMS0xNDI2MjQ_0194da32-b13a-4e2a-80f9-83a10b4192da"
      unitRef="usd">202000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RhYmxlOmY1MTg2YmM2NjQ5YTRlZTZiZWZjOWZlYTU5YzliYjI2L3RhYmxlcmFuZ2U6ZjUxODZiYzY2NDlhNGVlNmJlZmM5ZmVhNTljOWJiMjZfOS02LTEtMS0xNDI2MjQ_d3bd47ea-9489-4083-a653-6c5cf91ec0a3"
      unitRef="usd">6793000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjY2Mw_e0d70aae-e4e5-4dcd-9f1c-c43453ff5612"
      unitRef="usd">162000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80My9mcmFnOjk1NWU5ZmE2Y2ZmNjQ2MDFhMDY1ZjFlY2NhMTk0OGY5L3RleHRyZWdpb246OTU1ZTlmYTZjZmY2NDYwMWEwNjVmMWVjY2ExOTQ4ZjlfMjY3MA_341d1969-d109-45f1-9a67-0ff5ab966dbd"
      unitRef="usd">217000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjY0Mw_667773b9-11bc-4f02-ae85-2644e326aa15">FINANCING ARRANGEMENTS &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2023, we amended the credit agreements governing our U.S. dollar-denominated term loan credit facility and revolving credit facility and the guaranty agreement with respect to our Euro-denominated revolving credit facility, in each case to amend the net leverage ratio covenant to increase the maximum net leverage ratio for the four fiscal quarters ending March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. dollar-denominated revolving credit facility has a capacity of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $2.5&#160;billion&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our Euro-denominated revolving credit facility has a capacity of &#x20ac;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of March&#160;31, 2023 or December&#160;31, 2022.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper borrowing arrangements require us to maintain undrawn borrowing capacity under our credit facilities for an amount at least equal to our outstanding commercial paper borrowings. Based on our covenant calculations as of March&#160;31, 2023 we have capacity to draw approximately $2.2&#160;billion under our credit facilities, less commercial paper borrowings which were $50 million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we had $50 million of commercial paper outstanding with a weighted-average interest rate of 5.42% and an original weighted-average term of 28 days. As of December&#160;31, 2022, we had $299 million of commercial paper outstanding with a weighted-average interest rate of 4.75% and an original weighted-average term of 32 days.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMTk0Ng_fd5da7dc-41ea-4c39-b131-3a3a12d1bc1b"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjAxOA_7253dfe8-ed43-4448-804b-57058940060f"
      unitRef="eur">200000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i88ccfc347b0e4ba0aaf816a9331ce07c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjA3Mw_10bbac71-1d13-452e-a55d-ae6450364d52"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i8a56dbdd4ff14331a905150029de9251_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjA3Mw_40dd2197-9b2f-40ac-a60d-7ca607f7e1dc"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i50e14096fdd04423a5333d25f12d89a7_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTczNw_91b2da56-bf08-46e6-b2ed-d1aafe461a87"
      unitRef="usd">2200000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTg5Mw_d50891bb-fd70-4348-8fa3-c3eef23694f3"
      unitRef="usd">50000000</us-gaap:CommercialPaperAverageOutstanding>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjc0ODc3OTA3NTg4OQ_d50891bb-fd70-4348-8fa3-c3eef23694f3"
      unitRef="usd">50000000</us-gaap:CommercialPaperAverageOutstanding>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="idb2809f872c14e8ebe75278e58f5b315_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjQ1NQ_686e611e-cbe3-41f7-9496-b9f796798a15"
      unitRef="number">0.0542</us-gaap:DebtWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="i5251aea994574c9583ba547d9a6bac1f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjQ5OQ_266620c0-96cf-4013-a1db-85ee60090321">P28D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjUyMA_4b3705bc-be8f-4c22-a6f9-f25292cef94a"
      unitRef="usd">299000000</us-gaap:CommercialPaperAverageOutstanding>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ie998dbec09874c54aeb8ff608dc85931_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjU5Ng_a4ba97c8-0ef0-4349-84de-b5da24dc16d0"
      unitRef="number">0.0475</us-gaap:DebtWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="ib7ae7751804b4d54b57a0e6f8d4fc898_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80Ni9mcmFnOjQ1ZmVkOTRlMDEyOTQ0MGZiOGM3ZTViZTY5YmRlNGQxL3RleHRyZWdpb246NDVmZWQ5NGUwMTI5NDQwZmI4YzdlNWJlNjliZGU0ZDFfMjY0MA_7dd81c06-e6fe-4be0-a78d-51734db36955">P32D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfODczNA_13101419-6de3-4f51-97e9-487ebdaa7493">COMMITMENTS AND CONTINGENCIES &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2023 and December&#160;31, 2022, our total recorded reserves with respect to legal and environmental matters were $29 million and $28 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#x2019; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2023 and December&#160;31, 2022, our environmental reserves, which are measured on an undiscounted basis, were $17 million and $19 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that were not material to our financial results, which were paid in the fourth quarter of 2021. We have since resolved, without litigation, additional claims of injuries from exposure to ethylene oxide at Mountain Home for amounts within accruals previously established as of December 31, 2021. On October 20, 2022, a lawsuit was filed against us in the Western District of Arkansas alleging injury as a result of exposure to ethylene oxide at Mountain Home. On December 16, 2022, we filed a motion to dismiss and for a more definite statement. In response, Plaintiffs filed a First Amended Complaint on January 6, 2023. We answered the First Amended Complaint on January 27, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We acquired Hill-Rom Holdings, Inc. (Hillrom) on December 13, 2021. In July 2021, Hill-Rom, Inc., a wholly-owned subsidiary of Hillrom, received a subpoena from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the Department of Justice (DOJ) to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters. In October 2022, the DOJ issued a separate Civil Investigative Demand (CID) addressed to Hillrom, requesting documents and information related to compliance with the False Claims Act and the Anti-Kickback Statute. Baxter is cooperating fully with the DOJ in responding to the CID. The DHHS and DOJ often issue these types of requests when investigating alleged violations of the False Claims Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an &lt;/span&gt;&lt;/div&gt;answer to the complaint on January 28, 2022 and filed a motion challenging certain aspects of plaintiff's case on May 27, 2022.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjI3_130d4e77-8115-45ea-8c08-f749d5773120"
      unitRef="usd">29000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjM0_838a87a8-8ed6-41da-8f52-80f0be8ab993"
      unitRef="usd">28000000</us-gaap:LitigationReserve>
    <bax:SiteContingencyNumberOfSites
      contextRef="i8a129980c2e0429f900251c40212bfea_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjI0NQ_110f29ff-1cd4-4258-9ead-0289f4277e25"
      unitRef="site">6</bax:SiteContingencyNumberOfSites>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i83ac75103174457caa01d60ace762a52_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjg3OA_6e311cbc-92d6-40d9-87c7-aeb7454c15d0"
      unitRef="usd">17000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ia6f5b61f71de4b578b8f219e50d9e242_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfMjg4NQ_1f6cc772-c01a-4c91-9d87-d531480673b7"
      unitRef="usd">19000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <bax:LossContingencyNumberOfLawsuits
      contextRef="ia18ed76e0fa040a8aac24e70b8c0d1b2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl80OS9mcmFnOmU3ZWU0ZmUyNDIyODRjZTk4NmYzNjBhNDM1OGIzMmM3L3RleHRyZWdpb246ZTdlZTRmZTI0MjI4NGNlOTg2ZjM2MGE0MzU4YjMyYzdfNjM5NQ_111af4e4-763f-43d8-8995-c2f9b5685bad"
      unitRef="lawsuit">2</bax:LossContingencyNumberOfLawsuits>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfODA0_cc031618-967a-4f90-9bf1-f4594954d1a6">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash dividends declared per share for the three months ended March&#160;31, 2023 and 2022 were $0.29 and $0.28, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs&lt;/span&gt;&lt;/div&gt;In July 2012, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. Our Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first quarter of 2023 and 2022, we did not repurchase any shares under this authority. We had $1.3 billion remaining available under the authorization as of March&#160;31, 2023.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMTEw_c4ba8c49-c87b-4108-ad69-d87988037ecd"
      unitRef="usdPerShare">0.29</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMTg3_208d476b-84bc-4c67-b569-b805bc6f6baa"
      unitRef="usdPerShare">0.28</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="icb1e1e86edba409592faffa2c09656e7_I20120731"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMjk3_eb39f26f-70ec-4dfc-8f74-60a163506608"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i54acfe1b3c9e4d72a0d864d5c38acb28_I20161130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMzg2_0b2f25d7-9343-4b8c-8d61-9fc8e6fe03c3"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i4dcdbf9afbfe48f697caa407b52ea2a9_I20180228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfMzg2_e751553a-b3d7-414a-a433-97af0423402a"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i82b54d14b4714bb8909d97f501750950_I20181130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNDUw_b390ba77-baf6-4cc5-b4bf-90ff7a01a451"
      unitRef="usd">2000000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i3cda740eb170402f8aecbd918a7cb4dc_I20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNDkx_e5433c16-4ad4-4b1c-a971-6b98674b2393"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81Mi9mcmFnOjg1YmE4YTMwNTBiMTRiNWNhYzgyYjEyNGI1YjMzMmM1L3RleHRyZWdpb246ODViYThhMzA1MGIxNGI1Y2FjODJiMTI0YjViMzMyYzVfNzQ2_c90861dd-d255-46f5-a3e3-0562f29da95d"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA2NQ_c3dfe419-0dd6-43eb-94c3-a9977ef10ade">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income includes all changes in stockholders&#x2019; equity that do not arise from transactions with stockholders, and consists of net income, cumulative translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans, gains and losses on cash flow hedges and unrealized gains and losses on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;Refer to Note 10 for additional information regarding the amortization of pension and OPEB items and Note 13 for additional information regarding hedging activity</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA3Mg_10860920-e76d-4532-9d94-8e1d42571000">&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive income (loss) (AOCI) by component for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7a3e16bcba5455287abc55ac7a72c7b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0xLTEtMS0xNDI2MjQ_66fad8dd-508c-4bea-a590-a4fa02b2c903"
      unitRef="usd">-3386000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f4bdbd9802f43e4b40fdb623ef4c6b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0yLTEtMS0xNDI2MjQ_fad1d63e-a225-40d2-817b-ff22e9d576dc"
      unitRef="usd">-331000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38a1fa71e8d34f8f8b550e41ec2f74b8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi0zLTEtMS0xNDI2MjQ_987aa1a7-de54-436c-a70b-d60f6684f908"
      unitRef="usd">-119000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia34a05a406da4126b9897e999764cf3b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi00LTEtMS0xNDI2MjQ_1a343250-e44f-4c0c-847b-0290c52db34e"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iddc00ddfcf9a4d538640cf78c5d1745c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMi01LTEtMS0xNDI2MjQ_85c59601-6162-4d8d-9af6-c8a8e3395622"
      unitRef="usd">-3833000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0xLTEtMS0xNDI2MjQ_10d25f45-9d60-425a-a79d-b241dafa92c4"
      unitRef="usd">102000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0yLTEtMS0xNDI2MjQ_c238e319-85bb-4b9a-8389-2ee024b65874"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy0zLTEtMS0xNDI2MjQ_2b8bc078-c433-41e6-b187-09f9c30235c8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy00LTEtMS0xNDI2MjQ_1d746e33-8015-474f-93b6-ea250a71c58d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfMy01LTEtMS0xNDI2MjQ_e5429997-fe0f-4839-907f-9dce640a2d89"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0xLTEtMS0xNDI2MjQ_1989d402-1867-4f3d-9663-c984ec33e6c5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0yLTEtMS0xNDI2MjQ_c1715829-c9e0-466e-9a4e-d37473ce60be"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC0zLTEtMS0xNDI2MjQ_41028971-3c62-4239-b355-194724ebcb1e"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC00LTEtMS0xNDI2MjQ_7713d1d9-26fa-4a1a-aced-4e80019fcd5c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNC01LTEtMS0xNDI2MjQ_d92f0f9c-d786-4050-9ba9-d78941e6df87"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2935c0012c184ef09a9f69ca2c8292cd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0xLTEtMS0xNDI2MjQ_6f227065-5e7c-48cf-85ff-7df4c9f5f09b"
      unitRef="usd">102000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i614575b7558142db88b525cd20152c5e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0yLTEtMS0xNDI2MjQ_cb9cc040-0b4f-4dd2-84f3-f5b9929b011a"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8cf419df370f41f5a16aeeaa138491d7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS0zLTEtMS0xNDI2MjQ_b807fe53-7971-4cd7-a7ac-cf9af526e1c6"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if0dc1bf41ac64ef785658d6c83026443_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS00LTEtMS0xNDI2MjQ_8070ed04-4d87-4059-a973-0bb57b27f208"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNS01LTEtMS0xNDI2MjQ_06645578-22e3-4de4-8e55-9653c6dd1635"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1731323823d48a9ad85ad284c1026de_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0xLTEtMS0xNDI2MjQ_97bc62e2-1e96-4943-9989-95ae96fbb389"
      unitRef="usd">-3284000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e585fdb356847ee95bef768d6c8f6fe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0yLTEtMS0xNDI2MjQ_4159fbab-387a-4f2d-8427-fcdb72cfabd7"
      unitRef="usd">-337000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabbe53c3b4844245a71aa4170a3d6951_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi0zLTEtMS0xNDI2MjQ_f10d363c-69f0-42c2-a71f-1483e50868eb"
      unitRef="usd">-121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fe94c791c144fb3901d9ccada083e46_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi00LTEtMS0xNDI2MjQ_abde78f1-b1f0-41e9-bb55-33cb1261ee20"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i891fc74d6b294098b52b2dbacb9d8244_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjcyNDIzZDMzMDZiZjQ3YThiNjA4MDgxNzVmMGQxYjlmL3RhYmxlcmFuZ2U6NzI0MjNkMzMwNmJmNDdhOGI2MDgwODE3NWYwZDFiOWZfNi01LTEtMS0xNDI2MjQ_4cd4f2b9-2d07-44da-abad-a0eddef3779a"
      unitRef="usd">-3739000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4974271eca4848daac4ef6f3c0268466_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0xLTEtMS0xNDI2MjQ_ee2cc97c-d083-4600-a3f9-29b1469e53c2"
      unitRef="usd">-2907000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ba818d615df44fa9ab8dc663c356b0e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0yLTEtMS0xNDI2MjQ_382555b7-0525-417e-ba3b-a4d63f6d29d6"
      unitRef="usd">-347000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc59f5aaa04945a290aa672855b1c1ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi0zLTEtMS0xNDI2MjQ_c31a62ba-cdf9-466d-95a3-72be8feb04bb"
      unitRef="usd">-126000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i573b5203abe64eee9fc6bd8d764b6765_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi00LTEtMS0xNDUyNjM_df3ccbb6-4e16-4a32-a11e-21c818d35a83"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i154a7b3c49ee48b38613d9dec8d98845_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfMi00LTEtMS0xNDI2MjQ_98166ecb-099c-4a06-ad71-9fc7630e237c"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0xLTEtMS0xNDI2MjQ_9c4404e8-53dc-4b84-8dcd-c2039cfba782"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0yLTEtMS0xNDI2MjQ_75903bd1-317a-4bb2-897a-ec1e05c25151"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC0zLTEtMS0xNDI2MjQ_75947599-92a2-4e64-a2c5-3e8945f434f0"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC00LTEtMS0xNDUyNzE_85b74337-fa9a-415e-9b88-d1d0c1a40d74"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNC00LTEtMS0xNDI2MjQ_f740fc81-c823-4bbc-adcd-eb8ac742fb5d"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0xLTEtMS0xNDI2MjQ_b5633ca7-0cec-448e-bddc-01a89b7bc5d5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0yLTEtMS0xNDI2MjQ_d3632d10-a2af-4d45-8891-ee7e724a7f8b"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS0zLTEtMS0xNDI2MjQ_793d65a8-4526-40bf-8a12-80d3a00e0ef0"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS00LTEtMS0xNDUyNzE_a58dacd0-2fd7-4a50-ad0c-8b7f02ee1566"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNS00LTEtMS0xNDI2MjQ_9469fc5d-0b71-45a6-92d1-2b8431a2ae0f"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iebf337d7a41e4443b32a69a8e85ca6ec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0xLTEtMS0xNDI2MjQ_3ca67994-667a-417c-a800-eaccca3ff3e9"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7634abdaa7a24e1eb9543ad59ce75bd6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0yLTEtMS0xNDI2MjQ_54efedba-1ccd-459a-b803-a79b1a95df36"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie37f0b7b7b7c47078cad2dfb18e656b9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi0zLTEtMS0xNDI2MjQ_4f6461b0-6740-42a3-baf1-c932320c585f"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3562776ca246430ca98ee60b88c8cdf6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi00LTEtMS0xNDUyNzk_f8b93dab-e8c8-470f-84f8-1f9968530c9d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNi00LTEtMS0xNDI2MjQ_afb06115-7cab-46e3-9afa-5e7aed8c6835"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icc57a64dfa914805848eec366284d706_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0xLTEtMS0xNDI2MjQ_4a470f0a-ec32-476a-aad9-55fbbcd1a76b"
      unitRef="usd">-2922000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b3a5ddf7f0b4ea8ad0c518d49a70509_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0yLTEtMS0xNDI2MjQ_993aea4a-bcd8-4eaf-8ece-f192d5394f49"
      unitRef="usd">-338000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86fbdd6384f94375a9f88c4a431213fb_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy0zLTEtMS0xNDI2MjQ_197a677a-9c4c-45d1-8bf6-073a94f9d665"
      unitRef="usd">-128000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b60f9d6630f49ffa53859e738234d11_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy00LTEtMS0xNDUyNzk_04364994-6cd2-4a2a-bec1-667ea57c9a71"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibab71210a8c94981891c3847d80b517f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjkzOWIwMTA5NmRjZDQ4MjE5NWE4ZGM1ODA0YWMyMGRkL3RhYmxlcmFuZ2U6OTM5YjAxMDk2ZGNkNDgyMTk1YThkYzU4MDRhYzIwZGRfNy00LTEtMS0xNDI2MjQ_8c44fe82-74cd-4e61-a230-5a08805fe764"
      unitRef="usd">-3387000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RleHRyZWdpb246MTI2ZTY3NTQzNTJiNDJiZWJlMzgzYTJkMzdkNWViODZfMTA2OQ_b0f6af4a-8e35-444f-aabb-abf9b5508bb7">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfNy0xLTEtMS0xNDI2MjQ_0ed7b407-8377-474c-bfbb-18db657fa7a5"
      unitRef="usd">5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfNy0yLTEtMS0xNDI2MjQ_af5e399f-0d17-48b9-8a41-5858ac5a3536"
      unitRef="usd">-9000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOC0xLTEtMS0xNDI2MjQ_b1760ef7-2616-47ec-ae9b-0689ada9566f"
      unitRef="usd">2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOC0yLTEtMS0xNDI2MjQ_3677b8af-1db4-4f22-b88f-7d997659a5d8"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i6d6c4bc046de4d2c8887a35576b0c95e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOS0xLTEtMS0xNDI2MjQ_4b625179-1410-41d1-a8a2-60bd7446a355"
      unitRef="usd">3000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i45dd72ec6df8459bbe16e00ccedfe97b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfOS0yLTEtMS0xNDI2MjQ_e91f085a-f922-4f5e-9707-7ef89ae6c616"
      unitRef="usd">-7000000</us-gaap:NetIncomeLoss>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if5d70874f80c482cb0e5b8513c4530c3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTEtMS0xLTEtMTQyNjI0_4107c653-15d7-471b-a0b4-b9626d625085"
      unitRef="usd">-4000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id2eb0cff5ab142898e3663ceebe5e867_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTEtMi0xLTEtMTQyNjI0_0b0a5380-56d6-466f-b7bb-c3000061bad6"
      unitRef="usd">-2000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic023f2fc593e4fd29470ad3b703a07c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTItMS0xLTEtMTQyNjI0_2c7fd57b-70e9-40e9-bd21-2bae9de57cb1"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i16554c4f2d744cd9a29f4b0265752f73_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTItMi0xLTEtMTQyNjI0_9a8da52f-9950-48fa-be46-7d3fd409ead2"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTMtMS0xLTEtMTQyNjI0_3030af61-d2b8-4d40-a259-470fd026ecdd"
      unitRef="usd">3000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTMtMi0xLTEtMTQyNjI0_c70e7ded-acf8-469d-b4f6-bb19d4621dc7"
      unitRef="usd">1000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTQtMS0xLTEtMTQyNjI0_abd943e2-7a5f-4ef1-affe-a3f101a9dfdc"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTQtMi0xLTEtMTQyNjI0_a887e39b-d83f-4a54-b9a7-89f254918209"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i618947d55a0249a68e380c91f6074ce3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTUtMS0xLTEtMTQyNjI0_b7afd0cc-bb20-416c-ace4-5829c96d88db"
      unitRef="usd">2000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1ccb49369cdf47a39ce60b1c33fad55d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTUtMi0xLTEtMTQyNjI0_abdcbd0f-232e-447b-8b1f-b89558d1fd27"
      unitRef="usd">1000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i91aae7c820be40a39dc2a16e37f937df_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTYtMS0xLTEtMTQyNjI0_d4d77250-baeb-419b-8362-8505ae3d3fe1"
      unitRef="usd">5000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide752f889a824123acdfc488ef4c92da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl81OC9mcmFnOjEyNmU2NzU0MzUyYjQyYmViZTM4M2EyZDM3ZDVlYjg2L3RhYmxlOjM3Yzg5Mjk3NzBlZjRkM2ZiYmU3MDQwNjQ5OTMwYzhhL3RhYmxlcmFuZ2U6MzdjODkyOTc3MGVmNGQzZmJiZTcwNDA2NDk5MzBjOGFfMTYtMi0xLTEtMTQyNjI0_cea0738d-5e63-49dd-9a18-47061cd57bdb"
      unitRef="usd">-6000000</us-gaap:NetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODU_037a2b05-2e6b-4f23-a9e6-48261446311f">REVENUES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#x2019;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our business segments. Our three legacy Baxter geographic segments include acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. Our legacy Hillrom segment includes smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;To a lesser extent, we enter into arrangements for which revenue may be recognized over time.  For example, our Americas segment includes contract manufacturing arrangements, our Hillrom segment includes digital and connected care solutions and collaboration tools that are implemented over time and all of our segments include equipment leases and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we had $9.9 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of more than one year, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 25% of this amount as revenue over the remainder of 2023, 35% in 2024, 20% in 2025, 10% in 2026 and 10% thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price, which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in  accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2023 and 2022 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3&#160;billion and $2.4 billion as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for certain arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5Nw_058c585b-8103-4c06-82dd-1458b96650eb"&gt;one&lt;/span&gt; to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are delivered and billed, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA4NQ_0ec20cf7-5fe4-4e5f-af12-88aff4a5d833"&gt;one&lt;/span&gt; to seven years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the three months ended March&#160;31, 2023 and 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023 and 2022, $68 million and $50 million of revenue was recognized that was included in contract liabilities as of December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Net Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Global Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Global Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease medical equipment, such as smart beds, renal dialysis equipment and infusion pumps, to customers, often in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net investment in sales-type leases was $82 million as of March&#160;31, 2023, of which $24 million originated in 2019 and prior, $21 million in 2020, $20&#160;million in 2021, $14 million in 2022, and $3&#160;million in 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="i48c4b44d7aaf45f6a6e5c398103bc5cb_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfODA1_728d154c-21a6-47bb-810f-1fb73b928d7f">P30D</bax:RevenuePerformanceObligationPaymentTerms>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="i21b2d8e97e8244178d692d6892f4a85a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfODA4_c970e1fc-5249-461f-8ee8-f739987c8799">P90D</bax:RevenuePerformanceObligationPaymentTerms>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjU1NQ_9d071c45-4142-4b30-b074-04ed37f799a5"
      unitRef="usd">9900000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i5610c9c40f1541588c111ed258e20b5b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjkzMQ_88a3b367-31a8-4a77-b8ab-bf5b8137b18e"
      unitRef="number">0.25</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ifb101e2dce6d4a8da899e7f908565f3f_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjk4Ng_c104493b-69e2-4431-bedb-615cd433b0d3"
      unitRef="number">0.35</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i91e5bce880e748fa8fd4e3630bd445ad_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTQ5NzU1ODI1Njg0_6087e750-7a43-4c32-9171-4d256ee5b2aa"
      unitRef="number">0.20</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i61cf97becb9c4e1a9b859df1e52905f9_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMzAxMQ_1d55cf70-317f-4c1c-954e-f6ba335e7a73"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ib69465f840b74ac28588c55cf8bf2541_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMzAyNA_05313f55-cb81-44bb-b892-6b1cc5d59369"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:AccountsReceivableNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTMyNQ_51ad5f88-cfd6-493c-85fd-43780d75837e"
      unitRef="usd">2300000000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNDkxNg_a7f1c4fe-e968-4d63-9a4a-87b93b86f9ce"
      unitRef="usd">2400000000</us-gaap:AccountsReceivableNet>
    <bax:RevenueRecognizedContractPeriod
      contextRef="if002ac6e967144bd96115173fc7cf29a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTA4NA_1b827771-1a3b-4ebe-a5e7-b8d2d424126b">P90D</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="ib95b5cb2f8e647f6a99def589a703561_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNTUwMw_3a3d9471-b053-4de0-b44f-4ce5f2c2923a">P5Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i934c0cc8c80045549e4782969e1e7b84_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfNjA5MQ_9aa3e80e-5e1f-4bca-8739-88ad79fcab40">P7Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODE_3a030a6e-9afe-4ca0-8a00-7a44b5dc8999">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the three months ended March&#160;31, 2023 and 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023 and 2022, $68 million and $50 million of revenue was recognized that was included in contract liabilities as of December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ia6b196d8914241ada05ff36938bc292e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMS0xLTEtMS0xNDI2MjQ_d51f1303-3b51-497a-8bda-2d7e71bd995c"
      unitRef="usd">49000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ie3e73cac1b5c4796a4109810e816823d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMS0yLTEtMS0xNDI2MjQ_3aa7d5aa-7748-439d-9ece-d69793bff7fe"
      unitRef="usd">51000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iabeea204152c4e01befa7939da13274f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMi0xLTEtMS0xNDI2MjQ_a4be45a3-4623-4ea2-9abc-a6454b1d0b6e"
      unitRef="usd">42000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ieab095ac3325476aa40d27526c3ce9d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMi0yLTEtMS0xNDI2MjQ_c67ea28f-c4fb-47b1-a082-96557bb56699"
      unitRef="usd">43000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="idfc44eeeb3fe4cf8a2fa2850b25dbd4f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMy0xLTEtMS0xNDI2MjQ_732bbfb2-a9da-4964-9cea-f354280c857d"
      unitRef="usd">120000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i830f0bf194924d0e87c143bb795d1c61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfMy0yLTEtMS0xNDI2MjQ_d6544e97-1774-48d7-a86b-c034bee65cd1"
      unitRef="usd">121000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfNC0xLTEtMS0xNDI2MjQ_a316ab17-46ce-4184-879f-6f783497002a"
      unitRef="usd">211000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOmI1MzViNGI4NDk1NDRiNDliYTUwM2I5MWIxNjVkM2EwL3RhYmxlcmFuZ2U6YjUzNWI0Yjg0OTU0NGI0OWJhNTAzYjkxYjE2NWQzYTBfNC0yLTEtMS0xNDI2MjQ_23297c91-36db-4701-8461-3ef40a152af0"
      unitRef="usd">215000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMS0xLTEtMS0xNDI2MjQ_c336d7f3-4a9e-4bcc-b3ed-d978dae806d9"
      unitRef="usd">244000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMS0yLTEtMS0xNTQyMDk_11a5e64d-b760-40a1-8b9e-f603b6aa70d0"
      unitRef="usd">246000000</us-gaap:ContractWithCustomerLiability>
    <bax:ContractWithCustomerLiabilityDeferredRevenue
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMi0xLTEtMS0xNDI2MjQ_96dad7cf-bed5-4478-9cd3-330432a0ac32"
      unitRef="usd">113000000</bax:ContractWithCustomerLiabilityDeferredRevenue>
    <bax:ContractWithCustomerLiabilityDeferredRevenue
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMi0yLTEtMS0xNTQyMDk_cf927d1a-59d0-43b6-80b9-71ca8139a131"
      unitRef="usd">116000000</bax:ContractWithCustomerLiabilityDeferredRevenue>
    <bax:ContractWithCustomerLiabilityTotalRevenueRecognized
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMy0xLTEtMS0xNDI2MjQ_6a367565-46d0-4058-89d6-79f8b9d3eace"
      unitRef="usd">121000000</bax:ContractWithCustomerLiabilityTotalRevenueRecognized>
    <bax:ContractWithCustomerLiabilityTotalRevenueRecognized
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfMy0yLTEtMS0xNTQyMDk_3d1261bb-9707-424b-905c-9c096654c746"
      unitRef="usd">122000000</bax:ContractWithCustomerLiabilityTotalRevenueRecognized>
    <bax:ContractWithCustomerLiabilityCurrencyTranslation
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNC0xLTEtMS0xNDI2MjQ_56151e49-99c3-4415-8130-340ca5ec2359"
      unitRef="usd">-1000000</bax:ContractWithCustomerLiabilityCurrencyTranslation>
    <bax:ContractWithCustomerLiabilityCurrencyTranslation
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNC0yLTEtMS0xNTQyMjY_7a14ca8a-e464-45bc-b3f9-a764ffafc9eb"
      unitRef="usd">0</bax:ContractWithCustomerLiabilityCurrencyTranslation>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNS0xLTEtMS0xNDI2MjQ_af2dfdcf-8de8-47a1-b63c-a764ffe41dc7"
      unitRef="usd">237000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjUyNTAyZWRmMjVjMzRhZDdiMWFkYTFlMGY0YThjYjY4L3RhYmxlcmFuZ2U6NTI1MDJlZGYyNWMzNGFkN2IxYWRhMWUwZjRhOGNiNjhfNS0yLTEtMS0xNTQyMDk_ad5fa5d6-50ef-4d06-9a1e-c002373d7246"
      unitRef="usd">240000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTQ2Mg_9d020e76-d0b1-4047-b3e7-748c3c05a153"
      unitRef="usd">68000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMjc0ODc3OTA4MTQ3Mw_e7a7feb2-f7b5-474e-8ffd-b38b280ecab3"
      unitRef="usd">50000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i3ec046897a2946cd93ab85a15ee56c94_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMS0xLTEtMS0xNTc0MzA_96128a54-494c-4dfd-aaad-be689aeff2d1"
      unitRef="usd">92000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ie1bd13a49b7d429e82c8bdf69b96e60b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMS0yLTEtMS0xNTc0Mzg_ca793c11-3ef6-4ef0-8c06-5d4fe5682cb4"
      unitRef="usd">93000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i30142c94438942e98469e05b1af863d8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMi0xLTEtMS0xNTc0MzA_27e0127e-3974-4650-b15e-db4b858d89d9"
      unitRef="usd">119000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ie3508ca5e5c14a48b24d540f5319e20b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMi0yLTEtMS0xNTc0Mzg_a57c35f3-4a7a-4fb5-bd60-0bc3709c4c52"
      unitRef="usd">122000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMy0xLTEtMS0xNTc0MzA_a316ab17-46ce-4184-879f-6f783497002a"
      unitRef="usd">211000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfMy0yLTEtMS0xNTc0Mzg_23297c91-36db-4701-8461-3ef40a152af0"
      unitRef="usd">215000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i51119038860e46bab77a4b1e87a97094_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNS0xLTEtMS0xNTc0MzA_4b97ee00-2b0c-4dd8-afc2-76ddf86f2c64"
      unitRef="usd">160000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i23951dd4106e4790ac61468e0c4ec8df_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNS0yLTEtMS0xNTc0Mzg_d460a5e1-fb87-43e4-b897-c9b750aa61b4"
      unitRef="usd">164000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i341560a16fc74ca08d74ea499cbe59d7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNi0xLTEtMS0xNTc0MzA_ff221c57-7146-4fa0-8176-c58a6c854ddb"
      unitRef="usd">77000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib97450461ad646f683e7377c9387239a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNi0yLTEtMS0xNTc0Mzg_2e1cd325-9381-42be-8255-15d7ce913475"
      unitRef="usd">80000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNy0xLTEtMS0xNTc0MzA_1d197418-fd15-44c7-8b8b-34e90f26f0a0"
      unitRef="usd">237000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjZmOGY4NmVjOGUxMjRjM2RiNmVmNjZiNGM2NjA2MTBmL3RhYmxlcmFuZ2U6NmY4Zjg2ZWM4ZTEyNGMzZGI2ZWY2NmI0YzY2MDYxMGZfNy0yLTEtMS0xNTc0Mzg_7c2985af-a7d8-4671-87f1-c65cdb2fed92"
      unitRef="usd">244000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODI_c718e025-a5a6-4aa2-89af-4262a3f76257">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Global Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Global Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieed79c5aca8f438cb35994e6accb8277_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0xLTEtMS0xNDI2MjQ_71d29b0d-ddff-419f-9760-1518c11b72cd"
      unitRef="usd">232000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32733260a4bf466da30a8f6e7a69dc20_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0yLTEtMS0xNDI2MjQ_ff83c064-eac8-499e-9ca5-27a6c2f2f38e"
      unitRef="usd">660000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb9352b2578b4ff8af90d6737f465636_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy0zLTEtMS0xNDI2MjQ_4ec0b093-8ee7-4e36-b753-1ae94b3373e1"
      unitRef="usd">892000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7dff2da3bb745e083dfc8efbc4a6a2d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy00LTEtMS0xNDI2MjQ_ff925943-66bb-4478-a52d-9dbfde46051c"
      unitRef="usd">225000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ffe0a066678436faeb952bbc5692853_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy01LTEtMS0xNDI2MjQ_621f4c29-797b-4e56-9f01-8b103a56711b"
      unitRef="usd">669000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50262bb8dfd6483883e178e4d08c0ce7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMy02LTEtMS0xNDI2MjQ_b88d1a7c-74e4-4f72-9312-9b8e58fbac67"
      unitRef="usd">894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12de3de1a9974944bc8378eba2c65c03_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0xLTEtMS0xNDI2MjQ_d8db6cce-71a6-40a0-95a0-7ed728a7fad0"
      unitRef="usd">436000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79bf91abd1634761a2195c7f9d8d118a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0yLTEtMS0xNDI2MjQ_5f3e29ea-1523-45c3-80d4-f166ec7d01ab"
      unitRef="usd">251000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7a0d7a1030b4a098fc24e15ad2a801d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC0zLTEtMS0xNDI2MjQ_27cb272d-ccc3-47e0-8042-7f931cba8063"
      unitRef="usd">687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i820a760c47924ab98c99c4b2a9096d78_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC00LTEtMS0xNDI2MjQ_42643656-90f2-41e7-96ac-4fbf0cd4f75a"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc6075f06dbd490298097b3ed5cd4821_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC01LTEtMS0xNDI2MjQ_19eaa5c6-a51f-40b3-9e20-3329df860f00"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf1bbc48b59745a293d43e19e9033459_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNC02LTEtMS0xNDI2MjQ_710c3012-2c41-4ec4-8617-4c43f33fbd32"
      unitRef="usd">706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac2f4acb21d4eda95086e8322451c06_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0xLTEtMS0xNDI2MjQ_b28df9e8-d84c-4a62-9bb0-99cb7fc0e20e"
      unitRef="usd">173000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id093cc65fe2e41f685c58769f4731abe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0yLTEtMS0xNDI2MjQ_f3634c54-edd7-4940-8ca9-ce000e32bd90"
      unitRef="usd">350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b1f8777b66c4f1abea702af4a4f50d8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS0zLTEtMS0xNDI2MjQ_662bec28-a463-4330-ab5e-12fa155a1cf2"
      unitRef="usd">523000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ae97fbb983b4c339641d89166090167_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS00LTEtMS0xNDI2MjQ_106fb3dc-0ac0-429b-9362-3919393de3c2"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d21ce85e8b546008235897f9720292f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS01LTEtMS0xNDI2MjQ_426cb6c8-5adc-444e-a95c-cfda1e6b5efa"
      unitRef="usd">364000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a674bd62d60412dae3e15bda3d6fd5d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNS02LTEtMS0xNDI2MjQ_a9275716-b872-46c4-b02d-f1473622f40b"
      unitRef="usd">521000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18171446335341e6972e6ad0f0855341_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0xLTEtMS0xNDI2MjQ_5b28e2b7-3e61-4ab6-9e48-6ec5949faeaa"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d7450c4c4ea47f395399141fae391aa_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0yLTEtMS0xNDI2MjQ_e67e8fc3-7944-49f8-9535-c0176db244ec"
      unitRef="usd">146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32eccbe2241e419fbbbba27ba8251c58_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi0zLTEtMS0xNDI2MjQ_23626325-15fd-4e65-af9b-7d0af7c586ba"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f4f3a644eb645e3b6ffb4f9285599fe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi00LTEtMS0xNDI2MjQ_95840d79-26b8-4455-8be0-8b5253b66497"
      unitRef="usd">84000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i326ca958c6174cbd9f53bd4911788519_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi01LTEtMS0xNDI2MjQ_4bfe765c-0531-4c89-9ea8-1dbd0046375c"
      unitRef="usd">143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ffdd9abc5b147d1b6b3131424e764b8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNi02LTEtMS0xNDI2MjQ_f56bff3c-16bd-434c-a153-0e9febdb818c"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48702d534ce34e3d895104c00a42f7b9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0xLTEtMS0xNDI2MjQ_09827a13-69c9-4306-86f5-f3d8e86614ea"
      unitRef="usd">144000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77f8be4d668c436690b8ef4eaa3b1289_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0yLTEtMS0xNDI2MjQ_228411b4-e8f2-48c7-83ed-e2511a965025"
      unitRef="usd">102000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37ecf3e2ffa240ab97ef06571c436317_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy0zLTEtMS0xNDI2MjQ_38df9252-6ca3-4fad-8689-8f4098a50106"
      unitRef="usd">246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae75aad13a8b4f4a9d28f6c2a411306e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy00LTEtMS0xNDI2MjQ_5f8214d2-7b35-48af-be3a-4cb17fe49be5"
      unitRef="usd">136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36331106af6b44069480b11afb1c4eb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy01LTEtMS0xNDI2MjQ_0676f0fe-c7d8-4684-98f6-ba5b130d549f"
      unitRef="usd">92000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id70635d3e9e24de284e21b0565f0a12c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfNy02LTEtMS0xNDI2MjQ_36c7bf42-1952-4869-8e85-526c4d3d33f9"
      unitRef="usd">228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a994bb1351d426e972cb4ab45bf9e31_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0xLTEtMS0xNDI2MjQ_d962d383-2a1b-47b5-9fa8-53fa1b2e16e2"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if15645b93aa34aadb9ab25d167667aa4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0yLTEtMS0xNDI2MjQ_f6a7e5bc-3436-4231-928d-392173f79c6c"
      unitRef="usd">119000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e5c3586df22467d826986ca298658b2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC0zLTEtMS0xNDI2MjQ_10b6f70e-c075-48e7-9ff4-6e6bb7fa09d3"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifddaa3fea1ec401fb23364d3c78814ad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC00LTEtMS0xNDI2MjQ_b1e2774b-2e96-44e2-b9af-54f233edacb2"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70a9ffd20fe44b3494b57e15f7d91ccb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC01LTEtMS0xNDI2MjQ_1a720f8d-0efc-49e5-be3b-3057ede7118e"
      unitRef="usd">120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7a56542c97d47a0b0f0459e24442e08_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOC02LTEtMS0xNDI2MjQ_205c5c38-4e90-47ee-87d6-ad8929bd853f"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4237b6bc47b47e3be8d39761a9c6aa6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0xLTEtMS0xNDI2MjQ_410ee862-ddb4-4d90-ba45-31782eba9034"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2481cb453dff4f67b82d44e30bd6d0fb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0yLTEtMS0xNDI2MjQ_497c5dfb-2645-4ea6-b511-a31a24a55138"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cff1006b2cd4700a226e1343371d967_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS0zLTEtMS0xNDI2MjQ_dbd2223e-dab2-439d-9555-735931fa1a63"
      unitRef="usd">139000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f9f21fee0414681bd88793126bd2d5d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS00LTEtMS0xNDI2MjQ_2610b225-699f-4f4a-85d6-e68738df1dd8"
      unitRef="usd">52000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0865a1d47314456a3bf5d603919e3aa_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS01LTEtMS0xNDI2MjQ_2e59d67c-5c9c-4d42-b719-ea3ddd6cda1b"
      unitRef="usd">104000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65045dd2524b4052a661a980309aee0e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfOS02LTEtMS0xNDI2MjQ_e1238efd-16ff-42fb-ad44-8155407fb433"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65a6dd9348044feb8a8e67e815565350_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMS0xLTEtMTQyNjI0_5c399045-8161-4286-88ff-c0f72676ae27"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58acde9af12d40e88ea03e411ef7469a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMi0xLTEtMTQyNjI0_fe74e2b1-6b48-4739-bd8f-9b61304377ea"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8bcd8e837bc4dc08f1912d660ad261c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtMy0xLTEtMTQyNjI0_0943d2c7-5dce-417a-96fb-4940db542357"
      unitRef="usd">348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae2ec3cee867481bae76001f58c40302_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNC0xLTEtMTQyNjI0_f3d3c9dd-28b5-4630-8ca6-5ac1555b5e27"
      unitRef="usd">295000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8332d3c37964860a2fa8f6c0f6e8183_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNS0xLTEtMTQyNjI0_0adcea80-cc16-4dab-9a71-095c1875d937"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b5d26e5e396479bb46016c7624c2225_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTAtNi0xLTEtMTQyNjI0_421b1e89-a9b3-48b6-84fc-dc9bcc4c4844"
      unitRef="usd">383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c506923a318493ea4d9c20cbab2421a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMS0xLTEtMTQyNjI0_08ec6ce9-55fe-42be-afc5-8737e73dd71f"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f1768ac76934e2091b109112b486b74_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMi0xLTEtMTQyNjI0_ef52bea4-5dd9-49df-8eb4-312db5f8e6ae"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0ac9d56de7f4427a9059c8e448f30f0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtMy0xLTEtMTQyNjI0_0be8df65-5b76-4c8d-b6d5-f3f5e098e8f8"
      unitRef="usd">302000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie54c320fa8384fc9acd727cd9b93cb52_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNC0xLTEtMTQyNjI0_5fce53ae-69dc-464b-8c2e-0963aa4f3607"
      unitRef="usd">207000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88faf063570c4244819342e4932cf151_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNS0xLTEtMTQyNjI0_e8d073d3-7500-43e0-8439-6c9fe71a634f"
      unitRef="usd">87000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic892496e521b4b4180628d9710fcfde4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTEtNi0xLTEtMTQyNjI0_e40e99a2-52e8-49dd-a5a0-4c8f0cf11d92"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i639893b243a5412089b13acbee4be7d8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMS0xLTEtMTQyNjI0_718aabdd-61fc-4f46-80b0-c1d6c4a2ba24"
      unitRef="usd">38000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e5f7268c6da45c28b4cc8a8092641d4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMi0xLTEtMTQyNjI0_4c9a5d42-75cb-41eb-86f7-ef555a2160b9"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c3ca618644448a69e18c4788006dcfb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItMy0xLTEtMTQyNjI0_c300de87-2493-4345-a01d-3db9ec0c74a4"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c4c6783bfa6492680542b292f98ef46_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNC0xLTEtMTQyNjI0_29162997-fd9e-4324-99d0-f9aa47dd1796"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d7bcb4770d143ccb5cf3653c8dbd7ea_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNS0xLTEtMTQyNjI0_0f4cbfb4-bf78-43cd-a831-163499fc3a57"
      unitRef="usd">41000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04066796b2e844dd9677b2763ae8e6ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTItNi0xLTEtMTQyNjI0_0be81440-fa03-4ad5-baea-59db45fa43c1"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie43580480246408d913ffd6f7571c3c4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMS0xLTEtMTQyNjI0_23ad4dcb-a1ef-450b-9a59-71539e333bf7"
      unitRef="usd">22000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i700fd4a0950a4c45b9412d578fea8869_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMi0xLTEtMTQyNjI0_63a279a9-fee7-445e-953e-11933a3960bd"
      unitRef="usd">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i406d564a78fd4100975bf9f358114ad6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtMy0xLTEtMTQyNjI0_f9d4c705-5c8b-440b-b775-f9f75d4d235f"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ed76db4cef84a44b19a64f1d1833488_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNC0xLTEtMTQyNjI0_1a475243-7366-495d-b92a-25bb1f89050b"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50189ca1ce5346128884acb2fd951604_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNS0xLTEtMTQyNjI0_872516be-20f3-49b0-84ac-d26004705d74"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i556f482c728a4e6abc7fcb69f24c8e79_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTMtNi0xLTEtMTQyNjI0_4fc00098-75bd-49fe-96f5-3068df721bb1"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34e11ed2205046a495eb41670b8242bf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMS0xLTEtMTQyNjI0_68998ddd-fcb4-49b2-9884-a1137e670191"
      unitRef="usd">1734000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d5191430d4c4fa5b3ea2beb1699b836_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMi0xLTEtMTQyNjI0_49bd6d51-0804-48d4-ba15-3149cd7591c9"
      unitRef="usd">1915000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtMy0xLTEtMTQyNjI0_3e67196d-a1e7-4b29-848b-5619879b358e"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61f02dbb147d48a7be36808b0e938d20_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNC0xLTEtMTQyNjI0_0f7b75a0-99c1-42e9-915a-37110851db6a"
      unitRef="usd">1757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42fee9757d10432cb8ae120e6b418ddd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNS0xLTEtMTQyNjI0_c51b036f-6cd6-4137-a49d-43f671840dd7"
      unitRef="usd">1950000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjA3ZWNlMmQwN2IwNDRmNGViZjkxZmQ4NGEwNmY3YmRjL3RhYmxlcmFuZ2U6MDdlY2UyZDA3YjA0NGY0ZWJmOTFmZDg0YTA2ZjdiZGNfMTQtNi0xLTEtMTQyNjI0_f3fff65d-31a9-4801-ae4b-6652a0210916"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODM_31727caf-ea1f-4675-83f9-01ba505a16f7">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyODM_f12aa58e-ddfe-4d46-914e-bd1a0ec526bc">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2023 and 2022 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMS0xLTEtMS0xNDI2MjQ_11345ccb-6e43-4b39-afc8-eebe9216730b"
      unitRef="usd">4000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMS0yLTEtMS0xNDI2MjQ_fd0ed408-b210-49fe-8914-aaa684d54ba1"
      unitRef="usd">3000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMi0xLTEtMS0xNDI2MjQ_0ba13b7a-0e57-49c4-a7a8-ede0eb6bf5fc"
      unitRef="usd">124000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMi0yLTEtMS0xNDI2MjQ_d647f3b3-56cd-486f-b551-d5ec2887c2df"
      unitRef="usd">122000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMy0xLTEtMS0xNDI2MjQ_4658f10d-959b-4a66-b52a-b05fe584db46"
      unitRef="usd">15000000</us-gaap:VariableLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfMy0yLTEtMS0xNDI2MjQ_f70ac036-36a3-48a8-bc1a-d8983d317f27"
      unitRef="usd">20000000</us-gaap:VariableLeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfNC0xLTEtMS0xNDI2MjQ_27eba016-0281-4656-8947-dd7af6a3118d"
      unitRef="usd">143000000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RhYmxlOjE3ZjI4Yjc4MzA1YjQ2NTc5MmZiM2YxYWQ1ODY3ZmI2L3RhYmxlcmFuZ2U6MTdmMjhiNzgzMDViNDY1NzkyZmIzZjFhZDU4NjdmYjZfNC0yLTEtMS0xNDI2MjQ_e242c991-caac-4dcd-8466-f783831cac3e"
      unitRef="usd">145000000</us-gaap:LeaseIncome>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAxNzE_5b6cbab5-4cf7-4c2e-a6a3-8b499f003b67"
      unitRef="usd">82000000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="icd5a84bea14647598fb6658816f37588_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAxOTM_f3ff79b9-ed19-46f0-91af-cd63830b2b13"
      unitRef="usd">24000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="icd5848326be84436ade2b47357ffcccf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyMjY_8473eecd-b0b8-4166-a32e-87ca28f036c3"
      unitRef="usd">21000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="iff3416cbddea4d21a603a12d26373af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyMzg_fd7b3386-a2c6-4db9-abe2-5d5e0a5c3be8"
      unitRef="usd">20000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyNTA_a044b86f-d877-41db-98e6-ffa8fdd4bd86"
      unitRef="usd">14000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82MS9mcmFnOjI4ZjA1MzkwMDIxNzQ5NDQ5MzA3NTRlZDY2OTY2NGUxL3RleHRyZWdpb246MjhmMDUzOTAwMjE3NDk0NDkzMDc1NGVkNjY5NjY0ZTFfMTAyNjY_f772ef6d-d9dd-4168-8678-8c283993ee54"
      unitRef="usd">3000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxNQ_e2f9eef7-2019-4cb4-ac74-ada7adaf840d">BUSINESS OPTIMIZATION CHARGES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2023, we have incurred cumulative pre-tax costs of $1.6 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs, primarily related to implementation of business optimization programs, of approximately $24 million through the completion of initiatives that are currently underway. We continue to pursue cost savings initiatives, including those related the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations, and, to the extent further cost savings opportunities are identified, we would incur additional restructuring charges and costs to implement business optimization programs in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For segment reporting purposes, business optimization charges are unallocated expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs to implement business optimization programs for the three months ended March&#160;31, 2023 and 2022, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;amp;A expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023, $78&#160;million of the restructuring charges reflected in the table above, consisting of employee termination costs, were related to the ongoing implementation of our previously announced new operating model intended to simplify and streamline our operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022, $56&#160;million of the restructuring charges reflected in the table above were related to integration activities for the Hillrom acquisition, consisting of $38&#160;million of employee termination costs, $12&#160;million of contract termination and other costs and $6&#160;million of asset impairments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our restructuring liabilities as of March&#160;31, 2023 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfNjQ2_0096d07a-58c6-49db-bd5d-9e586d690d19"
      unitRef="usd">1600000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfOTc3_f49ec4b7-ec10-4a07-85ba-7e6c48b4a1d5"
      unitRef="usd">24000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bax:BusinessOptimizationChargeTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxNg_d0d827c5-3d8b-4761-9078-75b2c4192fd1">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:BusinessOptimizationChargeTableTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMi0xLTEtMS0xNDI2MjQ_50234265-762c-4e11-bdc5-8ef4f364ee9d"
      unitRef="usd">110000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMi0yLTEtMS0xNDI2MjQ_01e165e3-c868-4548-8fb9-2b3102bd30a3"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMy0xLTEtMS0xNDI2MjQ_5b43a160-0dea-494c-8a9d-e195c5e298af"
      unitRef="usd">24000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfMy0yLTEtMS0xNDI2MjQ_1301af76-9cce-47f4-8068-cd12c9b0dd25"
      unitRef="usd">14000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringCosts
      contextRef="id2279531cc564bc5b781f9558ed1add4_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfNS0xLTEtMS0xNDI2MjQ_bb8a4014-f4de-4b37-baf7-cda8dc810e64"
      unitRef="usd">134000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ibfb7557f0bfb4c129e4b02c93fd85afe_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjc4YzAzM2U3YjUxMzRmYmJiN2M4ODQ4M2Q2ZjI0OWZlL3RhYmxlcmFuZ2U6NzhjMDMzZTdiNTEzNGZiYmI3Yzg4NDgzZDZmMjQ5ZmVfNS0yLTEtMS0xNDI2MjQ_7a6200ac-451d-4e44-ab56-dc845c64958b"
      unitRef="usd">81000000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxMQ_f0e65d91-d402-4083-bf45-e3acd1f8b6a1">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i38f1c5a1ba7442d1a6b301c41e26e0bd_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0xLTEtMS0xNDI2MjQ_7335128f-d9b4-45ce-84e6-8431f1b77621"
      unitRef="usd">17000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i92e9e48c329d4d63aa8ed4f54c4d2d61_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0yLTEtMS0xNDI2MjQ_d1ced006-b709-4d76-80a3-4ff20d54c48a"
      unitRef="usd">63000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8d7f02b816254b8aa330323c3a69a6f8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi0zLTEtMS0xNDI2MjQ_0215cfcb-5b3a-4207-aa8e-55ee114b7861"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i50a9fd6731664971b019d860f06b8d7a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMi00LTEtMS0xNDI2MjQ_786d05f5-1ab2-4450-9b4d-702e174a2b9e"
      unitRef="usd">87000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaf58d18ba69645c388a1b80e92a29a6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0xLTEtMS0xNDI2MjQ_b1dd6cbf-c63c-41b4-bfd8-51d548db1013"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i857194e9005945168ca557c8b9cd6cf6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0yLTEtMS0xNDI2MjQ_cdccb12d-4636-4d0e-a1c3-1cc54acc67a7"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i080f246a03434c36b738f2ab73889cb7_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy0zLTEtMS0xNDI2MjQ_3beb6343-9d34-44c3-920f-ea260980adc9"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i723a8f8cd90d40c5b923bb953965b6f0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfMy00LTEtMS0xNDI2MjQ_9aa828f6-f467-41fc-a2cb-10bcc4620c67"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i45cdbf59bba942c799174d71fc78424f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0xLTEtMS0xNDI2MjQ_d82ac440-ec62-46dd-a9dc-664209f66e42"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7480c0baf3ef4031958b631683211304_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0yLTEtMS0xNDI2MjQ_9aad4d43-482d-479c-885f-89ce75e7ef17"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8ace030c17a84199b8a58d5de02660b0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC0zLTEtMS0xNDI2MjQ_0777bff5-1f4a-4dfd-afbf-d27e294ba5f2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibcb0c4c8a0364ddab4ced3d467f03536_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNC00LTEtMS0xNDI2MjQ_ae5e9a32-b4b7-49fe-b7f2-724851dd1046"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie9afb4c625184a3f99e2cb5a2e3d5eaf_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0xLTEtMS0xNDI2MjQ_ac821844-ecbc-4c88-9e8a-db37b2d1f4bb"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3c8d9d2e13254a4a851b924c07c94850_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0yLTEtMS0xNDI2MjQ_75d2334a-8133-4618-adfa-23096a7cf2e1"
      unitRef="usd">71000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibcdaac085a184fd991190127986b186a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS0zLTEtMS0xNDI2MjQ_08ae7ec6-88ca-4001-8715-99b74001c40b"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmZiNjVmNjYzY2VjOTQ0MzU5OTQ3ODNiZDc2ZTg2M2FkL3RhYmxlcmFuZ2U6ZmI2NWY2NjNjZWM5NDQzNTk5NDc4M2JkNzZlODYzYWRfNS00LTEtMS0xNDI2MjQ_78ab5adf-1f76-4b10-9e19-16ed77efea9f"
      unitRef="usd">110000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd11f2b19d644626913c68555b6a3ed3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0xLTEtMS0xNDI2MjQ_30669dcd-a082-4142-8d08-258644c1853f"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iba969a96aa1a4d5c9b9694620c56457c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0yLTEtMS0xNDI2MjQ_f648483b-87ce-46aa-8a82-b15d72cbaa21"
      unitRef="usd">47000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd088a28be84475899676efd77df7fb1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi0zLTEtMS0xNDI2MjQ_286c060b-32fb-416c-aa75-22f501dd87e9"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0844e0faf2924757a27a663c5f70585f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMi00LTEtMS0xNDI2MjQ_36a515d1-64e0-47af-9062-da77705d0640"
      unitRef="usd">49000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iafe3d35593ef467a942d74f57b0d973f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0xLTEtMS0xNDI2MjQ_ba6ddf02-35df-4247-98ad-34a9ae0963b8"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee715c6013774f86871bc93f1f3c5581_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0yLTEtMS0xNDI2MjQ_97fd5b57-7707-4bfe-a627-e765a07f617b"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2ded499efde348f38db33fa32a02f9c7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy0zLTEtMS0xNDI2MjQ_67fe7a95-6349-4e65-a2a7-cdb38f136319"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaf53b679288243c4b2c60ffa46acdbc7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfMy00LTEtMS0xNDI2MjQ_4773fac9-5c46-46c5-977c-c150cf5a4c22"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia1ebac333e6b4b7e824140ded41ed412_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0xLTEtMS0xNDI2MjQ_1eef68a6-b1dd-4e3c-ab6d-428b7a011fc6"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i360dc4f66e284c169a8571d8f06cfb23_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0yLTEtMS0xNDI2MjQ_d2af98f4-0a6f-4d76-8dda-f3d6bf5b559d"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i27eafd0032b54ff9b789fb388acb51f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC0zLTEtMS0xNDI2MjQ_312814fa-29ce-470f-a886-e2b69ba76352"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i301ed7692b8f4861bf3943d034b41d27_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNC00LTEtMS0xNDI2MjQ_bf35d19a-9c0a-4fad-95a7-2dca434a7c4b"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8dbd6d4f17c1483890abb77740b35017_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0xLTEtMS0xNDI2MjQ_bbe28957-f072-46da-bcc3-fbd51b983969"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7d39b8e7b0d742918fa14009236396be_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0yLTEtMS0xNDI2MjQ_18e60310-f428-4307-89d1-d56cdb9e70d5"
      unitRef="usd">65000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibf871b9974004097959095e896164ea5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS0zLTEtMS0xNDI2MjQ_12521712-4b65-4441-9b8a-b095393ae09d"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOjM0ODVjZmUxZGY4NzQwYTFiYzMyMmRlYjFiMmEwMGViL3RhYmxlcmFuZ2U6MzQ4NWNmZTFkZjg3NDBhMWJjMzIyZGViMWIyYTAwZWJfNS00LTEtMS0xNDI2MjQ_e1f7abc8-b033-4d29-b0f1-f57872eb8ea1"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8ef6dc9c2a204c7eb7bd1ef80318af8e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MjUyOA_ece48a94-d355-4053-9216-4c9099cd7fd5"
      unitRef="usd">78000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icbd8645e550c4ed8952d05182e882159_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3Mjk3NQ_68cdb79b-bd3c-4856-bfb3-d5d766aca528"
      unitRef="usd">56000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib5c12720ec2d4657b11334d2f5c03900_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MzA0NA_0cd055d8-4c6a-41f1-b565-446fb9f71758"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iab2e3d03af0e4a9d8b80b6d36fc10ad6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3MzA3Mg_e2c53649-7c25-4885-a6d8-6c2fec186e7f"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie7cece8bf1314a0bb7e3af8e0b6c6632_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjc0ODc3OTA3Mjk4OQ_f4ab1700-e11d-41d6-954f-21ad77c69a10"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RleHRyZWdpb246OWE0NGQwZTVlOWRjNDllMzk0MGMxMTZhYjU0NmFmZGJfMjMxMw_bb4c4a72-e090-4124-8c31-90eefda8206b">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i1ff73073d6be424295feaeb2acc57d80_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMS0xLTEtMS0xNDI2MjQ_522bd641-fa46-4b94-9bc5-781b04ffe3ba"
      unitRef="usd">107000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMi0xLTEtMS0xNDI2MjQ_08e99033-3551-4391-a14f-fc584ceb02b1"
      unitRef="usd">93000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfMy0xLTEtMS0xNDI2MjQ_54c85db3-0298-4892-b27c-38ce6d16d15c"
      unitRef="usd">23000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNC0xLTEtMS0xNDI2MjQ_82dc64f7-9587-4e31-81c3-b4d39ea9fc16"
      unitRef="usd">3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i0b09de98898c4bbab0f0e3dc023bd1a1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNS0xLTEtMS0xNDI2MjQ_94d953b9-4cc1-47d0-98d4-5986e1d35af0"
      unitRef="usd">1000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="if47e22ae3131468e92ac7e7b3405265d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl82Ny9mcmFnOjlhNDRkMGU1ZTlkYzQ5ZTM5NDBjMTE2YWI1NDZhZmRiL3RhYmxlOmE5YTgxZWUzMzBhMjQzYjE4NTQ4OTYzNTk1ODQwODM3L3RhYmxlcmFuZ2U6YTlhODFlZTMzMGEyNDNiMTg1NDg5NjM1OTU4NDA4MzdfNi0xLTEtMS0xNDI2MjQ_4cb6f839-d679-4eb5-9cb0-007ade21ce3f"
      unitRef="usd">175000000</us-gaap:RestructuringReserve>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RleHRyZWdpb246MWIyMGUyOGI1NjQ1NDY2OGFlNmY1MzhlMjVjNWY0NTBfODQ1_91e1430b-d825-41fd-9759-8cd1279531cc">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RleHRyZWdpb246MWIyMGUyOGI1NjQ1NDY2OGFlNmY1MzhlMjVjNWY0NTBfODQx_cd3563ee-f34e-4834-a20d-2ec4d94a56fe">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMy0xLTEtMS0xNDI2MjQ_cd4b442f-36ea-448e-945a-c110e91fa06a"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMy0yLTEtMS0xNDI2MjQ_0f4a121b-c0d6-4d64-9ef0-b2830511974d"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNC0xLTEtMS0xNDI2MjQ_fb3570bf-56dd-4394-b4c6-8acbe42c8057"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNC0yLTEtMS0xNDI2MjQ_cb216658-d422-4f50-99a0-c34b40535dad"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNS0xLTEtMS0xNDI2MjQ_76a9d14b-aa4e-4594-af85-789de52435ca"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNS0yLTEtMS0xNDI2MjQ_f6991e3e-e4c2-4eda-9840-e32ddfe8dbda"
      unitRef="usd">39000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNi0xLTEtMS0xNDI2MjQ_fa015aba-b7ab-487a-8901-9ad87b0c0447"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNi0yLTEtMS0xNDI2MjQ_3e528988-65d0-4371-b797-cf9bb132c266"
      unitRef="usd">-12000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNy0xLTEtMS0xNDI2MjQ_059efc9c-f850-4fd2-8ea5-b4a2bff712f3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4a9457be1bb24d1a8ad1f50fdd8575ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfNy0yLTEtMS0xNDI2MjQ_676fd516-cac4-4f1b-9190-d99725b6a23e"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfOS0xLTEtMS0xNDI2MjQ_0db7b93a-9e6b-4190-ba7f-06b454fe122c"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfOS0yLTEtMS0xNDI2MjQ_fcabe3f8-a45e-4b6d-b417-62f0c2fd495f"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTAtMS0xLTEtMTQyNjI0_858ba820-254f-4fb5-be7c-ddbb73d8b302"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTAtMi0xLTEtMTQyNjI0_fa545479-16a1-4467-96e8-527b7d46b175"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7090818d98c04f9698b3cecc0503d679_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTEtMS0xLTEtMTQyNjI0_ed930c95-d86f-4bde-a775-e59b69968c3f"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2ff138890195406fb3f8733e7cf82020_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83MC9mcmFnOjFiMjBlMjhiNTY0NTQ2NjhhZTZmNTM4ZTI1YzVmNDUwL3RhYmxlOmIzODQ4ZTg4ZTlhYTRhYjBiNWQ4MWYzZjU3OTFiOGFkL3RhYmxlcmFuZ2U6YjM4NDhlODhlOWFhNGFiMGI1ZDgxZjNmNTc5MWI4YWRfMTEtMi0xLTEtMTQyNjI0_cc55cfde-9d3b-4200-b8fb-5b6240224e6f"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfMTU1Ng_29e2269e-b7c9-4fea-a38d-44763375311c">INCOME TAXES &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was 35.7% and 22.3% for the three months ended March 31, 2023 and 2022, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, non-deductible expenses, non-taxable income, increases or decreases in valuation allowances, increases or decreases in liabilities for uncertain tax positions and excess tax benefits or shortfalls on stock compensation awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to tax shortfalls on stock compensation awards and an increase in our liabilities for uncertain tax positions, partially offset by a favorable geographic earnings mix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none were individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfNTg_c94ba282-2b2a-4364-95b1-9744e34986a5"
      unitRef="number">0.357</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfNjU_79bf498a-6672-4832-b32f-a59e10a4dc85"
      unitRef="number">0.223</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83My9mcmFnOjllM2YxYjdjNTMzMDQ1MjBiZjhkY2UwZTkxOTUyNWFkL3RleHRyZWdpb246OWUzZjFiN2M1MzMwNDUyMGJmOGRjZTBlOTE5NTI1YWRfMjE0_2c9b2dd0-e98f-47e2-b0cc-b2c8af38cb7b"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMTE2Nw_60ab1a1b-67a4-43ba-a688-a5f8b0dafd78">EARNINGS PER SHARE&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes 17 million and 4 million shares issuable under equity awards for the three months ended March&#160;31, 2023 and 2022, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMTE2OA_18956669-ebb7-465b-bcfb-3314f8ee2216">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMi0xLTEtMS0xNDI2MjQ_a527345d-70a1-482b-a2ad-22326c322cbd"
      unitRef="shares">505000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMi0yLTEtMS0xNDI2MjQ_dc09c924-adf3-4c13-b575-8256982da745"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMy0xLTEtMS0xNDI2MjQ_a7d01031-feba-4451-8bfd-be266ca5ae45"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfMy0yLTEtMS0xNDI2MjQ_87eb2669-ff35-4fb8-90c2-39c62a8e05ae"
      unitRef="shares">6000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfNC0xLTEtMS0xNDI2MjQ_eab563e0-21c9-4ce6-8c51-3bcf61c44d08"
      unitRef="shares">507000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RhYmxlOmJlMGEzZTI1Y2ZiZjRiZWViMDdhMDljOGNlMmNkMWY4L3RhYmxlcmFuZ2U6YmUwYTNlMjVjZmJmNGJlZWIwN2EwOWM4Y2UyY2QxZjhfNC0yLTEtMS0xNDI2MjQ_f9ac1761-34d4-460d-8fc3-30af9dedd3ad"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfODI4_c32701b5-d931-40b6-83de-702288ec4ef4"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83Ni9mcmFnOmM3ZTQ4NTU4NzdkOTRmYWU4NjFiNWZmZmQyY2QyYjQwL3RleHRyZWdpb246YzdlNDg1NTg3N2Q5NGZhZTg2MWI1ZmZmZDJjZDJiNDBfMjc0ODc3OTA3MTQyMg_83814830-728c-4dab-af68-0d9238ad2ffe"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwNg_34e1c17a-1c2c-4d7b-8502-82c1bfadd435">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value or net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cash Flow Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of foreign exchange contracts designated as cash flow hedges were $386 million and $398 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. The maximum term over which we have cash flow hedge contracts in place related to forecasted transactions at March&#160;31, 2023 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2023 and December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Net Investment Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, we issued &#x20ac;600 million of senior notes due May 2025. In May 2019, we issued &#x20ac;750 million of senior notes due May 2024 and &#x20ac;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2023, we had an accumulated pre-tax unrealized translation gain in AOCI of $47 million related to the Euro-denominated senior notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Dedesignations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no cash flow hedge dedesignations in the first three months of 2023 or 2022 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first three months of 2023 or 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we remove a net investment hedge designation, any gain or loss recognized in AOCI is not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first three months of 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total notional amount of undesignated derivative instruments was $632&#160;million as of March&#160;31, 2023 and $753 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, $3 million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2023.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9538dd5f2a2244a9adcb80fb4dd92160_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzU1NQ_628ac493-e033-410f-905b-55cb1b7db5ad"
      unitRef="usd">386000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id4f02046af9547bf90a5a5fecea5c89e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzU2Mg_0b26b3c1-6b69-42eb-ae96-0d2e6466111d"
      unitRef="usd">398000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i4c66e4f9c56742b18ccfe453072a0567_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzcxMQ_5ebd427e-2fd8-4c9e-9939-53ca0eb7d9a6">P12M</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8f7c52bc902e4958a1aa1af5261b13dd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzc1Nw_38c00733-1b1d-4d35-966a-f3a885948bc7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i98bfbbe989f94db8a2f6860f5daea064_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfMzc1Nw_52b3c302-c9ba-49b5-b638-119a7c6083aa"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ibd110d5b3b474fb9a4243053206a4b98_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDY1MQ_2e8072a2-313b-4925-8693-b8d6fa57a5e7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8bc91ff6eb4746318f5c648bd8d956ae_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDY1MQ_f66fc176-977e-4d5b-ab96-09274a7e0afc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0ae9704eed9e408f85ac8af9ab07b959_I20170531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDc4NA_bc26615e-be05-479b-92c4-b1f9764e006f"
      unitRef="eur">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i747bc7554666414992b2b24bb2e4b2b9_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDgzNA_084e8601-377d-451e-967e-0a9136884dce"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic5cedfb9fb234c4fa8f05974b6a48de8_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNDg2NA_7d5cf402-3285-4b38-a664-0a59510e6dee"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id9faaf9a5d1d4dc39fc43d27a01f474a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTE4OQ_cde6521b-0e69-4e75-bf20-55ecf9747a88"
      unitRef="usd">47000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5fcbc6210c814c8681aeb65ed4c8798c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTc5MQ_21268304-3fcf-431e-9c2a-c302a3eec7fa"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNTc5MQ_f29dd2e5-7bf2-40e0-b460-85f84454630b"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <bax:DerivativeFairValueTerminated
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjE4MQ_2f62ae85-6e2c-49f1-bf8c-3b133b3e4b7c"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeFairValueTerminated
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjE4MQ_cd7b96f0-1985-4567-9880-28b4e7eb5794"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjQ3Nw_200c90e4-3469-440a-9468-786e87401637"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNjQ3Nw_940ab267-4682-4792-8855-e1e266f737a8"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8be3a0f43b6f4f4697b04212b8b81e2d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzAwMg_a289ac71-5c4b-4be7-84a3-d51aab7c0199"
      unitRef="usd">632000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i496040ce8ccb46e6bb87e3ad9f95ec52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzAxOA_df84385e-7585-43a1-8385-3d54b331b1ad"
      unitRef="usd">753000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwNw_e2a4d8ee-ac00-440b-ba18-1432fb709150">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i2cc935ff843a4dc29ec8c895720e3066_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy0xLTEtMS0xNDI2MjQ_e2c08e7e-3d1d-4141-bef0-dc1cee86f8ab"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="id7a795c4b1fb4e3084ef17809809118d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy0zLTEtMS0xNDI2MjQ_43683746-90e9-4981-afa0-a27a2da8c259"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib752bbb3f58f4422b1f965bc7c89f074_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy02LTEtMS0xNDI2MjQ_d627c403-d753-40ee-9374-69261dba3040"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iea2285dfc1a7402a99c067a6e802ca97_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfMy04LTEtMS0xNDI2MjQ_cb1efaa2-ebef-4376-8361-6a103dcb9a95"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i189d98535fb942c99329457fb43522d1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC0xLTEtMS0xNDI2MjQ_530d9c8a-9a29-4e87-8507-e60d24d5b58b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i2c25693c2f1b4a5f9dfc483f5ca0a8b2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC0zLTEtMS0xNDI2MjQ_6b5630c3-f105-4cbd-9f6a-866d819cd95d"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifab0be122c59428e9024680a862f2c0d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC02LTEtMS0xNDI2MjQ_899aad96-513c-4beb-9b31-986d29e7d3a0"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ibaad8a6fd0bd4705ab16d4fb5b21406c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNC04LTEtMS0xNDI2MjQ_c882a4f6-e12b-4aa3-b02a-279803304e1d"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i66a9ab3f00c6441596fadb7fc37919f1_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS0xLTEtMS0xNDI2MjQ_568e550c-b742-4527-ae17-c42217c8e9c1"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8118589f429a4a0ca38950943ac2978a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS0zLTEtMS0xNDI2MjQ_95d0c49f-86ff-4a60-bb64-1e34b365cbff"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i91cf39a12b99429d8289596966b89fe2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS02LTEtMS0xNDI2MjQ_50e15ac3-b265-41e9-a682-1bf68cfc8cfe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i17ecdd9ca5f54679995d5d378c4d06ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNS04LTEtMS0xNDI2MjQ_df7a4204-cffb-41dc-85f4-c6a49cd230ef"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi0xLTEtMS0xNDI2MjQ_3aefc7c5-6718-458c-beaa-a0fb0e21d78c"
      unitRef="usd">-48000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi0zLTEtMS0xNDI2MjQ_a784a51e-11f8-4fcd-acab-1dc7939f13cf"
      unitRef="usd">39000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi02LTEtMS0xNDI2MjQ_9ed538b5-d56a-4227-ad49-a8ac28b1d419"
      unitRef="usd">3000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmEyZDdlMjZkNDY0ODQxZTFhODkxMGJjODBmNDJlNjA3L3RhYmxlcmFuZ2U6YTJkN2UyNmQ0NjQ4NDFlMWE4OTEwYmM4MGY0MmU2MDdfNi04LTEtMS0xNDI2MjQ_a180f834-bff7-446b-825b-4d10ca0094bb"
      unitRef="usd">1000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i46477fce4d7049aab502d6b4eb1ab53b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmE1NWNiOGJmNWNjYTQ4MjNiNTkzYTQzMjg4ZjA3YjE4L3RhYmxlcmFuZ2U6YTU1Y2I4YmY1Y2NhNDgyM2I1OTNhNDMyODhmMDdiMThfMy0yLTEtMS0xNDI2MjQ_9def2fbc-5073-4c75-b460-c3a36d3f91f7"
      unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i2c1f79300409417e829d19d1e521ffde_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOmE1NWNiOGJmNWNjYTQ4MjNiNTkzYTQzMjg4ZjA3YjE4L3RhYmxlcmFuZ2U6YTU1Y2I4YmY1Y2NhNDgyM2I1OTNhNDMyODhmMDdiMThfMy00LTEtMS0xNDI2MjQ_b739449a-6133-492f-8666-0f5dba81514f"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfNzU2Nw_ea5775b6-2f53-48e2-b5ed-bca1ab60eca5"
      unitRef="usd">-3000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwOQ_d37a0814-8341-46ef-a9e5-fae3d389a07a">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2023.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i671ceedc0954414bbc1ef559a31dc3b0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNC0yLTEtMS0xNDI2MjQ_224aa358-ba1f-4030-82a5-aaa098a90eb8"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8311fb17141a43e08936804f2663ce41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNC01LTEtMS0xNDI2MjQ_790b7f47-0e5b-434a-bd21-86719c7e9b65"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifc0855e415a24ea2bbed65f9964a98ca_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNi0yLTEtMS0xNDI2MjQ_12d99a88-5d68-4778-9acb-4f4d26c63d6f"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifc0855e415a24ea2bbed65f9964a98ca_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfNi01LTEtMS0xNDI2MjQ_1732c6f3-4ff0-4887-bf89-55bf097ec11e"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifa6620927c944ffab75861c764f15bbf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOC0yLTEtMS0xNDI2MjQ_bbf981e2-79bb-4049-8a27-5cf995c9f171"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9582e8bab32a4622a5341a018568c9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOC01LTEtMS0xNDI2MjQ_3cf76e16-1ac1-4e9c-960e-4fda01380dca"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOS0yLTEtMS0xNDI2MjQ_364a5a11-204d-4b1f-b1d5-2687c3417049"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjUxYWE4MmM4ZGFiNzQ0ZGQ4MzFjN2QyOWQ5ZmNiNTYwL3RhYmxlcmFuZ2U6NTFhYTgyYzhkYWI3NDRkZDgzMWM3ZDI5ZDlmY2I1NjBfOS01LTEtMS0xNDI2MjQ_cfdd1d38-d0fb-4f15-b9f0-1050d29a3186"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i56e1d124500c4886b5441bdd89954116_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNC0yLTEtMS0xNDI2MjQ_fe51bf43-75f7-415e-9767-d7009c2a3ee3"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7d40aa82836d4e5d80dbeabff53e5546_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNC01LTEtMS0xNDI2MjQ_2aba6554-7491-4558-a68a-c78d1b5cad25"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNi0yLTEtMS0xNDI2MjQ_91c63140-3450-4b89-b0aa-2f6bb757217d"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1c948d7d2b1548a88ef5244ba94afd6e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfNi01LTEtMS0xNDI2MjQ_9ba92cf3-61a3-4466-b9e1-033e70398989"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if6b248d3ee7c433a940949503db3e3fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOC0yLTEtMS0xNDI2MjQ_cd679f39-b2fc-4dbe-9890-7ea6a9818a51"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8d5a655bb88c41bfb5152c5fc3f19595_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOC01LTEtMS0xNDI2MjQ_0b61018a-279e-40f1-8d06-c12efa4de670"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOS0yLTEtMS0xNDI2MjQ_890fcc6b-4193-46d6-8e3d-1cade7388896"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjc4NTNmMDViM2UzOTRkMTBhMDVjMjlkZDE5YmY4ZmY3L3RhYmxlcmFuZ2U6Nzg1M2YwNWIzZTM5NGQxMGEwNWMyOWRkMTliZjhmZjdfOS01LTEtMS0xNDI2MjQ_6e0ee229-884b-4651-92bf-73ac32cc4339"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODc5OQ_75b25814-d3af-4859-b80c-885cae94fc28">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi0xLTEtMS0xNDI2MjQ_b55d12cd-ee42-4a47-870f-d898bbc7d927"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi0yLTEtMS0xNDI2MjQ_0e0a3ceb-15e3-4bb0-b82b-ab9ae752b346"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi00LTEtMS0xNDI2MjQ_ef921e0a-01e7-48a6-9d50-44146b4e5c52"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMi01LTEtMS0xNDI2MjQ_85e9bfca-9e78-42ea-88eb-055890f65331"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy0xLTEtMS0xNDI2MjQ_3ee128f1-0805-4d7e-8cff-77a244efb637"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy0yLTEtMS0xNDI2MjQ_d25fbce9-7461-4fbf-b89e-8139dba0e6c9"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy00LTEtMS0xNDI2MjQ_e2856bfd-9db9-48b8-a96b-c9f5138b535d"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfMy01LTEtMS0xNDI2MjQ_8c74e186-0e29-47ac-be13-dbafd783154e"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC0xLTEtMS0xNDI2MjQ_59c080a5-3316-4ac8-8456-848a90002ac0"
      unitRef="usd">5000000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC0yLTEtMS0xNDI2MjQ_69c3210a-caec-49ae-817e-d35f0a9d9e91"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement>
    <us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC00LTEtMS0xNDI2MjQ_459233a3-3d59-405c-92cd-e22cbdcf85b1"
      unitRef="usd">10000000</us-gaap:DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection>
    <us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjNjZTY1ZmZjZDMxYTQwY2FhMjA5ZjhkNjc1MDJmMWI4L3RhYmxlcmFuZ2U6M2NlNjVmZmNkMzFhNDBjYWEyMDlmOGQ2NzUwMmYxYjhfNC01LTEtMS0xNDI2MjQ_a34645f6-ac33-4045-a42f-f2d8626bf021"
      unitRef="usd">8000000</us-gaap:DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RleHRyZWdpb246MjdjNmRmM2U5YzhhNDA4NzgxNmMxMTE2YzY3ZDYyMGRfODgwMw_0a0157c1-1734-44a9-bd9e-60a22ece77b7">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="i607c52fdcfa04c428b2116b4f6436aa0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi0xLTEtMS0xNDI2MjQ_0d943f79-4700-42bb-b81e-ddd091925835"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="ifad00739353c4b57be82940bf374498e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi0yLTEtMS0xNDI2MjQ_e4652ef3-f047-4668-af6a-edf11474846f"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i607c52fdcfa04c428b2116b4f6436aa0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi00LTEtMS0xNDI2MjQ_86b9e9d2-d34c-4efc-8ba6-b446e845e682"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ifad00739353c4b57be82940bf374498e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl83OS9mcmFnOjI3YzZkZjNlOWM4YTQwODc4MTZjMTExNmM2N2Q2MjBkL3RhYmxlOjAyMTU4MmNiODM2NDQ4YTZiYTU0NTJjMTEzZGYwMDUzL3RhYmxlcmFuZ2U6MDIxNTgyY2I4MzY0NDhhNmJhNTQ1MmMxMTNkZjAwNTNfMi01LTEtMS0xNDI2MjQ_71f4b3ee-85a7-4e1d-a181-bda4b42cff1f"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxOQ_3e14fcb3-86a7-4b48-b50f-1100905ca70d">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, cash and cash equivalents of $1.7 billion, respectively, included money market and other short-term funds of approximately $369 million and $341 million, respectively, which are considered Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those available-for-sale debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of available-for-sale debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#x2019;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Instruments Not Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of equity investments without readily determinable fair values that we measure at cost, less impairment were $103 million as of March&#160;31, 2023 and $104 million as of December&#160;31, 2022. When applicable, we also adjust the measurement of such equity investments for observable prices in orderly transactions for an identical &lt;/span&gt;&lt;/div&gt;or similar investment of the same issuer. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNQ_6e69f5f6-44d5-46da-ac4f-dfc93bdaefa4">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0xLTEtMS0xNDI2MjQ_30f32742-d6d5-45ee-aec4-ec955de9a3c6"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0yLTEtMS0xNDI2MjQ_70902633-3d2c-407a-a666-9e615d7b6f09"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy0zLTEtMS0xNDI2MjQ_221bc864-0ee3-4104-bd57-df9c08506114"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMy00LTEtMS0xNDI2MjQ_7b0c0a2f-16c0-479b-b88c-da1df25ec83c"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0xLTEtMS0xNDI2MjQ_becf91e3-85fb-4b00-9c8f-5970bb2b34a3"
      unitRef="usd">42000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0yLTEtMS0xNDI2MjQ_4dd4c31e-03b3-4300-b25a-0927997a9a73"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS0zLTEtMS0xNDI2MjQ_3514bba4-ecd6-432d-b26d-2e821824fb67"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNS00LTEtMS0xNDI2MjQ_9f1300f7-6597-42f4-bd65-edddb5297d34"
      unitRef="usd">42000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0xLTEtMS0xNDI2MjQ_2ccfc1c9-ee63-473c-8554-9aa712a2000c"
      unitRef="usd">38000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0yLTEtMS0xNDI2MjQ_9d7bed27-b940-4aec-b246-3192e0c44b18"
      unitRef="usd">38000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi0zLTEtMS0xNDI2MjQ_a14c90d4-d11d-44cf-9adb-5fd32de2a807"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNi00LTEtMS0xNDI2MjQ_3f4b77cc-6f6e-4cb2-9ca7-2d6fe5227409"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0xLTEtMS0xNDI2MjQ_c7d4cd4c-d18a-49e2-a84c-4e3823beca98"
      unitRef="usd">88000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0yLTEtMS0xNDI2MjQ_be127a8e-50e9-4c73-8715-ccd3cb768e78"
      unitRef="usd">38000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy0zLTEtMS0xNDI2MjQ_fa93d471-140e-4906-aab4-a66c076aa3f7"
      unitRef="usd">8000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfNy00LTEtMS0xNDI2MjQ_0909d655-b03c-4281-9bc6-bf300e9c4cd8"
      unitRef="usd">42000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0xLTEtMS0xNDI2MjQ_44ef853d-f0a8-4c3d-8f1f-fcd2c7fdaf2d"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0yLTEtMS0xNDI2MjQ_1dd8726f-da45-4d26-a43b-d135bbcf212b"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS0zLTEtMS0xNDI2MjQ_a6f1c3ec-d232-4175-a41c-7f5d180ad28c"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfOS00LTEtMS0xNDI2MjQ_91e720d6-be30-4eac-b264-b95feba8d84a"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMS0xLTEtMTQyNjI0_91946f3f-38d6-4259-9ba4-97fb33dba09d"
      unitRef="usd">70000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMi0xLTEtMTQyNjI0_7cac0e40-5924-4607-8ee7-8e3d57d08015"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtMy0xLTEtMTQyNjI0_25f5a02d-0db1-4df3-b618-c6a7ebe1df9c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTEtNC0xLTEtMTQyNjI0_3ea0469e-1ef1-4783-ab88-7c5c8ca111aa"
      unitRef="usd">70000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icf5014e9c356493ea281263e29225f8c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMS0xLTEtMTQyNjI0_6754d150-8f75-46d0-8422-ac7324d60a7d"
      unitRef="usd">78000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ica5c4caed8134e6ea9df4b4330ae5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMi0xLTEtMTQyNjI0_39fe5319-5201-4b45-8bfc-76d52ab5bf04"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id86b1f179ffa42a495a950dfaa16e4ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItMy0xLTEtMTQyNjI0_126ef5f4-3f44-44aa-9fce-7a9607b908a2"
      unitRef="usd">8000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8107d66cdfef47cc96732db00726b56e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjlmODRhMGJiYjdlMzQ1NTU5MmEzMmZmZmQwOGE0MmQzL3RhYmxlcmFuZ2U6OWY4NGEwYmJiN2UzNDU1NTkyYTMyZmZmZDA4YTQyZDNfMTItNC0xLTEtMTQyNjI0_5507d820-89aa-4fa8-b449-6823aa3ea364"
      unitRef="usd">70000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0xLTEtMS0xNDI2MjQ_d598c15d-ab1f-4b50-b4ba-099edb5e17b7"
      unitRef="usd">14000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0yLTEtMS0xNDI2MjQ_dae98e2d-5ddf-403e-86f8-e22a7f297772"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy0zLTEtMS0xNDI2MjQ_eac12014-3f03-4a7d-9821-75217748d801"
      unitRef="usd">14000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMy00LTEtMS0xNDI2MjQ_47b2e1d3-3cec-4f33-a100-1d036d724585"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0xLTEtMS0xNDI2MjQ_4a4795ae-5765-4bac-a7e4-2c61855eed4a"
      unitRef="usd">47000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0yLTEtMS0xNDI2MjQ_391916cb-e5d7-48f3-9518-c30dd70e283f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS0zLTEtMS0xNDI2MjQ_612fba8d-e145-4b17-924d-c296ff840656"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNS00LTEtMS0xNDI2MjQ_5d39311d-8b84-47a8-9e4d-31f2234382ba"
      unitRef="usd">47000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0xLTEtMS0xNDI2MjQ_10ba0c47-2802-4fdc-b6c0-ea8231a5facb"
      unitRef="usd">32000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0yLTEtMS0xNDI2MjQ_9c6c3930-edb2-468b-b598-77401dc3d796"
      unitRef="usd">32000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi0zLTEtMS0xNDI2MjQ_95632357-8c23-491e-9647-01a959531616"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNi00LTEtMS0xNDI2MjQ_8e47843f-a040-4de2-8cb4-baca9f56ee13"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0xLTEtMS0xNDI2MjQ_1d54bddb-05a4-4fa4-a6e0-57d9ea41f911"
      unitRef="usd">93000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0yLTEtMS0xNDI2MjQ_834c8f21-fd72-4f18-8f45-ad7339f6fc0c"
      unitRef="usd">32000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy0zLTEtMS0xNDI2MjQ_e7aa544c-d032-48c3-ba62-3fa9e6cc0824"
      unitRef="usd">14000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfNy00LTEtMS0xNDI2MjQ_aa7766aa-e6c1-4a0b-b220-ab4a453ae811"
      unitRef="usd">47000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0xLTEtMS0xNDI2MjQ_654dcd76-9e25-4bde-8a64-48c6f06d5f28"
      unitRef="usd">12000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0yLTEtMS0xNDI2MjQ_9974e7da-163f-4906-91d4-2321c90590c2"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS0zLTEtMS0xNDI2MjQ_1aae1501-b7b2-44da-92b8-11896ef57ebc"
      unitRef="usd">12000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfOS00LTEtMS0xNDI2MjQ_29d91a13-cf8c-4e22-9702-03aeaee95e7f"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMS0xLTEtMTQyNjI0_60e94d2c-c57c-4605-9a29-5b6c8ebc4719"
      unitRef="usd">84000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMi0xLTEtMTQyNjI0_3683b56a-182a-4830-8eb0-442ae12b9a91"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtMy0xLTEtMTQyNjI0_24c625d3-a8a1-4d79-8d6f-0f433ec55f9b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTEtNC0xLTEtMTQyNjI0_bff6a6b8-c303-4bf9-8ecb-30a75362de48"
      unitRef="usd">84000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i60f96dbbad654789adba4c76777fb89d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMS0xLTEtMTQyNjI0_4ffa16e4-57f4-4b83-bdf6-247415c414ca"
      unitRef="usd">96000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifdf8fb434cd44ce6848c181c4eda76fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMi0xLTEtMTQyNjI0_eef01cef-5bd8-441b-be66-583f64b0a512"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6a401be8e879440883b9309dd7cd46eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItMy0xLTEtMTQyNjI0_7b243f56-70b5-4ff5-bae5-f3ab331bde5a"
      unitRef="usd">12000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i05af2841efd44956a910f7e3b2175557_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOjJkZGMxZjdlNzlhZDRkMDJhZmE5MDM3MzkwMDU1ZmI4L3RhYmxlcmFuZ2U6MmRkYzFmN2U3OWFkNGQwMmFmYTkwMzczOTAwNTVmYjhfMTItNC0xLTEtMTQyNjI0_a09160b6-4911-4754-a111-dd0d37662431"
      unitRef="usd">84000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i845de0a94ae6446bb04bb2a640d8e8dd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMTk0_70bb2803-ee00-4ab8-ac78-058f952c300f"
      unitRef="usd">1700000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic40f7b5955594ed3b2bf0f05f9b528be_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMTk0_7266a7d3-b8de-4e17-b972-9bb4f30e1aee"
      unitRef="usd">1700000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i37ecc9bb48ea468fbe53ecaa9574ab83_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMjg1_91c6757e-b9b4-4edd-9e94-afe61abdddcb"
      unitRef="usd">369000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i8ff491835ffe4fdf8c4b26233dcb9a9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfMjky_fadda5c1-9144-4099-a718-a2c7d5f31f5e"
      unitRef="usd">341000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNg_0df80f4c-cafe-4e91-a164-36aa0ad75d66">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and available-for-sale debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib1672a644c104e0cba0f5a365004ec05_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy0xLTEtMS0xNDI2MjQ_443b61de-1c5f-4dc6-bff8-d0e4c93a772e"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i37ead0a6833745b5a2c9a8c87f3eb359_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy0yLTEtMS0xNDI2MjQ_aaae5667-f28b-4c37-9044-63ceb4de6161"
      unitRef="usd">47000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3c61a0314afd43cd8e3a9aaaf26630eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy00LTEtMS0xNDI2MjQ_6ba2fad4-628e-439a-94a8-2c0b2c0713ce"
      unitRef="usd">143000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="icda293782fa046d38a077f41e8d52047_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMy01LTEtMS0xNDYxOTE_f8d43a9e-98b1-4fad-8882-106cd8f61b9d"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC0xLTEtMS0xNDI2MjQ_fd024d25-3440-4598-9333-b52fa27aa19f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
      contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC0yLTEtMS0xNDI2MjQ_58699a75-2fd0-4224-aa32-7574807e4e0f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC00LTEtMS0xNDI2MjQ_c2a83629-4f92-4807-834a-461e211a1cc8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
      contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNC01LTEtMS0xNDYxOTE_8e278327-0750-4c22-9a12-fc582b44a8e6"
      unitRef="usd">21000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS0xLTEtMS0xNDI2MjQ_e0b5d5fb-02d4-4024-92bb-d969ba0fdf64"
      unitRef="usd">-13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS0yLTEtMS0xNDI2MjQ_36696c1d-e0f3-43f3-888c-10b0d68cface"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS00LTEtMS0xNDI2MjQ_bb05c889-a6f0-46c8-aa82-29871c25ec4a"
      unitRef="usd">-17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNS01LTEtMS0xNDYyMDM_bd9c451d-7d19-421c-82d4-25bed9c0e87c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi0xLTEtMS0xNDI2MjQ_268f5793-83cd-4950-8f03-56bb167894be"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi0yLTEtMS0xNDI2MjQ_1bd1790e-901e-4d71-9fa1-1cb2b36d9dd5"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi00LTEtMS0xNDI2MjQ_26f87118-a71c-4271-9f0f-f7c87cd8609e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNi01LTEtMS0xNDYyMDM_5dc7ec2b-9029-418d-8da3-72e6be605c9d"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy0xLTEtMS0xNDI2MjQ_2fb5e67a-dbf3-4ee3-a916-69042eab37e4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy0yLTEtMS0xNDI2MjQ_c6f852d3-82bd-44fd-8f55-d800d5ac5084"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy00LTEtMS0xNDI2MjQ_03d4d0d6-5dcf-4708-be92-a3835e823c6a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfNy01LTEtMS0xNTgzODk_2602ef8b-8eac-4259-826c-b5b74067e9d2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ie7d54bdd7e6e4c6295ec9a828f52d044_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC0xLTEtMS0xNDI2MjQ_53f3fe87-b658-48fa-aee8-7fa200ccd1ef"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i92a7c9dc4dfb4ec790b51ac9cbf6a8ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC0yLTEtMS0xNDI2MjQ_84f10db6-4052-4d57-8237-6ad49ca780be"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i0b18275a651a4ca2b97424f4924272cf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC00LTEtMS0xNDI2MjQ_55bc038a-bbda-4792-a8f3-f854a1d8354a"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i43fbb3765ad2413888b31eba792ff5ba_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfOC01LTEtMS0xNDYyMTE_60ef0b8d-13ed-4696-9c87-49de66072df6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0f90874bfa6d48fba1bed7ac9573fcf6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtMS0xLTEtMTQyNjI0_cdeec621-145c-45cd-9b6e-f476913298ed"
      unitRef="usd">70000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7f96fffbf70b48c3af05ddc881ed1a92_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtMi0xLTEtMTQyNjI0_8bdbc3fa-802f-47fc-9f8d-1d24c45c3b61"
      unitRef="usd">42000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5885ecc04c124fd88f7d20f0411c5299_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtNC0xLTEtMTQyNjI0_574909c8-596e-483f-af06-fb8f9a2ecf2a"
      unitRef="usd">124000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i39589615eba84af88bd227d8332e4d0b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmVlZDRhNGM2ZTY5NjQwMDhiYTZhNGFkNDVjZjBlNTY0L3RhYmxlcmFuZ2U6ZWVkNGE0YzZlNjk2NDAwOGJhNmE0YWQ0NWNmMGU1NjRfMTAtNS0xLTEtMTQ2MjE5_f88fabc5-ad59-404f-8859-a33ebb008b4a"
      unitRef="usd">53000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDMxNw_4fa3419e-de46-4fa7-a50c-250a37606e1e">For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2023 and December&#160;31, 2022.&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy0xLTEtMS0xNDI2MjQ_3acd7795-68ab-4bea-b364-5758359cf56e"
      unitRef="usd">50000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy0yLTEtMS0xNDI2MjQ_b23ea312-ce73-4fd1-ac77-a177414d437e"
      unitRef="usd">299000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i4465ac79533347819eb60404998c9a41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy00LTEtMS0xNDI2MjQ_9a41a281-edc5-47e4-92ea-a5b7f40101e5"
      unitRef="usd">50000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfMy01LTEtMS0xNDI2MjQ_f842c284-867c-4739-b30c-fe7e7b735bb8"
      unitRef="usd">299000000</us-gaap:ShorttermDebtFairValue>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC0xLTEtMS0xNDI2MjQ_f46763ec-86e2-4899-8395-57f8d1fb38d0"
      unitRef="usd">1103000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC0yLTEtMS0xNDI2MjQ_fd9669b8-8cf7-4aee-af34-e29c114e7b30"
      unitRef="usd">1105000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i4465ac79533347819eb60404998c9a41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC00LTEtMS0xNDI2MjQ_9efea693-3323-479f-9d8e-7d91538a7685"
      unitRef="usd">1084000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNC01LTEtMS0xNDI2MjQ_23063f16-f78b-4c71-b62c-7576ed46bd3c"
      unitRef="usd">1079000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i3bc8aeefbd654849815b65f8dedd082d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS0xLTEtMS0xNDI2MjQ_49cba917-ccdf-4060-8202-82e23980a10e"
      unitRef="usd">15278000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="ibe45285509d54b74948837ef32da5fb8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS0yLTEtMS0xNDI2MjQ_1c681887-91ba-4828-bf42-0a8c2d3d6f1e"
      unitRef="usd">15232000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i4465ac79533347819eb60404998c9a41_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS00LTEtMS0xNDI2MjQ_5b5a6378-273d-4738-a825-5749f1ca5feb"
      unitRef="usd">14011000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i9fb955fb2b1749fa979c87c9f7a93003_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RhYmxlOmU2N2U0ZThlNDY2YTRkMjNhNjQ0Y2MxZmM3NmE5OTM2L3RhYmxlcmFuZ2U6ZTY3ZTRlOGU0NjZhNGQyM2E2NDRjYzFmYzc2YTk5MzZfNS01LTEtMS0xNDI2MjQ_d72ab5e0-1ed3-403a-8824-47cd68785045"
      unitRef="usd">13657000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="id39e31f62b29442da1752786dc58134e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDE4Mw_cb166b83-abac-444c-a13a-7eb17e60e5a8"
      unitRef="usd">103000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="i8411fdd837b543e6b9186cdf5182839f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84Mi9mcmFnOjg4YWQ3Y2U1OTA3MzRkMGZhNmNhNTJkZjkzNDNjYTA3L3RleHRyZWdpb246ODhhZDdjZTU5MDczNGQwZmE2Y2E1MmRmOTM0M2NhMDdfNDE5OQ_13d5e59f-54fe-4e9f-b18c-9b16492f3c8f"
      unitRef="usd">104000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5Mg_34fd1c70-2927-466f-863c-342dd0d92b2a">SEGMENT INFORMATION&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a global segment for our Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems; patient monitoring and diagnostic technologies; respiratory health devices; and advanced equipment for the surgical space.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;amp;D costs, manufacturing variances and centrally managed supply chain costs, product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are implementing a new operating model intended to simplify and streamline our operations and we expect that our reportable segments will be changed to align with that new operating model when it is fully implemented, which is currently expected in the second half of 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfNjE_8f65c018-18fe-47a9-a9ce-1de42c9be72f"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5Mw_91ac3f8d-ee32-44e2-9f42-51550bddd8ff">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bd21c5a704642b7add19a18376900db_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMy0xLTEtMS0xNDI2MjQ_c337e523-c44d-43c6-9253-e32d633dae3f"
      unitRef="usd">1602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMy0yLTEtMS0xNDI2MjQ_c31f4e8b-5f15-4caa-a00e-7325a69dc247"
      unitRef="usd">1626000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if10723145fec4c039ea5033c9599406a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNC0xLTEtMS0xNDI2MjQ_e1685c7f-55fe-40a0-b78b-51aded9b3041"
      unitRef="usd">714000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNC0yLTEtMS0xNDI2MjQ_b0202cec-e85a-4d56-b367-b69d6e56edb6"
      unitRef="usd">699000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNS0xLTEtMS0xNDI2MjQ_8d5d9da2-011f-4838-8b8a-2b5be450d035"
      unitRef="usd">602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNS0yLTEtMS0xNDI2MjQ_c460dc97-e65f-413d-a129-fa2933816123"
      unitRef="usd">627000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNi0xLTEtMS0xNDI2MjQ_9bf5de6f-a7f5-412c-8202-5389456654ec"
      unitRef="usd">731000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2931aa2efeee464695085541f236afb5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNi0yLTEtMS0xNDI2MjQ_b3b4cfbe-9ce0-4134-b1e1-910e59e426bd"
      unitRef="usd">755000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNy0xLTEtMS0xNDI2MjQ_8de7030f-ca4c-49f2-a2d6-cf585a1b6f20"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfNy0yLTEtMS0xNDI2MjQ_99838f20-d6e1-40d4-9509-24d3fb327872"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bd21c5a704642b7add19a18376900db_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfOS0xLTEtMS0xNDI2MjQ_c54186cd-2616-4d52-af1d-05433fa88fee"
      unitRef="usd">481000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id326de672d1e4b3da82fcc3cdf4ee2b4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfOS0yLTEtMS0xNDI2MjQ_0c4d503d-7e1a-4d5f-8b9f-8913e9f51c0d"
      unitRef="usd">610000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if10723145fec4c039ea5033c9599406a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTAtMS0xLTEtMTQyNjI0_df01736c-5223-45ca-8c5b-8c766894e001"
      unitRef="usd">106000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a80d230afaf49feb3dca08486479b58_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTAtMi0xLTEtMTQyNjI0_12251f9f-2f96-4a59-a1de-741649176d94"
      unitRef="usd">119000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91cb29f3f7a64cceaee98979a5471d32_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTEtMS0xLTEtMTQyNjI0_a829ab36-7e93-449e-8374-b6f558170519"
      unitRef="usd">107000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6600d5fbf3394855863797a9fd4b4b01_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTEtMi0xLTEtMTQyNjI0_9762e310-84ee-49e8-95aa-0694d94062d6"
      unitRef="usd">151000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2a7886fccb9a40bf9e47e19b221221d2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTItMS0xLTEtMTQyNjI0_77053b53-e59f-4292-8efc-dbec6d4d82c7"
      unitRef="usd">158000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2931aa2efeee464695085541f236afb5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTItMi0xLTEtMTQyNjI0_eef78e2a-16f6-4031-b1fd-cd91f6adbb34"
      unitRef="usd">200000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTMtMS0xLTEtMTQyNjI0_16598020-038f-4d37-9c15-a8465a7390d4"
      unitRef="usd">852000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmYzODk1NjQwOGM3NjRkNmI4YjY3Mjg2MGY4OTM0YjEyL3RhYmxlcmFuZ2U6ZjM4OTU2NDA4Yzc2NGQ2YjhiNjcyODYwZjg5MzRiMTJfMTMtMi0xLTEtMTQyNjI0_19314413-cec8-41e2-821b-df4f6fefb140"
      unitRef="usd">1080000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RleHRyZWdpb246MTllMDRjMjk5YTgyNGEwMzllODdhODNmNWI4YjIxYWRfMjc5NA_cd272968-86a6-40a9-83a3-f65c96a28390">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d8f5032283b4c13abb949fcc85a24da_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMi0xLTEtMS0xNDI2MjQ_83721879-d938-4965-a3fa-31cc596ac99e"
      unitRef="usd">852000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c0e7cc83d624907af537f69a7f78f77_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMi0yLTEtMS0xNDI2MjQ_483224fd-b6a6-4faa-b953-a3860fb63340"
      unitRef="usd">1080000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i353419505f7f47a39847c9b26776c895_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMy0xLTEtMS0xNDI2MjQ_0950475b-186f-43e1-8a37-782ad3510c1f"
      unitRef="usd">-666000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i22bd1d9d744b4e77b5508602e287cf98_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfMy0yLTEtMS0xNDI2MjQ_9c8ddeb1-ff51-47f2-9785-c16468ea3c6d"
      unitRef="usd">-917000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNC0xLTEtMS0xNDI2MjQ_946d1f73-c401-4fa9-9d04-de0de46b80e6"
      unitRef="usd">186000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNC0yLTEtMS0xNDI2MjQ_0a2ad29a-f466-4947-af05-0ed7e1ceef92"
      unitRef="usd">163000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNS0xLTEtMS0xNDI2MjQ_aee2eb94-f6a2-40b1-a856-e018aa0f74a0"
      unitRef="usd">-117000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNS0yLTEtMS0xNDI2MjQ_df819cd0-f6f7-4909-8d0d-1a3960e9fc3f"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNi0xLTEtMS0xNDI2MjQ_b30ade73-4082-4b99-8076-c9c97c0f7c45"
      unitRef="usd">1000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNi0yLTEtMS0xNDI2MjQ_3d08711c-74cc-42a6-b14d-1f7a8bc6fba2"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNy0xLTEtMS0xNDI2MjQ_41817a2c-a8fb-467c-a7ba-3bef91ebdbcd"
      unitRef="usd">70000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ideffcf08e2f0416abd9a2c0db6bafd44_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl84NS9mcmFnOjE5ZTA0YzI5OWE4MjRhMDM5ZTg3YTgzZjViOGIyMWFkL3RhYmxlOmMwOTQ0YWRhOGY1MjQ5ZDc5NjI4NTEzMWM4MzZhNTkzL3RhYmxlcmFuZ2U6YzA5NDRhZGE4ZjUyNDlkNzk2Mjg1MTMxYzgzNmE1OTNfNy0yLTEtMS0xNDI2MjQ_5271b875-c0ff-4d18-aa31-7bf532290afb"
      unitRef="usd">94000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2023, December&#160;31, 2022, and March&#160;31, 2022 (in millions):<xhtml:table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><xhtml:tr><xhtml:td style="width:1.0%"/><xhtml:td style="width:57.520%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.974%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:14.129%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.977%"/><xhtml:td style="width:0.1%"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td
          colspan="3"
          style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2023</xhtml:span></xhtml:td><xhtml:td
          colspan="3"
          style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</xhtml:span></xhtml:td><xhtml:td
          colspan="3"
          style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</xhtml:span></xhtml:td></xhtml:tr><xhtml:tr><xhtml:td
          colspan="3"
          style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,718&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td
          colspan="3"
          style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</xhtml:span></xhtml:td><xhtml:td
          colspan="2"
          style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
          colspan="2"
          style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td
          colspan="2"
          style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td
          colspan="3"
          style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,677&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,722&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMS0xLTEtMTQyNjI0_70346503-444e-4438-8b6f-f190223e337d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDItMi0xLTEtMTQyNjI0_2e0366d9-821e-43e3-9e71-771807eb0d96"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMS0xLTEtMTQyNjI0_fd935906-241d-48d6-8698-21c1ec12480f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RhYmxlOmJkOTM1NjkxZDc4ODRiODU4N2ViYjBhMzdiMjNkMjQ3L3RhYmxlcmFuZ2U6YmQ5MzU2OTFkNzg4NGI4NTg3ZWJiMGEzN2IyM2QyNDdfNDEtMi0xLTEtMTQyNjI0_8c030ee7-89ea-420e-9eca-245800568e2d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE5NmMzMDMzM2VmYjQ4ZTNhZjU1NGI3NjQ2NjZhZWQ2L3NlYzphOTZjMzAzMzNlZmI0OGUzYWY1NTRiNzY0NjY2YWVkNl8yOC9mcmFnOjEyODcxNWExNmJmMDQ2M2M5ZTE3NzMxNDQ4OWMyYThkL3RleHRyZWdpb246MTI4NzE1YTE2YmYwNDYzYzllMTc3MzE0NDg5YzJhOGRfNDIz_fdd57dd6-5451-408f-acce-f5fd0b86b934"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>84
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;U 3P.,HX'%@4-G/IS_:3<M"<VGVF40+BOY%0[I$#XP_K<] UR_^C"13;1W
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MU1C [TLA]-.-^>[2?F>;_@M02P,$%     @ D3J;5E?M%-GU @  ) @  !@
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M9S31^2"\P&]XP/T6RSWL48L].HK]'6\^7:JG+7A-^QKXZ!F./QI%P_,HO#@
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MKR_WZ.+3)1()YD2@E*+'-,N@:\05^M2^G=D20-7G[*B"6I90W@"4CQX9E8E
MGP$N/O>W(<$Z2^^4Y=(S!GS$_ ;Y[A7R',_7\*S>[^X9</RZT?TBGC\0KVK/
MNI'1/W=K(3D,Z7]UC54&&^F#J7E^*W8X(G,+)K(@_$"LQ:^_N('SFR[3#PIV
MEO>HSGMDBK[X F5)X(QHAT3I&A2NJO@<%GXPFL[L0YM>8Q0Z86UT1C6NJ<9&
MJA434HWR0;+2?=SZJ.<[7H=,9S2>ZLF"FBPPDOW!F1 PV_DVI3JPH/=-UQ^%
M'3"MT40/%M9@H1'L!<IN2K=7:$LHX3A#F,8(QU"?4C6.565&Y&VG"HNV1<,^
MD^,Z'7"=T=C3@T]J\(D1_!G&-.914@#'Y  RMBMFH(EVT@<)1AU8C<W8T;-.
M:]:ID?4OF1".0+!5@](ME%15-:X0)5)'.>T17+M^AU)G,S![7*=1$,?,V2'4
MUGNGWSZ3H$.G,PK\ ;R6P+E&O <J"92RNHL'&["*<_9YMSN;-$:3\0"BUR!Z
M[^CI'_1O%>.\\[IT.IM@ *]1*]<H"B>Y6A-8-9(*$TG\II\M5; V0]B=VAJ;
MZ6@ LQ$7UZPN#S78J:NU>*-^H1YW\30V[@!>HS*N66:4^!DF2%\_1CVLODTX
M-#T:B7'-&M-@(2PE3]=[B=<9-"-#E,%S*CDKBCU8E1-)W^L:F>GB]TT&JKG;
MZ)!K%B(#_1*_ 2^"%73TFK L)EP/'O:6%*-N<=?8A$/CH5$B=V)<!'[&G$*S
M"K13E&H1K<4SZMG/+OX^*MIYRHV@N69%6V*11N@"]@8QC"G,6[E?:I,OPX6M
M=G=NG.Z:4&OE#I03KY$USRQK]VFV5UNA]^-6 7^ J[4:Q&UDSG.-P^E;L6$E
M\34^@!QO":+[?*W6#YO3#@TV\4+"N@<&G9;>**,_.](^*MIY:S2*ZID5M1EI
M9?+Z_NJKY=CI%EVMT4#5]1I)]<R2VAY<)L*^3HZ=[I)$:]3=>=BM(X*<\&UQ
M<B)0Q/94EOOH^FE].G-7G$ETGB_=VU5YQM*$*8]\'HM]BD 9V4!(YR8$(EZ>
MHI0WDNV*@X@UDY+EQ65",!1F90#O-XS)TXWZ0'V6M?@.4$L#!!0    ( )$Z
MFU9CH3EC%P0   T.   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULM5?;
M;N,V$/T50@V*&(BCFR]):AM(O"UV@68;;+KM0]$'6AI;;"C2)2G;Z=?OD%(4
MVY*%%,@^V!*IF=$YAS/4<+*5ZDEG (;L<B[TU,N,6=_XODXRR*F^E&L0^&0I
M54X-#M7*UVL%-'5..?>C(!CY.67"FTW<W(.:361A.!/PH(@N\IRJYSO@<COU
M0N]EX@M;9<9.^+/)FJ[@$<S7]8/"D5]'25D.0C,IB(+EU+L-;^9A;!V<Q1\,
MMGKOGE@J"RF?[.!3.O4"BP@X),:&H'C9P!PXMY$0Q[]54*]^IW7<OW^)_HLC
MCV065,-<\C]9:K*I=^61%):TX.:+W'Z$BM#0QDLDU^Z?;"O;P"-)H8W,*V=$
MD#-17NFN$F+/ >.T.T250W3L,#CA$%<.3CF_1.9H?:"&SB9*;HFRUAC-WCAM
MG#>R8<(NXZ-1^)2AGYG-I4AQ42 E>*<E9RDU.'@T>,'5,IK()3[*,4<RNW@;
M()]$(G,@YX6@1<K0ND?ZY.OC!W)^UB-GA ERSSC'-=(3WR!$^R(_J>#<E7"B
M$W!B<B^%R33Y&6&EA_X^4JOY12_\[J+.@/=479(XO"!1$,4M>.9O=X\ZX,2U
MW+&+%Y^(5^MZ4M:_;A?:*,SNO]O4*Z,/VJ/;DK_1:YK U,/ &M0&O-F//X2C
MX*<VZN\4[$"(02W$H"OZ[#/N4,PQ;J-9^HZ<K]V(-K/!<.)O]L$W3<9Q;7(
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MB_HCA,:,4+2NO-IZ!-%F@F?'LEJ](LTNJGHT\J**.484%[2@ *4MH+0EE!9
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MT[:*H&W;G39@1U)T+7#(X(FG(2$M^Y$P^]E$=<XP+PF2/K]UVSZ'"/8YNV5
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M?DB_1/@!IVYQ\ &'HL-Q#V?2&<:XI)U!EG(.-E5#P27J!5)64X6'0.\/6?"
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M!%'9 -I?2FDVCCV@':OQ7U!+ P04    " "1.IM6.J(/FF<%   D#@  &0
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MOFJ,J]Y\^OG+S[_]_O/=JZL*U*CM*@TCW_F1R9F1$_&K*:N-$S^7F<KZXZ_
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MDJ$$\X:JOH%SLI/*KZX"N0P=89J(DQ@/[N6 /R$\*'@E!X 80Y?U/B*.&+F
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M%:R?'S=*PH.I [ZOC*GB"TW0_"^!-_\'4$L#!!0    ( )$ZFU;K.'-! @<
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MH?/X[44$-%SYP\"9-ERSN7%\:8?/FE])2-Z URMCW&'@'4SOKO4_4$L#!!0
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MJ')=Y:ZVQ>;[4FKO>QJII6Y\GNF1+E8F'K?N"8D:QH+$Y%AK0=4YBPS?E7@
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M6P\9[V-.%P(%LN%EGYCR1R*WJ#P?R;(;$2K" 8T:YH62;.ED4ZE\$$"%:AF
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MI<$&YE\4_9Y1VXIX-G#V;%KNMX,CA*K?X@I8\5[>.KZ 8#_9DD9-G)B<<87
M]6/#J< 1'G_OFCS9^XA!C93Q4XU'1&M"^IX95H>OP57Z"'H]GCXE\?E0HA?C
M#KJ!Z'2\/!D)ES[/TDNP3?PD6MN #ZSXR'.)'!_ _L;:T+^P@N$;^?)_4$L#
M!!0    ( )$ZFU9Z[Y=;.08  . .   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;*57[V_;-A#]5P@/&!+ M1VG[;8N,>"D:6<,;8*X:3\,^T!+)XF+
M1&HD9<?[Z_>.E&2G2-QA_1!'/XYW[][=/5)G&V/O74'DQ4-5:G<^*+ROWXS'
M+BFHDFYD:M)XDQE;28];FX]=;4FF85%5CJ>3R>MQ)94>S,["LQL[.S.-+Y6F
M&RM<4U72;B^H-)OSP<F@>W"K\L+S@_'LK)8Y+<G?U3<6=^/>2ZHJTDX9+2QE
MYX/YR9N+5VP?##XKVKB]:\&9K(RYYYM%>CZ8," J*?'L0>+?FBZI+-D18/S=
M^AST(7GA_G7G_5W(';FLI*-+4WY1J2_.!S\/1$J9;$I_:S:_49M/ )B8TH5?
ML6EM)P.1-,Z;JET,!)72\;]\:'GX+PNF[8)IP!T#!91OI9>S,VLVPK(UO/%%
M2#6L!CBEN2A+;_%689V?7<R7BZ6X?B=N;J^65Q\_S3\MKC^*HQM3JD21.SX;
M>T1AVW'2>KR('J?/>#P5'XSVA1-7.J7T\?HQT/40IQW$B^E!AQ^D'8G3DZ&8
M3J:G!_R=]BF?!G^GS_B[MKG4ZA_)73$4ET8[))O*V"0Z%3>6'&D?'YA,O%-:
MZD3)4BSQD-"1WHD_YBOG+7KJSZ<8B@!>/@V Y^R-JV5"YX.:8]DU#68__G#R
M>O+K@?1>]NF]/.1]=B&=<HQ[/X^G0!YV\ZD@T6C9I,I3*I3V9%4E$H.B:H<G
M2<\;;K*>(K>C"! NY /6B06OU@$(3!8Z&06B%8Q<LW(J5=*BV<31AH;"-%88
MVRX]%H5<DU@1:0&N:FD1K6ZL:Z3VPAOA =,V)1:S1TMY4X8X(3R_7%+26.55
M:W'UD!12YX2Z5Y5R05N.EE>7QP("UZ>YRP<QC?5*YR,Q3Q)C4UR6VZ%(R'I(
M'E9$8>R:)S/&:^-)I,HEI7$-BB TFY3E%M9)V:2!SZ<YZW-4+%@<#S8$3?"%
MN!LM1R(G33;XPFNJF7RV:S1CQ')$4#73<13,W\_G-\?LC*FXTZ&6H8O='K&[
MHH("4RD/JY%  [CO;0%7F*9,$47PAL$XL.:O1D=%#EDQL&\[8FJ95O>(0FZ5
MN=8-;&]#G02\LEB+D\F+WT-%V?V6I!7$:B3>4D+5BFR<ME94IN(H_#YR=3Q:
M1-9,K72K!)74V*@8T3"\^CYRL/WPWB1032'3OZ#U\;D&1N>P0X8$I,BDLJ+^
M2I0X_,YK;9R*<@8S[$>A^[%QVW86F+Y$ND)DV(1=3PP,E$E=YYRK/@<8UR3%
M/J(A$D5+P2D6V8U"6W M4H$[4@B*CN6 LFUT1H&AL]R1F'J,0.BF9[!U8'@%
MHO541G#!-Z+UK*@P1JE*)&_G'15/NX8^H/7HH0;-7(4V4M8@26Z*T0&Y?=7+
M[:N#.GFKW'TD^$ZWHA#$YI;*4'I@N+S^O'C[XN278/6^-"M4[ K]@5%+PK-K
MYI5WHC14T3VEUO\/Q;*I:Q#&FQQV*]6-TM<@=J'%%XK*P*Q!E.$M%4[E6F6@
M'.6!?)8E04$#O3R!>73F8BB\#[+(/<#E;'MLV YN5"F3-E$"4K"TC9A"W6U3
M!QC!')H1)\FUL"$G2(U#H\Y6;C"0W"NR;#O<5+71(:BT6'*T"XG^4.T<A .A
M-17Q1H"<2H!8*S37<7A=X!B'8H M[5@'XL0%#-UTL<,,'N(,81%UA0P# NH,
M9-HTZ&T<$(QU>[GO4[DA&>W7<<J ;"VCFF1Q%Q-X0B5>83?IJ&':N]V' 08R
MDB B%OM &E#A*%RF4:0VDO<U<7?/]:<]F#F9&@KE P<1PXC+'^>%P^QZ0#@0
MU@Z;VW>RUPYVU_'<%E_W0]:P$G3]T.TON_7['=**ZUJJ4JX4,&Y#DFW6WZS\
M,+8PWAI<I2Q,E$>]4!4.7F&?"!@E;Y6L"SVCL3=!J*?<A%-)VE"7$P2WA8,'
M+"-;N/#*95LT4<5(^*^26Y9_]$E<&<$<QM!NT9&D1V4HI(_ZN&,ZD0T/QFK;
MS1YU@YST@PQ5K@RHC&5J&W'X##8<-M(U6=2#LHQVV%8-Q@:R^Z10CO>^.BJR
M>?BV C@^C,0/D/YI__DVCU\M._/X[8<C?L[S65*&I9/13U [&[^GXHTW=?B&
M61F/+Z)P6>!$098-\)Z/7=T-!^@_:F?_ E!+ P04    " "1.IM6_AW-,:<$
M   M#   &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6R55VUOXC@0_BLC
M=K4"B2LDO+9+D>B;%FE+4=N]?CC=!Y,,X&MB9VVGM/OK;\:!M+VC:?<#B>W,
M///BQ^-AM-'FWJX1'3RFB;+'M;5SV5&K9:,UIL(>Z P5?5EJDPI'4[-JV<R@
MB+U2FK3"=KO?2H54M?'(K\W->*1SETB%<P,V3U-AGDXPT9OC6E#;+5S+U=KQ
M0FL\RL0*;]#]R.:&9JT2)98I*BNU H/+X]HD.#H9LKP7^%/BQKX8 T>RT/J>
M)]/XN-9FAS#!R#&"H-<#GF*2,!"Y\7.+62M-LN++\0[]PL=.L2R$Q5.=W,G8
MK8]KPQK$N!1YXJ[UYAMNX^DQ7J03ZY^PV<JV:Q#EUNETJTP>I%(5;_&XS<-'
M%,*M0NC]+@QY+\^$$^.1T1LP+$UH//"A>FUR3BK>E!MGZ*LD/3>^^3&??S^_
M/)_=3K[#Q70VF9U.:32=75Q=7TYNIU<SJ-^*18*V,6HY,LAJK6@+?E* AV^
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MIO3-@IHWT/I"*5M-6$']%33\#U!+ P04    " "1.IM6]!DPC;8(  #(%P
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6SM6-MNVT@2_96&)AC$@$82
MJ:L]M@';268"S&0-.\D^+/:A1;:DQE#=G.ZF'>W7[ZEJDI)L29D!]G$?1/'2
MK#I5=>K2O'RV[@^_4BJ(;^O"^*O.*H3RHM_WV4JMI>_94AD\65BWE@&7;MGW
MI5,RYY?613\=#";]M=2F<WW)]^[=]:6M0J&-NG?"5^NU=)M;5=CGJT[2:6X\
MZ.4JT(W^]64IE^I1A2_EO<-5OY62Z[4R7ELCG%I<=6Z2B]LIK><%7[5Z]COG
M@BR96_L'77S,KSH# J0*E062(/'WI.Y449 @P/BSEMEI5=*+N^>-] ]L.VR9
M2Z_N;/%/G8?556?6$;E:R*H(#_;Y5U7;,R9YF2T\'\5S7#L9=416^6#7]<M
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M2 .IU1DDOQ&C<QS&B7BTB_ L'?1*\%&,4C$:BMO*Y(7*A?JSTB5J K2;G*
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MV&9>0UEKGZD"$[!B2M8#SDXUQR+LAJ#$]T[,@)-V!IR<',EX_OLI;$HE?J.
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MMS35HG8"=+Y6RI8;YZ":DX?_ E!+ P04    " "1.IM6AL(ZPR0#  #3!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R-5=V/VC@0_U=&:56!=-I
MH+3= A)LTRL/"U'@K@]5'TPR$*N.G=JF;.^OO['S<:S$HGL@^&/F]^%X)M.S
MTC],@6CAJ132S(+"VNH^#$U68,G,G:I0TLY!Z9)9FNIC:"J-+/=)I0BCP6 2
MEHS+8#[U:XF>3]7)"BXQT6!.9<GT[R4*=9X%PZ!=2/FQL&XAG$\K=L0MVK^J
M1-,L[%!R7J(T7$G0>)@%B^']<NSB?<#?',_F8@S.R5ZI'VZRRF?!P E"@9EU
M"(S^?N$#"N& 2,;/!C/H*%WBY;A%_^R]DY<],_B@Q%>>VV(6O \@QP,["9NJ
M\Q=L_+QU>)D2QC_AW,0. LA.QJJR228%)9?U/WMJSN'_)$1-0N1UUT1>Y2=F
MV7RJU1FTBR8T-_!6?3:)X]*]E*W5M,LIS\Z3>+U=;=:P6'^"S>Y+G$*RV>[2
M>+=*X\=XO8-EO(X_KW:0I)L_T\7C%GH[MA=H^M/0$K]#";.&:UES12]PC>!1
M25L8B&6.^?/\D'1WXJ-6_#*Z"?C(]!V,AG] -(A&-_!&W6&,/-[H!;P4+==(
M5\["$B4>N#7P;;$W5M/E^7[-<(TWOH[G"NK>5"S#64 58U#_PF#^YM5P,OAX
M0^VX4SN^A3Y?4\DFJ+G*>=;JA0=E+*0HF.7R"%911%U 3.:PL05J2"@$RTJH
MW]YI[(>('40BF#37S-Z6LRL0#DI0E3MF;H"UE0[J )+$5JW8?<.4.;'Z0JPZ
M:8JZ$)S$2ZB<GCO8%9I$EO4-0G>#H,<EU800%&[Z_A*X1]1YWK<O<4M'SS.L
M"5_#A'[##["2%NFU-#I&[R :0_Q44;\@;(WVI"40BN,'9@P24&\\[D-O]*$/
MBU)IR_]AOK<T!H6B*..55V25>M\%KX$A#"-87QY$Z[71]>;5^V@8?73J)K7W
MYQ)?0^3V7N2^QJPQIY/N39SL_G-VS^"!Z2 S56*?T'MC_XSZUVYH>-%H2M1'
MWTX-89RDK7M.M]IU[$7=J/X+K]L]U>Z12P,"#Y0ZN'OW-@!=M]!Z8E7EV]9>
M66J"?EC05P>U"Z#]@U*VG3B"[CLV_Q=02P,$%     @ D3J;5L6PB!># @
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M!I3Q!=6:A]RGEM,0F8FDKM&UX2;B3I\O 7*)9@%>:2EX0 W<A#RAB<^I(-K
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M0BJV393]^F.U$&YVHQZM%FQN_:@6MO!S[W2JK:_;12>?I$[A6T"I)ULY5V3
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MULXZE#*=M[E\8M4ZZQ0+9:GO9,,5?1F@=@;T/%'*/DW<!L6W1O@;4$L#!!0
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MS:KO?'%("@NZYN9:;K]!E4\A,)%<%U>RK6(]AR1K;616@5%!QD1YIP^5#SL
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MX?\&E W YPLIS=/&CK3Z#Q;] 5!+ P04    " "1.IM63[$HM:L"   4!P
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MO\!\J:(&%QTC<U?&'J7!HNB:*WRV0-D G%](:78=NT#U$,9_ 5!+ P04
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MZ@]H-!A=W=P.>_>#FQ&<0"])N$LZ$S"0I7+<$1Q>H&5<F",R>;B[@,.#(S@
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MXI;X0!UO.PJ *:9<S=LYSOO.41+GD%X#U[X"CN6XX/DI !>_7;8,;/IQC*/
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M<@?$FAGE#\B5>-6F5%JS)%20Y*,30='YF6=F^";[.\?T_SK_*X?157Z=L+"
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MY[N_D\NEO^'B6:X %'H)*9,#:Z54=&7;TE]!B.4ECX#I*PLN0JST5"QM&0G
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M^!$@"V$-G]GQPY&!#LYN!8[Q< 7>;6#+A<AI5+ODTWE4L(5@]O<-\QP:\K_
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M(+!_4.7;M@?_0U[56]W^NI+)4A9-0/WWQSRO7A\T+W#\'H?+_P%02P,$%
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MDP:?LEMF.#9!60<\7TAIMAL;H![$R5]02P,$%     @ D3J;5HIL@SG+!
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MX1CQ*YKB1#Y94!8C(:=L:?*4811J4!R9CF6US!B1Q/!Z>FW*O![-1$02/&7
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M\=:'=^#GIPMT <.,2S#G\) *$I-?2)_#:(78$G.XO,$"D8B_D: G_P8N+][
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MDMT89BI /E]0*K83M4'9WWF_ 5!+ P04    " "1.IM6\[U@0M0%  "\+0
M&0   'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6RUFFMOVS84AO\*H15%"VRQ
M1=*WU#:0.%EJ8&F"N-F #?N@V'0L5!)=B8Y;8#]^U"6B:5$G%D!]:2R;?'7.
MX6OU,0_'>QY_2S:,"?0C#*)DXFR$V)YW.LERPT(O.>-;%LE/UCP./2$OX^=.
MLHV9M\HFA4$'=[O]3NCYD3,=9^_=Q],QWXG C]A]C))=&'KQSTL6\/W$<9W7
M-Q[\YXU(W^A,QUOOF2V8>-S>Q_*J4ZJL_)!%B<\C%+/UQ+EPSV=TE$[(1OSI
MLWUR\!JEJ3QQ_BV]F*\F3C>-B 5L*5()3_YY83,6!*F2C.-[(>J4]TPG'KY^
M5?\]2UXF\^0E;,:#O_R5V$R<H8-6;.WM O' ]Y]9D5 OU5OR(,G^1?MB;-=!
MRUTB>%A,EA&$?I3_]7X4A3B8('7,$W Q 1]/H#432#&!9(GFD65I77G"FXYC
MOD=Q.EJJI2^RVF2S939^E"[C0L3R4U_.$]/+Q\7\R_5B@>[NO\YOYW]??)W?
M?4&SSQ</-]<+]!N:\7#+(Q:)!/$U>F")B'=+L8O]Z!G--E[\S!+TX8H)SP^2
MCW+\X^(*?7CW$;U#?H1N_2"0:Y6,.T*&FMZPLRS"NLS#PC5A$73+([%)T'6T
M8BM]?D>F6.:)7_.\Q*#@K1>?(>+^BG 7$T,\L].G8R <4I:=9'JD1N^HD#P1
MR(M6:7U9_,+0/W_(\6@N6)C\:RI>+D[-XNDW_SS9>DLV<>17.U-TIN]_<?O=
M3Z;,+8EI=:!E'2BD?E2'96XH4\:Y3#^321]-+U/7[8X[+X>)5,?T!^40+;Q>
M&5X/#&]V=[,P10/.:EI_2V):@OTRP7Z;/NS;K(,E,:T.@[(. SL^S&5Z!QXC
M^,B&U2'8[,)A&=P0#&YQ\]X+MY\N3/& ,YNN@"4Q+<E1F>2H32>.;-;!DIA6
M![>K_D?NVO%BH7/HM(%[9$;#F'[/;$?W@!E<.,+,CU?&F,"931?"EIJ>)U9Y
MXC8]6:C;JH4E-;T6"EA<D ,:N))477ELRNJ0;HTG%4BX,$E<A]N _V0,"19+
M3O:R'PE+N63F($&QQDMC24U/74&*VVO5IE9IQI::7@O%,RZ("0ULVJ]X<%CQ
M:74,'=4859&&"Z-&O5'1?Z@..&'-QFMD24VO@,(9=]BJ7ZTRCRTUO1:*>EP0
M)AKX=53QHEOQ:W5,#7IB12,8IA'0KA"9PKI-E\F6FEX%13S8;=.RV"H5V5+3
M:Z&H"(.D<;IE"QV-/<F190UC:,V/=JQ8!<.L GH6@%=8MO$RM;&Q@A408=JJ
M9:T2DBTUO1:*D#"\CW.Z97MOPJMA2 V\8D4M&*:6&8]$["V%9MATM;C8L+@>
M8V'9QHO4Q@X,5F"$!ZT:UBHBV5+3:Z$0"<-;/J<;=EC=D#HV;'6(6X<%BELP
MS"VG.!;@65B]\6*UL6%#%"*1;JN;^59!R9::7@L%2N2-K:%3C5OH0,8U#*EY
MTA(%+P2&EQ-]"X$M?(?&Z]7&M@XYZ$.UVXBRVXEJ@YB((B9BJ1E5Z)B-6:12
M'5+WT"4*8\@;[:C3S L0+GR#QNO5QEX/4=1$6FU>$:OP9$M-KX6")V*I@46J
M[:F*=Z$A>GP*: @,-!=)P@3RPZWGQV%ZG, 8F]6='5MJ>L:*D$BK#2UBE9!L
MJ>E-?D5(U%)+BU;;5;C2YC>TM,SVI I;*(PM%7L"[ I+-5T96VIZXHJ':*LM
M+FJ5A6RIZ;50+$0MM;AHM7_E'I\",(RI>8C2@\,R,*"87 J1*BS7>'7:V,.A
M"GYHJUTN:I5\;*GIM5#D0RUUN:BARW5LU.J0NL>IHA$*TXC)J "5PFJ-UZ:-
MK1NJ2(>VVMVB5AG(EII>"\5 U%)WJ]#I&Y^612K0D#R^SL$YV)#)>Z7'@Q/Y
MNV@7B?RH:/EN>03Y(CMX>_3^I7L^RP\2*YG\7/.M3,&/$A2PM93LG@WD]R;.
MCPKG%X)OL].V3UP('F8O-\Q;L3@=(#]?<RY>+](;E >VI_\#4$L#!!0    (
M )$ZFU9>^Y^]< ,  )D,   9    >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;+5777/:.!3]*W>\G9UVIHV_ B19\ R0[):'- QNMC.[LP_"OF!M98E* LJ_
M7\EV'"".FS+9%Y!DW:-SCJ[DZ_Y6R*\J0]3P/6=<#9Q,Z]65ZZHDPYRH,[%"
M;IXLA,R)-EVY=-5*(DF+H)RY@>=UW9Q0[D3]8FPJH[Y8:T8Y3B6H=9X3N1LA
M$]N!XSL/ S.ZS+0=<*/^BBPQ1GV_FDK3<VN4E.;(%14<)"X&SM"_&ON!#2AF
M_$EQJ_;:8*7,A?AJ.Y-TX'B6$3),M(4@YF^#8V3,(AD>WRI0IU[3!NZW']!_
M+\0;,7.B<"S8%YKJ;.!<.)#B@JR9GHGM1ZP$=2Q>(I@J?F%;S?4<2-9*B[P*
M-@QRRLM_\KTR8B_ X#0'!%5 <!QP_DQ 6 6$A="262'KFF@2]:78@K2S#9IM
M%-X4T48-Y78;8RW-4VKB=#2ZCR>?;N(8[J:?)[>3OX:?)W>?8/QQ./OC)H8/
M$)?;"V(!0^LXU3N@'&:H4&Y0F08C&E/0PHYIN4[T6E*^A FGFA*[1PK>7J,F
ME*EW!O ^OH:W;][!&PMS2QDSFZGZKC9:+",WJ7B/2M[!,[Q#N!5<9PIN>(KI
M8;QK/*B-"!Z,& 6M@+=$GD'HOX? "\(&/N.7AP<M=,)Z7\("+WP&[]#,RF[X
M>R88 Y._6R+3?YI<*U'/FU'MG7"E5B3!@6,.?8'I1+_^XG>]WYHDOQ+8@0'G
MM0'G;>C1."-RB8V9409VBT![36TBW_?Z[F:?^M,YW5X]Y8!0IR;4:244XP8E
MX0D"X2G<Z0PEW.0K)G:(]3$8"Z4;.;=B_^R^O!+8@0W=VH;N_Y*8W=<TX)7
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M+?!PO6?_Y+RCES75,)/\&RM-/0D^!*2$BG;<+.7N!GH_YY:OD%R[)]GUL5%
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MDBC?7 D^%S*[0)]?)(EZVLDJV*Z6'OT/4$L#!!0    ( )$ZFU8\W[U=$04
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MS3TF>BK67R"8BGYAD]@6' A62HLP 1L&(>7QE[PD<<@ BN4C "\!>.\%E!)
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MUL#LSX30VXE]%J2O0/\/4$L#!!0    ( )$ZFU8ZG8RTPP(  'L&   9
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M(16I0'\^XEQ]WJ1/GO/_-.C]#U!+ P04    " "1.IM66J^]ME8#  !$#0
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M:_%5V>(K;8LG472ZQ^70_L'WF@T[&^%K/]^U;Q@BJRDU*)4:Z.?7-9)C5ZV
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MV;"J%IJ1.4Z8&O+U-Y()"C3?E#-I_J)U%NM8:)I(Q<,,#!F$-$I_\4MFQ!;
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MD%J'D \:@-012+T3R+#&4?\*( T$TN@0LA5)$X$TNX34 :2%0%I=0AH <H1
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M/TGU>#XW7R]_67[OG-R7"\[U;45Y^@M02P,$%     @ D3J;5D!K%[H  @
MQBD  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=I-3L,P$ 7@JU39HL;U;P%1
M-L 66' !DTS;J$ELV0;*[7%20 )!!2H2;].HM3UOXI&^5<_NGCW%R;9K^[@H
MUBGY4\9BM:;.QM)YZO/*TH7.IOPUK)BWU<:NB(G9S+#*]8GZ-$U#C>+\[)*6
M]J%-DZMM_CDVKE\4@=I83"YV&X>L16&];YO*IKS.'OOZ4\KT-:',)\<]<=WX
M>)0W%.S+A&'E^X#7<S>/%$)3T^36AG1MN[R+;5L6TW-+L=Q?XHL>W7+95%2[
MZJ'+1\KH ]DZKHE2UY:[HD?[DU.^8=I]\H/SQS+[ O/.V^!\S!,+]/NXMY$,
MIZ<^%Z*0FOVO^)Z82Q_\?C1,NZ;ZA]GY>I]<V(SSB&Q\''[''V?\7O^7?0B0
M/B1('PJD#PW2AP'I8P[2QS%('R<@?? 92B,HHG(44CF*J1P%58ZB*D=AE:.X
MRE%@Y2BR"A19!8JL D56@2*K0)%5H,@J4&05*+(*%%D%BJP215:)(JM$D56B
MR"I19)4HLDH4626*K!)%5HDBJT*15:'(JE!D52BR*A19%8JL"D56A2*K0I%5
MH<BJ4635*+)J%%DUBJP:15:-(JM&D56CR*I19-4HLAH460V*K 9%5H,BJT&1
MU:#(:E!D-2BR&A19#8JL<Q19YRBRSO]3UGOG-G\</S[+SC;]6SX;_[YY_@)0
M2P$"% ,4    " "1.IM6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )$ZFU97=X^G[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M )$ZFU:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ D3J;5ECW0RUJ!P  &C0  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M )$ZFU87*D7A@08  ',;   8              " @:T/  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " "1.IM65^T4V?4"   D"   &
M            @(%D%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ D3J;5A5L32#%!   UQ(  !@              ("!CQD  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )$ZFU9CH3EC%P0   T.
M   8              " @8H>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " "1.IM6DL @<=X"  #H!P  &               @('7(@
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ D3J;5C-A.(2&
M"   VDT  !@              ("!ZR4  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( )$ZFU8&X36O2@<  ",?   8              "
M@:<N  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "1.IM6
MYT5M[JD#   *"P  &               @($G-@  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ D3J;5JRG!_?2!@  ] \  !D
M     ("!!CH  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )$ZFU;GF)1Z=P(  &(%   9              "
M@6U;  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ D3J;
M5CJB#YIG!0  ) X  !D              ("!&UX  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " "1.IM69I+/ASH1   Q,   &0
M        @(&Y8P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( )$ZFU;K.'-! @<  /L3   9              " @2IU  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ D3J;5NVL75P! P  T 8
M !D              ("!8WP  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " "1.IM6TUE\4Z0#  "#"0  &0              @(&;?P
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )$ZFU8;,,O3
M&P,  .<&   9              " @7:#  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ D3J;5GE+"=W+#@  GC   !D
M ("!R(8  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "1
M.IM6$"E*]: )  !<'   &0              @('*E0  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )$ZFU:W,Q4SR08  "\/   9
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M970R."YX;6Q02P$"% ,4    " "1.IM6]!DPC;8(  #(%P  &0
M    @(%(NP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M )$ZFU:PNK1E"P0  #,+   9              " @37$  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ D3J;5H;".L,D P  TP8  !D
M             ("!=\@  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " "1.IM6Q;"(%X,"  "/!0  &0              @('2RP  >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )$ZFU8;=,7YY@4
M -T3   9              " @8S.  !X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ D3J;5A<!<EFA!0  ?A   !D              ("!
MJ=0  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "1.IM6
MY&'TMH0#  !F"   &0              @(&!V@  >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( )$ZFU:_?1V\#@,  '<(   9
M      " @3S>  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ D3J;5J^&:YN] @  $ <  !D              ("!@>$  'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "1.IM6[S\<)[L"  #-!@
M&0              @(%UY   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( )$ZFU9/L2BUJP(  !0'   9              " @6?G  !X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ D3J;5MRS^!L"
M P  9@@  !D              ("!2>H  'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " "1.IM6R52M P8#  "["   &0
M@(&"[0  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )$Z
MFU8!CG'LF@,  -40   9              " @;_P  !X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ D3J;5E3_.NFT @  O 8  !D
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M=#0W+GAM;%!+ 0(4 Q0    ( )$ZFU:#C6G6^04  )0B   9
M  " @8H( 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
MD3J;5A!4\S+I!   YAD  !D              ("!N@X! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " "1.IM6HJ_.HT,)   <;@  &0
M            @(':$P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( )$ZFU9UEXV6B 8  *\O   9              " @50= 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ D3J;5M5Q ;8T"@
MTV$  !D              ("!$R0! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " "1.IM6N??@[+<"  "4!P  &0              @(%^
M+@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( )$ZFU:*
M;(,YRP0  $0=   9              " @6PQ 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ D3J;5J&JI;4& P  ZPD  !D
M     ("!;C8! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )$ZFU:+X?%\G (  #,'   9              "
M@?)) 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ D3J;
M5MN?+NJ$ @  Z04  !D              ("!Q4P! 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    " "1.IM6FUH6>LT&   Y/0  &0
M        @(& 3P$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( )$ZFU8\W[U=$04  )<<   9              " @816 0!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ D3J;5EF[J;7Y P  814
M !D              ("!S%L! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    " "1.IM6N U3D!T#   1"@  &0              @('\7P$
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( )$ZFU8ZG8RT
MPP(  'L&   9              " @5!C 0!X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ D3J;5L)6&Q!#!0  =2   !D
M ("!2F8! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " "1
M.IM66J^]ME8#  !$#0  &0              @('$:P$ >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( )$ZFU9 I#)UWP0  /,<   9
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M;',O+G)E;'-02P$"% ,4    " "1.IM62F)FHGX%  #8+P  #P
M    @ &UA $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ D3J;5JQM4%<\
M @  KRH  !H              ( !8(H! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ D3J;5D!K%[H  @  QBD  !,
M ( !U(P! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %  4 #G%0  !8\!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>351</ContextCount>
  <ElementCount>294</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>101</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - FINANCING ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTS</Role>
      <ShortName>FINANCING ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - REVENUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUES</Role>
      <ShortName>REVENUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - BUSINESS OPTIMIZATION CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - REVENUES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESTables</Role>
      <ShortName>REVENUES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/REVENUES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - FINANCING ARRANGEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FINANCINGARRANGEMENTS</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - REVENUES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESAdditionalInformationDetails</Role>
      <ShortName>REVENUES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails</Role>
      <ShortName>REVENUES - Contract Assets and Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails</Role>
      <ShortName>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - REVENUES - Lease Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESLeaseRevenueDetails</Role>
      <ShortName>REVENUES - Lease Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/INCOMETAXES</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails</Role>
      <ShortName>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails</Role>
      <ShortName>EARNINGS PER SHARE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bax-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: bax:RevenueRecognizedContractPeriod, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  bax-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  bax-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="bax-20230331.htm">bax-20230331.htm</File>
    <File>bax-20230331.xsd</File>
    <File>bax-20230331_cal.xml</File>
    <File>bax-20230331_def.xml</File>
    <File>bax-20230331_lab.xml</File>
    <File>bax-20230331_pre.xml</File>
    <File>bax-20230331ex321.htm</File>
    <File>bax-20230331xex311.htm</File>
    <File>bax-20230331xex312.htm</File>
    <File>bax-20230331xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="877">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>90
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bax-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 32,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 877,
    "http://xbrl.sec.gov/dei/2022": 41
   },
   "contextCount": 351,
   "dts": {
    "calculationLink": {
     "local": [
      "bax-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bax-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bax-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bax-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 540,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://www.baxter.com/20230331": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 12
   },
   "keyCustom": 21,
   "keyStandard": 273,
   "memberCustom": 37,
   "memberStandard": 62,
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.baxter.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - BASIS OF PRESENTATION",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - FINANCING ARRANGEMENTS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTS",
     "shortName": "FINANCING ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - REVENUES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.baxter.com/role/REVENUES",
     "shortName": "REVENUES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - BUSINESS OPTIMIZATION CHARGES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES",
     "shortName": "BUSINESS OPTIMIZATION CHARGES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.baxter.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - REVENUES (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.baxter.com/role/REVENUESTables",
     "shortName": "REVENUES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables",
     "shortName": "BUSINESS OPTIMIZATION CHARGES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ic40f7b5955594ed3b2bf0f05f9b528be_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ic40f7b5955594ed3b2bf0f05f9b528be_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Income (unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Income, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ic40f7b5955594ed3b2bf0f05f9b528be_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - FINANCING ARRANGEMENTS (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails",
     "shortName": "FINANCING ARRANGEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CommercialPaperAverageOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ic40f7b5955594ed3b2bf0f05f9b528be_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Changes in AOCI by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i91aae7c820be40a39dc2a16e37f937df_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - REVENUES - Additional Information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
     "shortName": "REVENUES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
     "shortName": "REVENUES - Contract Assets and Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
     "shortName": "REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i34e11ed2205046a495eb41670b8242bf_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - REVENUES - Lease Revenue (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.baxter.com/role/REVENUESLeaseRevenueDetails",
     "shortName": "REVENUES - Lease Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:BusinessOptimizationChargeTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "id2279531cc564bc5b781f9558ed1add4_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ie9afb4c625184a3f99e2cb5a2e3d5eaf_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i1ff73073d6be424295feaeb2acc57d80_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i4b94da491c8941b89ce1ebf68c0c2723_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - INCOME TAXES (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.baxter.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails",
     "shortName": "EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails",
     "shortName": "EARNINGS PER SHARE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeNotionalAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeNotionalAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ifc0855e415a24ea2bbed65f9964a98ca_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i607c52fdcfa04c428b2116b4f6436aa0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i607c52fdcfa04c428b2116b4f6436aa0_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "icf5014e9c356493ea281263e29225f8c_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "icf5014e9c356493ea281263e29225f8c_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "id39e31f62b29442da1752786dc58134e_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherInvestmentNotReadilyMarketableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i0f90874bfa6d48fba1bed7ac9573fcf6_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "ib1672a644c104e0cba0f5a365004ec05_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i40418177dcd1484c97237105cd4eacb8_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
     "shortName": "Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i40418177dcd1484c97237105cd4eacb8_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i3bc8aeefbd654849815b65f8dedd082d_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i3bc8aeefbd654849815b65f8dedd082d_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails",
     "shortName": "SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
     "shortName": "SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i353419505f7f47a39847c9b26776c895_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "if5fd7c94ed6e478daa861a8a6a325f22_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20230331.htm",
      "contextRef": "i845de0a94ae6446bb04bb2a640d8e8dd_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 101,
   "tag": {
    "bax_A04SeniorNotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero point four percentage senior notes due May two thousand twenty four.",
        "label": "0.4% Senior Notes Due May 2024 [Member]",
        "terseLabel": "0.4% Senior Notes Due May 2024"
       }
      }
     },
     "localname": "A04SeniorNotesDueMay2024Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A130SeniorNotesDueMay2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Senior Notes Due May 2025",
        "label": "1.30% Senior Notes Due May 2025 [Member]",
        "terseLabel": "1.30% Senior Notes Due May 2025"
       }
      }
     },
     "localname": "A130SeniorNotesDueMay2025Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_A13SeniorNotesDueMay2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point three percentage senior notes due May two thousand twenty nine.",
        "label": "1.3% Senior Notes Due May 2029 [Member]",
        "terseLabel": "1.3% Senior Notes Due May 2029"
       }
      }
     },
     "localname": "A13SeniorNotesDueMay2029Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "label": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "negatedLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses And Other Current Liabilities",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued Expenses And Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AcuteTherapiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acute Therapies.",
        "label": "Acute Therapies [Member]",
        "terseLabel": "Acute Therapies"
       }
      }
     },
     "localname": "AcuteTherapiesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AdvancedSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced surgery.",
        "label": "Advanced Surgery [Member]",
        "terseLabel": "Advanced Surgery"
       }
      }
     },
     "localname": "AdvancedSurgeryMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AmericasSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas Segment",
        "label": "Americas Segment [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasSegmentMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AsiaPacificSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific Segment",
        "label": "Asia Pacific Segment [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificSegmentMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AssetImpairmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment",
        "label": "Asset Impairment [Member]",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AvailableForSaleDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-For-Sale, Debt Securities",
        "label": "Available-For-Sale, Debt Securities [Member]",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BioPharmaSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioPharma Solutions",
        "label": "BioPharma Solutions [Member]",
        "terseLabel": "BioPharma Solutions"
       }
      }
     },
     "localname": "BioPharmaSolutionsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BundledEquipmentAndConsumableMedicalProductsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bundled Equipment And Consumable Medical Products Contracts",
        "label": "Bundled Equipment And Consumable Medical Products Contracts [Member]",
        "terseLabel": "Bundled equipment and consumable medical products contracts"
       }
      }
     },
     "localname": "BundledEquipmentAndConsumableMedicalProductsContractsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BusinessOptimizationChargeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business optimization charge.",
        "label": "Business Optimization Charge [Table Text Block]",
        "terseLabel": "Summary of Business Optimization Charges"
       }
      }
     },
     "localname": "BusinessOptimizationChargeTableTextBlock",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_BusinessOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Optimization Programs",
        "label": "Business Optimization Programs [Member]",
        "terseLabel": "Business Optimization Programs"
       }
      }
     },
     "localname": "BusinessOptimizationProgramsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ClinicalNutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical nutrition.",
        "label": "Clinical Nutrition [Member]",
        "terseLabel": "Clinical Nutrition"
       }
      }
     },
     "localname": "ClinicalNutritionMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_CommonStock100PerValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, $1.00 per Value",
        "label": "Common Stock, $1.00 per Value [Member]",
        "terseLabel": "Common Stock, $1.00 par value"
       }
      }
     },
     "localname": "CommonStock100PerValueMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ConsumableMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumable medical products [Member].",
        "label": "Consumable Medical Products [Member]",
        "terseLabel": "Consumable Medical Products"
       }
      }
     },
     "localname": "ConsumableMedicalProductsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractTerminationAndOtherCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract termination and other costs.",
        "label": "Contract Termination And Other Costs [Member]",
        "terseLabel": "Contract termination and other costs"
       }
      }
     },
     "localname": "ContractTerminationAndOtherCostsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractWithCustomerLiabilityCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Currency Translation",
        "label": "Contract With Customer, Liability, Currency Translation",
        "negatedTerseLabel": "Currency translation"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrencyTranslation",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_ContractWithCustomerLiabilityDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Deferred Revenue",
        "label": "Contract With Customer, Liability, Deferred Revenue",
        "terseLabel": "New revenue deferrals"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDeferredRevenue",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_ContractWithCustomerLiabilityTotalRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Liability, Total Revenue Recognized",
        "label": "Contract with Customer, Liability, Total Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized upon satisfaction of performance obligations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTotalRevenueRecognized",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeFairValueTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Fair Value, Terminated",
        "label": "Derivative, Fair Value, Terminated",
        "terseLabel": "Derivative, fair value, terminated"
       }
      }
     },
     "localname": "DerivativeFairValueTerminated",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeNetInvestmentTerminated": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Net Investment Terminated",
        "label": "Derivative, Net Investment Terminated",
        "terseLabel": "Derivative, net investment terminated"
       }
      }
     },
     "localname": "DerivativeNetInvestmentTerminated",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DevelopedTechnologyIncludingPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology including patents.",
        "label": "Developed Technology Including Patents [Member]",
        "terseLabel": "Developed technology, including patents"
       }
      }
     },
     "localname": "DevelopedTechnologyIncludingPatentsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EMEASegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E M E A Segment",
        "label": "E M E A Segment [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEASegmentMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EnviromentalCleanUpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enviromental clean-up.",
        "label": "Enviromental Clean Up [Member]",
        "terseLabel": "Environmental Clean-up"
       }
      }
     },
     "localname": "EnviromentalCleanUpMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value and carrying value by balance sheet grouping.",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingLineItems",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingTable",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosure Line items.",
        "label": "Fair Value Disclosures [Line Items]",
        "terseLabel": "Fair Value Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosuresLineItems",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosures table.",
        "label": "Fair Value Disclosures [Table]",
        "terseLabel": "Fair Value Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueDisclosuresTable",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FrontLineCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Line Care",
        "label": "Front Line Care [Member]",
        "terseLabel": "Front Line Care"
       }
      }
     },
     "localname": "FrontLineCareMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes04Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 0.4% due 2024",
        "label": "Global Notes 0.4% due 2024 [Member]",
        "terseLabel": "0.4% Global Notes due 2024"
       }
      }
     },
     "localname": "GlobalNotes04Due2024Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2025",
        "label": "Global Notes 1.3% due 2025 [Member]",
        "terseLabel": "1.3% Global Notes due 2025"
       }
      }
     },
     "localname": "GlobalNotes13Due2025Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2029",
        "label": "Global Notes 1.3% due 2029 [Member]",
        "terseLabel": "1.3% Global Notes due 2029"
       }
      }
     },
     "localname": "GlobalNotes13Due2029Member",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_HillromMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hillrom Member",
        "label": "Hillrom [Member]",
        "terseLabel": "Hillrom"
       }
      }
     },
     "localname": "HillromMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "label": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "negatedTerseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Line Items]",
        "label": "Intangible Asset Excluding Goodwill [Line Items]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillLineItems",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Table]",
        "label": "Intangible Asset Excluding Goodwill [Table]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Table]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillTable",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_IntegrationActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integration Activities",
        "label": "Integration Activities [Member]",
        "terseLabel": "Integration Activities"
       }
      }
     },
     "localname": "IntegrationActivitiesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations, current, fair value disclosure.",
        "label": "Long-Term Debt and Finance Lease Obligations, Current Fair Value Disclosure",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations noncurrent.",
        "label": "Long -Term Debt and Finance Lease Obligations, Noncurrent",
        "terseLabel": "Long-term debt and finance lease obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsNoncurrent",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LossContingencyNumberOfLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Lawsuits",
        "label": "Loss Contingency, Number Of Lawsuits",
        "terseLabel": "Number of lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfLawsuits",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_ManufacturingArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing arrangements.",
        "label": "Manufacturing Arrangements [Member]",
        "terseLabel": "Contract manufacturing services"
       }
      }
     },
     "localname": "ManufacturingArrangementsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_MedicationDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication delivery.",
        "label": "Medication Delivery [Member]",
        "terseLabel": "Medication Delivery"
       }
      }
     },
     "localname": "MedicationDeliveryMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_NewOperatingModelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Operating Model",
        "label": "New Operating Model [Member]",
        "terseLabel": "New Operating Model"
       }
      }
     },
     "localname": "NewOperatingModelMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_OriginalWeightedAverageTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original Weighted-Average Term",
        "label": "Original Weighted-Average Term",
        "terseLabel": "Original weighted-average term"
       }
      }
     },
     "localname": "OriginalWeightedAverageTerm",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "totalLabel": "Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "totalLabel": "Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherProductOrServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other product or services.",
        "label": "Other Product Or Services [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductOrServicesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PatientSupportSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Support Systems",
        "label": "Patient Support Systems [Member]",
        "terseLabel": "Patient Support Systems"
       }
      }
     },
     "localname": "PatientSupportSystemsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceuticals.",
        "label": "Pharmaceuticals [Member]",
        "terseLabel": "Pharmaceuticals"
       }
      }
     },
     "localname": "PharmaceuticalsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_RenalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renal.",
        "label": "Renal [Member]",
        "terseLabel": "Renal Care"
       }
      }
     },
     "localname": "RenalMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_RevenueFromContractWithCustomerRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer",
        "label": "Revenue From Contract With Customer [Roll Forward]",
        "terseLabel": "Revenue From Contract With Customer [Roll Forward]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerRollForward",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_RevenuePerformanceObligationPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Payment Terms",
        "label": "Revenue, Performance Obligation, Payment Terms",
        "terseLabel": "Global payment terms (in days)"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPaymentTerms",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RevenueRecognizedContractPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognized contract period.",
        "label": "Revenue Recognized Contract Period",
        "terseLabel": "Revenue recognized contract period"
       }
      }
     },
     "localname": "RevenueRecognizedContractPeriod",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and Uncertainties Policy",
        "label": "Risks and Uncertainties Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties Related to COVID-19 and Global Economic and Other Conditions"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of derivative positions presented on net basis.",
        "label": "Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]",
        "terseLabel": "Derivative Positions Presented On Net Basis"
       }
      }
     },
     "localname": "ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]",
        "terseLabel": "Other Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_SeveranceAndOtherEmployeeRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance and other employee related costs.",
        "label": "Severance And Other Employee Related Costs [Member]",
        "terseLabel": "Severance and Other Employee Related Costs"
       }
      }
     },
     "localname": "SeveranceAndOtherEmployeeRelatedCostsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SiteContingencyNumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site contingency, number of sites.",
        "label": "Site Contingency Number Of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "SiteContingencyNumberOfSites",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_SoftwareArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software arrangements.",
        "label": "Software Arrangements [Member]",
        "terseLabel": "Software sales"
       }
      }
     },
     "localname": "SoftwareArrangementsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_StockRepurchaseProgramAdditionalAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock repurchase program additional authorized amount.",
        "label": "Stock Repurchase Program, Additional Authorized Amount",
        "terseLabel": "Stock repurchase program, additional authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_SuperfundSitesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Superfund sites.",
        "label": "Superfund Sites [Member]",
        "terseLabel": "Superfund Sites"
       }
      }
     },
     "localname": "SuperfundSitesMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SurgicalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Solutions",
        "label": "Surgical Solutions [Member]",
        "terseLabel": "Surgical Solutions"
       }
      }
     },
     "localname": "SurgicalSolutionsMember",
     "nsuri": "http://www.baxter.com/20230331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "verboseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "verboseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "verboseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XCHI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYSE CHICAGO, INC. [Member]",
        "terseLabel": "Chicago Stock Exchange"
       }
      }
     },
     "localname": "XCHI",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "New York Stock Exchange"
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r253",
      "r288",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r310",
      "r385",
      "r386",
      "r387",
      "r388",
      "r390",
      "r391",
      "r393",
      "r395",
      "r396",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r253",
      "r288",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r310",
      "r385",
      "r386",
      "r387",
      "r388",
      "r390",
      "r391",
      "r393",
      "r395",
      "r396",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r380",
      "r381",
      "r383",
      "r384",
      "r522",
      "r629",
      "r650",
      "r669",
      "r670",
      "r691",
      "r709",
      "r718",
      "r790",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r380",
      "r381",
      "r383",
      "r384",
      "r522",
      "r629",
      "r650",
      "r669",
      "r670",
      "r691",
      "r709",
      "r718",
      "r790",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r312",
      "r630",
      "r692",
      "r716",
      "r784",
      "r785",
      "r793",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r312",
      "r630",
      "r692",
      "r716",
      "r784",
      "r785",
      "r793",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r380",
      "r381",
      "r383",
      "r384",
      "r474",
      "r522",
      "r525",
      "r526",
      "r527",
      "r605",
      "r629",
      "r650",
      "r669",
      "r670",
      "r691",
      "r709",
      "r718",
      "r773",
      "r790",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r380",
      "r381",
      "r383",
      "r384",
      "r474",
      "r522",
      "r525",
      "r526",
      "r527",
      "r605",
      "r629",
      "r650",
      "r669",
      "r670",
      "r691",
      "r709",
      "r718",
      "r773",
      "r790",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r313",
      "r314",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r693",
      "r717",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r313",
      "r314",
      "r657",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r693",
      "r717",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r16",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r642",
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Net trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $122 in 2023 and $114 in 2022"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r382",
      "r685",
      "r726",
      "r728",
      "r777",
      "r781"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Environmental reserves"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r35",
      "r41",
      "r137",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r35",
      "r41",
      "r137",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "verboseLabel": "Pension and OPEB items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r89",
      "r207"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r34",
      "r41",
      "r137",
      "r235",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "CTA"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r228",
      "r236",
      "r237",
      "r553",
      "r677",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Hedging activities",
        "verboseLabel": "Gains (losses) on hedging activities"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r228",
      "r235",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r40",
      "r41",
      "r216",
      "r643",
      "r655",
      "r656"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r235",
      "r236",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r37",
      "r41",
      "r137",
      "r598",
      "r651",
      "r652",
      "r734",
      "r735",
      "r736",
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTAL FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r528",
      "r529",
      "r530",
      "r749",
      "r750",
      "r751",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash flows from operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r217",
      "r320",
      "r328",
      "r330",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r217",
      "r320",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for accounts receivable, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r59",
      "r79",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r37",
      "r41",
      "r137",
      "r734",
      "r735",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r176",
      "r189",
      "r211",
      "r250",
      "r296",
      "r302",
      "r308",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r549",
      "r554",
      "r577",
      "r715",
      "r788",
      "r789",
      "r808"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r203",
      "r219",
      "r250",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r549",
      "r554",
      "r577",
      "r715",
      "r788",
      "r789",
      "r808"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Accumulated pre-tax unrealized translation gain in AOCI"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r75",
      "r322",
      "r338",
      "r634"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r145",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r546",
      "r703",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r123",
      "r124",
      "r546",
      "r703",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r127",
      "r128",
      "r547"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital expenditures incurred but not yet paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Book values"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r61",
      "r205",
      "r673"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r56",
      "r61",
      "r65"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r56",
      "r168"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "negatedTerseLabel": "Deferred, net after-tax gains on derivative instruments"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r250",
      "r269",
      "r270",
      "r272",
      "r274",
      "r282",
      "r283",
      "r326",
      "r385",
      "r388",
      "r389",
      "r390",
      "r396",
      "r397",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r577",
      "r671",
      "r725",
      "r746",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperAverageOutstanding": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average amount outstanding of commercial paper.",
        "label": "Commercial Paper, Average Outstanding",
        "terseLabel": "Commercial paper, average outstanding"
       }
      }
     },
     "localname": "CommercialPaperAverageOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r23",
      "r181",
      "r195"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r377",
      "r378",
      "r659",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r749",
      "r750",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, end of period (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r42",
      "r232",
      "r234",
      "r242",
      "r638",
      "r647"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Baxter stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r132",
      "r133",
      "r140",
      "r232",
      "r234",
      "r241",
      "r637",
      "r646"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r131",
      "r140",
      "r232",
      "r234",
      "r240",
      "r636",
      "r645"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r52",
      "r239",
      "r635",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Contract Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r432",
      "r434",
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r432",
      "r433",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "verboseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized upon satisfaction of performance obligations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r72",
      "r301",
      "r302",
      "r303",
      "r304",
      "r310",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r48",
      "r630"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "COGS",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r249",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r414",
      "r421",
      "r422",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "FINANCING ARRANGEMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r177",
      "r178",
      "r188",
      "r253",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r588",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r170",
      "r172",
      "r398",
      "r588",
      "r687",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r253",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r588",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r103",
      "r104",
      "r105",
      "r106",
      "r169",
      "r170",
      "r172",
      "r187",
      "r253",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r588",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r452",
      "r490",
      "r511",
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net losses and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r452",
      "r489",
      "r510",
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r452",
      "r456",
      "r488",
      "r509",
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r486",
      "r507",
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r454",
      "r487",
      "r508",
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r59",
      "r291"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": {
     "auth_ref": [
      "r28",
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.",
        "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election",
        "terseLabel": "Derivative asset, fair value, total"
       }
      }
     },
     "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Asset"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r31",
      "r147",
      "r173",
      "r220",
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r27",
      "r29",
      "r32",
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r31",
      "r147",
      "r173",
      "r220",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r27",
      "r29",
      "r32",
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Derivative, fair value, net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r146",
      "r148",
      "r153",
      "r155",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r144",
      "r146",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r144",
      "r146",
      "r153",
      "r155",
      "r157",
      "r158",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r152",
      "r799"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain (loss) recognized in income, undesignated derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement": {
     "auth_ref": [
      "r221",
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of master netting arrangement, of derivative liability, security sold under agreement to repurchase, and security loaned. Includes financial instrument subject to master netting arrangement not elected or qualified to offset. Excludes liability not subject to master netting arrangement or similar agreement.",
        "label": "Derivative Liability, Security Sold under Agreement to Repurchase, and Security Loaned, Subject to Master Netting Arrangement, after Offset",
        "terseLabel": "Derivative liability, fair value, total"
       }
      }
     },
     "localname": "DerivativeLiabilitySecuritySoldUnderAgreementToRepurchaseSecurityLoanedAfterOffsetSubjectToMasterNettingArrangement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivative instruments designated as hedges"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Revenue From Contract With Customer [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r446",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Revenue From Contract With Customer [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r107",
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r243",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r267",
      "r269",
      "r272",
      "r273",
      "r274",
      "r278",
      "r563",
      "r564",
      "r639",
      "r648",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r243",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r269",
      "r272",
      "r273",
      "r274",
      "r278",
      "r563",
      "r564",
      "r639",
      "r648",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r804"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r251",
      "r532",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyAxis": {
     "auth_ref": [
      "r774",
      "r775",
      "r776",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of environmental remediation contingency.",
        "label": "Environmental Remediation Contingency [Axis]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyDomain": {
     "auth_ref": [
      "r774",
      "r775",
      "r776",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental remediation contingency, for example, but not limited to, asbestos, air emissions and mercury emissions.",
        "label": "Environmental Remediation Contingency [Domain]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteAxis": {
     "auth_ref": [
      "r684",
      "r685",
      "r726",
      "r727",
      "r728",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Axis]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteDomain": {
     "auth_ref": [
      "r684",
      "r685",
      "r726",
      "r727",
      "r728",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Domain]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r102",
      "r199",
      "r235",
      "r236",
      "r237",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r281",
      "r327",
      "r431",
      "r528",
      "r529",
      "r530",
      "r536",
      "r537",
      "r562",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r598",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r212",
      "r575",
      "r675"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Marketable equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r412",
      "r576",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair values"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r565",
      "r566",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r163",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r162",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Book Values and Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r412",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r566",
      "r602",
      "r603",
      "r604",
      "r687",
      "r688",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r565",
      "r566",
      "r568",
      "r569",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r412",
      "r477",
      "r482",
      "r566",
      "r602",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active markets for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r412",
      "r477",
      "r482",
      "r566",
      "r603",
      "r687",
      "r688",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r412",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r566",
      "r604",
      "r687",
      "r688",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value recognized in AOCI"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Fair value at end of period",
        "periodStartLabel": "Fair value at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value recognized in AOCI"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r163"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value at end of period",
        "terseLabel": "Fair value at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r412",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r602",
      "r603",
      "r604",
      "r687",
      "r688",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r145",
      "r150",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r323",
      "r324",
      "r329",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r423",
      "r429",
      "r561",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r682",
      "r756",
      "r757",
      "r758",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r209",
      "r359"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r356",
      "r358",
      "r359",
      "r361",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r84",
      "r632"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross other intangible assets, finite-lived"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r80",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r84",
      "r631"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Other intangible assets, net, finite-lived"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r60",
      "r802",
      "r803"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange (gains) losses, net"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r676",
      "r699",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r208",
      "r343",
      "r633",
      "r683",
      "r715",
      "r762",
      "r769"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r59",
      "r344",
      "r349",
      "r355",
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r47",
      "r250",
      "r296",
      "r301",
      "r307",
      "r310",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r577",
      "r681",
      "r788"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "auth_ref": [
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability hedged in fair value hedging relationship.",
        "label": "Hedged Liability, Fair Value Hedge",
        "terseLabel": "Carrying amount of hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r144",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r174",
      "r182",
      "r197",
      "r296",
      "r301",
      "r307",
      "r310",
      "r640",
      "r681"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes",
        "verboseLabel": "Total before tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r251",
      "r533",
      "r534",
      "r535",
      "r538",
      "r541",
      "r543",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r252",
      "r265",
      "r266",
      "r294",
      "r531",
      "r539",
      "r542",
      "r649"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r246",
      "r325"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "negatedTerseLabel": "Change in fair value of marketable equity securities"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in balance sheet items:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r357",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r81",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r78",
      "r82"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r171",
      "r185",
      "r238",
      "r290",
      "r587"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net of capitalized interest"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r184"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net",
        "negatedTerseLabel": "Interest expense, net",
        "negatedTotalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net [Abstract]",
        "terseLabel": "Interest Income Expense Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r676",
      "r699",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest rate contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r730"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r218",
      "r674",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r731"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseIncome": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.",
        "label": "Lease Income",
        "totalLabel": "Total lease revenue"
       }
      }
     },
     "localname": "LeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r18",
      "r250",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r550",
      "r554",
      "r555",
      "r577",
      "r680",
      "r788",
      "r808",
      "r809"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r180",
      "r193",
      "r715",
      "r748",
      "r759",
      "r801"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r204",
      "r250",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r550",
      "r554",
      "r555",
      "r577",
      "r715",
      "r788",
      "r808",
      "r809"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r5",
      "r178",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r23",
      "r781"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserve"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt and finance lease obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r97",
      "r98",
      "r379",
      "r380",
      "r381",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum length of time hedge in cash flow hedge"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r26",
      "r179",
      "r192",
      "r250",
      "r326",
      "r385",
      "r388",
      "r389",
      "r390",
      "r396",
      "r397",
      "r577"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Change in noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds, at carrying value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r56",
      "r57",
      "r60"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r45",
      "r60",
      "r183",
      "r196",
      "r202",
      "r230",
      "r233",
      "r237",
      "r250",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r271",
      "r296",
      "r301",
      "r307",
      "r310",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r564",
      "r577",
      "r681",
      "r788"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Baxter stockholders",
        "verboseLabel": "Total net of tax"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r135",
      "r139",
      "r230",
      "r233",
      "r265",
      "r266",
      "r736"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r129",
      "r431",
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Undesignated derivative instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r296",
      "r301",
      "r307",
      "r310",
      "r681"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total segment operating income",
        "totalLabel": "Operating income",
        "verboseLabel": "Total segment operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r280",
      "r592",
      "r596"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r145",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r223",
      "r224",
      "r226"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Available-for-sale debt securities, net of tax expense of zero and $1 for the three months ended March 31, 2023 and 2022, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r223",
      "r224",
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Debt securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r41",
      "r43",
      "r236",
      "r579",
      "r581",
      "r586",
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r222",
      "r226"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Hedging activities, net of tax expense (benefit) of ($1) for the three months ended March 31, 2023 and 2022."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "terseLabel": "Hedging activities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r226",
      "r229",
      "r556"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments, net of tax expense (benefit) of ($13) and $(11) for the three months ended March 31, 2023 and 2022, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r33",
      "r39",
      "r578",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r102",
      "r231",
      "r234",
      "r239",
      "r579",
      "r584",
      "r586",
      "r635",
      "r644",
      "r734",
      "r735"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r131",
      "r132",
      "r136",
      "r231",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r36",
      "r38"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension and other postretirement benefits, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2023 and 2022, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r36",
      "r39",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedLabel": "Pension and other postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other amortized intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableFairValue": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.",
        "label": "Other Investment Not Readily Marketable, Fair Value",
        "terseLabel": "Other equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Gains (Losses)",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other income, net",
        "negatedTotalLabel": "Other income, net",
        "verboseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r112",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r519",
      "r520",
      "r521",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "OPEB"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Baxter stockholders' equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r737",
      "r738"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r366",
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired, and investments"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r245",
      "r794",
      "r795",
      "r796"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "terseLabel": "Pension and other postretirement benefit plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r474",
      "r476",
      "r482",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r517",
      "r518",
      "r519",
      "r524",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Net periodic pension and other postretirement costs"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r111",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r519",
      "r520",
      "r523",
      "r701",
      "r702",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r733"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r54",
      "r120"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock issued under employee benefit plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r740",
      "r742"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r739",
      "r741",
      "r744"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "terseLabel": "Net decreases in debt with original maturities of three months or less"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r202",
      "r230",
      "r233",
      "r247",
      "r250",
      "r257",
      "r265",
      "r266",
      "r296",
      "r301",
      "r307",
      "r310",
      "r326",
      "r385",
      "r386",
      "r388",
      "r389",
      "r390",
      "r392",
      "r394",
      "r396",
      "r397",
      "r548",
      "r551",
      "r552",
      "r564",
      "r577",
      "r640",
      "r681",
      "r710",
      "r711",
      "r736",
      "r788"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r88",
      "r206"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r90",
      "r194",
      "r641",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r244",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r41",
      "r43",
      "r236",
      "r579",
      "r583",
      "r586",
      "r734"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Summary of Reclassification from AOCI to Net Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r69",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r69",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Operating Income to Income Before Income Taxes Reconciliation"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r741"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r122",
      "r198",
      "r816"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "R&amp;D"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r729",
      "r745",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash included in prepaid expenses and other current assets"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r364",
      "r366",
      "r369",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "BUSINESS OPTIMIZATION CHARGES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r365",
      "r368",
      "r372",
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Cumulative pre-tax costs incurred"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r365",
      "r368",
      "r372",
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected additional pre-tax costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r365",
      "r368",
      "r372",
      "r374"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Costs to implement business optimization programs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r59",
      "r370",
      "r372",
      "r778"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r365",
      "r366",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "totalLabel": "Total business optimization charges"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r366",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Reserve, ending balance",
        "periodStartLabel": "Reserve, beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r366",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "negatedTerseLabel": "Reserve adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r779",
      "r780"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r107",
      "r191",
      "r654",
      "r656",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r199",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r327",
      "r528",
      "r529",
      "r530",
      "r536",
      "r537",
      "r562",
      "r651",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r111",
      "r112",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r519",
      "r520",
      "r521",
      "r523",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r111",
      "r112",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r519",
      "r520",
      "r521",
      "r523",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r287",
      "r288",
      "r300",
      "r305",
      "r306",
      "r312",
      "r313",
      "r316",
      "r445",
      "r446",
      "r630"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Total net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r443",
      "r444",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Transaction price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligations period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Remaining revenue performance obligation, percentage of revenue expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r591",
      "r714"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": {
     "auth_ref": [
      "r593",
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable",
        "terseLabel": "Sales-type leases, receivables"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
        "terseLabel": "Sales-type Lease, Lease Income"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r321",
      "r335",
      "r597",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in sales-type lease.",
        "label": "Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss",
        "terseLabel": "Sales-type lease, net of investment in lease"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "auth_ref": [
      "r280",
      "r594"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sales-type lease revenue.",
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Sales-type lease revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r41",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Summary of Changes in AOCI by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r146",
      "r153",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Summary of Gains and Losses on Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Classification and Fair Values of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Net Sales from Contracts with Customers by Global Business Unit"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Instruments Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r683",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Other (Income) Expense, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r368",
      "r372",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r92",
      "r93",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Components of Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r91",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Activity in Reserves Related to Restructuring Initiatives"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r67",
      "r68",
      "r70",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r67",
      "r68",
      "r70",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Information for Our Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r284",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r310",
      "r316",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r368",
      "r374",
      "r683",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r296",
      "r299",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r110",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r2",
      "r177",
      "r190",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-Term Debt, Fair Value",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r201",
      "r284",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r310",
      "r316",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r363",
      "r368",
      "r374",
      "r683",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r250",
      "r269",
      "r270",
      "r272",
      "r274",
      "r282",
      "r283",
      "r326",
      "r385",
      "r388",
      "r389",
      "r390",
      "r396",
      "r397",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r577",
      "r671",
      "r725",
      "r746",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r102",
      "r199",
      "r235",
      "r236",
      "r237",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r266",
      "r281",
      "r327",
      "r431",
      "r528",
      "r529",
      "r530",
      "r536",
      "r537",
      "r562",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r598",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r281",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r102",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "negatedLabel": "Stock issued under employee benefit plans and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r107",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock issued under employee benefit plans and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining value available under stock repurchase programs"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r74",
      "r715",
      "r748",
      "r759",
      "r801"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Baxter stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r129",
      "r130",
      "r138",
      "r199",
      "r200",
      "r236",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r327",
      "r431",
      "r528",
      "r529",
      "r530",
      "r536",
      "r537",
      "r562",
      "r579",
      "r580",
      "r586",
      "r598",
      "r652",
      "r653",
      "r748",
      "r759",
      "r801"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, end of period (in usd)",
        "periodStartLabel": "Balance, beginning of period (in usd)",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSSummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r323",
      "r324",
      "r423",
      "r429",
      "r561",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r756",
      "r757",
      "r758",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Common stock in treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r25",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Common stock in treasury, at cost,177,658,649 shares in 2023 and 179,062,594 shares in 2022"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r365",
      "r366",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseIncome": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.",
        "label": "Variable Lease, Income",
        "terseLabel": "Variable lease revenue"
       }
      }
     },
     "localname": "VariableLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r753"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r268",
      "r274"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r267",
      "r274"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13644-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>91
<FILENAME>0001628280-23-013357-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-013357-xbrl.zip
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MBD0O1>Q"(8R1A0VJ5MRGVJ5W=%\[J8,KVW*3I2YJ=BDSHN( 6 EK ;;>JE0
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MD )!TD(R* ;5;>_4F,7#G">G_'NF[JG$E8/A8#;@KNB3L='I4D KSQ"B(B&
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MVZJCBV[U!?76#ZYPI+$X0?6J%0RK)5=2D,%@,A)?)*@>K"?JP)K&X\%(!'5
MP\_+3UR=\'0\>MWZ5;02%1V)_RH5I8*-UK5>W*U2,1KQ=:G: !"Q VQD=5!9
MG*[DZI0&CMDZ#]$R&=3&6S;1&%<Q=T!7:##YF8:G_/W9#M/T]**4[.,)__<I
MC_+99];TZN2/3IT^YRSNN#LU0#*Y#)FXH+; GBF6"DFXHR()3S5V"K,/+W^0
M*[;V@6=/6_/ WX%M>W1R.IO.S]"+<H$W3X *^J2K#K%6 D,2;9 $'*42:<]
M'2@BLP@!,K<"]+=# :U"\3Z7RA5"SM$':TH2_VY\<KX#U0H7(4#V5H#^/D6O
MT9>4J'@' 2.51)"##R'4A+$#-7V[@MD")ZI*Q;8''7(!R.P1,&O4K5LI!5]S
MIS"[I1U+B,L)E):PCS%$ (5H4[0JEA)$HCQW8*;SEG8L58"4HVH0-%>Q0*TL
M<M2J!K;)Z."<"S=#@&X<[5B< -G 0E93 F0"+]Z,G>5,$OT$H(3V9O#6/[-
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M;G8[-L<&54TYKR87]+@6! 2] YSAN* '0X AG !E-69:Z> 83PF1$,G6>ZU
M5]F2GD&W=-#=7>>%EY$-C0%6XKC8&Q1!%RP#V$CIE26&N#(+&5H\(J\&]OK3
M"NR_1P,L,4JX)H\_=PK(&1]YS7FXV@,+F7BK(]Z]2;5CJ6.,$P20<RD+"M1
M$T_3R06+#0F"LI0%16YBM1ZQT)EYGB_S5'L4(S-/I<QS5_))P[R."P5@2*;$
ML]( (ZP$5@5.,$7&8SUB'KGP>>E:G\*XU2H2/]IUARE48OTJ0+1;VK3:98WN
MJLI _*0_*BH%,>LG/(N\6Q].NKT!&/C>>:1',QFBDW.W/X%%LBIY7DZ6@SA7
M_NSV>MVOL7OZ>5&<:U%\-RG'M8BB11@#F!!I-U$;H.)Z"#BG6E/C!2MW$^NT
MW9%YX6GP0E7B.?-"!;QP5RQS:Z@V4@,6$ 4T$ 8T\P1PK*/]3@12,&4VJRR?
M0(WV0>LMF:[%[WFJ/E]JWU1YH=WM'-_24>G4<BCK@?IQ_%/7Q :7A1ISPK,E
MZ9._XQ@D&MJ-(U#6F+EH#72[#-/8_][[.=]"Y?3U<8JLP4Y!S3T0/NVI1KH"
M6B@"F"&2&A9M?S3:WH%U"L?,8*Q,%&0P/AX8[VH)@@B6U$$ H?: &DV!0:1,
ME:H0,BH.K!V!D=4(C,_" 7-3V^E"7Y5UFW-0]'(KGKP=]7,FGLJ)YW!*J#1Q
MQDN14BKHJ *8D/$GQH"#P;MHR$ 4<"(>K&KFWWCNJ*NZV$E&W1)1-Q%:13CF
M,,3U7;B0]MDD,"S^JDSP4!!&K)2C>,;L/%C]<M\;^I\F1;^UJ98=!4O3 FD4
M_O[>TYF8*B<F.R70.FA%# \ !8\B,4&;*L\R$%<2)(7'2'F>JC40E/.EUPIX
M%<J!#+P5 .^N(HAFOB7$1.'MA ?48@4T83BE)T:>AJ"\I EX<11K!+P<;'T[
MB_HM7;"0D^#>WIDI''(-R:NR[87,6DMDK>-)N4")@XI@ @RGT8XA&@/E' %(
M*R%2; 1!(:5F%+PJ[\',V,AYU6NL,C)0EPS4N_*",:1Y'#G@80KL)5X"[:T
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M"S16'B!HF3-2ZTA$/V&UJ;-J&8269]4ZS2KG?<IVG_S*A"5N"T!B+( V6+A
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MSY_$Z^*D+\:Y"7\;=O30M>+5O]?TV7YK=8IXLW;*=GI_&V_Q&O]1ZMPT>71
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M-W[*NN&GN@$J"KT6Q! 3?Q+80&&Y, 0[BF0(?%8$'XS=#B62QR)B_'D9E/.
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M4:^MD;,B^*GGU%X9*+_=!24B5"*L+2#<!! 5@@:*$PPLID(HREBPJ;R8K/@
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M.&&5YAQZM[&-Z"(;HDO"U?S2N(:(6B3QU!,FC\J=BID\%B>/";>A)II%R]H
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MY8:XQZ#_ *.F+-S_>S<V;8[E^R-O/&+EW;<6U0&7YP< B)$KLBH7^>6&$\P
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M;8Q4B)CUE6ZG%;.!D#WD,(CO#9#+_RZ_/H:U %,&=K#=R_KA$)'+,8P5D_S
MLN-P"=]P4\S[>I5^$7]T0'WO#$ M /G0Z?:NS?WZ4IY%.[S^^U!!@9%]MT-%
M+ VMFP(^B4WX"JR,\=+D91];)7F O6'%G:Q_E<<,Y:C..MUF&.IW9S8+UN+S
MMTR3\=HPCR((N&:C/"48C0$DXEC5R*^YHH&B!PMVY5^_EFIR10ZE:SQ+HB%9
MW*:'-,A*U)@>QG;'U?W7*62DEWZWC:9U#1CC>3G)T:Q_N?/K0Q*&;SOP6RC5
M@*.AJM4 R>]+^Z$<H\TF5)9XERLZJ4F$01S/"735T7#@@ZR!G8_T@',@HE8>
M2?ZO9<\OC?)\X7 P/Q_#R'0;+M+=+N(G1H8Q:61=H]2:KG;?VT%F5E!=1G@0
MQX!W71^RK4[N5%"2SH@YUN]8+S",P_?8!1J)HTZ;P_5R V!ET*)O+=*$$3=Q
MJG5_ES3'S\<E31?NDKY2.B]=SKM7WI"5\SGCVJ4&MG-1WS[\=M#ZC&MT!]=.
M<O6_'7'0>MNL7[QME,?0[_*]NV<3&MA^#==;'T%;^W!QD"L$;N_BVGZS<?#E
M,ZM]V2V+MAW".&LG?Z;:_L%9[>RK8H9@Q232/%C$)7?(T<20#\%SK(D*TD[X
MG#%-(G))C$E<F024&80BRL+_C ,RO*6Q??K\_OW?.[7L;?Z[>+M;WZJ_V87?
M=NMO]S[6'NR _N4@;@Y:4.8C42E0RGA225/K9) FVBB<#G[ACN*MH2.L]Q$T
MC,;W?(B]E8O390_:VT[W33<"O?[=Z?7V\U>OF2KK6U]I)$![/B*7([MX-& A
M4.$0XV 5$.H92>F^=@%;LEUPN:NEA-[N#%P?9&XQWOZ5%)+3:B4V<I7$WJ!5
M>@=&5O^X._3(NVEO3#6,ISIR^5[YE_K'W1@+$*+]X][(U3FESF&IA617YZ6,
M?#:U!I78,.3N"GT/KMZ'-YA90*W!_%AQW\=.2<<9KSB@99S]RL<6&I3/J7K=
M_@3IER$AET7M[E&C[Q%K^ 3QG/=;EAL52N^Q!@]MZS&=#.96L_M^D[UGB<GG
M/L?[U)M<*'+,I=OQ,GGEGB7?_QS5"9[>-V]AK9^?)!Q\[BT!9I[U4H.^5[</
MWW7C9*S$3IHPJQ+!_5!#913!W6P>[!\?U^"S@Q88*1<?O]5./,_/J7_9P0>M
M'5:GNZ2V?T1N1W#O??GG>._=SCD8+XW#[?I)_1V\[^((#)X/Y #&>;#OV<')
MYQ][V],+B#B+5:+$HZ"31-PJ@7))$:0(IMYYP;RD:YN$++RDT?)S52H$>ID(
M-*^6@Q4"+0*!)E+I4J*)$*(1CYXA[A1%)A*+$J:62TT,\[FITKP3Z1:*0,O6
M/!_W\*>]\AF6H;MO*\7C',!2'NU=G<:."\\][_IR"T#MAWBX?P;?[W.OE1S!
M.@6^*]"> ;3K;R;51FM(T+!/"!,B,G(KY!@WB-+H>&!,6>K6-N?5!>]5%LN:
M/XL%$'\^81UIPJ A61>,I1X')YU-@?.2Q>B8Q>Z1F5NQV/Q8;+(>7= :$Z:0
MMXDC+@Q&UCF-B!#P:;3!85WF(:XDBSVURVWUM8,OW48_HDY*#U,%'M4P_@FF
M^Z^GU 7N9\J5.[('&U)AURS8-:6I"$!4;B?"D<H5-&$?";+!&\0\DX$&9AA-
M8---8-?$4<R,;+Y0S> E<]S<58.*XQ;*<1/: A/2V,@E*.2"(4X=1\YX"=H"
MURXZA:T4*\EQE1OAEVZ$,CO*GP^CJT<ASM=RM"I/PMRUAQQO#K]=3Z6Y;_C<
M>+?VKS9KZVJO*IR;!>>FG%<9ZTWTQ"(CI$/<484T4Q(I:Q+Q5AB=JW0_VE=<
M.1Y6S/%0<>2*<.2$YA$<CTEHAW ,"G'K@#>-\H@D*ZF/6G#/5I<CG]I/,:=Z
M9BNHMER+&HHY\>F1\4+/K[+D@@_RGU%IR?E+E'E5&J_.^.<O(Z94#>=<&=@&
MB6"O$N+$)V2E#"AJ+:DP4FE"%W#&7Q7+K2#MV4#:O,KE5I"V"$B;4'NCM=QR
ME9 '-1?Q$ #2(O.("PF6#K4D6ITA[244OEV8PGQ93'>&9.15JS-[IZFRV)0Y
M=7<!VF77DIV:'_O+?-=;^;%*2"?+P/#@N<-:LQ 5#1$,2DX$$;]*L%QL\NPG
M?QS#H!GWTFX[UWSH=,^';H5^E2[[X:L7VBH6.3(V.<2CT,@Q[U"2S"GE&+%8
M3:3++B\C=KQEUZOC5*F=3YW:^=I2")]!LNA55FB&^GNF#3Z#>8WK6EZ?VLUL
MP5>:V??Q>DV@*I&O2J-9@(OM4F$"8JN-:>UEF)^M75'[\OGB\-T'>KB])0[R
M/:V_CFO;'T1M^Y_FP9<==G 13@ZW=R?,SX.3;S]@'M\.X9VU[68CFY5@KI[5
MM[^=U<$T/=@/)W5:!W/VGU2;$F'%'*<R\(28<02,3A*1-80AP3GAH'1I#2K7
MIB;/*6NF IQ7#3CSRARN &<.@#/A[R+*:V$\15HYCSA)"FFM#$I>BA  ;4(D
M:YN*Z><"."\W8.Q+I_NM&%9ES(6SJ_BP!2LV>;UWV^^'JUT!S2Q ,R7"BS!+
ML<$,129UKDB0D-56HZ"(T,Z >,A P\BJ9KZ\4JZ:N_2NN.H17#5Y7"6BBCYR
MQ()1.3X\(FV%1UAXJPP5,AJYMDD-6R&N>KFY7V\;[4;O.(;BJ-,)KR/_ZRD%
M]'BYW^75?A8=89\'SDR)]'$A1AI <'LL<V-LCI&66B/)O5 I4A^D+QMCFWE5
M%*I2P%93?E=,MRBFFQ#NE' :M:6(.Y-3Q55 5KH *K/5PDO*M'.9Z:1^=$6&
M.3+=0PWP!T;"/(\3F6MGU;.J7'-:EY?A/)WSFCQS<)^[1E6/_0K2YP7ITPKL
M4!,H=<&AP+D&7$\>&9#%R#$7B35&D:3 7ELWCX^9GCNLSOW\IP*X"N"6K+U6
M #=?@)O465-T/+'<:\\DQ&W2R%&>4" L)6>%9#IE@%/DT2=*JP%P-P.>;X<Z
M_ZP;QS("7-]W<_/4_OG[IFWWM]IAY_\&C=.<(/NJ0UN/OCI828 1BZ)F$7$J
M-3+68>09+"\.3"DZV2%R>:&MXVU;+\J-&S;Q'F_=>@$H5D6\5A&O5<1K%?&Z
MBA&O<^L1<D^%\@HM3R_1,EZAI>V7=7J?/@YVV>ORE#%IRY[K$WA-[M2MWG4[
MO5?A&M_A=0K7G1SQW+S[</_CR0&H735: S/C(]QWP&M?:F>'7VKG$V;&_A$#
M\X/N;1_EYMW-^KOZ\=Z7W8N#"S SWGV&>1W].+CX$^;SU]0XV4 $-9A;Y&(R
MB&L3<Z_O@#A/,L#VQF!C[F^Q+E>YP/R022I >N6 -"\O1P5(2P.D";^'<E)9
ME0**)OL]6&#(YOJHS#OADK!>:%("$J>3U1I7$9"6%$>[;+;<\G[0&@Q[LX=X
MV@7R+[.;EQ]-N^R9SU(W=FYU>*Y6>_O:8L/OS5@6;&N'K58'EN6B_/Q. *NP
M:V[8-24T%[#).\TU"ACT*!ZQ1U8JB1S3R>$HHE1I;5-.U:7N7VCV41&$-S6E
MU\V<<VO%5S'GZC'G9 5H%:PQC"&O S GBSE!AQ,DJ58*% LF \O,R?DJ,.>2
MZR4^?^=4.S[4,;6T\_+G8B4N_K!\A6W(A3NU7LG)^9* ?DJ(M?%),&T#"E9K
MQ"4!H"?: .0K0EQTQ.80:[$.A/:TM<>6[.^J<*["N27ZRBJ<FR_.32BT7CKE
M _4(AZS0YM!VRRE%@4OF,>QE8J#0\G6CGKC&XOS<:"L;'K2;C[5CK[_;]IU6
M!#88?[ S;&>ZW>CY9J<WZ,977P^OMO4U6JZB811YG%OW&>^1DTXBX:,7@A$J
M,7Z:H"$BRAR#X=X5H\TKXX2J,*%5"1-:Z7;,8YS#&>6F/5T^IS"9_>-NC$4+
MKCONY2X%,93!,E=10;\.!EK*:B];,5U,/-A#O3/3J67)D[UG;-ASGR-=.,DO
MK:?*L_0"7LKF.);-[=C/S5- 5VCT84P7,12-T455I%H5&+*8AKFWU/L78LN"
M$G\"ROSV47YV\_#DXS'8IJ)^L7NQMU\[JYW\<WQ =\_WMK^=W;9E#]_]!;/Z
M@/>V\SS^:=7?[7"XCM5.P Z^V#JO?WE[<G"RR_?V_YQZ<JISRI[B&F'#,>(I
M4F1R;003E13!84]"SM"F\\K/7A6?7 4U+PUJYMXIN(*:1T'-A-O,,6P5MA0%
M*0CBGEED*)?(R\2=5<1'J=<V]0K7:;PCAN,9**#/([3M4L=LE-Z\*J)M*:K4
MT'6Z=QJ[M@]+5N'<+#@WY1C4,V&]D0'!'G/$"8G(*$R1MDHPP2)A+O>4FSP#
MK2+1ELY4"U,:*J9Z%%--!I'!KL N$"08": \:(>,MP+A8 @ HI<X@'2<+!+Y
MM#SU##2#%Q^^-M5Q546L59$<J^#<NM4]?KH4&1F@95Q')4;N+4:F5:]B/%D3
M.4?$Y*:_% MD)/R6F/.6XV E"SG):<[NKBI K8*U9P-K<]")*UA;**Q-:,>P
M-X)$R1#\:Q 7S",7,LI9%J.A3A$*L*;%RT"UIU:O5S88[JH9[%[_.';KG79G
M;(#>8+DJ%"X?? 5LL$L(%MKGUK 26<$9"GF)/?,^>?N$H7#E!A;#7:O"X*HP
MN"H,K@J#J\+@JC"X*@SN:>VHMYTN_-DNX@]_;-M'L?C7D6T >Q7-3J\7>X]Q
M+KY"._N%6]*+<Q".R/#-H-N-;7^^WX4)#<?S#LCQ;Z#%S^UN'$9EO@SK^F3K
M1_WD+[AG%\96XS"6"W@?KUW\U:SO-[_5WKT]@;$U]_:_T=O6=6U[A]; .CB
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M!P"=_JQM9G8E-0=A*)RL]Z!"@<0ZM>=EP) M'S!GR:-M3$%Z9W'@!$L-ZA]
M2]DXF:EH9I8\;X9U_TO=/#3Z R!GT-9S(DCX<]"O=_H'L?_>-D*%)=.QY#,#
M,2-4I!P[BQQ3#G&2>^/2()%4#.#?,*LP*)=J,F;YP6(&=/U\CI2<LS!D+8RU
M@B05$@/-76 ]LYBIZ."1=,!!IBA!L2?$H$ 8R!3M%#*)"Q09 ;R)&CB7KFV*
MR?J6Q5WBY#:V%I-J?+G0UDB?N9W%Y+B.S"8AN%.22RDMJ*E?.5O[A>VR.'B>
ML%TH_N^A-0ATT^F6,_L=K,_8S5>M;;*-8L$E=MYU.N$,EGS8:0ZTJ 8 =JE?
M]:ZUFEN5TCKG(V(^^4;J7SZ+P]8./:"'K?S<VO;;X]KV 3D\>=L\H/7CVOXW
M>-:!N$W,>_N?R>%^LW4 [SULP97;!V>U+SMG]9-_6K4O_\#;=G[L[<.X3YJI
M=N'/]SY\%8Q(!4N+@J4 :@ RR*G$$='<1$,4!D$Z1"6@SABV,B0XSU2RRBFK
M0+C:!. '8)@< %22*>G;I7C>[>UM?]G]^^]BJ[Y=[.W_[\['8K>^OP6K]N??
M.\76IT\[^Y_6B_K._J09?IT-I@KZ7X_EUMA!$9"@_($FD'@2UN!DI-1:!1VQ
MMWQM13@'5FU$O;\RZ4=^&PD/G3#REU7":CS65\Q,%[6MK]12A550B!DL<\M&
M8"8/XD%'HI,6F";!EU*G:D)5IL,*/=FGTFQVSK+_I=$K+ @B( H/=N20I4"3
M/1IM9>'."S?HP4-ZO:(7C[(FO/$TA:V,WB",/J2N%<<;C"VD )4DK'KLPAY[
MORV;;\&GY5?,FK7FTS,H K952AI[=];,LYK-3FUGZV7,9.O]UIN7,9/_!8;I
M=EHO8S+[';#&;TQE%>ITS7,=[GF2_:=MVK8?>].VHX\M%[O%R)<V44BMJHKS
MDJKBS. 14]QI1:0-6E.N(]6>>\&$)()%9E7ZNIO)A=!?.<+&!LLS<70]S)P9
MQ3"$9GW_FSC<WF+P+SW<AN=_V>'UUH$ $P?>N4L.OWR$^^K?;L<PU.EGLI?C
M'+8]_'OX#>9"#O:/Z.')-U&'^1V<_-,\?+?SHT8_IMJ4K$,9E;<*!Q0Q_.!:
M8V0<P8A@QS@WQA 2UC;I.FQ@58^K0IZ51AXJ@K!))49HY%H*%Z4TRB1EJ-#8
M^MF1IP*76<!E(D"*8A:(EAZ99%G.P,'(Q< 19E9(!9M"H@5PT::"E@I:5AI:
M&'&&&<J3$8I3XBS3%G09'1FQ$4M70<MBH>7B-K2 :L)%(!YY;=RP5@[H*@*9
M&*/&U$C%L]XRI3Q5!2T5M*P2M&B2L(J"ZN! :P&$T312BBTGR1*A5&4O/2'N
MX(F.9UHX&K% ^8 2<6\4,B*G%^LDI16&@-6TMLG6S?-IO%TASRM%'L]Q4DX8
M(40^9&:.NH03%LDX@",7*^1Y0N0A$RES3+&H'$4D!HUX8 EI"1@DG!),44J#
MDVN;<EWSR;"F542>JJY,M0C5(E2+\ K*+(WK^1?]7-"_60;R5 67KFDBCOLD
M+</"&<(-TX8I;:TDV47(@HPS1]./59)I#16&ZS]NJ%#I)3/H)?6I[5P(CUH%
M!-JC #O(<F2MB"B[Q; CQ$6OUC;)H\VAJL+2?'A-)"MY2(DI(SA+R5@,VX<]
MP8')R%S%:RO#:Y/EEL T<U)*!+NN$!<2(X.Q0<Q;H[ VW :VMDDK5EL-5G,A
M**Y="L!OG'N0;DY9$I1P@GGM0\5J*\-J$P<,),E$E">(.*)S<0>!#(/?C)?1
M.V*EQ[YBM95A-4,H]5':$+7DSB3#C$U,*.RH)32(BM56AM4F?.HVZ:@PED@F
M2Q$GE"-'HT.8B8A)E(EILK;Y:*]6Q6HK6AVW8K5%L=J$$]DIXY@4'$5G0:J!
M<H(L9A@I0R1CFC'N*4BUR2X#3\1K"ZF;B7]6,VF*;WO5W$DW([$ON[<7TWIV
M+V^A7MSIWSS6Y#GC/'-@J\#_K..6.Z&=\\H#Z@?.*%%1E\>#,\![=3PX-V2?
M4NU<40I2F&FD0@Z(TCXBZY1&R:FH0#%VR8@RD%O-N;'R?#!V^04V*W![S>#F
M@W!4NR"P4UPEH0TV5DC'?"2!>3<[N%7X-0M^3;@V)?=,RAA13 3G8P2)+%,!
M,4DMV/!!4JH!O\R\NO)4Z%6AU[-%+^"1&*)Q@<2LG!&MB?5,Q,2$Q%2)"KT6
MBUX3WF+E4R1>8:2Q$;F^I4%&*8.2QY80IY)B,8>C/]I?7*%7A5[/';V\-4DS
MITUDFD=0O*(D.IJ$DU?&:5\9ED\(;1/>>8.]Q)YR%(($PY+[@!PA 6%""0%M
M.3J%RXCW2C6KP*T"-\U%B-@:;J/D7#J'N0/[17(<=-0A5.#VA. V<1YB!4_2
M,X+RT3'B*?#<S,$A%[DC6NJR'%P.JI=S3N=Y*G![>$N%)5:-+DOAO1TU$3B%
MVSOA/OT#UO/UW3@LYKP*!YJ[K5/;Z.:R?,/#RU\T^L3/DXD?7I+Q9 <8?.N\
M=K%+]_9WV-Z'K]3"+FAA$2R[ 66#@T6EL$5&>")SB+ @=&VSW9DLW-N-8>"'
M[2<:[:L2B=W8'/:RZ'>*QN5V%,VR_>-EL<1[%% ?T2;/Y1!/.[U&62MW^/3O
M\8]Q8;Q26%R[:\3F^.H6ZX"C!_V[;YFH@76+Z^X\;%TL.^I;:W7MYW'WJI[7
M442N&^TW9!,,_7?;/+/GO;7?;J(*0,KUY;R]$L/Y;O['=7_;G/;6Z55FGTW5
MV''SPW&YXU&#E9M]$'^-Q(LI'.OLCVM%8]\V #5C69PYQ%3^\3>0^T2MYIT?
MN?Q^[JTZKC*;!<RK+C5[]#4$"XH@ULAYSA"G@H%NH1("''-248=3$*M5:K8W
M: &=G>>H@LZ@6W2F$^H3E9@%?-C 0XR8M<8L-1MF,35FF:D>^^P>*^=9NA9G
M/?SGF6Y/=*E\3F4VKP0,:F8),PD[,Y03O;$D50GBE=OL-X,>O!%DRU!_AHD=
M-TY?2$'B[?@]-CNG0,']Z(_;\*JC\_51?Z(L:$]M'T;Z0B8[5&5MJP/CN'@@
MTSZHB?FJ+,!^UX98JLXO?JJ[[=R#R^=> Q]C+Y91I]GS,B+X;%8OC:CG/+4;
MEN;R:*>J+)T7XF<-B'X>VSSW);J'UE6]X$6]X(46G'C7[0!,WV&_/R:)XP4<
M5TZ;U7,^<"0ZG\]'[WD(7"INE<%<1PF(RI,4]XZF>'NW>Z\DIU=P$-DZ(+7]
M(WK0JL$8/HB#_8_-P_W#QN&7PY.]+X?-@_W/XN"BV3@XV9WH)0_C_[&W?=@X
MN,B^P>9Q_=T_S7KK+QAO#<;PSW%]OPG/^*M1.SE,M2GA^U1Z)ZARB$D>$6PB
M0]KP',B/C1062Z)=CK+@XM'A^W/,@ZR@XUE#A]=*8!M% 'C@C!LG>'22$HJ)
MX4E5T+&*T#$1.8\)%9)8A:RR !C,,F02<8C*Y $\<#)69^C0<I6J%530\:RA
M0T0KA8Z)1VTYQ]3J: 0W%N238,JG^4%'A0ZSH,-$9'JRTL)&661R(VS.34).
MA CHZQ2G/@:>6ZTS^NCV+A4V5-@PJL4B#0G8YP $R@W&6G!%)!=!,1.M,_?%
MAEF##BHU8XY ,A$'CIE-SK*(J'9DE&!,-49,!:694U'F%!>R+M2CX\ K**F@
M9%2#0#-!$TN,JL@)$2X1PW10G@837<2+@Y(*+69!BXG ZERYU1)%D+#>(YY;
M)!CX!-$0DC4\9(FPM@F;5V%%A16KE7DQU0ZIE(U%P@>=R,OPD7J!&5+8@=5B
M4ZYF@A5RF#BOM(O4X+5-LP[&RZH R$,/;U?\*&G+^T%KT+3]&,:!'@^O7SYE
MRJM;$N]?JW4(<VTCMJ[M0P4U,T!-_<WDR0M7AH.VXA AN4FE\P19JP6"#70L
M<2:\ KM&T,DFE1/1>#.R^N)*3[Y8/EO"B<6=?%;)^[DQX<09!I$:<TL%XE2!
MN9!X0,9:C"Q6). (JAQ+N7H9T%_%AD_/ADOP_E?B;BZ<-G$>@"..QFJ.),$Z
M-WP'I=J9+/BL381K'UANG,HGSP,J/IL+G_W/_],@K_YX6/9XM:35DJZ<-)B7
MXZ52RIY45$PX8:@W"8Q7BD#-SCY<!OJ89 D%;H,%_5MR1[)2IM2D$V;YPN*A
MH;S/N1+XO5+)[^D >TTEBV:>\LKA\VKYINJQ7T'QW*#XTZ23*AI)(DX.89D;
M?U')D 'IBB()'H0NB-LA%)NYM6YXNAIK%1Z];#Q:@@^OPJ/YXM&$OXZ# ,'4
M&:1)[B-C?4#6>X4T&  X1P)YEYM^SC'FN,*C"H^>;2ASB4<5Y,P".1..2YZ8
M<5Y%%#0#R$F8(\L)1\*KY&R*TANSMJDGSP<JO*GP9I7PI@J/?@'P-!$>S7,C
M!A8P(C8RQ!6/R#(PV$+$)F@B4XAVON'1%4)5"%5%7;]F$)J(NM:&"+"_$F(A
M1UT'[I )42")24R:<B$HGV?4=05!%00]KV!NL,0JQ6B1F#1QBI@[#EO**%)1
M2,0UP0B$B4?"Q!24LBG(E$OLP]8^"U2:0Y&N*57_GW.5KNWH8\O%[KA0%YU3
MH:Z?+-.<JD15;WA>;ZC*=559:L]<L0F& HI2 =84XXXI1SC#D7IN%5A=@96*
M#26TJKFS,DK-E')=$GOA)0TH.<81-\0BYYU"4OA@J5/2*34LUU4EN%;0,2^W
M3%+))2JBC(E3Z2Q.- 0'>K311%I20<<*0L?$T;FRGL<D*')2DISJDI!VB2.A
M1 *I("*CMBS7Q:J2/!5TS DZ')/&@ZR25E.NJ=/!:2NQ!$@)1 8]/^BHT&$6
M=)@LU\4,M@#QB%*F$(]6(*MM0 3V3R>9 /-S'="YA?E5V/#JL4%'EV1P!-MD
MN!0@C!PS"2OA.0W8V?MB0W4>_81 ,G$>39S4R4>+5.!@H3C'D%&@=0A*' GY
M)$_(JEQ7!25SA9+(%?, )<83G8-:C%/,,LHBIRXPLT HJ=!B%K28.#B.QDHE
M$T6)$E [3,#($AZ0\T+E*#O.F:O*=558,<\T (Z3<L(((7*G4N:H2SAAD8P3
M5+MX?ZRHRG4M&3XFSGB]!'KE-B&, 3DX)@QISC0"F\5$IF&77<CENIA>&9]&
M5:[K%6>L+^$0IJI?\GBHV9M2KHMJ4"NE)0A QB.N D':DH1\HA0T3.H5(6N;
M7%5U@E: SY9P8E%5AE@\$TZ>8:2$#1,)A: (F LF(6L<L"-SP09BL<*E<T%K
M7;'AT[/A$KS_E;B;"Z=-G =X+R1)6B%C"6C6FH%-3K1%(F PF3@C4F;#G*U"
M!987R6=5;:EJ25=_26>JH3HGQTNEE#VIJ)APPFAF:(J&(\&"!LM(8&2I@-^\
MU"K$7-M1YQHQPK 5$!:/+-<U#("?%CA<U?.:]T*]'.?Y'-=DY43 :KF_J@H\
M\T3[*17!G%0\IN"0B[DX(XL*@85 D#9)<6Z!!=*P(IB><[+G?)!WD=F@%>15
MD/<$GL@*\N8+>1->1Z.HD[EWJ502($\R@32.$2B*!18X!?'%L]?1\$FO8P5Y
M%>2],LA;@M>WJFLV,ZI->'B-=T1YXI#'2H#9'@DR04LD- Y$@,0"<;6V:>:<
M'%]!6@5ISP_2JE#U%X" $Z'J*3)%21+(JT 13U8A9XE %@M,$GP7 EM(Z;0*
M!"L0?'X@6 79/P^<FPBRS_7- ^P4<H19Q".U8+\F@S2S!#M.# UV =79*I2K
M4.[YH=RBT@.J G +AKV)<VG8NP!FK46&:X,XU@Q9*1B27OAD2/38LEP 3DTY
MEWZ6P%<>;?_6M_#&S?&,ZH,6L(R'OT/C^^9_X,=X%BW;/6JTAV/!9:FKI? C
MS?RX>^ND^4;*0!%_G,9V+Q9GME?\UPRLFT0**I>W#A)T%1VLU9)8;27(/I$H
M_;I=UF[,IU7W*^)X/89D+]WFZ!?-O<WXOQ_/#[^$4T>YW-O_3 [WFZT#>.]A
M*W/CP5GMR\Y9_>2?5NW+/_"VG1][^S#NDV:JP5^ULZ\1!X6MC2CR*! //B"3
MB$>>,RY82D(2"K;5E#8=!5!9,^^T;8>9MA^TRN03UI$FS(FT+N2P?!R<=#8%
MSLOMI^/MI]7V+VC[66WK*^,D$",-"@0#]HI$4,[T1!AVWCHC9<B)692HN[<?
M5K?H'T?XKQMCT8*=/NX5$6R'4-1LUQ\/(7I4^I&5U)*W=;WHQMYIA(=]C\WS
MC4L(+^$OORS33*,]*'=U"(CE!EDC?88$%I/C.C*;A.!.22ZEM( H7[E<>S(4
M55-0]&>5,?E&\9\;^#\'H+S)&]O1];<;/=_L] ;=N ^/_K/9\=^>F-KKC3&U
M?R"@(GS; W6CMKUS#M2):^\.&WOO:NQP_Y_&X?Z!.&A];-;???AQF]KKV_^T
MX/VB_N[S66U_5]2W/YS!>_G!16C6O_S5K)\T&X?O/N/#[;>9VC& G91**>8,
M(B0G(R1,D8U:("HYCXQ*:XD8@A407@Q;&3-HC%Q;91RP!.><:L$TV-,\!,JI
M]72MB  AI[#D_>X MO3M;GVK_F:W_J[8^OAQJ_YNI[93W_\T*>:'Y+XL(ARJ
MUM=9:D@ OY[=S=4P&L/C9,1)@'S RDK,0&LCT22+I?%KF\44YKW!VU/'\>OG
MK@8SKVV^Z<;0Z!=OK6\T&_U&[!4WI[<RFEL)RJG1[?6+_QO8;C]VBTXJ,7B]
M. -]KC7$Z'R5'\[)'@&"P\?]7G'4 ?6U#5INT1ETB\\;GS9 16XV;1> K-UI
M-=IE BD\LU4T.S"GT1/2<%7.2Y3OQN^=YO?\C&G?YO<>P;AL.W\P?G-QUN@?
MCR5#T>^4K]\9=#LWWGOGD]>+!JBEUA\7WH)B"O>7TRQ?U@;UM1EA6O8H%B44
M VU_CVT80+ZPT89GE3?!M2W[H]$:M*;=,Q9W*8\L-;+Z,%[?4NSE495R;USM
M&);[KT$[%@R/__P43_NC@LCXFE2\72:9;3R0LNZT>Q9+<GL_H92[:>$8C <+
MVW4*'\"?G;1(:)P^\)FT5ZV]3YYQY7#DSH+NG'* D '9ZR.^LSNAOBV8_X9A
M[*4AFHS Y/S-H-L%)OBST^UVSF"QWHQ6Y7XJK'EM0AW4X/K1UQ1$L"J /"?1
M(NZ9R?Y3@IAEEM  DI[D#*B-NRJBN:$>.XWLGHB12C28#?@FV:CXG_^GF>1_
MW$G:<="=#VE/V&/S)^VGMLZ6KZ]N_=C;^JJH8"%%C6+@#(%^II'&W"&AL- &
MB$?BE \$)F,_QM;91K&3I2&00RFSKI066'*P!WI97L*FRHUB_SAV(R@&\&/A
M:+A;?_LSFKE)$ZGQ(P9T$;N=2W+ KX\<&)@O!#M )$40V.Q #H)&9(4(*+=
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M',S89!@,W"G.";,Z\LA9#(1IQ@D63Q$<-MVC\B46MIMUF7Q,'T,^73WM=L+
M]XMFP[I1C-(I:!+M_OHU/6E]>.1?5G=KQB.0C2"'RHBB_K'MPS,;O?S481Q3
M%E)-N'G0[96*4G:RND$/!M,#%1V&T,W@!*+VZIW%V7%LYP]R'^E&]KVV>PV
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MS@17Y()O?VUW,@7 )AT7S^I)A)\YUV;^!;.?O=.!7T85Y,-#LTU:TU>676?
M!Q7D3S]DBHJ!OWU='93W?.#A)F-#=/**@S+%0?W>*M7PL) /(Y#-5^Z2Q5PE
MQ8HLK,0RW*>RC_/BAK6LK6MNQH*X4'C_2QR.]QNVII+]U4W'IW%5?(YO/P!%
M%;X ]RP+/<VV]9AA@"MM)<]J"EHH91^;@18[?5Y/FXDKR>*S[I%2LW#2RZ==
M[7VFT^R:R&KAB07";/WRS_M_?BUJS%4KV,,9=]'H!$Y\ ,<#Z'RMC02@'N<2
MGPDU1F-/(^;4)(,Q%01,)S",7(KVAER5J0SH'%/X  ^X=,6>;Y?XU$[*'P_F
M@PI@.9V"Z3^(W97)B'YHHPG^CK??[1."$VQ^0L0'CGB>16& <Q&FVB1.E8I4
MK*T/VF?S=M.'$3!C M6LE4\7T.7C./>Y*D&;^OO0#D$+K" UZ]OY U!Y[2E@
M )Q7YNE>OS#XH;VP_= ;#7)'"[AF$*O20)MM& !%6T 6H/W<=RH,'E8$G4V$
M3BQ46CXKQ FTV4Z%[&P&Y2R!4[]W7*OC-?"V\@R4[/.S7RK)G=]@BM)+7499
M;+W6S"7PY:_M4"LEM@4<,L;NPPCH=]1K%_4BO_&@%"_F+TVML91\%K8I5LC7
M;*UD4,XYS47B'8,54/U>\!U>Z64N6K0E-%N_1): E[N<RRV+R9"YVH$,K6I,
M9WRA.?C7/>CE&U_EYLDCJV3D00^,AGRK8F,=@@#OY6#*M( <3IN;I11SDE]Z
M%^?<[+(J\W8L7?+['$>;8RPEH=J6/%>P;[/!FK43.VCGBV_MF6/6*T$P(Z!2
M"^6MQ21(;'U4DEI!O]<SMY&=H+;S9Z]_11;\%P3?E5!1X\I9C$H';&=C7T9&
MB'<>&9J=.3@8I)57R$8P> 3W1.00][<Z8MS696=E$DZ2I$B(.9X-1E*BQ$0!
MSXZ4T^]UV37'?\?CYUDH)0E6J:+(8Y++24UIMZQ0$(QPC:5B3L'Q7^^QG?'E
MM3:R?3Z)N-2@.HA3X++0)S.V?7[8$W/I?!G;M97T>C+Z[)M*X+4N/=&KIM02
M4=FM&Z.#T6 (8H28(O>* ,B\.99ZXV8+<,0GG5P;!*?3R0+CO/6G/<_AKM:K
M+$/ $'L3>_ N=NQ5V-K\;PN>T(^_M;9M[;[\IU_LX9-RICLG651.;5(V_HJ)
M6-^AZ$.;[<K>S(_I#U^TMK.# FRXRS\ 0>P<MGN5PG&Y3M =XD&LXY#'0#KM
MDTXFSNX(!&ZVD/J5M1K*?=QHK$OUJF6-[;/LNRPJ3^>\-MUJWR@<(LCQJ@_%
M(,[;<W:4;=%#VS_.E']ULV;7"JS2 0-X6&U[.YL%>?67-4YPAS_L66;'\NA>
MI;*4M<.&C=J#[+,9GL;8S78[\%(5-YQYE6+B5DK5V+]0(JG5=54(=FJ#0J6Y
M@?[RC7NVN]-*3'$UOX+S >O_+T 5.*^_7TR*8LJ>#>JW!)HCC\V^U_ISJCX8
M(+SPB^O-LZS<CG+9Z%692'0,*C>$L9ACJZWUE$>%G?8X$%?)1'R#8795\DT,
ML_]63VQLLVL"6J+89L0F'CE2DB7$\\1 ;8Q GN9 HM3"V;"V/CR=+U=MU0=:
M1Z@KH+,'P*$ D:.)NW0A KT%"=KM 1\#,%9,W4ZI9N,*THY&_;J8U8Y]1_"]
MXK/*[IH<2QH> G5W@<?.LI%4\*-FKTNNS#>;9K:M#"C9FO@+A/"+UD;_"U!^
MA1B9N^&ZBSAK<8R9MX*AJ>4.>B-@@U:PQ_8@7O':9:R*<./B3LPX<I+9(+LF
MZXMK>3'J9@VBG=IYZTHXK'(>3G\^]BS6?DU@@H[M5W?N9Z]UJM=E^Z6DM)_;
MXI23&+?:R>]6W,/C*-#XW.H3&AZV^V&F=Q"I2E/+D@9CKW@=S)OH(W6!ZJ4"
M4BL=+Z;K^DYL.XR?E'OI@*$W\Z@"I$77&< .UB&TKSDM(YN%H#!->1-?3(?W
MZG!<,6YK>BE&ZS>H!-[C"@E<><TZ2\56ZO4 #CY^;?=&@RI79!(,M5>2X\==
M?. U=D!*^V$O?TCQV-JTX_TN[3.OXY)/&>AGF&1"G%?9XOP63#'[NF6-DY43
M.9717Z^L==P;>^9!7!ZW!Y4<+-L$?X.GC)N%5PZ6RGE1-)?BT@.F^N>20\8W
M_;.TI]JHM:-7$TD.#_H;>#5[OV5=Y%?"QMW!:1&U>6N^X[M4W:V1TOTJCOF%
M?*D:#T7*H_= HW_U.B4"^P+VSK]L_9+_ +3[:WZMRP-B8]*"#?Y[!'28?WLQ
MN4OUY4QCIX<]T%-0[[0+#QF,'-@@[;PS0![UG;.YXF.[N&/S%2>]V+43)T_K
M8[?H4Q_RF0Y:.RFU?3%2WA8D K1IC=7TL6=I,SN*2HIJ>4JTG9SP#[3RUPCP
MM_4!C!ZXQZ#U2[GXK[\^_%J*YV/1P4 I\Z,J7)6_TNY6$CI37@D!5P904?G:
M-H/". H/JF$',.Q5Q?H;P"GCR/L&T!SZ/VW_)<=SRXN,LC^K?OW2.,=EC0\$
M_Y=)@<)X;9.[7'VKOT'=SQOQR^;.W[_6<9_BDKNZX,J9_36.HU/C[;U\.BRZ
MU_K:ZV1>!"F3G7@'V5Z8O&TIB^@6#/W:CJ?51HZ_7'+I3L<Z;8'*\BJ^5]MV
M6<J-LJ)ZS4OM_#V7=G;%^BP$=HE=&1+&WP,$&%4T,W8,OBIAJ+>7_L2O>=N.
M\\-^>?5V\]<,T?"@.K8T17X/?_CUCI5,R.NW*K_E^!B+^*Z/$5ZFDJV3S<R7
M]L#.[U;;4F_B\/PD%IE0O^*@2L.<\;@6 RNT0**,NS'4"32S+S6/8M?'[R=_
M?!A=?UIZ4/VBAJ/<H*$@-$@N.T&T\NFO$Q$P96K6TN\:++R$MP+VMGL^@;GN
M%(".\:5^W-@(O@)C5ZWA"7)]4R5]D5M@Y/.!VRQ\L:\OKUOY[]>L_/=K5UT]
MX(KM/6;ZBD[RN\0Z?)SUC+('+*\WT^4'>(N,M9GZA_WLFMBH7H9H@R>\,5&V
MKUX&JG=-DUF_Z1[86L6 [P$O%0UV6.FL8+"58'?^6TW%E6U?Y1V5DB_;!WWM
M[:N/Y:FNW<^:U &@5!A<@F!-"MTF2^C[.8[@U4D3>F"PN::HX,8THTI['(.X
M7Z@P5MA5L=.,YNL/,Y%W"S>,+4%;Q&:5M##6;O_7H&H^VLO^CXD.FGLI?;M4
MXOM+HDJ7KQ5RU7ZK)$K>>TG4AT/;CZ#FPB,'KT&='IYO=$/YL#0^^L>>%Y5B
M18JBR-:DG.^ [!V_YGN[6Z?;NW^TM_*UG[8/]RX.SO>.7I_#L\@>W'7K>(O,
M-7K?_+>]MWMX",\D6V_>GI5KZ9]'.YM_PWW>XKVC?]OPS?.]BW_3SN8&WO<>
M,R*)1D8JBW@R& &_$)2X,-P('HB5LWE[R>>F<B3B@#&<C]+6YL@438;1"'^:
M+8GZL+OSZO_\M?/?S=?O/XQS?UZ_^_AV=^^Z>JAO)!G>_/"KB\WM+$Q(V'NG
M.1;>.)D;&J@HK(;/W0KUC\[)N9OM;"UTPV#5#-/+)8;Q$FO/4BX5 O0<9,;Z
MT9[_WQ$9_R?V"^\NM[D,751'V>M^& (>3,YB_.C-^GU7Q07\X)"QM?OZ=-]S
M9[7G!GFM'.($:V1#'A2AE=$:,Q5]6%O'+Q?5KMP8 +_FE.\X&:0YY=N=\@';
MIU@'KJ1#FN>)"%XJY 2<LM.Y#81,L/&VG/)\[<IJU:PL!MMR]*WW\60$H)25
MLG_ZO8.^/1[<PM)X3!?A8N%XL["[= N2.K'ICQY88L4_W>X7O]V@94?#PUX?
M5C.N4)GL$EPV.LF*\JT*SQR))&H9@[,<&V%HLBEE_C52R%C:.L*IJ)O:.I8S
MNSRR^L0V)HO=*%YY\B0Z.CX\4Q]]8?LQ#SVF,B&%(S!U2![II#B2V!+)!)82
MZ]S#<4&_+W?9Q:57=S_M95J'(WG9VEE,1^/)"9F,VA.R&IX73T)W.C!SJRZA
MW/H4B6/>1!X4M3CHW.'8,VV]HV4Z/:BTA.'%Y%02<Q>3TF1!LT35T-1"FKHX
MH/O8T41%4 BL:X:XTT!301)DP.3.'4(P\^Q6O:?SJ#&7C$TN1:Z3-#GMD6/E
M!(V66E/.5X.4U\WY/L#Y1B6($,PBQ^"0.>$66<X8,LJ"+D99[A>QMDX63%&X
M'D3&LU@ +;9[7VOO,#!MT0__C*Y?^5S@F%_<#2LT==F&Y8XK^.&TP288E00F
M2H DPA4M-5AQ_[2TO?GQ=!_$#W96Y2GM28)2Z05RW"5D<$K*8F*Y(#?('R"=
M:9+1E?OX+C3"?+"*X^B(PD#,2=OHP;X@VBKO (RJA**<@]W0R'W3R)>S_2@
M73P!\K"Y]L,1CZQ1!$EGM%3<499+YA?AS=4^T^TK\4G\LK4Y&N?8+AY^-36
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M#X7(+ I)2A+WU"!E%*!0%!*9E'NP.(*9%5(1XK)%=N=VE0T*-2AT+UTZ,)4
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M($!!%36BU8CVNR.:2SEFR9A< XMCHXPPV(BHC2221UM[N:J$= M>+D(%)8J
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M(KON7CG %0E;V<G5"Q?U=)5!CN<105@F0:HH#Q;Q73VPL/0<WU4N1'QG=SI
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MUN/(,1*&<L0E5DC'F'^P(%3 &A-1N;R E\Z)93DD:DY\0DX\N<:)H+ (BVE
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M'L7F;G_KU5'BR)UE7+&H&?<Q6"83SFT2K:4X8'QC<3JS//@BN0;_5Y"RM@^
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M<VLG>\94%)0ASWE G'F)#!4,@1$:)&/!1I8C35Y)_.!<HP?E05]M1U[CR_/
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MOZ+*R>PZ;V'"S8"3\TV5XS@SWLW$63O9>?>GMQJI 6V$Q.IBA_WKO^?2+;5
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M3Y\NP%K[\IMU]?W:NKZX^?[YVXUU]<FZ^GH!YEP)S+CB_=\P76*C6F"M0*V
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M(%*2;@#R 1 >I=SW^DV=7G>1A$#Q</;O/B)PG@Q#.4H\'?[ZDUY@[%23L!.
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M@1C)B5XD2$+K0R!"!U?_Z(; 0H(PHA-$D;EFW3H#=,5]P%9SWA9+A#)WJ$$
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MW7V'GX_P(7<XHZW UJ28('CG"*)&?YMY\K#X[Z[G ?;6+/X(9.5_,W8)$E0
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MJ9@%21Q9%-:@=(4TY@L;AW>[MS(?),80<%2S[L:N/>8D$D?&,IQ0S'Q H;R
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M=:O"=](R.7^FBD@>CN2::SBI6]<CIV:99OHH\\POF+J!ZY@M'RG$'8]AV]A
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M< 6>#U!R.,_%/405="/41'OEI<-@A;WVTD%#]NI+!X*RUU\Z&"IZ6.$\>NF
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M5:(/.K3?$&9CHJ,[*B[^V%DG?K?F.DKC\O*O#+6FZU)/2A!/PF?+)7&G-'@
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M] 9&R4%25I@2JU^VL4I(#I>5#=DH$(X^"?%U\IE'G=\Z_9>RDUA<6@G EVT
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M/9>6HB$*)4WSZ)RB5L1@#F\D=TS8VH!XL#ND2E.TSM1&:0V*D (N/8?F-6-
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M0&8)Y<[IA*:P];6=WH]AVMT)UQWO[RH=5?G0@8)9)I+G]1CO4:5G4^+9,T:
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MW^#!_&KJO&<%EP;4?+C4J/0@.)YIS%88SZM+WI.L6-F?_EB//UWTU%M=3-$
MU$]?PK()XYJ5L&Q!]=U5-87LF+2>A(A'JQ2(T$HGB.$NE[I!T/4;<3Z7$I;Z
MDK !L9]?"0O/S!OF\9:&4LZ02AO I!))SKB@DTW JN<)_A0E+!N)S6Y+6#;A
M^1Y+6!9HI70F!QD(\-)I64<@UG&'9H\WWJ20;/61VILA/#")J\V3IU FPKES
M6F8BHB]-,%11%G4@+/$H<TQ [S8G_UG+1"K)4'6N=*!MOX%Q_RN:'\6X6,ZP
M_MB?_'/N7*%*9)"<*#8;.%K:N^N0B(U@LW8:R5$[M>TA/#^?H5:-.QVDD?S
M5M(#QC[>G'K?!%M'YMI#N/9CM=7CXEKQJ,2"#FZI!S'*Y"1P"L0Q 40RK4D
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MY/*+[X^+AW)9"F58R*(,MK$215'92"QE92:3L98S"\W*5E8^_!#XVIYJ%6L
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M&([!#_K_@]\BN5\!ZJIPX;^5@C<(V@5B:&D#5@:0.NE\J?J-03!JH'JCM2K
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M=W.UE?:#5;'-I=#!XOEU-L7OOX;YOW'Y[F*:'\!#[EU"2_ *I^M4%POT_%K
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M=R%J"TWO%XL+K&W\0?!L(MC$JRW(##A'MB 309 92#)@W6[UEH2\'(&Q:<M
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M5C#/0/YM&+UO#^WE_ZZ_Q+# __ZO_P=02P,$%     @ D3J;5D_E."VE_P
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M>)3+4I;72_%E=2^+M^NBT![QISEE\X66(\O?Y .3Q4Q%-(4HDH##3&JG%6.
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MBC.52AS:!HF<%C.UUS_\,_J?0:UN4.D;B+4TJ:/(/L:A ]3N-]\?5 ._^2\
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M"(YRI^;G;52OHDWJ_,U6^Z!1/ZCTM_=(7(;AO+,W$+@#4\L6U^LSN/9P^5P
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MU\$Y/T$-"?G LU*-]E;WX*9%>ZM^L-4_N!X:;8>,LP%1'ROM[,2SWOFH^\I
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MPGM^P/-5;?PR9<:M3.X%N(,JYG[NVH^!MWD3-W0N/BZ;XEN[]7)#K)A^C!5
ME*7ZGXP 2F((F)",$8G#-),N+'M>Y-28="<'J\K*GK-UU8BJ5MR-'BT MZ-
MOS .3',["!IM ^VV-OH.5:#8'AY/1&8A<%2RL@=@GY <KNS;.D7-EU*\D4O]
MP\H47/\L5S=53;8Y;SXUM#>C4<1)FJ4 X@@#%(7:P0M9#$06QR**8H)-,0G[
M<C"V@IT(:(1:,5K+X+%1,S 3Q+PJD%ZN@I_JEK _NW9>L1P 2V]L %@'7U%7
M*@>-=E5#ABKT-FCUWOSI;87SVT+JM^(TSCWZN+B!YJV[BZ78D7N^N(%QV G&
M\?J^U4.Y.3B:JSFO7+0O:[U ON9\_;"N?+4J",;X<(6\-V_I4U.+I^IMI& 8
M9RR50,C0A+!$,: Q9 #'4@A-:S*T.PWRH<S4/*Q]6X)\O3*KUAUSFO"Q%P:=
MJQKE?Q#M"'&LH1F8)"\;%>^=KWR@ZJWNYP6JC%P?]'+0#NN(>KAG7P9^W+;2
MD&PUBWBJD()"+TQ-IE%(.:!A+ !DH<@@8U#$HHUPOG4AUY=RK-[*EW',MZ/P
MYN-.^Q=3=MZ5"_?@U*C1C'$%0DQC@!0* 8E,!$.82)&Q3"_Y([=)J@>.HTX\
MG@&TG2#ZPS(XZ>\B\JX+D1X,?MQL;ZR\=_N1F?:X<8?L>>)[_1BQS>_GM+Q_
MD=H_@UD*9:I]3169KF*<(H"A?K69A)S'*I0(0K?DCY.R>M#CP"]VI:K;NWP:
M2;N7^C)T1HHW:LN!&"4/*H'X>]//8N'IE3\M9]1W_ZRY^R1P_H)^;/!>*<FU
M-]96:OZJ7[4O2]-=S_R_*<#W1!>&>ZI:\'-N#ACT'ZZ7XN4'.]_4ZM49;>_F
MY6->TD7525E?80XN\N5JOEQKEZ^N+I(ORUF,TSA5>IT;*1$!E'$"6)1BD' I
M,YZ@%+D%Y;R^25-S6FI$S/2L]FO,:XUE4/]<=U'4AE]5_U:E9QO[J["?8H-.
M]7<WKGS]0;$DY==7=$+LOWUP-@7V#1[F07E;/2A5&\X=4Z^"+0K-5\RCL_?A
MRRLV\ 0M/D$%4'7E+D3!%B-_$\]TQMO3##<!@T:=2B=@[XDY>T*:]7,./LM5
M[6N8(*\9BD2$,Z2 "*6>IU44 H8R#%2:9BPBE!+EU&OAQ=VG>()6'Y4%=%6?
MX%?ADJL\>$-_Z$F[;C1\GR\TG(X1KR]AC2D+LT2:SHA, &3Z6&#&(= +,26@
MP%$JX]F3+%ANZP#U!G97RG#0UHTLEK*:5U;TQR7@V<WIO0$9>'HU#UF[I*J#
M<J_WGK4;ZK<MX5$D/$T\+^\]ZAQPU*Q].C[^I7[,N)-X_''YN%Z9NEM-GB3-
M,(0"A0 BO8A!1$% L A!!..$40:EI%:9Y^=%36V9L9N-7:D:&%U[IJAV(&SW
MTOO!;6 &Z N9\XM_'@U/+- A:%1*.&_P/C]87-$S9E+[96*^6)OH^6^2-QV
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M4B,'*?@$\C"$P>O=^QX_:@D/^?+;2M^KK@;W95L0?I;JUT PRD&(.0$H3!7
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M^0>M ZPO[-VM)E\O5^4-?39K5[TZTI\4:REV4GR:C<*(R$@*9@IJ<PB0Y"'
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MQ,"30FN)0SN3%U/%,.M\3_CZ2LBY4)MQ4W;\0'>0U./IMI=4GII%(DM#QE)
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M- $493' (4XBGBC,4VX3TSLIJYR(<(20XCJ:G[^(YI\WT?R+>C>BV,,GH!N
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MJ2ES[S'&Q189;[6GSX@;N0JUG?&']:@MK[O4C_\US\7W^6)1A\&'2<9D"!-
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MU2>[H?#6%>>HD)$;VG09>MB+IO/;O?LZOXR UVY(<_JAW0,,4Y2 $%$(4)Q
MP"*][$DPQY@)FA$HW9K(G1;F\IR/TP/N\Y&T(^=>S:>@Q82B$,H$F&X9 %&N
M .&QB9<A$4YY1D/JE"CF!]@Q^/5(DH_6U1NP=ESK!ZZ!^?8X4@-4*CB/AK\&
MUJ<$C=VP^HS!1QI4G[NB'_U6,V<=33&3"6-Q;#JQAM3T=DP2P 1/ 5,DTUCR
MD*3(I9K SKV=6&"$2@"5:L$#+320;N_^+F!V+WM/& 9^NVL$:K7\O<I';/7T
M[N[>>=27]8A)^V_GL:_T>QU_HS_F#^N'3W)YM[K_HF[G#U6K 5/3VS2H_[#(
MOU>_1[,P42R,( &"*SUO*[.?$A*]6,*0Q3*$2/_990:WECRU";U1/%A4FIN-
MWY76O?:73$H6U]H'2JO?QX6R'P\[+A@$Y8&9H@7XTP9@HW:='FV:* 1&\\"H
M7G_FCTV<T?+$-?9R1V4B9SCV><K]!FXL)N1\]GZYFJ^>O\J[>;DJZ'+U63]9
M,YEE88A,PVC*E G*#P&%(@,QQ1+%D' 46Q7M/25@:IQ4ZQALE0R,EG;4<Q+$
M;H;Q <W 1.*(BC5=G#/]""N4DO_Y+G_Z15]:$X+^8<L#)V\XRNM^SISVK3[[
M/?=XYX_+E1ZP.5O(JD'G^Q]-49R]AA\\$3!))2!8Q6:=( ")>08BF$:(,24C
M.]?#6N+47N^MTG77V6"C=L].(/;8=Y/ ((@.OJW[:F#:AU=[!W6D8&L?X#I%
M83L!U1&3;7>?T2*TG<S:C==VN]!#]+;^119/\FN^6'S(B^^T$+,TIBG$I@=R
M%&9 NV&:N1.) &>*R2A"41@Y5:T](V]J;/TR2+G1-_C=:!PT*E\2UGT$<+NU
MH$<8!Z;HBQ"\+-[[-"Y#Q'T?D?9Z\=^G3>^, ^^XK.<6<4-5>^7^;[6_62ZJ
M^:NM6363G$O,(@@$SS33L#0&#&404!*G,<MD1J%3<Q9[T5,CG4W7CM565\>-
M9GO8+?>A!P%SZ&WJ1NFKPWXH.XKO%NGSN)GM#)BOO6Y[P>-NA3L#<K!3[GZ'
M"X.I?Y.T7!=5H:2_SU?W?UWFS/"C<;L^+A_7JW*395R)U[]IG32-OJ'EO&SK
M?S^W6M5E8LV&V:DX\1F,98(@SO2:&!& PD@"QJ7FP(@+D<4B2E/<*SI[;$LF
M1ZGW^K=J2U^9H.2GJHA:H6V^6\[_J]Z)OO[R]F//"._1GQ,[TOYO,?H#SP&[
M,>@[, 3?-0[!+A!!C43P$HJJI$4-1E"A<;7IO/#\HKQKT*)B'J6SZ4$#1+B_
MUAC[#ID?W8[7B<%_K>$Z&=3_:@KU[(:Q+E?Z+L5764_]Y?W\L:U\@+(LQ)1@
M@#-ACHT0 YA@!E*&0LH)(@EV6DETR)K</->HJN>V'5T=^U1T0&LW\7@";."I
M88/5"S4'B%&S@,-7(X<.2>,V93AO\D&#!8M+^AXI7PNAGYSRK?[Q2W&;?U_.
M,(8<0<H A#0%B D.**0QR A,.<I"I81E?'"'%)>'?9S X.88M='T*C"Z:BP#
MHZWK$?,AJ+:GS!<!-<Y!LQM"/8Z;3V)PP8GSX3U'/G0^:=3AN?/IK_9S"&Z,
M<U$5N:\\CIN\7!5R-:\]FJ;E7_EN7O)%;OR<G8QHA1E)$09$( X0S\Q/' *2
M9)G,H(H)<4H5ZJO(U%R)F_>?OWW\\CFX_OPN^'+['^^_!C=?OMU^?7_[\>O[
MW]Y_O@W>O/_\_L/'V^#FZY=?OU[_]LW-R^@]7G8NR!BC,/C)2:MOT"H\4+O[
M2\'RY+WT5F-4U^92L/;]GHOOUX\O=WHQMXNVSW+U(I3OAII:O>VB*F4JDR$"
M^O\S39-4 9;A"$0I91PF"<W<:-)1_M38L<UHH7PU?^K1PM05?BPCFL"8@HP2
M!1".(CU+*06P(A$7D2 A2MSRV08<@'%\6:-U6=<_DN7/0;ZL@K3''!2[J6A
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MC1O[96'T0?"7S37N3MM;_;GI>/1YK7U#<^MF.Q5F*L8H0X"GB@*4\0C@4%+
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M\L .TTIY9S%XJ?.OE[*L]]4A#^7_WLQ6,X<VH9?,D1U/]HQ[ST196P\:YD]
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MYRBR=B&R-[QZ?G\<0-6?$%<;$KZE>XZ.]3Y*/FUNGQ3V:;VH>]&NC@:?*UW
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M7?1AXK";%CV"?+!=T>=8[G'[QUG^\(,NG^EC/M\49%5M?LJ$I)(286)U#E'
M(T@DCF"88"9H$JE$6LD@M TR-J+?V@FVAMH'G">1/!^C^\"G9^8\ DV'!*23
M&-E'XSZP&B@,=_DZ.47=YS!H";=/7CI8G'W.^&: ??:SE]6@72TTKZZK0^)2
M46:7_;!K%YD0' 9!F, P"JB1?0@@(1&!*A$H("K(TDAVJ52S&WYL)/GK_?VG
M?]Q^^0*N[NK.G;=W3U=WO]Y^_'(#KAX?;YX>]8+SYJE;K9'EG-B%L_TAW3/=
MUH87V2 [TRNUJT;J5$^=/;L!Y[D6RG+P=ZF8<@/F5%V5XUTZ"P/JP/*)_EE)
M:'V4"ZEFZREC,L913" ERNB;2I/#D&J6$Q$.DY1D<1"ZT-J)<<;&7]4R;TW_
MK)7]G/7[CL*IXCAF*,*0LY3HJ!ES2 ,-+$_3*$X#KE)"G(44.P,ZL*A]/Y#:
MD;R'[UW/;%[AHTW<"AA^J*STV-GB# [^I F/CC*T]F";JT?$!5L_[L:KJ^5Z
M^E@V<?E5YM^7].7'C--YU:LSB4,9AR&%@@<((HDI)%$6PXBF&<9*LAA9L6KK
M*&/CU*:%=H]^.XCM#[XW:/H.XAK&>>QQ:N5^V].N;]!XTO6_=D]Y^[T'><:M
MW*N?<+L/NV^+W<D_MOMM7W,AZZJI.,4H1CB#(@I-"PK$(-.K0*C"1&"&& IB
MJQ2=EC'&]FQK,QO;W86A]AL^IW \OR?F 9V>'^\CP'38$CN%D/V.F >D!MH0
M<_DJ.6V(G8&@93_LU)6#;8>=,;VY&W;NHY<L#Q_UW!<5R-L#0TEH*,,DA P)
M8MI?9)!P(2#+DHB'2 6!6VG.B7'&1G=5K+ZUT^94SPE7ET7-16@-LZAQ JKC
MFN8D#%[7-(>CO,.:YJ2KQ]<TIS]^J5+/[<+TAB_.*>M,ZH^O)G-0D\\W.2\3
M&W[,7HHZ,AQ0)8*,P%"9MGZ1PI!0&4#)>!PF:1"$BG83VW$Q8VQ44ID)FG9V
M%<=QF@X[BND?Y)X9Z!B^WHO\+D/)N^J+DQ'O)-S2!:C3VBN=[N:^XCM2_[PJ
MNQ?$B-$T(X;-*(((Z;^1 &4PR5C"8D%)BIGMFN_D*&/CKJ-U^BNWGA#ML)Y?
M GH!JV<.ZA\G^X6@%[P&6@I^WJK& =' K:C*\J3F<A:.EF7AZ6L'6QB>-;^Y
M-#S_X:XYR&)FO@AT_D!GXG9Q35]FZYV&$(FC#*4)3(BI@A:*0R*9COU"*1*"
M2)()IQ/$UM'&QI [8\NZ-%-3*(7I@SAS%D%LA]DNG/,&7L^,V<#-& IG"U"9
MVD?]KPTHWO)@V\8:.*'5PNW#S%2;B[KQ2"6/__A#RO47,VMZG.JL1W"<1%)F
M4&:(:A*A A*193!BBH<HX5R$3B1R>JBQ,4AE*2A,!;6M;LS1 JP=;?B!JV?.
M.(Z4QS,U>S0\D47+0(,RQ7F'W]*$Q17=N_%]UN&+YI]")?VS_MEJJA 3/ H8
MI&%1%*\8Q(B$4'(=76")B$#$M1W?P2AC8X9MK[G24E":"@I;W?OQ'8+:3@W>
MH.J9%3JAU*DCWTD4+FK)=WC7P7ORG73L6%.^TQ]VWVYYW+S(I=HLQ.-L+>LJ
M "*2D&9"P(Q(_:P+AB#1C[AIZ10BD?)4QM8U)\<&&-MCOK41%$;:[Q8<1>_\
MALJEF/3\/+^!H\-A^E%<[#=0+L5GH+V3'4XK8Z>G[9(VYUMV2HY>-M@F29O1
MS?V1UL]U[4:W6M\KD\F]NM+WE<N?,RY71AA\*K-0X2Q-8:00TCR&8TBIDC B
M09(P21,>6<EOGQ]J;(QF+#5*%T;7S5&EIP5/+"E-HBR$.$GU$E&_!R#EB=0O
MAR0.>,JHC+A;:O6%B Z:7=T/IG:K0S_?O)[?&S5 A9E5UXG2T*)-A<_^<>?0
M\-8][N1  _>..^?P8>>XLU=X;>%<-1P][)'(C;9%S!GD5#"()%>0,%.Y%Q N
M8QI&*7$JVG,<?VS$7+=<[MR0TA5_*C,<\RR#H:9H\PX4$!,I8,QC1H6(])I>
MN@C$]XG_ (KQ@^-OQ^\]HMHSZ3MULI[4+<=[;UQ]#KE^.U2?''T,K:C/06/9
M<_KL;2X6B_XD7Y:2ETW/]=_GLI -78BK9Z,@^E_%ST^J5T^E9(1RGD$:&H4E
M+!1DL4IAK(?%81@IBI!;L.K+M/&%MDU!8=%PK;,$]&539WG0.N1T#'0FVYB'
MID]&V;GRJHBKFWY-P)O.!9/]U@6]B#A[ =R_9/-E9KV70+,7,%ODF/W<OQN=
M/_(?4FSF\EX91>B%_H*]EC*HZR(M9B<D@:)0Q@0C2!*].D"$19"25$(541KA
ME&5*. GBV0X\M@5";:VS +\UTG;LV@=^?>];5R:;V'-K]*025UY7N8"@%YT.
M5[0\49_UL(-2FRL8;ZG+^?I+:RRV67LZJCWL-3E-$Z0BE40P1::J@B4!9(+$
M4(2"A%&$122=J,EVX+%1T[F^PUUK*L[ ;\=7?8#:][GY\=:^=HUYF53Y4O;8
MF=<.1N^%%6>&?:=2"CLP3A=/6%[?L47DGORQ#AR^S!;R=BV?5U.4L9!&BL L
MCB*(4K/[2B(.$6=Q0#+*TMBI>/3T4&,CJS?:VX4NK#$6%-8ZUI"V(&S'3GYP
MZYF/ND+FWAWR+!J^.D.>'FC8KI!G'3[H"'G^BFYD44O=ELO!>[6M9-<K0#5;
MFW$_:_LK,0^C@9LO5OE\)LQ*LJR$R602\@ IJ/_42S6];H/8])S5*[0@X1D1
M*77*%+[<I+&1S[Y'9CVRDULHG:KEK0N%\MJS0NRZX9M;^9+'&;8CM6'GK6?R
M&VK*G,G2'\J>2-6#08.2KS\ WY*TQSMW/"R9S_,_3!;XYWSY*=^PM=K,KSC/
M-WHT;9S4@:8>Y%L^G^O%PA]T*::(4A/Y$6CVVR"BL80X,52NN9O&2BG'XWAG
M"\9&U5L'@#80U"Z V@>P<P+\;MP GTL_'$G9?:8L#T'ZQ+__TXZW&$_ _GQ<
M+Z68F4H3'9E:PN]^K-$50E_G%\[C#WM0T16>@Q.)SC?JFACZ_)PO'M<Y_U?9
M3C!FH8IDFD#)5*:7P$I!'!.3X*XPQ3*-6&!5PG)J@+%16VD?6!D#)^ O(7BA
MU4[=!-#-^D>^G/V7CEBB21 $]?^KI)@)F*U6&_W+%,<31-"$(%3]"LP6P&0?
M%Z>,YLOLF@KY9E;L>.X2K'NFL0KFQQ+FOY?XWA;P^4QY/.Z_MT3'-[<?.+WQ
MN'.'28TG/M>1(.AR^5JHE[SD2Y/@\FRXZ$@)?U7 P+)4\"3*( ]99F*G%.(T
MIE!&L2 \D 0K[,0?;N./C5X^YOF_2CIQS89VQ-V2(?I#L_>E9VEQI5_R55)C
M9JGEYKT2OR-,OGC&<?1A::@;- <LU?$V74\QV7HGS72GOV95V7D<LS0E2A@=
M?!/M4 PI3B@4D4094@F.7;7@C@\T-EHR=H*=H1-@3'4]FCR!J>U1Y.5(]7[T
M> 2D'NKXST'A[?CPQ# #'Q>V.WMX/'CF\QTU/C:KV4*N5E?\WYO9JI 2*?ZZ
ME/77.,)812K",(Q#"E&:8(B1C&&2$8XE,J7^3G5Q9T<<&T?4!H.&Q1-0V^RH
M_'$6;CO6\ IBS_31CE\?>B"VX/B2!3D[WK#J(+;N'XB$6%_8,;W3U$(^Z6N_
MZ*!5?I,_Y4(OZ5F8R$S''C F40H1HT:=GV10\TX89"D+"''+Y3PVRM@XI3 2
MFON"N3$3+$L[';,XCP)JQR 7P]0S:S00*BR<@&]G('+/PVR#P%?2Y=$QALVP
M;'/S()VR]</NDB%7 7J4BUF^O,O7<O5I([_25PT2JE;K1H.090Q#&:8)1"2)
M(<:: 6(2BR3$*$0BL!4/:1]J; P0_!7]WZ"T%Q0&@T]F.4]?S38ILE?/. -P
M.QGXA:UG1FA'K(/PR!GH["5(_$$XD!C)_Y'+'+SDL\4:*'U3\"+UC?6HWR58
ME0 O"H!%!?#ZCQRL?^2;E=G&7_^A/_I:7.A)Q<0.OQ8]DS,W&$S9Q,Z1IL:)
MY17= J[[]0^YW.89E,T'JFYJ=W(]94K(1.E02R0QAR@TJ>HR03 ( Q%$+&(,
M.RITM ]H]2 ,6LI8V OR;>[.K+!X A8M6=)=D+8+R3R@-PP3E[#M4IZJKB(?
M*F-_F9@L=']QFATNG@*V,X,-&KG9.?XVA+.\RKU_XM5J1A\HGZD9KUZ1BF5Z
MB1902)4B$"680!(2"AEC <*8B2SCMGT3#^X^MHCMZN'JVKY/XB%8[21P,00]
M/_/&-E 9Y_&DJ=7M"_HA'MYSL#Z()]UI]C\\_:%+2V>W9T=E:^JKA:A+1V9&
M1*TX+A3WBV^2;Y9+31 ?Z6JV>E/U&3-)" \4E $.]'.=44@8"6 DF0AB1!F+
MK)9EO5@W-EYXW#P_T^6KR0+^/%O0!9_1>>.X9%6?T0I UZ#1>B)?@*V;H/"S
M:PVOCRFWW#5ZKXGL>[>I40V\FZ()*)TKLI<:[NUF]' .!ZH<]@B_]_)B'[:]
M4PVR1UA/%RK['*3CPK".#NML\UK+-U)$)%) E2C-^S@2D"B1P"BA*&8H54'L
ME/1X8IRQ,?AN)5/;Z;CZ.P&GY;+O<I#Z7N\=X--#KM$9&'PM[TZ,,NRZKMW5
M@P7=F8]W36A<_?@\S_\P7=EDW:3M*?\H->_,Z6JE0U,I_C%;_Y@MGOZ0\Y_R
M:[Y8_UA-!4$AR2):RAH@J@3$01#"%#$F,2<ICW"]:_3DDM_8R9P.>TI/@^05
M*;G4+%YL)0&J-(O!-?T3?->.K4S4(';E_+-=J.B:&MEM!NUHJ<\)&2C76GL
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M>1:AB&&5015G1@4)QY"EBL$HC#%*%>=2!2Z4=3C$V(C)6 A-AGXA.N=&1D<
MM*.<RV#IF5@*1+9";CWDXI_VWA-#'!E@4!XX[>#;I[WED^XU\S>+GS-MBZF^
MG5_/)5W\]E)]*Z7D0::P@DBD 40\H5#''AQFA"22R(3CP"K!OG64L3W9I:&+
MTE)0F HW+_95UZ?A;'_(O8'4^^G+SL82'O#;2P>9WM,XV1>C>\%KH-KS/=QX
M];7R)-5[%H>6$O/3UPY647[6_&8!^?D/^^_@^&!^4$@>%9]ZR%?KI5S/R@7G
M1[F0:K8VNZBK*_'/S6I=[:'>JR=M;QRH4 =''(:IB"%"TL1&#$,LDTPQJB33
MRSFG=-.>++5Z9H;MD5 Z4YP6Y$5"R\N>/X"5#JV*LY="X)?^J=>*91[ZA^JW
MOYA??/A+^$MQG[_$16<!DY"ZIP8L%V;7ZJO^VOP <3@!YCDI+C!A@A&Q7+V4
M=;+S%GWM0;]8=C'C>WY9WJ_-Y(?2R5^ <=.HS*G90D]OY5-Q"'6JO238.5M_
MY*FEDZC7/I,>)F2 ?I.76#F:OI,>H';I/^ECN%YJ)K:;GV<3Y1%7DF 2Z2^+
MJ3P3^C\X9@B2C(@TDB'F>E2?=1/6IHWOS?7?OG;"_FMA]QH:=*H'KZ%H'(;]
M-ZJC< 9]F%H*>[/&5$_A#*9C387[_?WTVWQ8YM^7]'E5K<U9(BF+C026DAE$
M*@T@#8,81BA"C,9IA&AX2:?-_>'&MC=TO"=D;?-E+2#? 'U^L\@O?#V393MR
M';:/+""\K']F=RB'[ISI]F6\N'7F<6 <FV:^N<F[MLL\[M"Y1IDGKNJH>S.?
MYW^84.YSOOR4;]A:;>97G!NF7^UT_LO3O?64H83CA,>0Q<K($@H":80RF&9(
MQ2J1))#<2?C&9?2Q<?+6^&)?AU9F-[J.3  O+7>4NW&:$KLHN#>@>V;OVL9&
M2Y$)V ?^>BG%;%WMMUR? =Q=\J8+<+XT;YS&'E;TI@LL!ZHWG6[209N[E/A^
MD$O]?7DV ]ZS^:P4 *^:CIHSS=64(!K+1*9&V$9 E,H0LBQ2,)6,I&E$42"L
M8TS;0<?&:I7.=M4 J] "7($/IL<=?5W]XJ !;0OZ^7BS#RA[YJW*Y$+4M#8:
M[*S6/Z_P+0SO 54'7>T>T!U*5=L/RFXJVXYPM6ELV]YJ.(5M1^?V]+5=K[W@
MM/0N7Y@*$KHN>O&9K>Y*_F>:XDB26 :0I2&#B/,$,A%D$+&815D<JMBULWO[
M@./; 2Y/I6:%D1U*P\[@FR@9I1D/(,\R"5$F,L@B;K;FN0IC2:B*MQI&3_;%
M>-Y!?AJ@*J]?I#.9IBJ@"E)36H2R&$.6Q 2F',4J(#(+$9_^E$N6VZZV/(!<
M\7MSV/^N^#J<8GO!;)##Z*:E6S70RMC3P5NWH^2SJ/@\$3X]V/ 'NV<=/WH^
M>_ZJ;B_$C^51W*,YB?N2EZD$5W_.5M,X#6BH-$%S@9!^%688Z@4.@5DJ5:#_
MQWF4N&S6G!IH;"N8RDY0& IJ2]VXXR2H=JSA ZJ^]\6/H@1^-V9ZS)T^AX0G
MCC@YS*#L<,[9M[QP]O/^$PJO?M+9W&RK?,Z7IMOKHRE(*]K4'\L@Q'&:X4#
M1"2%[@*!C& "A2*Q0C@* [>",%^&C8UQMK9#O?2!*VU]49P!5EL?CN8)ZG_^
MEUSF979@.*;L0*=OB4,@-?#<]QUR7=].RIJ3Q\9$[W\9C#M[A<IU:M_.LV(Z
M!\OTZX+U *E]3F:-)I>O"Y@NR7N=[N^^0=YFPGY!WT+HX6X7/V4Y=O'#NGCY
M8Y%9]#:KU3 $2A(L>8P@"4W'R] <&R*]GHT#Q0(>\BABF8UTSP"V.KU:!MMC
MX'LYQK-J73<O^82;.EIEZFA_%'6TADX6109?[7KYBPGX7M!0=5F5"+9\@\'$
MO*+L-Z3[_NJ</QT8T1=BD"5^2\>/R6%-M?XN:*?!SNOR%V]>2=5WX:W[D];7
MTN#?!?LSC1%])P8Z"AG9=\/I2&6@V6HYB>G;@L$.< :"LGGN,]207=6Z5^OE
MAJ\W1G1%6U"UE[XR:Z8BD&HTC-BV58FS+$),I3 -3 VR##&DB5*0*"ZR+.6Q
M")WZ>W4Q8FQKW(^_/=[>W3P^@ON'I]NOM__GZNGV_@Y<_^WJVZ\WCZZ2VQWF
MQ&Z5V3?2O:<--,PO KFZ'?K.@_TV-WTTN+D$1&]JVAU,&%A$NSM(A]K9%]RK
M&R]JPGXV0KGZ3H\_J/X.7VW6/_*E$=R;BE@F*!42RC34RS73Z)"(B$$FJ<HX
M4C25R(7^6L8:&\N5IH*5L74"Z-;.(@-J51AOF0-E [0=IWF"KV?JJI![+)$K
M#04[2_VQDP4<GDBH;:1!N<;"Y;>48G/)I66=MPM#6T7EX%V^_B17L^^+@K=6
M)K0KCCFW'ZCC/",P+%G*8L4$#!-F>J D!)(@"6 6<!PJ' F4.?5 N=BBL;'0
MK[M]FC="J'4RQ&8AMLX!L:L'G.W\ZUJ5V756[<ALT+GJF?(:=9@-6X'V!NS<
M 70%*H>:GWJSR/:J0^T-8^]EEUWM>:=ZRPOA.UUH>>F-W;?X;Q=K_=6=L7DI
MRG?SIQ$:U0/]FN?BC]E\_F6VD+=K^;R:1BRA291$4-(H@0B9:GN]XH5I(G@@
M>"HYL:KQ<1IU; R\,[R2I=R:#FK;P>_&>E"8[U ^:#\1Y[>^>X&W9](< [+V
M&\F](#S0EK WI)TV<YT1:]F6M;_78!NLSNXUMTK=+^X6HA?];\PW[%YM^^0>
MV:&]8JM"TGC*29!F2B4PQ*&$* X8Q(QS*#B7*$-"QLRIAXWC^&,C_ZWYI3S&
ML4YVM>F.S09=)\8NINX1[IY?!EZ0=HZ/.^+E*1IV'7W0V+<C-&\CW:ZW<8]K
MK_/%:O-L4F2^2C'C=/ZPS,6&KVLIAA!CK@26,&(9@DAB'<UJ1H,QI2AA#(4I
M2FVCV3-CC8W&=N:"REY0&VP?5)W#]WR0ZA&UWK<P3P+602?D''+V0:A'! <*
M/1M(/E=(OKQ%TI,"K24X+5'FN3L,%EM:NM*,*&TO<2/6U7(]_4K_G#UOGJLO
M*PTU=49A"GF<9B9"))!)%<(P"U+,E B"S"I"/+CSV$BS,L[N,3_$J9T.+_*^
M9_*K[/(HGW_2V[9 2E_4"*+TOW8!U.']!GDR3[I1/X>G/^#Q@$4'4-76X+%3
MX=5N;P.'"0]4@"&7(3=MZ23$*4M@P +*&!-*1SX7'Z[86C.VI_O$CKU)M*CW
MZ(\F6JPZ;$GYF<X+3E7ZF*3W.5'Q-3]^3E)<<>WS%,7:EO<_07&%S>KTQ/FF
M'3?4^ \I-G-YKVZ*;M/_F EM1:%S479U*Z0O/FL@;O[4/+:@\^O-:JU7N,O5
MQ]<Z)-.V/LKESQF7JUU:&V,951Q3B%3"-%W'(22)";$$SV)%8H:(<-IZZ\O2
ML5&YR5PV)3$K8+Y_X+INSU9VEMPZ!=@KJ"2-MK*%ORUFCE("_<V_Y0[?&&:U
M9^ZOG"BGLW9C?R*WJW'S0JA] ;\_%0O-7E(A>P?>UZ9B;W8.N_W8-]P'&Y6]
M#]A1EI/SS?.FR )MRZ_?UN#R-$:,<PK#@"M3J1U!@J6"4E(>R5@IG#J]1AS'
M']O+H6%^U;^EI8+.49W3<6;L"+Y'O'NF[2;4%D5(=V49O-=RYX[@^5+I=!Q]
M6)W.;M <*'5VO$W'W'2Z^F$.C/0?-__>Z*!_7H3ZZVNZ7+[J4+]LEAM&"4W#
MB$,2ZZ 9A3*!F% )11"AA,6<\,1)WL9JU+$175'39Z*AH@A8[NQV3%*W0MR.
MRKSCV/>I3PUA\9>&R1/3B[BVVG<_8B>4?.6S6XTY;&:["PP'.>Y.%W?C(E.N
MN-!3^?J/?/FO6Z.]KJ,\HZTE,IJQ!"IL9!!EE$*L$(4)PXPQ(@)%,Q?R.3[,
MV-C&&&>RT%]*\]PXY@22=J1R.3X]L\C6P FH4:J,G("B)Y,_ZFC'PA-7G!AD
M4')H=_0M&YSY=,=UF,G36]5:^VD2!AE-**2*&GUPRB$5(852!8QF*A!I0&QT
M3([>W>EA'T!YI%!0K3L8 %J8ZKA4V@//<B'4%9*^ESF%77TT&#CFL*^ER=Z]
MAUUX''/K8%EQ]$-=3TU;BBCJMN*I8,RDN&8I22#BF$'"4PJ92F)&$Q$2Z7@V
M>G;,L;W"/QVM%0-BKUZID MR+B [C[_M8:975'L_LFRO]/*84-$!(&]GC^='
M'/B$T1J"PW-$^TO]ZV_N*:*<ESS2],2C0%)(4H$@(A&!+$TS&*%,Q3)2G+AM
M<O@S;6S$YBZ4YET/K8?YMV/,]YG5GHG57=%J4.&J_K ?0&W3T;#1Z&UV ]1%
M<;/C"%U%6,JDA7_,UC_J<\5MN]7J[/';MOY_FD6("*S7FTJD'"*<1/JU@"GD
MDN(0227#B+CILK@,/S;"K_,%&@()FQ>CW:(G9Z6T6T;./%?@I=$;*-]VI''=
M('>;*<N=\M[P[WO+O#)\/]=FTNQ&7<_.SGZ?"C!=</,F"N,T^, Z,5V .92.
MZ727;A3X=;;(E_J^MPO-&7*U?M#KTUQH/EY*NI*?9/GG-%.*9UB'P$G$8HB0
MZ661! ED<:K2A"H68*?]=KMAQT9YUS],'W>SM[S07P@S3?E\;I:;L_^ONF]K
M;EO'TGV?7X&7,[.[RMC#"T@"9ZJFRG&<W:G)CE-Q]NGIV@\J7!UURY);DKWC
M_O4' $F)NE$ !=+LOB2.3'*M]4'X""RL2V6&)ZLY@N_&9N$A[9G%/N]B6.MM
MN\EIS4&M.OBI5CY@!QT_M )QEZ/003G+#XA]KO*\VX^CA)Q.RK"P^T<ZF]7Q
MHQ,L]48\5@+FL5F'Y:* 5.E-.5:2IP03%1>1"QF=>/[86*=4$5@=-T&T;D1S
M"L%V1@F 2\_4X0>),SF<,?P("ZPD__EA\?*?^LZ2 /0/VWE_ZGF#3/ SQM0S
M^=QEW985'^AT:8__?]7S_WEI<]$_+.4_GN6<O[Y?/.J-W21)!**44"@9SB!*
M]5QF/!&PP$SF>H61D]2KRJ^#S+%-;:-R&=ER!1I:@XW:?NL)%]3=%A.!L>R9
M#HY"!WXO]0SH^/= )="*P47BH,L%#PCVUPH^MUY<5/?]]&4JY%RL](K$%N!\
M;[Q'2RDF5,5(X8)!'L4(HAAAR"2G,(LH)C0O!$N]0K5=A(Z-=ZSC5M3: E&I
M:7PUQH5O2_ :_<O&XWJ!3I<K^TO[:?<*O*='Q=5C$Q;KWOTTS9J\&XWM#J<L
MT6OZ5Y5J]U*@]RQ(X2OUGA;Y5B5[SX+04KOW_+V7)C1^ENMW<B[5='VS6*U7
M-I=JFYY&,(X5P0DD*!,0)3B%A#,!I<BQ)BPN,N)7&<Q-[MCXRF0ME%O+*0>5
MVL#H7=;G-^Z#]4)?,5\9I[,))BY/K[[H2^3CTVQ1MJ&_M3]*N7G$%RW%TV?C
M.G)NA-;#>/3,:;7&QK5OAJ4Y&D/E CIA%3RSKUWJ&^7I.4%Q.NO.[?:.>\#I
M?+J6GZ8O4NP57K3UJI,DQD6489CIY1=$.$>0IHS"A)JL:YSG>>;4E,Y-G!>C
M#=B[?E,BE%8!CG.YO@+*V@)GQAC/+6 [Z(Z[OV!0]DQ&I:+0:@KVZZVN I?U
M=D,EU,:O7=BP>SXGPP^V>VYW7=!6:LK7TF:?3 C"4A9(,P@V'5/B.((D)A)&
M)$(\46DAE-<R:??Q8UL-;;4K0ZJF<U/'MFQ0\+243W0JZA['9:I^E8)[02CY
M'MYN--(=Q9YIHP&@T2QPYZ8#BT/V9-H^?/AN2P>&'>VC='A5URE>G70;QY!>
MX7_9QI'<;<)(;G^8]MM2?)L^ZDONU'TC^*3<,,03Q0C-$]--CIKCHHQC2!4K
M8($2P0B)BQ@K/W((H]CX:*4RZ%3(COE<*^[+'(&&T95SAA^<WMG*FF1B>NH!
M:E@%MF9=@=HP4%IF]FA-V^JC]9"$%Q;N8%092*V!238LF(?T'/CY'7U?IFK4
M-WWO]5R\GRZU-+U4U$IH<9],M,#*_OE5<CE]L955J6G,MW[=<[#@2!1:KQCF
MS*SYI&20Y Q#F6"5BP@+B5(OUU@0M<9&ZM8J:)X+K/Y7Y5]5)+>GZRO,P#EZ
MQ@8?CKX=9]N1,&ORTB:P,:H<EU4]/EO#KD!M6K_>M:!XAW*^A5%J6-]<4" /
M7'=AG]Z-P;\L%WHIN'XU[O.U5L14?W@R'G:C6!5G0$2><DI06:<:24X@2>($
MIIG 19)&-!5>T1T.,L?&O;7*5_:<86VG_4;M*V 4/Q^DT'D W&@V,*P]<^BG
MQ?RA\O9]V^VM%#[8PP.90&SG(G%0*O. 8)^G?&[M6AEF-\CTX_R:\\7S?+W:
MLM\DBV1:9%Q!CC($$8H$I"FBD$8)HI+*.$NBR5P^F'14-QYR$>LT8T@Y8YK"
M^YLXM8XF6V>SKIBW>,>[0^[&.\%@'*J\S$$LNO&V;F#=*AVRSHP[1,&JSCB(
M'+@&C3L(AQ5I/.[MN)?]OEBNO\GEX[O%<KGX0Z_"5I,LSTF:)1E,F*D%*DV
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M\.^3__W\U_L)R8G,8B1@D1>QR33"$*.D@%',DRS-\@PK[,)$FR>.C5X^RS_
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M&70C><;4_9WAN<L[-__08SQE,VFCK\UQ]>T//GL66E2=UCS)B,RB)$LA1:R
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MCKV:2CM)'1NC?EO2^8IRZPU]6DZY!'1F)YL49DXO-WT+G[;6@,7&'$_/D]O
MN"X8 \/=^XK1ZMOL!=E0&6QUO@K>#=(+JF +1Q>9 Z\</6 X7#KZW'QA:-?J
M_:;=P>H=G1DA]]^E7'\R0ZWEO'O=7E!7U#"MN-^]5I7_ZW8 ^EK+K)-<QECF
M60$+_1]-=C&'#&/->$BJ0F1$8IIT"NP*KNK8&'(;'+0"#5NO0&4ML.:"VMXK
MP%X;UX%-.9JR.;TUT7.7W>/7PHUJQS'8/?/SH./</=:KMR$('>D57M&WB?/J
M#?"345[]2>SV6KKFW*Q'5N6:W3SP6J\1_S!Z?5@L;Y92E$7\]K;(3!)9Y#*#
M/#$1Q&FN($FS& J29#36*^V(>95?Z:;&V%XG&YV!7CZ ]XMGME;/,U ;Y_=F
MZ#@R;JS?/]X],WIM -A:H-?6._B75@!C1J_>B<NP#$3-'948E'8O VJ?4B]\
MFG_XV?6C9F9.ZX3(&-,"TRPU8Y$9%P,V[=<CF$9YS!*:)B@CKF%GNX\>':U5
MVKG'F.U!U<Y)EP'0-\]4B@6L#7_:W@M"R/8>.%CHV'%#FB%C)Z[HMES9+HXV
M*ZH[M?W0QM!/(H%RG*<,\H@RB%BLM\**,YC'"6=Q*B0KD,_BQ$7HV.9L8_="
MR_[8RNR!7HSR?NL0)\C=5AVA@>QY[C<PK'N,/[._26Y/1'ZEJ[4)2)%K>V1R
MO5SJ6VU!"+U[+*O=WRFU:@GH\5YH^, 7:%GA)'+0180/"/M+!J][_0O3WL[7
MT_7KM1#Z2[BJ_C)'S_&$9ABERK1LS'-AJE5*R"0F,.:,$Q2GO,CHY$4NV<*E
M-NU).3YSIRFMORE4J@HJ):_J'X!1%]S-/4K4G@:WG7N" =8SV71&RJM0[5DD
M.E6J/?W4P4K5GC6L6:OV_,4=:Y0M%UQ*83L>U >B>B]BP^2JEM+SAVNNN<9&
MV$YDD4:$%1$L<NM%406D.>8PR8F,8UQ$2G@Y[CWECVW-4H9XJEI10#>:=HB,
M]1T+MQ5,CPCWS"^UYF5+EY\VC5WU2N5/5=6RC0%@:T' TF3=H M5GLQ3^K E
MRKI!<U"FK.-CNI%=:[7_B:(942*GL%#(G$FB%+(B3J%>ZL01XW',$^ZVXG&2
M-[Z5S^;,Z(\3K2K\Z*P=;11+A+,,Z\VNU.O+)"OT^A)QB&.E"I+E!6%J\J07
MN@MQOZ;+]<"([TON#_7Z/(^:PI8/T[D-Q5@H4&H0$O(HI3P2A$*"L# UIC%D
M)$-0)23/TX2;_U20W\X=V[('!KR6.PC<TA08[0-HMQ=S,.AZ?@UWIP7O%ZX3
M)(%>K^VR!GV9.IF]_^ITN\G_S$"_DL4S7]\M[^7R9<JE3;7.24%B)3$DF4@A
M0BF%.$TCF"F*,JE81"*G+F2G!(QM75_I:),H*C7=CQ*.(GC^0.%27/I?C>]#
M$C15O<W\"TX9CCYVL+.&-J.:)PZMUW5<[,[H:G6G[M<+_O?W"Q,F.$F25&*,
M%.1,1!!%>@+KE9:>SRF+$A5%.!)>R6>'(L8VCZV&YB5O=02_EUIZ!KP=0=+Q
M#7\1/GV_UCVA\7^9G[0^U!O\4,"PK^V3!AZ\JT]?V6URWW]?+-=Z CV^EVR]
M.1F8Y(7@6. ,QGI-#Q&7$<1%FD"59U1A+A$A3J_I=C%CF^162VC4M!4._2;W
M"23=)OCE^/0\R4MHOAEHC(I78!M6&FZBMZ,0:+*?$#+HA&\W='_2G[FZ:S2!
MFLZEJ"KX?]&#;:KX\[7I4KE^7L[OYN:SLC#?)%9()FFLH/YRZ+=\G.<0<U.1
M'\DHHBEF"O&Z6(4;(?B(=YH&NW4K^C[:JW0%2ZNL*:9I>HA438]\8PP\!L*-
M38*#.U3,@54;5'H#H^05V&!=ZEYW9]>0F]]7=4U#!AKX8Q<LX,!#],"!!_Z@
M' 8@='A&@ (:51Z\30@LJX1>B[\]K];FB&!"8\U>LDB@E$) A"(!B=(\%R4T
M+XAB,BF<:NA[2Q[;TJ>L>,1?P7JK[04U,UI!=R.Q7J#LF<%VJV=42E^9$LER
M^C '&Y ;=MA*/A6I]511PP6\/LIJM,I]N]H:+G"T%MAP>L"%F9+OIRL^6YAR
MR*MKMK+^V8E($U80IGF*(P61)BA("TU;*F.IXG%.T]BKAD:;L+'QTW:[ 1K:
M@M]K?;NF'A[#V8V?0J'7,R5U!ZY[+E\+(J&S\8Z)>IM\NA:C3V;$M=W3N4>P
MU$_;]![D19)FC%&8%)$I)DH3O< I$"11)&F68)1@KV2UO>>/C29J]8 L];/!
M4\8WR>G3=$UGTW_JC<2TNLB[+^T.LFXL<0%>/1/#!JI*M: M98_9'*Y[[,[3
MAVX4>\RT(SUACUYV:>+'Q[E9AMC@INNYJ+)BMU%-6SK9O,N2B"BA)SO$42I,
MF4 !,2D*F*<J31*A?Q99MWP0;UW&QA6-%(>&+?98LK*F$0O8>'EV7G1<,HZN
MCI]!1J=W/U!_ W-!XDEG2(/GH_AK\D9I*ITA.YV]TOV1W<A7[_*$_&R^K55"
M)\YCF0H<PT+EYF@LC2%6-H0]3DB&14:$\F'4?0%CHTFK'[!7^-'= 7)N''8)
M'CT34PF%U2U@3NPYPP/1Q\'C!^6$4\;M3_23UW5(2?O!OYN\Q"K2 N5*,I;J
M_0]-<H@T/I!F$L.$YTE:L"PKF)/WY/#18YNQM7:>42I',&N?L9<AT?-<=0?!
M+XGLJ+W=,L=V'S5<NMA1$W9RQ(Y?T:%W<=TZ\L-B>4]GTAQ@WV_:1E:O!9;3
M%%."H$BR!"(B**0X07IB2LYB%'.<./7F=!4XMND:JK^F,^#ML[H/&'N>ZUL$
MM;[0*'QEHU3 5N<NC9%=L/1HDAP8TZ$:)I_'-E#_9 ]\VGHINSQFN+[*'D;M
M]%CVN:]C6*^M$O2!<AOG7W:3PP1+(AE$,N401;G>VDB3HJOW/#1!.8V%4S>Y
MTR+&QKU5G:Q:Q7-QZ*Y NNUT+H.G9T[U1,8_J/>D\:&">@\%#!O4>]+ @Z#>
MTU=VC7]93Y>V'HL)J3$E%.VW,I.*Z/\K6*#8I$L6!62J4) 33:$LTA,?>9T%
M'1<SMBF^U;(,&#-Z^D:V'(73;9)?#E+/$_T8/L%G>SL*P8)/C@H9.-*DS=##
ML)+6JSMV:EG,'[Y5T<+7<W%3GGS:3@7;BMZ:#3*:,ZR)(!(R,GG3&)(B3V$<
M"T4Q9Q'G3MLN/[%C8P>C]3;BWYXQE$4X))C9'BR-G@!7^J/5:M.G\FFQ](^2
M<QP<-VX)#WG/7&/1WB016+3+3C=;=0-V3O%")U2'%#>APW9"\0+BH..)W]T=
M-R/;\(PZ'=FVL3+O6;T722PSI7EAB(HQ2+C>FJ0%48*C0DK%O'8EIV6-C9T:
MJFX+L1ME/7<H+>@Z;E7"8-;WGN447.%W+^?Q"+6-:9$T['[FO,D'&QN'6[KQ
MQ>T_GLU6J8Z.0(F*<)X@B(3$]B16[VQ8HM<RG+.TP C[4<3NX\?&"J5VG<-0
M]K!S(X#NB/1]SN,,AO<D/VYSH'F]]_!!I_)QP_9G[XFKNM8&_49_?!1ZW3Q5
MT[+=P^?G,IXB(YGD*8<)-KF%.4D@UC,6"IXAJ1!5C#FE&I^5-+II7%:]U-J"
M775!J:]O?=!3 +=/\*"P]3W7NR+6H4[H&30NJ!5ZZLD#UPL]8^!AS=!S-UP:
MW+K:A,5_VO18ID3%!&?*1*Z;XFX%@8Q0"K%"J62%2@3%W<)7CT@;&T'L=&MJ
MY'%T[VO=#K;;2B 8A#V3Q47H71 FVH)*\$#08[+>*-2SQ>S3P9QM-W6C$UOP
M\[-6OG32E>G$U5E]&A6DD!&&6""]2T@0@333C,(I+A+]+RD*KUCX%EECHY*R
MR.U\,8>U][)+J8(V<-W((Q!D/5-'B=96S:K(0 \QGPYX!"*--DF#4H:#R?N$
MX7)+-[HP\>-2;*H=;NC(?CY!LBAX1B-("*,029Q $N<)3)79F6 I)?4BC%9I
M8Z.,&[I<OMI2Y+9KKTFB^V[U!U/-TW[$T0ZS&W4$ Z]G\BCUW!8UW5E\V%^&
MHP\G3 (12+NL02G$R>Q]$G&[J6O A6VB;(J/'ZNFNO&U817)2&1"KSMX#E&:
M,4@IR2"5A(M$Y8JF3GW3/.6.C5HJM<MR_,>K G?V;KH.A1OI] !PS_03"-NN
MO=A=D0K;C?VLU+?HQ^X*Q8F.[,ZW7UAII&9$&U=*3>:<N)M_-;&FIM;).[J:
MKGZ;+Y@I>6("4C_.GY[7^M<:"GV7]0/=T!E_+@NA?%W,9A\6RS_H4DP*(1*]
MXV)013F""%$.F4@2R%,ALPBC.&)>OIO>-1X;39K1UP;96).Z9<E2SDQ].].%
MC?)_/$]74WO\WK'Z26]C[\:NHQK1GGEYNPC<%KPW>0FUO::@W<9B8$V^ DVC
M@;4:[)I]!1J&@]^-Z:"RO8_"+GV/4^CJ,+WI^S8E9OJ&_V2=FMX%=XT:6GTW
M_S<GE2]T)FU'9/UVG)JJ@N87UW.Q^T'CRB^V6\?'.5^:4*;WLOQ;_WOV++11
M=0[<5TVWMTI)$V6@OV>*X!22-"X@BB6#!.<QC*($<YDFYG^3]<)$1SD&U0RI
MOM?;;6-$G_[Y4F4PG0.N;;NR?P*Y-='&!RXW -C?^P8^#?H%<7OKC7?8>WX%
MWMA1-G^"AD578&LL*"\QX[[WX>X=)0J@A@'\5 /QIRNPP0)L4H -&J"$(V0(
MV%L,8["HLD&5'SA0[2T&YC#V[4VTZ-@%@'^7XGDF[]2Q0I?O7DUFPITRL7O?
MY(_U.XWVWR=$()$1TVB-$?TVS+#2[T5)H9(X*A*]N9.Q5_Y !QW&MF&[?WY\
MI,M7XRJO*M*\FK=;9<)*_[#9O.U6BOTXUVNK\D34L^E AX%S>TOU/!P]OVIJ
M[<U0'"W*"]AKF>FD+R@CA+_9398Q!EAK NZ?+L R5-.##AH,VQ&A.T0'[1(N
M>%0W^OR+G#Y\UQ/[^D4NZ8,LXZ+>3V?/^K/[[U1_L>^>UZNU7M:86E7;0MA*
MI2F/&8>2X1PB28G>4' ",2UB%B&"*?;RD'748VPT6K[2S,P41G=3!VY;"P/\
MI!EU98TY72\[Z"BY\>4 V/?,F;4%H#*A"JJTG9VL :!AP16H;#/=VFMCPC'F
MA6@&8LVN6@S*G!="M<^>ESXNZ +4KI'MFLG0]6J[ADG2(D]Y@B''PI3>PP(R
M64A(49(C0K)$4*\&=)[RQ\:8-XO'I\7<^DP.%CPW>M > JTK3X['16O*$"CW
M?JK:A+3T3Y1K>:OR6ZP>SZ'6[\KQI/0QK!K/0>.X8CS[F(Y>Z\7CHUSR*9U]
MH4]R6<5/$D%E2ID)+DL2B'"<01ISJG]2<9+&A4BE5UG1HU)&R%N5DL!JZ=L[
M^QB0CD[82^'IVU>ZATP/L:>M$ 3KC7U,QL ]L5O,/.R%W79QU]2W&VG".&8?
MYT+^^!_Y.HECE60QBJ% A5Z]<"(@Q3&!@@O**"8LSYQ<9R<EC&V>5XE;E9;
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M>&ULW+U9<YM)<BY\[U_19[[;D].U+P[;)RB)TC LD3+)GK;/#:)6"1X0T %
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M!"-"[W:K^W#%]9#P>M*L.TFT9S2<I7 Y1213YL^'\U$:J&B2X"YCN%[NEC
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MYK4E22M(N@G$E.OIZ5LW3U\FTY\HDXC(M@R8DBB)8%)Y01>!:$F518VS%"L
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M&T#'BC%D5XR(++7G2+ZA0H/P)(%G$G]11'F4BQ&.5$;)D\3TFZBMAI8ZPFX
M-0<Q+B;AN=%G-XQ'X[?NVW#N1M<BHL1R8BRRX 4>Q8:#\1XW@Z<A2$^SK3Z*
M[%F"^DUX5D-//:$W@*#3-,=#.<7K?CK7UE,R[Y!2",(2$&6VHC$B Q5.!E=>
M-]G:TR-64])O5K$:9BJ(N0&P'(1P>7$Y*IFPIW*@5XSQDI2G60"3D:.39\M$
M7\TA11L3HS)X4_OMU]K$]5O,5,\,=:*,!E"VNKCOBA>B \:7Q*#$2H.X:#4X
M:7()+V,F(I!0?<;R<_3TW%FM>H!53?8-X.@F3_$1+>^BN_O *QLI!@0E'O!H
M;TN5"&$<\%!6)4Y(RM6ND7A,12/5#A4S?ML)N &(/'QP<C1^G%$_Q;WP?C+]
MPTWCP N.5IE+4"E;$$YQ<)91D"$G$CP1JGKWO0U);"0UN"4B'K?4[TP]#:#O
M[<,Q]G?[8<D0I5-" 9[.:&R#$V"RLU &02D?28[52Q6?HZ?WD<G= >'I5-)N
M6MD:8=\6C^%P+TWGE0["A[+:ZJ&0D4090@UNW5*\D"GZ%0S=#)&2SL+0[#JX
M=JU!>>\3F?>&W1XTW0S*5R3UEOMWH$+F-!"" 0_#3:LD>K!$$V J>9ML%-K4
M]OJ>)*;WN<][PV(=?31P3-]IZ):$C)&G )3JN.PA;!)2;GAVCB?J2/7X8<,6
M>EW.FM@;=+:4> -86>NQN5.*\W([;I/3()A/X*A48)ARG&;N'=EG56<;C_SV
MB:_J6FH >0MI'<UFERF^NYR6 W]YOBY,[O5PA;2HB466%VH=R!R=\X(!94RA
M##D%3R.%G*BB,@4J8OUTR,9D]CXX>K_N6X<Z;.(AR!-,_MV-+M,3/$:3T64(
M$A@M=VJ..W#&>Z#9,F.%52+7CH4WI[+W&=5]P[26!ALPIN^&WX<QC>/L3C)@
MX+DA*G("A&N'45&6X').&"39Z'E4S/O:=Z*KZ.A]I/7><+:S%IJP=Y^&X\ET
M$8DOH^O5K8X&G&27HXW@T*D%87-$Q\,J\%'E%#2)NOJ-^WJ4]3[V>F]XZT!3
M#=BR9_.9F4:NHA1E+FVI42G/H*@-N)L8RYIQ$6@'W7!VS#)W.9:ZC33S)FK9
M,0%W.*[HUNV>>HPB&<:"+E$7;BZ1%%@K$U!#4^2::I]J5SON,<G<Z43KUY9E
MWD3554&^YP>15P^<9]T^A7R\REX>0;[ 7/WGCS<KWHX11$,9O.<0'$.+*0P#
M1+8'%HDSBCC\7GV3\30]%28<E\_\/)T4[S>^^?D;RO]H?()(1OV-OQR$.?K%
MBZ:J-V_])#.N#%),OERTQQ1*RQ,*C'EJO'6XSVLG%#>GLI'*A%T1M&)><I?J
M:L"!O).-1ZI=4FBC318!*?<H*$$<,$505L%G/#CZO?_H#$!=Z_GI*Y!-A-X
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MMZ_#X$:+>#]KKKA2'JREY:::"S3,Z!9H&C!,$_@_7:NS/*YR!TKXMUL8/4M
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MQQF7>) > ID\NE.E@Q!371D6=<S(4L36.>\>NG&B-#J'0J?.< NJH )?[7Q
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MW7FEKF3]32%33!!;MWLOV=>[ASM=PFL7,L,M9&GNNWSGO;RYUE\)W/>*G;\
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M4CV%!Q\UK<C%BT]G-82GR#"5>SCD,]]!U;_AJRS_?=C)OP%02P,$%     @
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MV6&XH[B\%_-9Z*HJB%CL/T!87&"@DRN^>A2)54Z)(8 34K]Z5'$'"7?E%&#
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M+3(P,C,P,S,Q7V1E9BYX;6Q02P$"% ,4    " "1.IM63^4X+:7_  "C4 H
M%               @ $VSP( 8F%X+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4
M    " "1.IM6/1;40F&:  #OV08 %               @ $-SP, 8F%X+3(P
M,C,P,S,Q7W!R92YX;6Q02P$"% ,4    " "1.IM6Q*.A4'X$   *$0  %0
M            @ &@:00 8F%X+3(P,C,P,S,Q97@S,C$N:'1M4$L! A0#%
M  @ D3J;5I'ZF-L%"   >B8  !8              ( !46X$ &)A>"TR,#(S
M,#,S,7AE>#,Q,2YH=&U02P$"% ,4    " "1.IM6]XNTL?8'   .)0  %@
M            @ &*=@0 8F%X+3(P,C,P,S,Q>&5X,S$R+FAT;5!+ 0(4 Q0
M   ( )$ZFU:E-4U?<P0   T0   6              "  ;1^! !B87@M,C R
E,S S,S%X97@S,C(N:'1M4$L%!@     *  H DP(  %N#!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
